
<html lang="en"     class="pb-page"  data-request-id="43e58052-98b6-40e1-951b-970b3888fbbc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2014.57.issue-15;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm500729a"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Indazole- and Indole-5-carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency" /></meta><meta name="dc.Creator" content="Nikolay T.  Tzvetkov" /></meta><meta name="dc.Creator" content="Sonja  Hinz" /></meta><meta name="dc.Creator" content="Petra  Küppers" /></meta><meta name="dc.Creator" content="Marcus  Gastreich" /></meta><meta name="dc.Creator" content="Christa E.  Müller" /></meta><meta name="dc.Description" content="Indazole- and indole-carboxamides were discovered as highly potent, selective, competitive, and reversible inhibitors of monoamine oxidase B (MAO-B). The compounds are easily accessible by standard..." /></meta><meta name="Description" content="Indazole- and indole-carboxamides were discovered as highly potent, selective, competitive, and reversible inhibitors of monoamine oxidase B (MAO-B). The compounds are easily accessible by standard..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 16, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500729a" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500729a" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500729a" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500729a" /></link>
        
    
    

<title>Indazole- and Indole-5-carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500729a" /></meta><meta property="og:title" content="Indazole- and Indole-5-carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0020.jpeg" /></meta><meta property="og:description" content="Indazole- and indole-carboxamides were discovered as highly potent, selective, competitive, and reversible inhibitors of monoamine oxidase B (MAO-B). The compounds are easily accessible by standard synthetic procedures with high overall yields. The most potent derivatives were N-(3,4-dichlorophenyl)-1-methyl-1H-indazole-5-carboxamide (38a, PSB-1491, IC50 human MAO-B 0.386 nM, &gt;25000-fold selective versus MAO-A) and N-(3,4-dichlorophenyl)-1H-indole-5-carboxamide (53, PSB-1410, IC50 human MAO-B 0.227 nM, &gt;5700-fold selective versus MAO-A). Replacement of the carboxamide linker with a methanimine spacer leading to (E)-N-(3,4-dichlorophenyl)-1-(1H-indazol-5-yl)methanimine (58) represents a further novel class of highly potent and selective MAO-B inhibitors (IC50 human MAO-B 0.612 nM, &gt;16000-fold selective versus MAO-A). In N-(3,4-difluorophenyl-1H-indazole-5-carboxamide (30, PSB-1434, IC50 human MAO-B 1.59 nM, selectivity versus MAO-A &gt;6000-fold), high potency and selectivity are optimally combined with superior physicochemical properties. Computational docking studies provided insights into the inhibitors’ interaction with the enzyme binding site and a rationale for their high potency despite their small molecular size." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500729a"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500729a">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500729a&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500729a&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500729a&amp;href=/doi/10.1021/jm500729a" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6679-6703</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm5007275" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500739f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Indazole- and Indole-5-carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nikolay+T.++Tzvetkov">Nikolay T. Tzvetkov</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sonja++Hinz">Sonja Hinz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Petra++K%C3%BCppers">Petra Küppers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcus++Gastreich">Marcus Gastreich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christa+E.++M%C3%BCller">Christa E. Müller</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Pharmaceutical Institute, Pharmaceutical Chemistry I, PharmaCenter Bonn, University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">BioSolveIT GmbH, An der Ziegelei 79, 53757 St. Augustin, Germany</span></div><div class="corresp-info"><strong>*</strong>Phone: +49-179-5284358. Fax: +49-228-73-2567. E-mail: <a href="/cdn-cgi/l/email-protection#83edf7f9f5e6f7e8ecf5c3f6edeaaee1ecededade7e6"><span class="__cf_email__" data-cfemail="deb0aaa4a8bbaab5b1a89eabb0b7f3bcb1b0b0f0babb">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Phone: +49-228-73-2301. Fax: +49-228-73-2567. E-mail: <a href="/cdn-cgi/l/email-protection#37545f455e444356195a42525b5b52457742595e1a55585959195352"><span class="__cf_email__" data-cfemail="accfc4dec5dfd8cd82c1d9c9c0c0c9deecd9c2c581cec3c2c282c8c9">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500729a&amp;href=/doi/10.1021%2Fjm500729a" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6679–6703</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 23, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 May 2014</li><li><span class="item_label"><b>Published</b> online</span>16 July 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 August 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500729a" title="DOI URL">https://doi.org/10.1021/jm500729a</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6679%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNikolay%2BT.%2BTzvetkov%252C%2BSonja%2BHinz%252C%2BPetra%2BK%25C3%25BCppers%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D15%26contentID%3Djm500729a%26title%3DIndazole-%2Band%2BIndole-5-carboxamides%253A%2BSelective%2Band%2BReversible%2BMonoamine%2BOxidase%2BB%2BInhibitors%2Bwith%2BSubnanomolar%2BPotency%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6703%26publicationDate%3DAugust%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500729a"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2385</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">51</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500729a" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Indazole- and Indole-5-carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nikolay&quot;,&quot;last_name&quot;:&quot;T. Tzvetkov&quot;},{&quot;first_name&quot;:&quot;Sonja&quot;,&quot;last_name&quot;:&quot;Hinz&quot;},{&quot;first_name&quot;:&quot;Petra&quot;,&quot;last_name&quot;:&quot;Küppers&quot;},{&quot;first_name&quot;:&quot;Marcus&quot;,&quot;last_name&quot;:&quot;Gastreich&quot;},{&quot;first_name&quot;:&quot;Christa&quot;,&quot;last_name&quot;:&quot;E. Müller&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;6679-6703&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500729a&quot;},&quot;abstract&quot;:&quot;Indazole- and indole-carboxamides were discovered as highly potent, selective, competitive, and reversible inhibitors of monoamine oxidase B (MAO-B). The compounds are easily accessible by standard synthetic procedures with high overall yields. The most potent derivatives were N-(3,4-dichlorophenyl)-1-methyl-1H-indazole-5-carboxamide (38a, PSB-1491, IC50 human MAO-B 0.386 nM, &gt;25000-fold selective versus MAO-A) and N-(3,4-dichlorophenyl)-1H-indole-5-carboxamide (53, PSB-1410, IC50 human MAO-B 0.227 nM, &gt;5700-fold selective versus MAO-A). Replacement of the carboxamide linker with a methanimine spacer leading to (E)-N-(3,4-dichlorophenyl)-1-(1H-indazol-5-yl)methanimine (58) represents a further novel class of highly potent and selective MAO-B inhibitors (IC50 human MAO-B 0.612 nM, &gt;16000-fold selective versus MAO-A). In N-(3,4-difluorophenyl-1H-indazole-5-carboxamide (30, PSB-1434, IC50 human MAO-B 1.59 nM, selectivity versus MAO-A &gt;6000-fold), high potency and selectivity are optimally combined with superior &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500729a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500729a" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500729a&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500729a" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500729a&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500729a" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500729a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500729a&amp;href=/doi/10.1021/jm500729a" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500729a" /></input><a href="/doi/pdf/10.1021/jm500729a" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500729a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500729a%26sid%3Dliteratum%253Aachs%26pmid%3D24955776%26genre%3Darticle%26aulast%3DTzvetkov%26date%3D2014%26atitle%3DIndazole-%2Band%2BIndole-5-carboxamides%253A%2BSelective%2Band%2BReversible%2BMonoamine%2BOxidase%2BB%2BInhibitors%2Bwith%2BSubnanomolar%2BPotency%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D15%26spage%3D6679%26epage%3D6703%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jmcmar.2014.57.issue-15/production/jmcmar.2014.57.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Indazole- and indole-carboxamides were discovered as highly potent, selective, competitive, and reversible inhibitors of monoamine oxidase B (MAO-B). The compounds are easily accessible by standard synthetic procedures with high overall yields. The most potent derivatives were <i>N</i>-(3,4-dichlorophenyl)-1-methyl-1<i>H</i>-indazole-5-carboxamide (<b>38a</b>, PSB-1491, IC<sub>50</sub> human MAO-B 0.386 nM, >25000-fold selective versus MAO-A) and <i>N</i>-(3,4-dichlorophenyl)-1<i>H</i>-indole-5-carboxamide (<b>53</b>, PSB-1410, IC<sub>50</sub> human MAO-B 0.227 nM, >5700-fold selective versus MAO-A). Replacement of the carboxamide linker with a methanimine spacer leading to (<i>E</i>)-<i>N</i>-(3,4-dichlorophenyl)-1-(1<i>H</i>-indazol-5-yl)methanimine (<b>58</b>) represents a further novel class of highly potent and selective MAO-B inhibitors (IC<sub>50</sub> human MAO-B 0.612 nM, >16000-fold selective versus MAO-A). In <i>N</i>-(3,4-difluorophenyl-1<i>H</i>-indazole-5-carboxamide (<b>30</b>, PSB-1434, IC<sub>50</sub> human MAO-B 1.59 nM, selectivity versus MAO-A >6000-fold), high potency and selectivity are optimally combined with superior physicochemical properties. Computational docking studies provided insights into the inhibitors’ interaction with the enzyme binding site and a rationale for their high potency despite their small molecular size.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Monoamine oxidases (MAO, EC 1.4.3.4) are flavin adenine dinucleotide (FAD) containing enzymes localized on the mitochondrial outer membrane which catalyze the oxidative deamination of biogenic amines and monoamine neurotransmitters. Two isoforms of MAO are present in most mammalian tissues, MAO-A and MAO-B, distinguished by their substrate and inhibitor selectivity.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Epinephrine (adrenaline), norepinephrine (noradrenaline), dopamine (DA), tyramine, and tryptamine are substrates for both isoforms. MAO-A displays higher affinity for the substrates norepinephrine and serotonin (5-HT) than MAO-B and is inhibited by low concentrations of clorgyline, whereas MAO-B exhibits higher affinity toward phenylethylamine (PEA) and benzylamine and is potently inhibited by selegiline.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> The reaction catalyzed by MAO results in the production of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and other reactive oxygen species (ROS), which may contribute to oxidative stress and cell damage.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The protein sequences of MAO-A and MAO-B are ∼70% identical.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Both MAO isoforms show regional differences in enzyme activity and distribution in the human brain.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Highest MAO activity is observed in the basal ganglia (striatum) and hypothalamus, whereas the cerebellum and neocortex show low levels of MAO activity.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Serotonergic neurons and astrocytes contain predominantly MAO-B, while the MAO-A isoform is mainly located in catecholaminergic neurons.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The activity and the expression levels of MAO-B in the human brain, but not those of MAO-A, increase with aging and may be associated with the loss of dopaminergic neurons in the substantia nigra, where MAO-B is the main form in glial cells.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Increased MAO-B activity in the substantia nigra is thus observed in patients with Parkinson’s diseases (PD).<a onclick="showRef(event, 'ref2 ref7'); return false;" href="javascript:void(0);" class="ref ref2 ref7">(2, 7)</a> The relationship between oxidative stress and progressive neuronal impairment indicates that inhibition of MAO-B activity may have neuroprotective effects.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a></div><div class="NLM_p">Selective irreversible and reversible MAO-A inhibitors are used in the treatment of depression and anxiety disorders.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Selective MAO-B inhibitors are currently applied for the therapy of PD, mostly in combination with the dopamine prodrug levodopa, to reduce the metabolic degradation of dopamine and increase its half-life.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Because of their potential neuroprotective effects, MAO-B inhibitors may be useful for the treatment of other neurodegenerative diseases as well including Alzheimer’s disease (AD).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Recently, MAO-B inhibitors with ancillary activities have been proposed as multitarget drugs for the treatment of PD and AD.<a onclick="showRef(event, 'ref9 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref11">(9, 11)</a> Examples for this new strategy include dual-acting acetylcholinesterase (AChE) and MAO inhibitors for AD,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> dual-acting A<sub>2A</sub> adenosine receptor (A<sub>2A</sub> AR) antagonists and MAO-B inhibitors for PD,<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> and triple-target drugs acting as A<sub>1</sub> and A<sub>2A</sub> AR antagonist in addition to inhibition of MAO-B for the treatment of PD and AD.</div><div class="NLM_p">Several selective MAO-B inhibitors, including the irreversible inhibitors selegiline (<b>1</b>)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and rasagiline (<b>2</b>)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> as well as the reversible inhibitor safinamide (<b>3</b>),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> are currently in clinical use for the treatment of PD (for structures, see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Selegiline (<b>1</b>) is a potent and selective “suicide type” irreversible MAO-B inhibitor (human MAO-B, IC<sub>50</sub> = 6.79 nM; human MAO-A, IC<sub>50</sub> = 1700 nM)<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> used in combination with levodopa therapy.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> One major drawback of <b>1</b> are side effects evoked by its amphetamine metabolites.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of irreversible (Irr) and reversible (Rev) MAO-B inhibitors in clinical use.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The irreversible MAO-B inhibitor rasagiline (<b>2</b>, human brain MAO-B, IC<sub>50</sub> = 14.0 nM; human brain MAO-A, IC<sub>50</sub> = 710 nM) is not metabolized to amphetamine derivatives and is used for both monotherapy in early PD and as adjunctive therapy in late-stage patients with PD experiencing motor fluctuations.<a onclick="showRef(event, 'ref16 ref21'); return false;" href="javascript:void(0);" class="ref ref16 ref21">(16, 21)</a> However, irreversible MAO-B inhibitors may show safety issues and pharmacological side effects.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Therefore, selective and reversible inhibition of MAO is believed to be advantageous. For example, the reversible MAO-A inhibitor moclobemide is successfully used to treat depression and anxiety.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Reversible MAO-B inhibitors are currently being developed.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Safinamide (<b>3</b>) is such a compound, which is being evaluated in advanced clinical trials as an add-on therapy to dopamine agonists or to levodopa in PD patients with motor fluctuations.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Besides MAO-B inhibition (human brain MAO-B, IC<sub>50</sub> = 9.0 nM; human brain MAO-A, IC<sub>50</sub> = 45 μM), it shows additional mechanisms of action including inhibition of DA reuptake, inhibition of excessive glutamate release,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and sodium channel inhibition.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">A wide range of MAO-B inhibitors with common structural features has been developed to date (for examples, see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31 ref32">(28-32)</a> These include small mono- or disubstituted heterobicyclic compounds such as the 2,5-disubstituted indole <b>4</b>, 5-nitroindazole (<b>5</b>), 7-[(3-chlorobenzyloxy)]-4-[(methylamino)methyl]coumarin (<b>6</b>), isatine (<b>7</b>), and its C5-substituted analogues (<i>E</i>)-5-styrylisatin (<b>8</b>) and 5-(4-phenylbutyl)isatin (<b>9</b>). The 2-propargylamine-substituted compound <b>4</b> is an irreversible MAO-B inhibitor that is similarly potent as selegiline (<b>1</b>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> MAO-B inhibitor <b>4</b> was found to exhibit neuroprotective effects in several in vivo models of PD.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures and potencies of previously described MAO-B inhibitors.<a onclick="showRef(event, 'ref11 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref11 ref29 ref30 ref31 ref32">(11, 29-32)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>5</b> was described as the most potent MAO-B inhibitor within the class of nitroindazoles.<a onclick="showRef(event, 'ref11 ref30'); return false;" href="javascript:void(0);" class="ref ref11 ref30">(11, 30)</a> Recently, aminocoumarin derivative <b>6</b> has been identified as a promising clinical candidate with high MAO-B inhibitory activity and suitable pharmacokinetic properties.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Another small molecule, isatin (<b>7</b>), is a weak inhibitor of human MAO-B (IC<sub>50</sub> = 31.8 μM), but its C5-substituted analogues <b>8</b> and <b>9</b> are more potent, reversible MAO-B inhibitors.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p last">Because of the promising pharmacological properties combined with only minor side effects of selective, reversible MAO-B inhibitors,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> we aimed at developing such inhibitors with improved properties. In the present study, novel classes of most potent irreversible MAO-B inhibitors were discovered, namely indazole-5-carboxamides (designated class I), indole-5-carboxamides (class II) and (indazol-5-yl)methanimine derivatives (class III). The new compounds were evaluated at rat and human MAO A and B and optimized in order to improve their MAO-B affinity and selectivity, as well as their physicochemical and drug-like properties. Computational studies were performed to understand their binding modes and to explain their exceedingly high affinities.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06158" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06158" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Compound Design</h3><div class="NLM_p">Our design of novel classes of MAO-B inhibitors was based on the general formula <b>I</b> containing a heterobicyclic ring system linked to a phenyl moiety as displayed in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> (L = linker, R = H or halogen, and Het = heterocycle). The pharmacophore in <b>I</b> labeled in red incorporates the key structural features found in all previously described MAO-B inhibitors <b>4</b>–<b>9</b> (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). For simplification, we divided <b>I</b> into two scaffold fragments representing the common structural motifs (building blocks) used for the construction of these MAO-B inhibitors.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rational design strategy to obtain MAO-B inhibitor <b>10</b> and further structural optimization to obtain class I MAO-B inhibitor <b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We prepared and evaluated only six compounds (<b>10</b>–<b>15</b>) in our rational design strategy to obtain a compound with the desired high, subnanomolar potency and MAO-B selectivity. To design the initial compound <b>10</b>, we studied the core structural characteristics of the known MAO-B inhibitors by considering their potential for further scaffold variation, novelty, and accessibility (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Structure–activity relationship (SAR) examination for MAO-B potency and selectivity showed that electron-rich spacers such as a double bond, an ether, or a methylamine group were well tolerated by MAO-B, while C3- to C4-alkyl linkers led to less potent and less selective compounds. Because linkers like C1- to C4-alk(en)yl (<b>8</b> and <b>9</b>) or ethers (<b>3</b>, <b>4</b>, and <b>6</b>) are already well-established in a number of structures with MAO-B activity, we decided to replace these by an amide group in <b>10</b>. Furthermore, C5-substitution in several heterobicyclic motifs has been observed to be beneficial for potent, reversible MAO-B inhibitors.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Except for the coumarine derivative <b>6</b>, which is substituted at position 7, the MAO-B inhibitors <b>4</b>, <b>5</b>, <b>8</b>, and <b>9</b> are C5-substituted (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). On the basis of previous studies targeted toward dual A<sub>2A</sub> adenosine receptor antagonists/MAO-B inhibitors,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> we conjugated a 5-chloro-substituted morpholinopyridine motif (blue box) at the C5 position of an indazole moiety (gray box) to obtain compound <b>10</b>. The 5-chloro-6-morpholinopyridine was selected as a bioisosteric replacement of halogen-substituted phenyl residues due to its polarity and favorable physicochemical properties.</div><div class="NLM_p last">Similar to the benzyloxy group in the potent MAO-B inhibitors safinamide (<b>3</b>) and compound <b>4</b>, the bulky moiety in <b>10</b> may extend through the substrate cavity into the entrance cavity of the bipartite active site of human MAO-B.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In fact, the first compound <b>10</b> designed through a rational design strategy provided a moderate inhibitory activity at human MAO-B in the high nanomolar range (IC<sub>50</sub> 220 nM), being 45-fold selective for MAO-B over MAO-A. These results encouraged further exploration within the series of indazole-containing compounds related to <b>10</b>. In the next step, we performed a systematic modification of <b>10</b> by introducing a hydrophilic 1-methyl-pyridone moiety (modification A) or a more lipophilic 2-chloro-6-fluorophenyl ring (modification B), respectively, to obtain compounds <b>11</b> and <b>12</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). While <b>11</b> showed no activity at all, compound <b>12</b> exhibited lower potency than the parent <b>10</b> with a micromolar IC<sub>50</sub> value of 3.30 μM at human MAO-B. Compound <b>12</b> was subsequently modified with 2,3- and 3,4-dichloro substituents at the phenyl ring to obtain <b>13</b> and <b>14</b>, respectively. The chlorine substituent at the aryl C3 position was kept constant. Both compounds showed progressive improvement of MAO-B inhibition from micromolar (<b>13</b>, human MAO-B, IC<sub>50</sub> 2.59 μM) to low nanomolar potency (<b>14</b>, human MAO-B, IC<sub>50</sub> 12.4 nM). The choice of the 3,4-dichlorophenyl-substitution pattern appeared to be essential for obtaining very high MAO-B inhibitory activity. Finally, we obtained a further dramatic increase in MAO-B inhibitory potency by inverting the amide linker leading to compound <b>15</b>. Thus, we developed indazole-5-carboxamides as a new structural class of extraordinarily potent MAO-B inhibitors (designated class I). <i>N</i>-(3,4-Dichlorophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>15</b>) was evaluated at rat and human MAO-A and B; it was identified as a highly potent inhibitor (20-fold more active than <b>14</b>) with remarkable selectivity for the MAO-B-isoform (human MAO-B, IC<sub>50</sub> 0.586 nM; human, MAO-A, IC<sub>50</sub> >10000 nM), surpassing the activity of all recently developed MAO-B-selective inhibitors. The indazol-5-carboxamide scaffold subsequently served as a starting point for the design, synthesis, and biological evaluation of a number of compounds, many of them with MAO-B inhibitory activity in the subnanomolar range and significantly improved physicochemical properties. We also prepared two additional classes of MAO-B inhibitors differing from <b>15</b> either by replacement of the 5-substituted indazole by a 5-substituted indole (designated class II) or by exchange of the amide connection by a methanimine linker (class III).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">All new compounds of the present study were prepared by amide coupling reactions,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a><i>N</i>-alkylation,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and iminoalkylation reactions<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> using a variety of reagents and conditions as illustrated in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Amide coupling was performed by reaction of the differently substituted carboxylic acids <b>18</b>–<b>20</b>, <b>21a</b>–<b>c</b>, <b>22</b>, <b>39</b>, and <b>50</b>–<b>52</b> with substituted amines <b>17</b>, <b>23a</b>–<b>k</b>, <b>25</b>, or aminopyridine <b>24</b>, respectively. With the exception of carboxylic acids <b>18</b> and <b>19</b>, all building blocks used for the syntheses of the final products were commercially available. Amide coupling was conducted in the presence of Hünig’s base (<i>N</i>,<i>N</i>-diisopropylethylamine, DIPEA), using the condensation reagent <i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate (TBTU) in acetonitrile or, alternatively, by applying 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride (EDC-HCl) as a coupling reagent in methanol.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In general, amide coupling reactions were performed at room temperature for several hours. The conversion of the starting materials was monitored by thin-layer chromatography (TLC) or by high performance liquid chromatography (HPLC) coupled to an ultraviolet (UV) detector and to electrospray ionization mass spectrometry (ESI-MS) analysis. Products <b>10</b>–<b>14</b> and <b>16</b> were obtained as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Compound <b>14</b> had previously been described,<a onclick="showRef(event, 'ref36 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref39">(36, 39)</a> but in the present study we used different reaction conditions to obtain <b>14</b> in higher yields. The carboxylic acids <b>18</b> and <b>19</b> were prepared by two- or three-step reaction procedures according to published procedures (for details, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). A methylene group in <b>16</b> was introduced in order to study an extension of the spacer between the 3,4-dichloro-phenyl ring and the indazole moiety.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indazol-5-yl-amides <b>10</b>–<b>14</b> and <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) for <b>10</b>–<b>14</b>,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> carboxylic acid <b>18</b>, <b>19</b>, or <b>21a</b>–<b>c</b> (1.0 equiv), 5-amino-1<i>H</i>-indazole (<b>17</b>, 1.0 equiv), TBTU/DIPEA (1.2 equiv), acetonitrile, RT, 3–72 h, yield 23–73%; (ii) for <b>16</b>, 2-(3,4-dichlorophenyl)acetic acid (<b>20</b>, 1.0 equiv), 5-amino-1<i>H</i>-indazole (<b>17</b>, 1.0 equiv), EDC–HCl (1.1 equiv), methanol, RT, 3–4 h, yield 56% (<b>16</b>).</p></p></figure><div class="NLM_p">The preparation of indazole-5-carboxamides <b>15</b>, <b>26</b>–<b>37</b> and <b>38a</b>–<b>b</b> is depicted in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The compounds were prepared by amide coupling reaction of commercially available 1<i>H</i>-indazole-5-carboxylic acid (<b>22</b>) with differently substituted anilines and related amines (<b>23a</b>–<b>k</b>, <b>24</b>, <b>25</b>). To investigate the impact of the substitution pattern of the phenyl ring on biological activity, we introduced a broad variety of substituents mainly in the 3- and 4-position including halogen atoms and methoxy and hydroxyl functions. To introduce structural diversity in position N1 or N2 of the indazole moiety, <b>15</b> was alkylated with methyl iodide, yielding a 3:1 mixture of <i>N</i>1-/<i>N</i>2-methylated products <b>38a</b> and <b>38b</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The reaction occurred in the presence of potassium carbonate in <i>N</i>,<i>N</i>-dimethylformamide (DMF) at room temperature, and the reaction time was optimized by monitoring of the conversion.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The mixture of <b>38a</b> and <b>38b</b> was separated by column chromatography. The structure determination of <b>38a</b> and <b>38b</b> was carried out by heteronuclear multiple bond correlation (HMBC) NMR in combination with <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Indazole-5-carboxamides <b>15</b>, <b>26</b>–<b>37</b>, and <b>38a</b>–<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) for <b>15</b>, <b>32</b> and <b>34</b>, 1<i>H</i>-indazole-5-carboxylic acid (<b>22</b>, 1.0 equiv), differently substituted anilines <b>23a</b>,<b>h</b>,<b>j</b> (1.0 equiv), TBTU/DIPEA (1.2 equiv), acetonitrile, RT, 3–72 h, yield 11–30%; (ii) for <b>15</b>, <b>26</b>–<b>31</b>, <b>33</b>, and <b>35</b>–<b>37</b>, 1<i>H</i>-indazole-5-carboxylic acid (<b>22</b>, 1.0 equiv), differently substituted anilines <b>23a</b>–<b>g</b>,<b>i</b>,<b>k</b>, <b>24</b> and <b>25</b> (1.0 equiv), EDC–HCl (1.1 equiv), methanol, RT, 3–4 h, yield 18–67%; (iii) <i>N</i>-(3,4-dichlorophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>15</b>, 1.0 equiv), MeI (1.3–2.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.3 equiv), DMF, RT, 16–20 h, yield 47% (<b>38a</b>) and 9% (<b>38b</b>).</p></p></figure><div class="NLM_p">To increase the compounds’ polarity and water solubility, we introduced a bioisosteric replacement for the 3,4-dichloro-phenyl residue, namely a 3,4-dichloropyridine moiety (compound <b>36</b>). An extension of the spacer between the indazole core and the substituted phenyl ring was introduced in <b>37</b> by coupling of <b>22</b> with the corresponding 3,4-dichlorobenzylamine (<b>25</b>).</div><div class="NLM_p">Indazole-6-carboxamides <b>40</b>–<b>49</b>, which represent 6-substituted analogues or isomers of the indazole-5-carboxamides (<b>15</b>, <b>27</b>–<b>35</b>) described above were obtained by coupling of 1<i>H</i>-indazole-6-carboxylic acid (<b>39</b>) with anilines <b>23a</b>,<b>c</b>–<b>k</b> as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. This set of compounds was prepared in order to investigate the role of the indazole nitrogen atoms for MAO-B inhibition, in particular, the supposed role (and position) of the NH as a hydrogen bond donor in protein binding.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Indazole-6-carboxamides <b>40</b>–<b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1<i>H</i>-indazole-6-carboxylic acid (<b>39</b>, 1.0 equiv), differently substituted anilines <b>23a</b>,<b>c</b>–<b>k</b> (1.0 equiv), EDC-HCl (1.1 equiv), methanol, RT, 3–4 h, yield 22–71%.</p></p></figure><div class="NLM_p">Replacement of the indazole ring of <b>15</b> by an indole, an imidazo[1,2-<i>a</i>]pyridine, or a [1,2,4]triazolo[4,3-<i>a</i>]pyridine moiety led to compounds <b>53</b>, <b>55</b>, and <b>56</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). These were synthesized in order to create diversity of the heterobicyclic core via variation of the electronic properties of the ring system while keeping the 3,4-dichlorophenyl substituent of lead structure <b>15</b> constant. Furthermore, alkylation of <b>53</b> was performed by <i>N</i>-alkylation with methyl iodide under mild reaction conditions, yielding <b>54</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Indole-5-carboxamides <b>53</b> and <b>54</b> and <i>N</i>-(3,4-Dichlorophenyl)carboxamide Derivatives <b>55</b> and <b>56</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) carboxylic acids <b>50</b>–<b>52</b> (1.0 equiv), 3,4-dichloroaniline (<b>23a</b>, 1.0 equiv), EDC–HCl (1.1 equiv), methanol, RT, 3–4 h, yield 17–36%; (ii) <i>N</i>-(3,4-dichlorophenyl)-1<i>H</i>-indole-5-carboxamide (<b>53</b>, 1.0 equiv), MeI (1.3–2.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.3 equiv), DMF, RT, 16–20 h, yield 68%.</p></p></figure><div class="NLM_p">Finally, the amide group was replaced by an imine linker. For the preparation of <b>58</b> and <b>59</b>, aldehydes <b>57a</b>,<b>b</b> were reacted with 3,4-dichloroaniline <b>23a</b> in the presence of a catalytic amount of acetic acid in ethanol under reflux (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The chemical stability of product <b>59</b> was investigated by LC/ESI-MS and compared to that of amide <b>54</b>. For this purpose, we analyzed stock solutions of the compounds in DMSO (10 mM), which had been prepared for biological testing and kept for 70 days at room temperature (for details, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Figures S3, S4 and Table S2">Supporting Information, Figures S3, S4 and Table S2</a>). We observed that the imine <b>59</b> was relatively stable and showed only moderate degradation under these conditions (15% hydrolysis), while the amide <b>54</b> was found to be completely stable. Imines <b>58</b> and <b>59</b> will offer further opportunities for modification to obtain more stable compounds: e.g., in analogy to the preparation of safinamide (<b>3</b>), the imine double bond may be reduced to an aminoalkyl group.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Molecular mechanics calculations showed that the formation of the <i>E</i>-isomer was favored over the <i>Z</i>-diastereomer (for details, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Figure S5">Supporting Information, Figure S5</a>). NMR analyses (<sup>1</sup>H and <sup>13</sup>C) confirmed the sole formation of the <i>E</i>-isomer. However, the possibility of an <i>E</i>/<i>Z</i>-isomerization of <b>58</b>, e.g., after exposing it to daylight in dilute solution, cannot be excluded.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0015.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 3,4-Dichlorophenyl-substituted (1<i>H</i>-indazol-5-yl)methanimines <b>58</b> and <b>59</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1<i>H</i>-indazole- or 1-methyl-1<i>H</i>-indazole-5-carboxaldehyde (<b>57a</b>,<b>b</b>, 1.0 equiv), 3,4-dichloroaniline (<b>23a</b>, 1.0 equiv), acetic acid (0.2 equiv), ethanol, reflux, 1–24 h, yields 89% (<b>58</b>) and 90% (<b>59</b>).</p></p></figure><div class="NLM_p">Our synthetic strategy to obtain novel classes of MAO-B inhibitors provides several advantages. These include easy accessibility of the final products by only one or two steps using commercially available starting materials. The procedures allow the possibility for broad structural variation in the last step, and the preparation of compound libraries for fast analysis of SARs. Moreover, the procedures will enable simple scale-up from milligram amounts to large, multigram or even kilogram quantities.</div><div class="NLM_p last">The new compounds were isolated by column chromatography and subsequently recrystallized to obtain pure products. All final products were fully characterized by NMR spectroscopy (<sup>1</sup>H and <sup>13</sup>C) and mass spectrometry (LC/ESI-MS), and their structures were confirmed. The purity of all compounds was determined by HPLC-UV to be at least 95% (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Monoamine Oxidase Inhibition Studies</h3><div class="NLM_p">The compounds were investigated for inhibition of human and rat MAO-A and MAO-B using recombinant enzymes (human) expressed in baculovirus-infected insect cells<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and mitochondria-enriched rat liver fractions as sources for the rat MAO isoforms, respectively. Enzyme inhibition assays of reference and test compounds at human MAO-A and MAO-B were performed by a fluorescence-based assay with the substrate <i>p</i>-tyramine measuring the production of hydrogen peroxide formed as a byproduct of the enzymatic deamination reaction (also see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The inhibitors clorgyline for MAO-A and selegiline for MAO-B were used to block the respective isoenzyme in rat liver fractions for determining selective inhibition of the other isoenzyme. The selective inhibitors were also used as positive controls in human recombinant MAO-A and MAO-B assays, respectively. Determined inhibitory potencies (IC<sub>50</sub> values) for reference inhibitors and all new synthesized compounds are collected in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Potencies of Compounds at Monoamine Oxidases</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0016.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0017.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0018.gif" alt="" id="GRAPHIC-d177e1439-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0019.gif" alt="" id="GRAPHIC-d177e1440-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last"><i>n</i> = 3, unless otherwise noted.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Selectivity Index = IC<sub>50</sub>(human MAO-A)/IC<sub>50</sub>(human MAO-B).</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last"><i>n</i> = 4.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Structure–Activity Relationships at Monoamine Oxidase B</h3><div class="NLM_p">The biological evaluation of 37 novel compounds at human and rat MAO-A and -B enzymes resulted in the identification of highly potent, specific MAO-B inhibitors from three related chemical series: indazole-5-carboxamides (class I, compounds <b>15</b>, <b>26</b>–<b>38a</b>, and <b>38b</b>), indole-5-carboxamides (class II, <b>53</b> and <b>54</b>), and (indazol-5-yl)methanimines (class III, <b>58</b> and <b>59</b>). Most of these compounds contain a disubstituted phenyl moiety attached to the heterobicyclic core structure by an amide or an imine linker. Among the tested compounds, <b>29</b> showed high inhibition of MAO-B ranging from submicromolar to subnanomolar potency. The majority of potent compounds showed high selectivity for MAO-B without noticeable inhibitory activity at MAO-A.</div><div class="NLM_p">5-Chloro-<i>N</i>-(1<i>H</i>-indazol-6-yl)-6-morpholinonicotinamide (<b>10</b>) showed a moderate inhibitory activity at human MAO-B (IC<sub>50</sub> 220 nM) and was significantly weaker at the rat enzyme (IC<sub>50</sub> 1990 nM, 9-fold). Considering the hydrophobic character and the bipartite structure of the active site of the human MAO-B enzyme and the binding mode of known inhibitors,<a onclick="showRef(event, 'ref35 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref35 ref44 ref45">(35, 44, 45)</a> the bulky and polar 6-morpholino-substituted pyridine moiety of <b>10</b> might be too large, e.g., as compared to the reference inhibitors <b>1</b>–<b>3</b>. Therefore, we focused on reducing the molecular mass and also introduced more lipophilic residues into the target structures. In fact, the introduction of the smaller but more polar <i>N</i>-methylpyridone residue (compound <b>11</b>) abolished MAO inhibition completely. Better results were obtained by introducing a phenyl ring substituted with electron-withdrawing groups (mainly F and Cl). Introduction of a 2-chloro-6-fluoro- or a 2,3-dichloro-substituted phenyl ring resulted in compounds <b>12</b> and <b>13</b>, which were weaker than <b>10</b>, indicating that <i>ortho</i>-phenyl substituents were not well tolerated. To evaluate the importance of <i>meta</i>,<i>para</i>-substitution at the phenyl ring, we evaluated the dichloro-substituted isomer <b>14</b>. Compared to the lead structure <b>10</b>, 3,4-dichlorophenyl derivative <b>14</b> showed a remarkable, 18-fold improvement in MAO-B inhibition (human, IC<sub>50</sub> = 12.4 nM; rat, IC<sub>50</sub> = 138 nM). Thus, <b>14</b> was the first highly potent and selective MAO-B inhibitor within the series of <i>N</i>-(indazo-5-yl)benzamide derivatives. The structure of <b>14</b> indicated that a lipophilic 3,4-disubstituted phenyl ring and a carboxamide linker might be favorable when connected to the indazole C5-position. To further study the role of the linker, we introduced a methylene group between the aromatic ring and the amide carbonyl group producing (indazol-5-yl)acetamide derivative <b>16</b>. The elongation of the linker led to a 71-fold decrease in potency (human, IC<sub>50</sub> 882 nM) in <b>16</b> compared to the corresponding benzamide derivative <b>14</b>. At the rat orthologue, <b>16</b> was virtually inactive. Because of this result, we decided to keep the carboxamide linker for connecting the two ring systems. However, in the next series of compounds, we inverted the carboxamide function by connecting indazole-5-carboxylic acid with aniline derivatives (compounds <b>15</b> and <b>26</b>–<b>38</b>). This modification of the linker provided a new class of extraordinarily potent and selective MAO-B inhibitors, some of which displayed subnanomolar potency. Indazole-5-carboxamide derivative <b>15</b> exhibited 9-fold higher inhibitory activity at human MAO-B than the standard inhibitor safinamide (<b>3</b>); it was 21-fold more potent than its isomer <b>14</b>. Compound <b>15</b> exhibited a slight preference for human versus rat MAO-B (human MAO-B, IC<sub>50</sub> 0.586 nM; rat MAO-B, IC<sub>50</sub> 1.43 nM) and did not inhibit rat and human MAO-A at a high concentration of 10000 nM. We therefore considered <i>N</i>-(3,4-dichlorophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>15</b>) as a new lead structure for further structural variations to explore the SARs of this new class of MAO-B inhibitors. The corresponding derivative without substituents at the phenyl ring (compound <b>26</b>) led to decreased inhibition (human MAO-B, IC<sub>50</sub> 117 nM; rat MAO-B, IC<sub>50</sub> 708 nM). 3,5-Dichlorophenyl-substitution (compound <b>27</b>) resulted in a potent compound which was only 2–5-fold less potent than the 3,4-dichlorophenyl-substituted analogue <b>15</b> (human MAO-B, IC<sub>50</sub> 2.75 nM; rat MAO-B, IC<sub>50</sub> 2.73 nM). It should be noted that <b>27</b> was the only compound of the present series that showed no species differences. Thus, <i>meta</i>- and <i>para</i>-substituents at the phenyl ring appeared to be crucial for high inhibitory activity at MAO-B. Following this observation, we subsequently introduced different substituents in the 3- and 4-position of the phenyl ring. 3-Chloro-4-fluoro- or 4-chloro-3-fluoro-substitution (compounds <b>28</b> and <b>29</b>) led to remarkably potent inhibitors of human MAO-B (<b>28</b>, IC<sub>50</sub> 0.679 nM; <b>29</b>, IC<sub>50</sub> 0.668 nM), comparable to the potency of the parent compound, the dichlorophenyl derivative <b>15</b>. The 3,4-difluoro-phenyl substituent provided MAO-B inhibitor <b>30</b>, which was similarly potent (IC<sub>50</sub>, human MAO-B 1.59 nM); it was approximately 6-fold less potent at the rat enzyme (IC<sub>50</sub> = 8.89 nM). In contrast, the introduction of 3,4-dimethoxy-substitution at the phenyl ring (compound <b>31</b>, IC<sub>50</sub> human MAO-B 185 nM) was not as well tolerated by MAO-B, leading to a >300-fold decrease in potency compared to the dichlorophenyl derivative <b>15</b>. Consequently, we continued by replacing only one of the 3,4-chloro substituents in <b>15</b> with a methoxy or hydroxyl group (compounds <b>32</b>–<b>35</b>). While two methoxy substituents had been unfavorable with regard to MAO-B inhibition, the exchange of only one chloro substituent of <b>15</b> for a methoxy group (compounds <b>32</b> and <b>34</b>) was tolerated and resulted in an only slight reduction in inhibitory potency. Both, the 3-chloro-4-methoxyphenyl (<b>32</b>) and the 4-chloro-3-methoxyphenyl derivatives (<b>34</b>) were almost equipotent at human MAO-B (<b>32</b>, IC<sub>50</sub> human MAO-B 3.42 nM; <b>34</b>, human MAO-B IC<sub>50</sub> 4.36 nM). At rat MAO-B, both compounds were less potent (<b>32</b>, rat MAO-B, IC<sub>50</sub> 21.9 nM; <b>34</b>, rat MAO-B, IC<sub>50</sub> 43.1 nM). In contrast, a hydroxyl instead of a methoxy residue in the same position of the phenyl ring resulted in a significant decrease in affinity (<b>33</b>, human MAO-B, IC<sub>50</sub> 123 nM; <b>35</b>, human MAO-B, IC<sub>50</sub> 37.5 nM). In contrast to the methoxy-substituted analogues, we observed a preference for the 3-OH (<b>35</b>) versus the 4-OH substitution (<b>33</b>) with regard to MAO-B affinity. Our SARs thus revealed that electron-donating groups such as OMe and OH resulted in lower MAO-B inhibitory activity than electron-withdrawing substituents (e.g., Cl and F) at one or both <i>para</i>- and <i>meta</i>-position of the phenyl ring in lead structure <b>15</b>. To enhance water solubility of this relatively lipophilic series of MAO-B inhibitors, the benzene ring of <b>15</b> was bioisosterically replaced by a 5,6-dichloropyridine residue (compound <b>36</b>). The resulting indazole-5-carboxamide derivative <b>36</b> exhibited high MAO-B inhibition (human MAO-B, IC<sub>50</sub> 5.42 nM; rat MAO-B, IC<sub>50</sub> 26.6 nM) even though somewhat weaker than that of lead structure <b>15</b>. Introduction of a 3,4-dichloro-substituted benzyl moiety to probe a linker extension (compound <b>37</b>) led to a considerable decrease in MAO-B inhibitory potency (human MAO-B, IC<sub>50</sub> 388 nM; rat MAO-B, IC<sub>50</sub> 837 nM), in analogy to the effect observed for the indazol-5-yl-acetamide homologue <b>16</b>. Because of the high MAO-B inhibitory potency and selectivity of compound <b>15</b>, we used the 3,4-dichlorophenyl and the carboxamide linker as fixed motifs for further modification of the C5-substituted indazole unit. As a next step, we introduced a methyl substituent on one of the indazole nitrogen atoms, resulting in isomers <b>38a</b> and <b>38b</b>. Methylation at the indazole N1 position (<b>38a</b>) slightly increased potency at MAO-B, providing the best inhibitor of the present series (human MAO-B, IC<sub>50</sub> 0.386 nM; rat MAO-B, IC<sub>50</sub> 1.43 nM). Compound <b>38b</b>, an N2-methylated regioisomer of <b>38a</b>, was less potent than its N1-substituted analogue and than the unmethylated lead structure <b>15</b>, but it still showed high MAO-B inhibitory potency (human MAO-B, IC<sub>50</sub> 1.44 nM,). Its affinity for the human enzyme was 15-fold higher than that for the rat enzyme (rat MAO-B, IC<sub>50</sub> 22.5 nM), being one of the compounds that showed major species differences. Moreover, <b>38b</b> was also identified as the only example in all series having notable inhibitory activity at MAO-A (human MAO-A, IC<sub>50</sub> 420 nM; rat MAO-A, IC<sub>50</sub> 1740 nM). Thus, the N2-methyl substitution of the indazole moiety was found to be beneficial for MAO-A inhibition, although <b>38b</b> was still >290-fold selective for human MAO-B over human MAO-A. Our results indicate that the indazole NH is not required as a hydrogen bond donor, and the binding pocket of MAO-B is able to accommodate substituents like methyl groups at indazole N1 or N2. The high potency of compounds <b>15</b> and <b>27</b>–<b>30</b> shows that 3,4-disubstituted phenyl-5-amidoindazoles represent a new class of highly potent and selective MAO-B inhibitors, which may be suitable for further development as diagnostic or therapeutic drugs.</div><div class="NLM_p">Further systematic SAR analysis led us to investigate a small set of C6-connected indazole-carboxamides (<b>40</b>–<b>49</b>) with the same substitution pattern as the corresponding isomeric indazole-5-carboxamides (compounds <b>15</b>, <b>27</b>–<b>35</b>). Compared to the indazole-5-carboxamides, the corresponding indazole-6-carboxamides displayed greatly reduced MAO-B inhibition. Only 3,4- or 3,5-halogenophenyl-substituted indazole-6-carboxamide derivatives (i.e., <b>40</b>–<b>44</b>) possessed some, although only moderate, inhibitory activity at human MAO-B, whereas methoxy- or hydroxyl-substituted compounds (<b>45</b>–<b>49</b>) were inactive or only very weakly active. The most potent compound in the indazole-6-carboxamide series was the 3,4-dichlorophenyl-substituted derivative <b>40</b> (human MAO-B, IC<sub>50</sub> 67.1 nM; rat MAO-B, IC<sub>50</sub> 466 nM). However, <b>40</b> was still 115-fold (human MAO-B) and 326-fold (rat MAO-B) less potent than the related indazole-5-carboxamide analogue <b>15</b>. The 3,5-dichlorophenyl derivative <b>41</b> had a moderate inhibitory effect (human MAO-B, IC<sub>50</sub> 335 nM; rat MAO-B, IC<sub>50</sub> 423 nM). Similar potencies were observed for the corresponding 4-fluoro- and 3-fluoro-substituted analogues <b>42</b> and <b>43</b>, which were moderately active only at the human but not at the rat MAO-B (<b>42</b>, human MAO-B, IC<sub>50</sub> 234 nM; <b>43</b>: human MAO-B, IC<sub>50</sub> 316 nM). Within the class of indazole-6-carboxamides, in which the position of the indazole NH is altered in comparison with the indazole-5-carboxamide series, the MAO-B potency decreased in the same rank order as observed for the more potent indazole-5-carboxamide isomers (<b>15</b> and <b>27</b>–<b>35</b>): 3,4-di-Cl ≈ 3-F, 4-Cl ≈ 4-F, 3-Cl > 3,5-di-Cl > 3-Cl, 4-OMe ≈ 3-OMe, 4-Cl > 3-Cl, 4-OH ≈ 3-OH, 4-Cl. One exception was the 3,4-difluoro-substituted compound <b>44</b>, which was less potent than expected (compare to <b>30</b>).</div><div class="NLM_p">To further explore the heterobicyclic part in the so far most potent series of indazole-5-carboxamides, the indazole residue was replaced by different heterobicycles, resulting in compounds <b>53</b>–<b>56</b>, while the 3,4-dichloro-substituted phenyl ring of <b>15</b> was kept constant. Replacement of the indazole by an indole residue (compound <b>53</b>) resulted in an extremely high MAO-B inhibitory potency (human MAO-B, IC<sub>50</sub> 0.227 nM; rat MAO-B, IC<sub>50</sub> 1.01 nM), showing only weak inhibition of MAO-A (human MAO-A, IC<sub>50</sub> 1300 nM; rat MAO-A, IC<sub>50</sub> 6790 nM). Thus, the indole derivative <b>53</b> was 3-fold more potent than the indazole-5-carboxamide analogue <b>15</b> at human MAO-B; it represents the most potent MAO-B inhibitor of all compounds investigated. The activity of its <i>N</i>-methylated derivative <b>54</b> at human MAO-B was 10-fold lower (IC<sub>50</sub> 2.26 nM). On the basis of their high bioactivity, which was comparable or even superior to the indazole-5-carboxamide series, the indole-5-carboxamides <b>53</b> and <b>54</b> may as well be considered as suitable candidates for further drug development (class II MAO-B inhibitors).</div><div class="NLM_p">Next, we continued with the modification of the indazole residue by replacing it by an imidazo[1,2-<i>a</i>]pyridine or a [1,2,4]triazolo[4,3-<i>a</i>]pyridine moiety (compounds <b>55</b> and <b>56</b>). In comparison to the indazole-5-carboxamides and the indole-5-carboxamides, compounds <b>55</b> and <b>56</b> showed a large decrease in inhibitory activity at MAO-B. The 3,4-dichloro-phenyl-substituted imidazo[1,2-<i>a</i>]pyridine-6-carboxamide (<b>55</b>) containing a bridge nitrogen atom had only moderate potency at the human (IC<sub>50</sub> 141 nM) and rat MAO-B (IC<sub>50</sub> 1140 nM), while the [1,2,4]triazolo[4,3-<i>a</i>]pyridine motif of <b>56</b> led to an almost complete loss of activity. This indicates that the position of the nitrogen atom (N1) present in the indazole and indole moieties is essential for MAO-B binding and has a strong impact on potency. A second nitrogen atom is well tolerated only in the neighboring position (e.g., N2-position of the indazole). Introduction of a third nitrogen atom (compound <b>56</b>) resulted in a virtually complete loss of MAO-B inhibitory activity (cf. docking studies below).</div><div class="NLM_p">Finally, the carboxamide linker in the 3,4-dichlorophenyl-substituted indazole derivate <b>15</b> was replaced by an imine function producing Schiff bases <b>58</b> and <b>59</b>. Both compounds showed similarly high MAO-B inhibitory potencies as the corresponding indole-5-carboxamides (<b>53</b> and <b>54</b>). The unsubstituted indazole derivative <b>58</b> (human MAO-B, IC<sub>50</sub> 0.612 nM; rat MAO-B, IC<sub>50</sub> 3.69 nM) was slightly more potent at MAO-B than its N1-methyl-substituted derivative <b>59</b> (human MAO-B, IC<sub>50</sub> 1.03 nM; rat MAO-B, IC<sub>50</sub> 4.55 nM).</div><div class="NLM_p last">From all 37 tested compounds, 29 were found to be potent inhibitors of MAO-B. In the series of indazole-5-carboxamide derivatives (<b>15</b>, <b>27</b>–<b>38a</b>, <b>38b</b>), all compounds were found to be active at MAO-B. The highest inhibitory potencies were achieved with the compounds containing a 3,4-dihalogenophenyl residue (<b>15</b>, <b>28</b>, and <b>29</b>) and an <i>N</i>-unsubstituted or an N1-methylated indazole core (<b>38a</b>) inhibiting MAO-B in the subnanomolar range. These compounds are significantly more potent than the current irreversible (selegiline, rasagiline) and reversible (safinamide) standard MAO-B inhibitors (>13-fold). In the classes of indole-5-carboxamides (class II, <b>53</b> and <b>54</b>) and (indazol-5-yl)methanimines (class III, <b>58</b> and <b>59</b>), selective MAO-B inhibitors with similarly high potencies as those of the best indazole-5-carboxamides (class I derivatives) were discovered. The most potent MAO-B inhibitor of the whole series was indole-5-carboxamide <b>53</b> (class II inhibitor), which contains a 3,4-dichlorophenyl residue. It inhibits human MAO-B with subnanomolar potency and was found to be 23-fold more potent than the standard inhibitor safinamide (<b>3</b>). The optimized structural features were a 5-indazole or a 5-indole moiety connected to a lipophilic, substituted phenyl ring through a polar linker with a length of two atoms.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Species Selectivity</h3><div class="NLM_p last">Significant species differences and moderate correlations between human and rat IC<sub>50</sub> values were previously described for other classes of MAO-B inhibitors.<a onclick="showRef(event, 'ref14 ref28 ref46'); return false;" href="javascript:void(0);" class="ref ref14 ref28 ref46">(14, 28, 46)</a> Therefore, all new compounds were tested at human as well as rat MAO-A and MAO-B in order to assess potential species differences. Because most compounds were inactive at MAO-A, species differences at MAO-A could only be noticed for very few compounds. However, for many compounds, major species differences in the inhibitory potencies at MAO-B could be observed. With the exception of <b>27</b> and <b>54</b>, which were virtually equipotent at rat and human MAO-B, the potency of the compounds at human MAO-B was generally higher (5.2-fold on average, with compound <b>38b</b> showing the highest deviation of approximately 1.2 log units between IC<sub>50</sub> values at human and rat MAO-B) than at the rat orthologue. The plot of all determined pIC<sub>50</sub> values at rat MAO-B versus pIC<sub>50</sub> values at human MAO-B gave a linear regression with a slope = 1.00, <i>y</i>-intercept = −0.67, and <i>R</i><sup>2</sup> = 0.89, thus displaying a clear correlation between rat and human MAO-B enzyme inhibitory activity (for details, see <a class="ref internalNav" href="#notes-1" aria-label="Figure S8, Supporting Information">Figure S8, Supporting Information</a>). Nonetheless, it appears to be indispensable to determine MAO-B inhibition not only at the human enzyme but also at the species used for preclinical studies.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Mechanism of Monoamine Oxidase B Inhibition</h3><div class="NLM_p">The goal of the present study was to prepare novel reversible MAO-B inhibitors. Reversible inhibition is expected to have considerable advantages compared to irreversible inhibition, as discussed above. To investigate whether the indazole-5-carboxamides (class I compounds) are reversible or irreversible inhibitors of human MAO-B, we performed reactivation experiments with the representative human MAO-B inhibitor <b>15</b>. For this purpose, the inhibition of reactivated human MAO-B by <b>15</b> was evaluated at a concentration that represents its IC<sub>80</sub> value versus <i>p</i>-tyramine as a substrate. The enzyme activity of <b>15</b> was measured for 22 min in the presence of low concentration of the substrate <i>p</i>-tyramine (10 μM preincubation) followed by a large increase in substrate concentration (to 1.0 mM). The irreversible inhibitor selegiline <b>1</b> and the reversible inhibitor safinamide <b>3</b> were tested as reference inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reactivation of MAO-B: recombinant human MAO-B enzyme was treated under assay conditions with inhibitor <b>15</b> at a concentration that presents its IC<sub>80</sub> value (1.0 nM) in the presence of the substrate <i>p</i>-tyramine. The irreversible MAO-B inhibitor selegiline (<b>1</b>) and the reversible inhibitor safinamide (<b>3</b>) were applied at concentrations of 30 and 50 nM, respectively. After a preincubation period of 22 min, the substrate concentration was increased from 10 μM to 1.0 mM, and the fluorescence was measured over a period of 5 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In case of a reversible inhibition, after preincubation followed by an increase in the substrate concentration, the MAO-B inhibitor will be replaced by the competing excess of <i>p</i>-tyramine and a subsequent enzyme reactivation can be observed. In the experiment with the inhibitor <b>15</b>, an elevated fluorescence can be detected after increasing the <i>p</i>-tyramine concentration, indicating that <b>15</b> acts as a reversible MAO-B inhibitor. The measurements with the reversible reference inhibitor safinamide (<b>3</b>) clearly showed the expected reversible mode of interaction with MAO-B, which is proven by an elevation of the fluorescence after increasing the substrate concentration, similar to that observed for <b>15</b>. In contrast, in the experiment with the irreversible inhibitor selegiline (<b>1</b>), the residual activity was not significantly enhanced after increasing the substrate concentration. These experiments clearly indicate that the indazol-5-carboxamides are reversible inhibitors of MAO-B. This was expected because they do not contain any reactive moieties.</div><div class="NLM_p">To further examine the interaction mode of the indazol-5-carboxamides with the binding site of MAO-B, the type of enzyme inhibition was determined by Michaelis–Menten kinetic experiments. For this purpose, the initial rates of the MAO-B-catalyzed oxidation of <i>p</i>-tyramine at six different substrate concentrations in the absence and in the presence of three different concentrations of the selected representative inhibitor <b>15</b> were measured. The results are depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. Michaelis–Menten kinetic parameters <i>K</i><sub>m</sub> and <i>V</i><sub>max</sub> of human MAO-B inhibition were determined in the presence and absence of inhibitor <b>15</b>. The maximal velocity (<i>V</i><sub>max</sub>) remained almost constant at different concentrations of <b>15</b>, whereas the Michaelis constant (<i>K</i><sub>m</sub>) rose with increasing inhibitor concentrations. The Lineweaver–Burk plots for different concentrations of <b>15</b> were linear and intersected at the <i>y</i>-axis with the plot for the uninhibited enzyme. In addition, a Dixon plot was calculated (see <a class="ref internalNav" href="#notes-1" aria-label="Figure S9, Supporting Information">Figure S9, Supporting Information</a>). The obtained results indicate that the indazol-5-carboxamides are competitive MAO-B inhibitors.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mode of MAO-B inhibition: saturation curves (top) and Lineweaver–Burk plot (bottom) of the inhibition of recombinant human MAO-B enzyme by different concentrations of <b>15</b> (0, 0.1, 0.5, and 1.0 nM) in the presence of <i>p</i>-tyramine (0.05, 0.1, 0.25, 0.5, 1.0, and 1.5 mM) as a substrate. In the Lineweaver–Burk plot, the reciprocal MAO-B inhibitory activity was plotted against the reciprocal substrate concentration (double reciprocal plot, <i>n</i> = 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Molecular Modeling Studies</h3><div class="NLM_p">The structure–activity relationship analyses of indazole-5- and indazole-6-carboxamide analogues provided useful information about the main structural features determining their MAO-B inhibitory potency. A detailed examination of their potential binding modes revealing the most significant interactions within the substrate binding site of MAO-B might provide additional information including an explanation for the observed preference in inhibitory potency of C5- versus C6-substituted indazole derivatives. Therefore, we selected the structurally related compounds <b>15</b> and <b>40</b> for docking studies. While <b>15</b> is one of the most potent MAO-B inhibitors investigated here, compound <b>40</b> was found to bind with considerably weaker affinity. The modeling study was particularly focused on the estimation of main interactions taking place at (i) the indazole NH function, (ii) the carboxamide linker, and (iii) the 3,4-dichloro-substituted phenyl ring. We carried out docking experiments of <b>15</b> and <b>40</b> followed by a HYDE-based selection of the top (FlexX-scored) solutions using the X-ray cocrystal structure of human MAO-B with the reference inhibitor safinamide <b>3</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a>, see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>).<a onclick="showRef(event, 'ref44 ref47'); return false;" href="javascript:void(0);" class="ref ref44 ref47">(44, 47)</a> The docking simulations were performed with conformationally relaxed ligands using LeadIT software. Overall, the docking studies reproduced the experimentally found binding modes and activities of several ligands well (we tested with a small set of structurally different compounds).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> While treating protein protons and N↔O flips as flexible, the HYDE module in LeadIT was utilized to evaluate the accuracy of the predicted ligand/enzyme interactions. Following standard procedures, the ligand and safinamide complexes obtained from the initial dockings were postoptimized using HYDE technology.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The automatized yet visual scoring method was recently developed to rapidly compute estimations of binding affinities; previous experience has shown its usefulness to improve the selection of correct poses from dockings. Furthermore, there appears convergence when selecting <i>n</i> = 32 binding poses per ligand.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Docking studies with LeadIT give strong indication that <b>15</b> and <b>40</b> occupy the same substrate cavity space as previously determined for safinamide.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In each docking case, the ligand molecule could be unambiguously modeled in the electron density binding region, assuming that both ligands do not covalently bind with the flavine (FAD) cofactor in contrast to some irreversible MAO-B inhibitors like selegiline and rasagiline.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> However, there were significant differences in the binding modes of <b>15</b> and <b>40</b> at the active site of human MAO-B. In general, from the ligand perspective of <b>15</b>, the docking model led to the proposal that the binding pocket of human MAO-B can be divided into three different subpockets inside the protein: a heterocyclic binding pocket anchored in the “substrate cavity” close to the FAD cofactor (hydrophobic region I, S1), a postulated H-interacting linker region, and a highly lipophilic halogen binding pocket (hydrophobic region II, S2) positioned in the “entrance” cavity (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Predicted binding modes of <b>15</b> (A) and <b>40</b> (B) in the human MAO-B (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a>) active site. The ligands and the cocrystallized safinamide <b>3</b> are colored in orange, light blue, and broken white, respectively. For clarity, only the relevant residue side chains are shown in gray. Clipping planes have been used for better visibility. All structures are represented as stick models. The postulated H-bond interactions between the carbonyl group and the water molecule HOH1247 are displayed as pink lines.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The heterocycle-binding site of the pocket is limited by the FAD cofactor; however, some space remains unoccupied by <b>15</b>. The aromatic part of the indazole ring shows a π–π arrangement with the amide plane of TYR326 below and CYS172 above the plane. In addition, slightly more distant, but still within the distance limitations for hydrophobic contacts, LEU171 interacts with the indazole moiety, too. The carboxamide linker of <b>15</b> plays a remarkable role. It forms the basis for the only obvious hydrogen bond “anchor”: a well-formed interaction to HOH1247 (CO---HOH1247 = 2.04 Å). Such an interaction was also observed for the 6-substituted analogues, for which <b>40</b> served as an example. Below the ligand amide linker, there is a π–π-type arrangement with TYR326, which itself (using its hydroxyl-group) showed another interaction to HOH1247, eventually rendering this water molecule even more conserved (protein-HOH1247 interaction not shown). In the back of the groove, in the region of the carboxamide linker, there is the side chain of LEU171, which maintains the hydrophobic character of that part, rendering the amide placement favorable there. Finally, the 3,4-dichlorophenyl substituent of the ligand occupies a strongly hydrophobic binding pocket in which it is placed with considerable affinity gain by releasing water molecules (hydrophobic effect). There are a multitude of hydrophobic amino acids contributing (notably leucin and isoleucin residues), the most important ones being ILE316 (below), PRO104 (hydrophilic side, limiting the pocket), ILE199 (top right), ILE198 (above paper plane), and ILE199 (above paper plane, not shown to improve visibility). The upper right “roof” of the pocket is formed by the TRP119 ring system with the closest distance to any of the halogen atoms being approximately 3.5 Å. Summarizing our findings, we can conclude that (i) the indazole side of <b>15</b> is dominated by hydrophobic contacts, (ii) the carboxamide linker exhibits a hybrid feature providing an H-bond acceptor (the carboxylic oxygen) and serving as a hydrophilic anchor, while additionally using its π-character to form hydrophobic interactions, and (iii) the 3,4-dichlorophenyl side is dominated by hydrophobic interactions (halogen binding pocket, HBP). In agreement with the HYDE analysis (compare below), the binding is heavily dominated by hydrophobic contacts, and therefore, it appears to be largely entropy-driven, owing most of its strength to the release of water molecules from the hydrophobic environments. There is only a single H-bond anchor mediating this type of interaction between protein and ligand.</div><div class="NLM_p">In the case of the 6-substituted indazole <b>40</b>, the situation is similar (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The heterocyclic moiety of the binding groove is limited by the FAD cofactor. The back of this part of the binding site is represented by the phenyl part of PHE343. It is oriented in a herringbone-like arrangement with respect to the pyrazole part of the indazole moiety. On the other side, i.e., below the pyrazole, we find the amide side chain of GLN206 forming a stacking interaction. Moving further to the right, another hydrophobic contact can be made out: LEU171 and GLN206 form a sandwich orientation with the phenyl part of the indazole moiety. Moreover, similarly to the docking results for <b>15</b>, the oxygen atom of the carboxamide linker interacts with HOH1247 (CO---HOH1247 = 2.15 Å), which itself bridges to GLN206-amine and the ILE199 backbone-carbonyl groups. The 3,4-dichlorophenyl moiety of the binding situation in <b>40</b> closely resembles the one of the above-mentioned complex of <b>15</b> in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a>.</div><div class="NLM_p last">In summary, we observed that this class of compounds is likewise dominated by binding through replacing water molecules. The only relevant H-bond is formed by the central linker of the molecule, however, this very water molecule is highly coordinated also by protein residues, making it more essential for overall binding. One route to further optimization of these classes of compounds might be to replace HOH1247, e.g., by a suitable alkyl substituent. However, this would lead to even more lipophilic compounds. Finally, docking studies are in line with a proposal of a noncovalent binding mode to human MAO-B, typically associated with reversible inhibitory activity. This finding is in agreement with the experimentally confirmed reversible mechanism of action for <b>15</b>.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> HYDE Visual Binding Assessment of 5- versus 6-Substituted Indazoles</h3><div class="NLM_p">Comparing compounds <b>15</b> and <b>40</b>, it is difficult to understand why the C5-substituted indazoles exhibit higher affinity toward human MAO-B than the C6-substituted analogues (about two log units difference between <b>15</b> compared to <b>40</b>). To find plausible explanations, we subjected both compounds in their docked conformations to a HYDE Visual Affinity Assessment (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compounds <b>15</b> (A) and <b>40</b> (B) placed within the PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a> cavity in a HYDE Visual Affinity Assessment (ligands rendered in stick model with atom coloring by HYDE: green = favorable, red = unfavorable for affinity; the relevant ligand atoms C3, N1, and N2 are labeled in white, atoms of LEU171 and TYR398 behind the binding site surface). The surface has been colored by the respective amino acid elements; clipping planes have been used to enhance visibility and therefore not all atoms are visible for all residues and FAD.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When comparing the two substitution scenarios, distinct differences become visible. In the case of <b>40</b>, the indazole N1 atom (lower center) essentially has no contribution to affinity. Besides the fact that the modeling shows no H-bond contribution, the desolvation penalty for this atom amounts to approximately 0.5 kJ/mol. This is slightly overcompensated by the desolvation gain from the binding site (around 1.0 kJ/mol), totaling to a negligible contribution overall (HYDE shows it in almost white coloring). The neighboring N2 atom exhibits a somewhat higher desolvation penalty (approximately 1.0 kJ/mol), while the enzyme binding site behaves indifferently; furthermore, there is again no bond formed which could overcompensate the loss from desolvation penalties so that the overall contribution stays at roughly 1.0 kJ/mol in the view of a HYDE analysis. While the halogen-phenyl part and the carboxamide linker stay similarly favorable with respect to their affinity contributions, the situation changes for the 5-membered ring in the indazole moiety in <b>15</b> and its surroundings. Here, the placement of a more hydrophobic atom in the binding groove around the lower part of the indazole-5-ring is obviously especially favorable (PHE343, TYR398, FAD). According to the ligand docking, the C3-position in the C5-substitued indazoles occupies that very spatial region which is occupied by the N2 in the C6-substituted analogues. This is a subtle yet distinct effect and entails higher affinity. According to the HYDE calculations, the C3 atom at this position now contributes with a desolvation gain of about 3.5 kJ/mol, whereas the N2 atom is not able to overcompensate this, given its desolvation penalty of almost 2.0 kJ/mol. The N1 atom also contributes indirectly, inducing a receptor desolvation contribution of about 0.5 kJ/mol, and therefore, overall, a positive contribution of the three relevant atoms of approximately 4.0 kJ/mol occurs, giving a strong pointer to the origins of the enhanced activities for the 5-substituted indazoles. Furthermore, taking into account that the only remaining atom contributing slightly unfavorably in the 5-substituted indazoles is N2, it appears natural that further optimization of this class of compounds could proceed from, for example, a vector at this very N2 position. This assumption is experimentally confirmed by compound <b>38b</b>, which contains a methyl group at the N2-position in the indazole moiety and was not only well tolerated by human MAO-B but also showed a moderate activity for the human MAO-A isoenzyme. Further, a hydrophilic substitution should make this atom less accessible for water, entailing a “quenching” of desolvation effects and, therefore, an improvement of affinity.</div><div class="NLM_p last">In conclusion, the 5- and 6-substituted indazoles <b>15</b> and <b>40</b> exhibit different binding affinities based on their different entropic contributions (hydrophobic effects) to the total binding energy. The visual analyses with HYDE provide indications that the C5-substituted indazole <b>15</b> contributes with almost 1.5 kcal/mol at its C3 position. In contrast, the C6-substituted analogue <b>40</b> has no favorable desolvation contribution by any atom in the same spatial area (whereas the remaining molecular parts keep their contributions constant). In this more hydrophobic region, a nitrogen atom (N1 position in <b>40</b>) is present and, with respect to desolvation effects, the difference between the bonded and unbonded states amounts to zero. That means, the N5 atom is assumed to be solvated in both the unbound and bound states; consequently, the affinity contribution from desolvation effects, being the difference in ΔG between these two states, is not affected. In addition, it does not form any hydrogen bonds and, therefore, its contribution to the overall affinity can essentially be neglected. Summarizing, HYDE was able to help understanding activity differences by visualization and quantification of effects of (de)hydration and H-bonds.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Physicochemical Properties</h3><div class="NLM_p">On the basis of their potent and selective inhibition of MAO-B, 14 compounds were selected for further evaluation (<b>15</b>, <b>27</b>–<b>36</b>, <b>38a</b>, <b>38b</b>, <b>53</b>, <b>54</b>, <b>58</b>, and <b>59</b>; see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The selection criteria included inhibitory potency toward human MAO-B with an IC<sub>50</sub> of <10 nM and greater than 1000-fold selectivity for MAO-B over MAO-A. To evaluate the drug-likeness of the selected compounds, we calculated several physicochemical parameters, including lipophilicity (clogP), topological polar surface area (<i>t</i>PSA), and ligand-lipophilicity efficiency (LLE),<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51-53)</a> and compared them to the reference MAO-B inhibitors <b>1</b>–<b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Physicochemical Properties of Selected Compounds and Reference MAO-B Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>M</i><sub>R</sub></th><th class="colsep0 rowsep0" align="center" char=".">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>N</i><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">clogP<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">tPSA (Å<sup>2</sup>)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">LLE<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">selegiline (<b>1</b>)</td><td class="colsep0 rowsep0" align="char" char=".">187</td><td class="colsep0 rowsep0" align="char" char=".">8.18</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="center">2.85</td><td class="colsep0 rowsep0" align="char" char=".">3.24</td><td class="colsep0 rowsep0" align="char" char=".">5.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rasagiline (<b>2</b>)</td><td class="colsep0 rowsep0" align="char" char=".">171</td><td class="colsep0 rowsep0" align="char" char=".">7.85<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="center">2.30</td><td class="colsep0 rowsep0" align="char" char=".">12.0</td><td class="colsep0 rowsep0" align="char" char=".">5.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">safinamide (<b>3</b>)</td><td class="colsep0 rowsep0" align="char" char=".">302</td><td class="colsep0 rowsep0" align="char" char=".">8.29</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="center">2.48/2.20<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">64.4</td><td class="colsep0 rowsep0" align="char" char=".">5.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">306</td><td class="colsep0 rowsep0" align="char" char=".">9.23</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="center">3.60</td><td class="colsep0 rowsep0" align="char" char=".">57.8</td><td class="colsep0 rowsep0" align="char" char=".">5.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">306</td><td class="colsep0 rowsep0" align="char" char=".">8.56</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="center">3.60</td><td class="colsep0 rowsep0" align="char" char=".">57.8</td><td class="colsep0 rowsep0" align="char" char=".">4.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">289</td><td class="colsep0 rowsep0" align="char" char=".">9.17</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="center">3.13</td><td class="colsep0 rowsep0" align="char" char=".">57.8</td><td class="colsep0 rowsep0" align="char" char=".">6.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">289</td><td class="colsep0 rowsep0" align="char" char=".">9.17</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="center">3.13</td><td class="colsep0 rowsep0" align="char" char=".">57.8</td><td class="colsep0 rowsep0" align="char" char=".">6.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">273</td><td class="colsep0 rowsep0" align="char" char=".">8.88</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="center">2.67</td><td class="colsep0 rowsep0" align="char" char=".">57.8</td><td class="colsep0 rowsep0" align="char" char=".">6.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">301</td><td class="colsep0 rowsep0" align="char" char=".">8.47</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="center">2.83</td><td class="colsep0 rowsep0" align="char" char=".">67.0</td><td class="colsep0 rowsep0" align="char" char=".">5.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">301</td><td class="colsep0 rowsep0" align="char" char=".">8.36</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="center">2.83</td><td class="colsep0 rowsep0" align="char" char=".">67.0</td><td class="colsep0 rowsep0" align="char" char=".">5.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">307</td><td class="colsep0 rowsep0" align="char" char=".">8.27</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="center">2.60</td><td class="colsep0 rowsep0" align="char" char=".">70.7</td><td class="colsep0 rowsep0" align="char" char=".">5.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38a</b></td><td class="colsep0 rowsep0" align="char" char=".">320</td><td class="colsep0 rowsep0" align="char" char=".">9.41</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="center">3.72</td><td class="colsep0 rowsep0" align="char" char=".">46.9</td><td class="colsep0 rowsep0" align="char" char=".">5.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38b</b></td><td class="colsep0 rowsep0" align="char" char=".">320</td><td class="colsep0 rowsep0" align="char" char=".">8.84</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="center">4.08</td><td class="colsep0 rowsep0" align="char" char=".">46.9</td><td class="colsep0 rowsep0" align="char" char=".">4.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="char" char=".">305</td><td class="colsep0 rowsep0" align="char" char=".">9.64</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="center">4.37</td><td class="colsep0 rowsep0" align="char" char=".">44.9</td><td class="colsep0 rowsep0" align="char" char=".">5.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="char" char=".">319</td><td class="colsep0 rowsep0" align="char" char=".">8.65</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="center">4.60</td><td class="colsep0 rowsep0" align="char" char=".">34.0</td><td class="colsep0 rowsep0" align="char" char=".">4.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="char" char=".">290</td><td class="colsep0 rowsep0" align="char" char=".">9.21</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="center">4.38</td><td class="colsep0 rowsep0" align="char" char=".">41.0</td><td class="colsep0 rowsep0" align="char" char=".">4.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="char" char=".">304</td><td class="colsep0 rowsep0" align="char" char=".">8.99</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="center">4.50</td><td class="colsep0 rowsep0" align="char" char=".">32.0</td><td class="colsep0 rowsep0" align="char" char=".">4.49</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last"><i>N</i>, number of heavy atoms.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Calculated by the  <cite>Instant JChem Program</cite>, version 6.0.2; ChemAxon, <span class="NLM_year">2013</span>, <a href="http://www.chemaxon.com" class="extLink">http://www.chemaxon.com</a>.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">LLE: ligand-lipophilicity efficiency = pIC<sub>50</sub> – clogP.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Data from ref <a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">18</a>.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Data obtained from  <cite>CINAPS Dossier: Safinamide 3/29/2009</cite>; National Institute of Neurological Disorders and Stroke (NINDS):  Bethesda, MD, USA <span class="NLM_year">2009</span>.</p></div></div></div><div class="NLM_p">The clogP value was in all cases lower than 5, which is in agreement with the well-known rule-of-5 for drug-likeness.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> Compounds <b>28</b>–<b>30</b>, <b>32</b>, <b>34</b>, and <b>36</b> exhibit a clogP value of less or about 3, which is considered as optimal for perorally administered drugs, being in the same range as the reference drugs <b>1</b>–<b>3</b>. Compounds <b>28</b>–<b>30</b>, <b>32</b>, and <b>34</b> have lower molecular weight (<i>M</i><sub>R</sub>) than the reference drug safinamide (<b>3</b>). Moreover, all selected compounds are more potent at human MAO-B than the reference drugs <b>1</b>–<b>3</b>. The mean number of the heavy atoms for the new compounds was always lower (HA<sub>mean all</sub> = 20.3) than that of the reversible standard MAO-B inhibitor safinamide (<b>3</b>, HA<sub>SAF</sub> = 22) but higher than that of the irreversible MAO-B inhibitors <b>1</b> and <b>2</b> containing 14 and 13 non-hydrogen atoms, respectively (see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In general, most of the new MAO-B inhibitors appear to have optimal physicochemical parameters for allowing oral bioavailability (log <i>P</i> 2–4, <i>M</i><sub>R</sub> < 400 and <i>t</i>PSA 50–90 Å<sup>2</sup>).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Together with clogP and <i>M</i><sub>R</sub>, the PSA is used to assess the compound’s ability to cross the blood–brain barrier (BBB). For all selected compounds, the <i>t</i>PSA values were ranging between 32.0 and 70.7 Å<sup>2</sup>, and therefore, they are expected to be orally bioavailable. Furthermore, compounds with a PSA value lower or equal to 61 Å<sup>2</sup> are classified as “good” for brain penetration.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The PSA for most of the selected compounds (except for <b>32</b>, <b>34</b>, and <b>36</b>) did not exceed the required limit for brain permeability of 60 Å<sup>2</sup>, and therefore, these may be considered as promising central nervous system (CNS) drug candidates.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> A further parameter frequently applied in the lead generation and optimization process is the ligand-lipophilicity efficiency (LLE) that combines potency and lypophilicity.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> For most of the selected compounds (except for <b>54</b> and <b>59</b>), the LLE value was found to be within the range of 5–7. Compounds with a LLE >5 can be considered as suitable drug candidates.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> In the case of the selected new compounds, <b>28</b>–<b>30</b> possessed an optimal LLE value of more than 6 and may therefore serve as drug candidates suitable for further in vivo evaluation. To assess the relationship between lipophilicity and bioactivity, we plotted the clogP values versus the pIC<sub>50</sub> values (human MAO-B) for all target compounds as well as reference drugs <b>1</b>–<b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Distribution of clogP versus pIC<sub>50</sub> values (human MAO-B) for reference compounds and newly developed inhibitors. The reference drugs and selected novel classes of MAO-B inhibitors are indicated in red (<b>1</b>, <b>2</b>, and <b>3</b>), green (indazole-5-carboxamides, class I), violet (indole-5-carboxamides, class II), and orange (indazol-5-yl)methanimines, class III) circles, respectively (also see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The blue dashed lines represent the preferred range for clogP values. The red dashed line indicates the average clogP value of 3.09 of all synthesized compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The reference drugs and the structurally novel MAO-B inhibitors (class I, II, and III) are shown in colored circles. The white circles represent compounds that are only weakly active at human MAO-B. All compounds with the exception of <b>53</b>, <b>54</b>, <b>58</b>, and <b>59</b>, display acceptable clogP values within the preferred range for CNS drugs of 2–4 (blue dashed lines).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The clogP value for compound <b>38b</b> is at the upper limit (4.08), while <b>11</b> is a highly hydrophilic compound with a clogP of 0.43. There was a significant correlation between the pIC<sub>50</sub> values of indole-5-carboxamides (<b>53</b> and <b>54</b>) and (indazol-5-yl)methanimines (<b>58</b> and <b>59</b>) at human MAO-B and their high lipophilicity with clogP values in the range of 4.36–4.60. Among all presented compounds, <b>53</b> was not only identified as the most potent (pIC<sub>50</sub> = 9.64) but also as one of the most highly lipophilic MAO-B inhibitors of the present series of compounds. The N1-methyl-substituted derivative <b>54</b> (clogP 4.60) is even more lipophilic and represents the most lipophilic compound of all series of inhibitors investigated in this study. The distribution of the clogP values plotted versus <i>M</i><sub>R</sub> and <i>t</i>PSA values indicates that newly developed class II (<b>53</b> and <b>54</b>) and class III (<b>58</b> and <b>59</b>) MAO-B inhibitors possessing <i>t</i>PSA values between 32.0 and 44.9 Å<sup>2</sup> are less polar than class I inhibitors (for more details, see <a class="ref internalNav" href="#notes-1" aria-label="Figure S10, Supporting Information">Figure S10, Supporting Information</a>). The plotted pIC<sub>50</sub> and clogP values demonstrate that highly potent MAO-B inhibitors (e.g., compounds <b>28</b>–<b>30</b> and <b>34</b>) with an optimal lipophilicity suitable for further CNS drug development were discovered (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).</div><div class="NLM_p last">Additional physicochemical values, known as important predictors of drug-likeness,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> were calculated, including <i>p</i><i>K</i><sub>a</sub> values, distribution coefficients (clogD<sub>7.4</sub>), hydrogen bond donor/acceptor (HBD/HBA) counts, rotatable bonds (rot), water solubility (<i>S</i><sub>W</sub>), and molar volume (<i>V</i><sub>m</sub>) (for details, see <a class="ref internalNav" href="#notes-1" aria-label="Tables S3 and S4, Supporting Information">Tables S3 and S4, Supporting Information</a>). The properties of the new MAO-B inhibitors were compared to the profiles of the top-selling 25 CNS drugs, and many of them were found to perform similarly well. The physicochemical properties for the new compounds are in the suggested limits (clogP = 2–5, <i>t</i>PSA < 90 Å<sup>2</sup>, <i>M</i><sub>R</sub> < 500, HBD < 3).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The mean clogP value for all new compounds was 3.09, whereas the mean M<sub>R</sub> and <i>t</i>PSA values were 229.1 and 60.5 Å<sup>2</sup>, respectively (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Of all new compounds, <b>30</b> is predicted to possess oral bioavailability (<i>S</i><sub>w</sub> = 0.36 mg/mL at pH 7.4),<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> lead likeness,<a onclick="showRef(event, 'ref52 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref52 ref54 ref55">(52, 54, 55)</a> and fulfill the rule-of-3 criteria (<i>M</i><sub>R</sub> ≤ 300, logP ≤ 3, acceptor counts ≤3, rotatable bond counts ≤3, <i>t</i>PSA ≤ 60)<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> for CNS drug candidates (for details, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Tables S5 and S6">Supporting Information Tables S5 and S6</a>).</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> The Most Promising Lead Structures</h3><div class="NLM_p">As the most promising MAO-B inhibitors of the present series with drug-like properties, compounds <b>29</b> and <b>30</b> have to be highlighted (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). To improve their physicochemical properties while maintaining high potency and selectivity at human MAO-B, <b>29</b> and <b>30</b> were designed and evaluated in a two-step drug optimization process. In addition to the already discussed physicochemical properties (e.g., <i>M</i><sub>R</sub>, clogP, and the number of heavy atoms HA) and ligand-lipophilicity efficiency (LLE), we also used the binding efficiency index (BEI)<a onclick="showRef(event, 'ref51 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref51 ref53 ref54">(51, 53, 54)</a> as a metric value to assess the properties of lead structure <b>15</b> optimized derivatives. Additionally, the indazole-5-carboxamide derivatives <b>15</b>, <b>29</b>, and <b>30</b> were aligned and characterized by high shape and field similarity.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0010.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure optimization process of lead structure <b>15</b> toward derivative <b>30</b> with improved properties by replacement of the 3-Cl (step a), or the 3,4-di-Cl atoms (step b) with one (<b>29</b>) or two fluorine atoms (<b>30</b>). The binding efficiency index (BEI) is defined as BEI = pIC<sub>50</sub>/<i>M</i><sub>R</sub> (in 1/kDa).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Starting from <b>15</b>, we stepwise replaced the chlorine atoms at the phenyl ring in position 4 (compound <b>28</b>, not shown) and position 3 (compound <b>29</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), respectively, with fluorine atoms (step a). In the following step b, both fluorine atoms at positions 3 and 4 of <b>15</b> were replaced resulting in <b>30</b>. During both steps, the relative molar mass (<i>M</i><sub>R</sub>) was consequently decreased from 306 (<b>15</b>) to 273 (<b>30</b>). Because the number of heavy atoms (HA) for all three compounds is equal to 20 (see Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), we additionally applied the binding efficiency index (BEI) as an alternative metric value to the ligand efficiency index (LE) in order to quantify the drug optimization of <b>15</b>, which showed the same trend.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The BEI values were calculated by using the measured binding affinity (pIC<sub>50</sub> at human MAO-B) dividing it by the <i>M</i><sub>R</sub> (in kDa). It is well known that during a drug optimization from hit to lead to clinical candidate an increase in <i>M</i><sub>R</sub> is typically observed.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> In contrast, in the presented series of MAO-B inhibitors, the potency within the chemical series of indazole-5-carboxamides is not strongly correlated with molecular weight. Because of its well-balanced profile, compound <b>30</b> may be considered as a promising CNS drug candidate for further development. Similar features were observed by several compounds of the series of indazole-5-carboxamides (class I MAO-B inhibitors) like 3,4-chlormethoxyphenyl-substituted derivatives <b>32</b> and <b>34</b> as well as 3,4-dichloropyridine containing analogue <b>36</b>.</div><div class="NLM_p last">The selected MAO-B inhibitor <b>30</b> was analyzed by a superposition onto both the reference ligand safinamide (<b>3</b>) and lead compound <b>15</b>. For this purpose, the 3D alignments were computed with flexible ligands and <b>3</b> as the template bioactive structure (for details, see <a class="ref internalNav" href="#notes-1" aria-label="Table S7 and Figure S11, Supporting Information">Table S7 and Figure S11, Supporting Information</a>). On the basis of their physicochemical interaction model (e.g., reflecting donors, acceptors, delocalization, and amide character of the molecules), compounds <b>15</b> and <b>30</b> showed a 72% and 75% identity to <b>3</b>, respectively. Furthermore, the volume overlaps reflect a spatial coverage of <b>3</b> in the range of 85%. The overlays give a hint to the higher MAO-B potency of <b>15</b> and <b>30</b> in comparison to <b>3</b>. In addition, the superposition experiment supports the assumption of a relatively rare (compare docking results) interplanar twist between the phenyl and the indazole ring planes, enforcing a nonplanarity between the amide function and at least one of the ring systems.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77335" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77335" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, we discovered indazol-5-carboxamides, indol-5-carboxamide, and (1<i>H</i>-indazol-5-yl)methanimine derivatives as structurally novel classes of MAO-B inhibitors. Structural optimization and SAR analyses led to the discovery of remarkably potent competitive and reversible MAO-B inhibitors with subnanomolar potency. Furthermore, the binding mode of selected C5- versus C6-substituted indazole-carboxamide derivatives within the binding pocket of the human MAO-B enzyme was investigated. The molecular modeling studies provided insights into the main interactions and structural requirements of enzyme–inhibitor binding and broadened our understanding of the compounds’ requirements for achieving high MAO-B affinity and selectivity. Thus, several indazole-5- and indole-5-carboxamide analogues with different substituents at the phenyl 3- and 4-positions (e.g., compounds <b>28</b>–<b>30</b>, <b>32</b>, <b>34</b>, <b>36</b>, and <b>53</b>) and those with an <i>N</i>1-methylated indole or indazole moiety (e.g., compounds <b>38a</b> and <b>54</b>) were identified that may serve as promising lead structures or even drug candidates, e.g., for the treatment of PD and AD. Moreover, they will be highly useful as pharmacological tools for in vitro and in vivo studies and may be suitable for the development of radioligands, including diagnostics for positron emission tomography (PET). As an example, compound <b>30</b> can be highlighted because of its remarkable in vitro MAO-B inhibitory activity and its well-balanced physicochemical profile, which is predictive of CNS bioavailability. Future efforts will be directed toward further improving the compounds’ drug-like properties with regard to water-solubility, bioavailability, metabolism, and toxicity and to evaluate the new MAO-B inhibitors in relevant animal models.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45082" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45082" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry</h3><div class="NLM_p">All reagents including 5-amino-indazole (<b>17</b>), different substituted anilines (<b>23a</b>–<b>k</b> and <b>25</b>), 2,3-dichloro-5-aminopyridine (<b>24</b>), carboxylic acids (<b>20</b>, <b>21a</b>–<b>c</b>, <b>22</b>, <b>39</b>, and <b>50</b>–<b>52</b>), and indazole-5-carboxaldehydes (<b>57a</b> and <b>57b</b>) were obtained from various producers (Acros, Sigma-Aldrich, Alfa Aesar, and TCI) and used without further purification. The experimental procedures and spectroscopic analysis for the carboxylic acids <b>18</b> and <b>19</b> are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Solvents were used without additional purification or drying unless otherwise noted. Reactions were monitored by thin layer chromatography (TLC) using aluminum sheets coated with silica gel 60 F<sub>254</sub> (Merck). Compounds were visualized under UV light (254 nm). Preparative column chromatography was performed on silica gel 60 (Acros Organics) 0.060–0.200 mm. Mass spectra were recorded on an API 2000 mass spectrometer (electron spray ion source ESI, Applied Biosystems, Darmstadt, Germany) coupled with an Agilent 1100 HPLC system using a Phenomenex Luna HPLC C18 column (50 mm × 2.00 mm, particle size 3.0 μm). Purification by RP-HPLC of final products was performed an a Eurospher 100–10 C18 column (250 mm × 20 mm, particle size 10.0 μm, flow rate 10 mL/min) using Knauer Advanced Scientific Instruments (Berlin, Germany) preparative pump 1800/100 coupled with a Smartline 2600 UV diode array detector (DAD) with an UV detection in the range from 220 to 400 nm. The purity of the tested compounds and stability control of selected compounds <b>54</b> and <b>59</b> was determined by HPLC-UV obtained on an LC-MS instrument (Applied Biosystems API 2000 LC-MS/MS, HPLC Agilent 1100) using the standard or modified LC/ESI-MS method as described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. All tested compounds possessed a purity of not less than 95%. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance 500 MHz NMR spectrometer. DMSO-<i>d</i><sub>6</sub> was used as a solvent as indicated below. NMR spectra were recorded at room temperature (303 K). Chemical shifts (δ) are given in parts per million (ppm) related to that of the solvent. Coupling constants <i>J</i> are given in hertz (Hz), and spin multiplicities are given as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (br). Melting points were determined on a Büchi melting point B-545 apparatus and are uncorrected. The carboxylic acids <b>18</b> and <b>19</b> were prepared as described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Procedure A for the Amide Coupling to Produce Compounds <b>10</b>–<b>16</b>, <b>26</b>–<b>37</b>, <b>40</b>–<b>49</b>, <b>53</b>, <b>55</b>, and <b>56</b></h4><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Method 1</h5><div class="NLM_p last">A solution of the corresponding carboxylic acids <b>18</b>–<b>20</b> and <b>22</b> (1.0 equiv), different substituted anilines <b>17</b> and <b>23a</b> (1,2 equiv), and TBTU (1.2 equiv) in acetonitrile (2–3 mL/mmol) was treated with DIPEA (1.2 equiv), and the reaction was allowed to stir overnight at room temperature. The precipitate formed was filtered, dried at 70 °C, and purified by column chromatography on silica gel (eluent: CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v).</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Method 2</h5><div class="NLM_p last">A solution of the corresponding carboxylic acid <b>21a</b>–<b>c</b>, <b>22</b>, <b>39</b>, and <b>50</b>–<b>52</b> (1.0 equiv), different substituted anilines <b>23a</b>–<b>k</b>, <b>24</b>, and <b>25</b> (1.0 equiv) and EDC–HCl (1.1 equiv) in methanol (3–5 mL/mmol) was stirred overnight at room temperature. The reaction was concentrated in vacuo, the residue was treated with a water/ether mixture (5:1, 12 mL/mmol), and the mixture was stirred for 30 min at room temperature. The precipitate formed was filtered under reduced pressure and dried at 70 °C. The crude product was purified by column chromatography on silica gel (eluent: CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v).</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 5-Chloro-<i>N</i>-(1<i>H</i>-indazol-6-yl)-6-morpholinonicotinamide (<b>10</b>)</h5><div class="NLM_p last">The compound was prepared following method 1. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>10</b> as colorless crystals (241 mg, 37%); mp 238–239 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.43 (t, <i>J</i> = 4.72 Hz, 4H, morph), 3.74 (t, <i>J</i> = 4.42 Hz, 4H, morph), 7.51 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.68 (dd, <i>J</i> = 1.26/8.83 Hz, 1H, Ph), 8.03 (s, 1H, Ph), 8.24 (s, 1H, ind-het), 8.40 (d, <i>J</i> = 1.89 Hz, 1H, pyr), 8.85 (d, <i>J</i> = 1.89 Hz, 1H, pyr), 10.44 (s, 1H, −NHCO−), 13,11 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 44.0 (2C, morph), 66.1 (2C, morph), 110.1, 111.4, 119.7, 121.5, 122.8, 124.8, 132.0, 133.5, 137.3, 138.5, 146.1, 158.7, 162.6. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 356 [M – H]<sup>−</sup>, positive mode 358 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> <i>N</i>-(1<i>H</i>-Indazol-5-yl)-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxamide (<b>11</b>)</h5><div class="NLM_p last">The compound was prepared following method 1. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>11</b> as a white solid (61 mg, 45%); mp 247–249 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.52 (s, 3H, Me), 6.43 (d, <i>J</i> = 9.46 Hz, 1H, pyr), 7.49 (d, <i>J</i> = 8.82 Hz, 1H, Ph), 7.68 (dd, <i>J</i> = 1.58/8.83 Hz, 1H, Ph), 8.10 (s, 1H, Ph), 8.05 (dd, <i>J</i> = 2.53/9.46 Hz, 1H, pyr), 8.20 (d, <i>J</i> = 1.27 Hz, 1H, ind-het), 8.80 (d, <i>J</i> = 2.52 Hz, 1H, pyr), 10.29 (s, 1H, −NHCO−), 13.09 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 37.4, 53.3, 110.1, 111.1, 112.8, 117.9, 121.6, 122.8, 132.2, 133.4, 138.5, 142.7, 162.0, 163.0. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 267 [M – H]<sup>−</sup>, positive mode 269 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 2-Chloro-6-fluoro-<i>N</i>-(1<i>H</i>-indazol-5-yl)benzamide (<b>12</b>)</h5><div class="NLM_p last">The compound was prepared following method 1. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>12</b> as a white solid (128 mg, 72%); mp 270–271 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.37 (dt, <i>J</i> = 0.95/8.36 Hz, 1H, Ph), 7.44 (d, <i>J</i> = 8.19 Hz, 1H, Ph), 7.49 (dd, <i>J</i> = 1.89/9.14 Hz, 1H, Ph), 7.52 (s, 1H, Ph), 7.52–7.56 (m, 1H, Ph), 8.06 (s, 1H, Ph), 8.23 (s, 1H, ind-het), 10.72 (s, 1H, −NHCO−), 13.0 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.5 (d, <i>J</i> = 6.24 Hz), 114.9 (d <i>J</i> = 21.7 Hz), 120.4, 122.8, 125.7 (d, <i>J</i> = 2.99 Hz), 126.2, 126.4, 131.3 (d, <i>J</i> = 5.99 Hz), 131.6, 131.7 (d, <i>J</i> = 8.98 Hz), 133.7, 157.9, 159.9, 160.0. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 288 [M – H]<sup>−</sup>, positive mode 290 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 2,3-Dichloro-<i>N</i>-(1<i>H</i>-indazol-5-yl)benzamide (<b>13</b>)</h5><div class="NLM_p last">The compound was prepared following method 1. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>13</b> as a white solid (127 mg, 73%); mp 265–266 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.49 (t, <i>J</i> = 7.88 Hz, 1H, Ph), 7.52 (s, 2H, Ph), 7.58 (dd, <i>J</i> = 1.57/7.56 Hz, 1H, Ph), 7.75 (dd, <i>J</i> = 1.27/7.89 Hz, 1H, Ph), 8.06 (s, 1H, Ph), 8.23 (s, 1H, ind-het), 10.55 (s, 1H, −NHCO−), 13.0 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.4, 110.5, 120.6, 122.8, 127.5, 128.3, 128.8, 131.3, 131.8, 132.2, 133.7, 137.3, 139.6, 164.1. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 304 [M – H]<sup>−</sup>, positive mode 306 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 3,4-Dichloro-<i>N</i>-(1<i>H</i>-indazol-5-yl)benzamide (<b>14</b>)</h5><div class="NLM_p last">The compound was prepared following method 1. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>14</b> as a white solid (101 mg, 41%); mp 277–278 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.52 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.61 (dd, <i>J</i> = 1.9/8.83 Hz, 1H, Ph), 7.81 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 7.96 (dd, <i>J</i> = 1.89/8.2 Hz, 1H, Ph), 8.06 (s, 1H, Ph), 8.22 (d, <i>J</i> = 1.27 Hz, 1H, ind-het), 8.24 (d, <i>J</i> = 2.21 Hz, 1H, Ph), 10.38 (s, 1H, −NHCO−), 13.0 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.2, 111.6, 121.5, 122.8, 128.1, 129.7, 130.9, 131.4, 131.7, 133.7, 134.3, 135.5, 137.4, 163.1. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 304 [M – H]<sup>−</sup>, positive mode 306 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> <i>N</i>-(3,4-Dichlorophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>15</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>15</b> as a white crystalline solid (336 mg, 76%); mp 271–272 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.60 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.65 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.78 (dd, <i>J</i> = 2.52/8.83 Hz, 1H, Ph), 7.94 (dd, <i>J</i> = 1.58/8.83 Hz, 1H, Ph), 8.18 (d, <i>J</i> = 2.52 Hz, 1H), 8.28 (s, 1H, ind-het), 8.48 (s, 1H, Ph), 10.49 (s, 1H, −CONH−), 13.35 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.2, 120.3, 121.5, 121.6, 122.5, 125.0, 125.7, 126.8, 130.7, 131.0, 135.2, 139.8, 141.3, 166.2. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 304 [M – H]<sup>−</sup>, positive mode 306 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 2-(3,4-Dichlorophenyl)-<i>N</i>-(1<i>H</i>-indazol-5-yl)acetamide (<b>16</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>16</b> as a white solid (145 mg, 56%); mp 274–275 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.69 (s, 2H, CH<sub>2</sub>), 7.33 (dd, <i>J</i> = 1.89/8.19 Hz, 1H, Ph), 7.41 (dd, <i>J</i> = 1.58/8.83 Hz, 1H, Ph), 7.47 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.58 (d, <i>J</i> = 8.20 Hz, 1H, Ph), 7.61 (d, <i>J</i> = 1.89 Hz, 1H, Ph), 7.99 (s, 1H, Ph), 8.08 (d, <i>J</i> = 1.26 Hz, 1H, ind-het), 10.15 (s, 1H, −NHCO−), 12.94 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 42.1, 110.0, 110.3, 120.4, 122.8, 129.4, 129.8, 130.5, 130.8, 131.4, 132.1, 133.5, 137.1, 137.4, 168.1. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 318 [M – H]<sup>−</sup>, positive mode 320 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> <i>N</i>-Phenyl-1<i>H</i>-indazole-5-carboxamide (<b>26</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>26</b> as a white crystalline solid (180 mg, 76%); mp 285–286 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.08 (dt, <i>J</i> = 0.94/7.57 Hz, 1H, Ph), 7.33 (t, <i>J</i> = 6.3 Hz, 1H, Ph), 7.34 (t, <i>J</i> = 7.25 Hz, 1H, Ph), 7.63 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.74 (dt, J = 1.53/7.57 Hz, 1H, Ph), (dd, <i>J</i> = 1.26/8.83 Hz, 1H, Ph), 7.95 (dd, <i>J</i> = 1.58/8.83 Hz, 1H, Ph), 8.25 (s, 1H, ind-het), 8.52 (s, 1H, Ph), 10.22 (s, 1H, −CONH−), 13.30 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.1, 120.4 (2C), 121.3, 122.4, 123.5, 125.8, 127.5, 128.7 (2C), 135.1, 139.6, 141.2, 165.9. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 236 [M – H]<sup>−</sup>, positive mode 238 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> <i>N</i>-(3,5-Dichlorophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>27</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization four times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>27</b> as a white solid (190 mg, 62%); mp 303–305 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.30 (t, <i>J</i> = 1.89 Hz, 1H, Ph), 7.65 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 7.51 (d, <i>J</i> = 2.52 Hz, 1H, Ph), 7.91 (dd, <i>J</i> = 1.57/3.15 Hz, 1H, Ph), 7.92 (d, <i>J</i> = 1.89 Hz, 1H, Ph), 8.28 (d, <i>J</i> = 0.63 Hz, 1H, ind-het), 8.48 (dd, <i>J</i> = 0.63/1.58 Hz, 1H, Ph), 10.51 (s, 1H, −CONH−), 13.35 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.1, 110.3, 118.3 (2C), 121.7, 122.4, 122.7, 125.7, 126.6, 126.7, 134.1, 142.0, 145.2, 166.4. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 304 [M – H]<sup>−</sup>, positive mode 306 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> <i>N</i>-(3-Chloro-4-fluorophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>28</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>28</b> as a white solid (190 mg, 66%); mp 240–241 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.40 (t, <i>J</i> = 9.15 Hz, 1H, Ph), 7.64 (d, <i>J</i> = 8.82 Hz, 1H, Ph), 7.71–7.77 (m, 1H, Ph), 7.93 (dd, <i>J</i> = 1.27/8.83 Hz, 1H, Ph), 8.11 (dd, <i>J</i> = 2.53/6.94 Hz, 1H, Ph), 8.26 (s, 1H, ind-het), 8.47 (s, 1H, Ph), 10.41 (s, 1H, −CONH−), 13.33 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.2, 116.9 (d, <i>J</i> = 21.7 Hz), 119.1 (d, <i>J</i> = 18.2 Hz), 120.6 (d, <i>J</i> = 6.73 Hz), 121.5, 121.8, 122.5, 125.7, 126.9, 135.1, 136.9 (d, <i>J</i> = 2.99 Hz), 141.3, 153.4 (d, <i>J</i> = 242.84 Hz), 166.1. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 288 [M – H]<sup>−</sup>, positive mode 290 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> <i>N</i>-(4-Chloro-3-fluorophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>29</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from PE/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>29</b> as a white solid (95 mg, 33%); mp 247–248 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.54 (t, <i>J</i> = 8.52 Hz, 1H, Ph), 7.63 (dd, <i>J</i> = 1.57/8.82 Hz, 1H, Ph), 7.65 (d, <i>J</i> = 8.82 Hz, 1H, Ph), 7.93 (dd, <i>J</i> = 1.58/8.51 Hz, 1H, Ph), 7.97 (dd, <i>J</i> = 2.21/11.98 Hz, 1H, Ph), 8.27 (s, 1H, ind-het), 8.47 (s, 1H, Ph), 10.52 (s, 1H, −CONH−), 13.34 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 108.3 (d, <i>J</i> = 25.7 Hz), 110.3, 113.1 (d, <i>J</i> = 17.95 Hz), 117.1 (d, <i>J</i> = 2.99 Hz), 120.5, 121.6, 122.4, 125.7, 126.8, 130.5, 135.2, 140.2 (d, <i>J</i> = 10.22 Hz), 157.0 (d, <i>J</i> = 243.35 Hz), 166.3. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 288 [M – H]<sup>−</sup>, positive mode 290 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> <i>N</i>-(3,4-Difluorophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>30</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>30</b> as a white solid (163 mg, 60%); mp 239–240 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.41 (q, <i>J</i> = 9.14 Hz, 1H, Ph), 7.54–7.59 (m, 1H, Ph), 7.64 (d, <i>J</i> = 8.45 Hz, 1H, Ph), 7.93 (dd, <i>J</i> = 1.26/8.51 Hz, 1H, Ph), 7.96 (ddd, <i>J</i> = 2.52/7.57/13.24 Hz, 1H), 8.27 (s, 1H, ind-het), 8.47 (d, <i>J</i> = 0.63 Hz, 1H, Ph), 10.42 (s, 1H, −CONH−), 13.33 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 109.3 (d, <i>J</i> = 21.7 Hz), 110.2, 116.6 (q, <i>J</i> = 3.24 Hz), 117.4 (d, <i>J</i> = 17.7 Hz), 121.5, 122.5, 125.7, 126.9, 135.1, 136.7 (dd, <i>J</i> = 2.74/9.22 Hz), 141.2, 145.5 (dd, <i>J</i> = 12.71/241.59 Hz), 149.0 (dd, J = 13.22/242.85 Hz), 166.1. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 272 [M – H]<sup>−</sup>, positive mode 274 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> <i>N</i>-(3,4-Dimethoxyphenyl)-1<i>H</i>-indazole-5-carboxamide (<b>31</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>31</b> as a brownish solid (183 mg, 61%); mp 258–262 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.74 (s, 3H, OMe), 3.76 (s, 3H, OMe), 6.93 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.36 (dd, <i>J</i> = 2.53/8.83 Hz, 1H, Ph), 7.51 (d, <i>J</i> = 2.52 Hz, 1H, Ph), 7.63 (td, <i>J</i> = 0.94/8.83 Hz, 1H, Ph), 7.94 (dd, <i>J</i> = 1.58/8.83 Hz, 1H, Ph), 8.24 (d, <i>J</i> = 0.63 Hz, 1H, ind-het), 8.46 (dd, <i>J</i> = 0.63/1.58 Hz, 1H, Ph), 10.1 (s, 1H, −CONH−), 13.35 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 55.6 (OMe), 55.9 (OMe), 105.8, 110.0, 112.2, 112.4, 121.1, 122.5, 125.7, 127.6, 133.2, 135.0, 141.1, 145.2, 148.6, 165.5. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 296 [M – H]<sup>−</sup>, positive mode 298 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> <i>N</i>-(3-Chloro-4-methoxyphenyl)-1<i>H</i>-indazole-5-carboxamide (<b>32</b>)</h5><div class="NLM_p last">The compound was prepared following method 1. Repeated purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>32</b> as a white solid (33 mg, 11%); mp 276–278 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.84 (s, 3H, 4-MeO), 7.15 (d, <i>J</i> = 9.15 Hz, 1H, Ph), 7.65 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.68 (dd, <i>J</i> = 2.53/8.83 Hz, 1H, Ph), 7.94 (dd, <i>J</i> = 1.57/8.83 Hz, 1H, Ph), 7.97 (d, <i>J</i> = 2.52 Hz, 1H, Ph), 8.24 (s, 1H, ind-het), 8.48 (s, 1H, Ph), 10.25 (s, 1H, −CONH−), 13.34 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 56.3 (OMe), 110.1, 113.0, 120.2, 120.6, 121.3, 122.0, 122.5, 125.7, 127.2, 133.3, 135.1, 141.2, 150.8, 165.7. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 300 [M – H]<sup>−</sup>, positive mode 302 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> <i>N</i>-(3-Chloro-4-hydroxyphenyl)-1<i>H</i>-indazole-5-carboxamide (<b>33</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>33</b> as a yellowish solid (169 mg, 59%); mp 272–274 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 6.94 (d, <i>J</i> = 8.82 Hz, 1H, Ph), 7.50 (dd, <i>J</i> = 2.53/8.83 Hz, 1H, Ph), 7.62 t(d, <i>J</i> = 0.95/8.82 Hz, 1H, Ph), 7.85 (d, <i>J</i> = 2.53 Hz, 1H, Ph), 7.92 (dd, <i>J</i> = 1.57/8.82 Hz, 1H, Ph), 8.24 (s, 1H, ind-het), 8.43 (dd, <i>J</i> = 0.95/1.58 Hz, 1H, Ph), 9.92 (bs, 1H, OH), 10.12 (s, 1H, −CONH−), 13.29 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.1, 116.5, 119.1, 120.6, 121.2, 122.0, 122.5, 125.7, 127.3, 132.0, 135.0, 141.1, 149.3, 165.6. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 286 [M – H]<sup>−</sup>, positive mode 288 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> <i>N</i>-(4-Chloro-3-methoxyphenyl)-1<i>H</i>-indazole-5-carboxamide (<b>34</b>)</h5><div class="NLM_p last">The compound was prepared following method 1. Repeated purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>34</b> as a white solid (34 mg, 11%); mp 280–282 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.85 (s, 3H, 4-MeO), 7.36 (d, <i>J</i> = 8.82 Hz, 1H, Ph), 7.46 (dd, <i>J</i> = 2.53/8.83 Hz, 1H, Ph), 7.64 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 7.71 (dd, <i>J</i> = 2.21 Hz, 1H, Ph), 7.94 (dd, <i>J</i> = 1.57/8.82 Hz, 1H, Ph), 8.27 (s, 1H, ind-het), 8.47 (d, <i>J</i> = 0.63 Hz, 1H, Ph), 10.32 (s, 1H, −CONH−), 13.32 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 56.0 (OMe), 105.0, 110.1, 113.0, 115.2, 121.4, 122.5, 125.7, 127.2, 129.7, 135.1, 139.8, 141.2, 154.5, 166.0. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 300 [M – H]<sup>−</sup>, positive mode 302 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> <i>N</i>-(4-Chloro-3-hydroxyphenyl)-1<i>H</i>-indazole-5-carboxamide (<b>35</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>35</b> as a brownish solid (151 mg, 53%); mp 307–308 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.19 (dd, <i>J</i> = 2.52/8.83 Hz, 1H, Ph), 7.25 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 7.62 (td, <i>J</i> = 0.95/8.82 Hz, 1H, Ph), 7.68 (d, <i>J</i> = 2.21 Hz, 1H, Ph), 7.92 (dd, <i>J</i> = 1.89/8.83 Hz, 1H, Ph), 8.25 (s, 1H, ind-het), 8.45 (dd, <i>J</i> = 0.95/1.58 Hz, 1H, Ph), 10.16 (bs, 1H, OH), 10.22 (s, 1H, −CONH), 13.32 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 108.6, 110.1, 112.2, 114.1, 121.4, 122.4, 125.8, 127.3, 129.5, 135.1, 139.3, 141.2, 153.1, 166.0. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 286 [M – H]<sup>−</sup>, positive mode 288 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> <i>N</i>-(5,6-Dichloropyridin-3-yl))-1<i>H</i>-indazole-5-carboxamide (<b>36</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>36</b> as a brownish solid (112 mg, 53%); mp >290 °C (dec). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.67 (d, <i>J</i> = 8.82 Hz, 1H, Ph), 8.05 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 8.21 (s, 1H, ind-het), 8.34 (s, 1H, pyr), 8.44 (s, 1H, Ph), 8.74 (s, 1H, Pyr), 12.8 (s, 1H, −CONH−), 13.55 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.1, 111.1, 120.5, 123.0, 123.2, 123.9, 126.3, 126.7, 127.1, 135.3, 136.1, 141.4, 163.1. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 305 [M – H]<sup>−</sup>, positive mode 307 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> <i>N</i>-(3,4-Dichlorobenzyl)-1<i>H</i>-indazole-5-carboxamide (<b>37</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>37</b> as a brownish solid (196 mg, 61%); mp 205–206 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 4.48 (d, <i>J</i> = 5.99 Hz, 2H, CH<sub>2</sub>), 7.33 (dd, <i>J</i> = 1.89/8.20 Hz, 1H, Ph), 7.57 (s, 1H, Ph), 7.59 (s, 1H, Ph), 7.88 (dd, <i>J</i> = 1.26/8.82 Hz, 1H, Ph), 8.20 (s, 1H, ind-het), 8.38 (s, 1H, Ph), 9.06 (t, <i>J</i> = 5.99 Hz, 1H, −CONH−), 13.26 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 41.9, 109.9, 120.8, 122.5, 125.4, 126.6, 127.8, 129.3, 129.4, 130.6, 130.9, 135.0, 141.1, 141.3, 166.8. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 318 [M – H]<sup>−</sup>, positive mode 320 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> <i>N</i>-(3,4-Dichlorophenyl)-1<i>H</i>-indazole-6-carboxamide (<b>40</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>40</b> as a white crystalline solid (161 mg, 52%); mp 272–274 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.62 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.67 (dd, <i>J</i> = 1.26/8.51 Hz, 1H, Ph), 7.79 (dd, <i>J</i> = 2.52/8.83 Hz, 1H, Ph), 7.90 (dd, <i>J</i> = 0.94/8.51 Hz, 1H, Ph), 8.16 (s, 1H, ind-het), 8.18 (s, 1H, Ph), 8.19 (s, 1H, Ph), 10.59 (s, 1H, −CONH−), 13.44 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.4, 119.7, 120.4, 120.8, 121.6, 124.8, 125.2, 130.7, 131.0, 132.1, 133.8, 139.3, 139.6, 166.3. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 304 [M – H]<sup>−</sup>, positive mode 306 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> <i>N</i>-(3,5-Dichlorophenyl)-1<i>H</i>-indazole-6-carboxamide (<b>41</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>41</b> as gray crystals (173 mg, 57%); mp 277–279 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.32 (t, <i>J</i> = 1.89 Hz, 1H, Ph), 7.66 (dd, <i>J</i> = 1.26/8.51 Hz, 1H, Ph), 7.90 (d, <i>J</i> = 0.63/8.19 Hz, 1H, Ph), 7.92 (s, 1H, Ph), 7.93 (s, 1H, Ph), 8.16 (s, 1H, ind-het), 8.19 (s, 1H, Ph), 10.61 (s, 1H, −CONH−), 13.46 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.4, 118.5 (2C), 119.7, 120.8, 122.9, 124.8, 131.9, 133.8, 134.1 (2C), 139.3, 141.8, 166.5. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 304 [M – H]<sup>−</sup>, positive mode 306 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> <i>N</i>-(3-Chloro-4-fluorophenyl)-1<i>H</i>-indazole-6-carboxamide (<b>42</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>42</b> as an ecru solid (205 mg, 71%); mp 257–259 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.42 (t, <i>J</i> = 9.14 Hz, 1H, Ph), 7.68 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 7.73–7.78 (m, 1H, Ph), 7.89 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 8.10 (dd, <i>J</i> = 2.53/6.62 Hz, 1H, Ph), 8.16 (s, 1H, ind-het), 8.19 (s, 1H, Ph), 10.52 (s, 1H, −CONH−), 13.44 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 109.5, 116.2 (d, <i>J</i> = 21.69 Hz), 118.4 (d, <i>J</i> = 18.2 Hz), 118.9, 120.0, 120.03 (d, <i>J</i> = 6.98 Hz), 121.2, 124.0, 131.5, 133.1, 135.9 (d, <i>J</i> = 2.99 Hz), 138.6, 152.7 (d, <i>J</i> = 243.09 Hz), 165.4. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 288 [M – H]<sup>−</sup>, positive mode 290 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> <i>N</i>-(4-Chloro-3-fluorophenyl)-1<i>H</i>-indazole-6-carboxamide (<b>43</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>43</b> as a white solid (64 mg, 22%); mp 281–282 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.56 (t, <i>J</i> = 8.51 Hz, 1H, Ph), 7.63 (dd, <i>J</i> = 1.89/9.14 Hz, 1H, Ph), 7.67 (dd, <i>J</i> = 1.26/8.51 Hz, 1H, Ph), 7.89 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 7.97 (dd, <i>J</i> = 2.21/11.98 Hz, 1H, Ph), 8.16 (s, 1H, ind-het), 8.19 (s, 1H, Ph), 10.62 (s, 1H, −CONH−), 13.45 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 108.4 (d, <i>J</i> = 25.7 Hz), 110.4, 113.4 (d, <i>J</i> = 17.7 Hz), 117.3 (d, <i>J</i> = 2.99 Hz), 119.7, 120.8, 124.8, 130.5, 132.2, 133.8, 139.3, 140.0 (d, <i>J</i> = 10.22 Hz), 157.0 (d, <i>J</i> = 243.59 Hz), 166.4.; LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 288 [M – H]<sup>−</sup>, positive mode 290 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> <i>N</i>-(3,4-Difluorophenyl)-1<i>H</i>-indazole-6-carboxamide (<b>44</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>44</b> as a white solid (186 mg, 68%); mp 264–266 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.43 (q, <i>J</i> = 9.14 Hz, 1H, Ph), 7.56–7.60 (m, 1H, Ph), 7.66 (dd, <i>J</i> = 0.95/8.20 Hz, 1H, Ph), 7.89 (dd, <i>J</i> = 8.19 Hz, 1H, Ph), 7.96 (ddd, <i>J</i> = 2.52/7.57/13.24 Hz, 1H, Ph), 8.15 (s, 1H, ind-het), 8.18 (s, 1H, Ph), 10.54 (s, 1H, −CONH−), 13.43 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 109.4 (d, <i>J</i> = 21.44 Hz), 110.3, 116.8 (q, <i>J</i> = 3.24 Hz), 117.4 (d, <i>J</i> = 17.7 Hz), 119.7, 120.7, 124.7, 132.3, 133.8, 136.5 (dd, <i>J</i> = 2.49/8.98 Hz), 139.4, 145.6 (dd, <i>J</i> = 12.72/242.1 Hz), 149.0 (dd, <i>J</i> = 13.22/242.85 Hz), 166.2. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 272 [M – H]<sup>−</sup>, positive mode 274 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> <i>N</i>-(3,4-Dimethoxyphenyl)-1<i>H</i>-indazole-6-carboxamide (<b>45</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>45</b> as a gray solid (174 mg, 59%); mp 204–206 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.74 (s, 3H, OMe), 3.76 (s, 3H, OMe), 6.94 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 7.35 (dd, <i>J</i> = 2.52/8.83 Hz, 1H, Ph), 7.50 (d, <i>J</i> = 2.52 Hz, 1H, Ph), 7.67 (dd, <i>J</i> = 1.26/8.51 Hz, 1H, Ph), 7.87 (dd, <i>J</i> = 0.63/8.51 Hz, 1H, Ph), 8.14 (s, 1H, ind-het), 8.17 (s, 1H, Ph), 10.19 (s, 1H, −CONH−), 13.36 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 55.6 (OMe), 55.9 (OMe), 105.8, 110.0, 112.2, 112.6, 119.7, 120.5, 124.5, 132.9, 133.0, 133.7, 139.5, 145.3, 148.6, 165.6. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 296 [M – H]<sup>−</sup>, positive mode 298 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> <i>N</i>-(3-Chloro-4-methoxyphenyl)-1<i>H</i>-indazole-6-carboxamide (<b>46</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Repeated purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>46</b> as a white solid (144 mg, 48%); mp 160–161 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.84 (s, 3H, 4-MeO), 7.15 (d, <i>J</i> = 9.14 Hz, 1H, Ph), 7.67 (dd, <i>J</i> = 1.26/8.51 Hz, 1H, Ph), 7.70 (dd, <i>J</i> = 2.52/9.14 Hz, 1H, Ph), 7.87 (dd, <i>J</i> = 0.94/8.51 Hz, 1H, Ph), 7.96 (d, <i>J</i> = 2.52 Hz, 1H, Ph), 8.15 (s, 1H, ind-het), 8.17 (s, 1H, Ph), 10.33 (s, 1H, −CONH−), 13.41 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 56.4 (OMe), 110.1, 113.0, 116.5, 119.7, 120.4, 120.6, 122.1, 124.6, 132.5, 133.1, 133.8, 139.4, 150.9, 165.8. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 300 [M – H]<sup>−</sup>, positive mode 302 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> <i>N</i>-(3-Chloro-4-hydroxyphenyl)-1<i>H</i>-indazole-6-carboxamide (<b>47</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>47</b> as a brownish solid (160 mg, 54%); mp 263–265 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 6.95 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 7.52 (dd, <i>J</i> = 2.52/8.51 Hz, 1H, Ph), 7.65 (dd, <i>J</i> = 1.26/8.51 Hz, 1H, Ph), 7.85 (s, 1H, Ph), 7.86 (dd, <i>J</i> = 1.26/8.51 Hz, 1H, Ph), 8.13 (s, 1H, Ph), 8.16 (s, 1H, ind-het), 9.93 (bs, 1H, OH), 10.23 (s, 1H, −CONH−), 13.39 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.1, 116.5, 119.2, 119.7, 120.6, 120.7, 122.1, 124.5, 131.8, 132.7, 133.7, 139.4, 149.4, 165.6. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 286 [M – H]<sup>−</sup>, positive mode 288 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> <i>N</i>-(4-Chloro-3-methoxyphenyl)-1<i>H</i>-indazole-6-carboxamide (<b>48</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Repeated purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>48</b> as a white solid (203 mg, 71%); mp 156–157 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.86 (s, 3H, 3-MeO), 7.38 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.45 (dd, <i>J</i> = 2.20/8.51 Hz, 1H, Ph), 7.68 (dd, <i>J</i> = 1.26/8.51 Hz, 1H, Ph), 7.72 (d, <i>J</i> = 2.21 Hz, 1H), 7.89 (dd, <i>J</i> = 0.63/8.52 Hz, 1H, Ph), 8.16 (s, 1H), 8.18 (s, 1H, Ph), 10.44 (s, 1H, −CONH−), 13.42 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 56.0 (OMe), 105.1, 110.2, 113.1, 115.4, 119.7, 120.7, 124.7, 129.7, 132.5, 133.8, 139.4, 139.6, 154.5, 166.1. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 300 [M – H]<sup>−</sup>, positive mode 302 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> <i>N</i>-(4-Chloro-3-hydroxyphenyl)-1<i>H</i>-indazole-6-carboxamide (<b>49</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization three times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>49</b> as an ecru solid (150 mg, 52%); mp 257–258 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 6.95 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 7.52 (dd, <i>J</i> = 2.52/8.51 Hz, 1H, Ph), 7.65 (dd, <i>J</i> = 1.26/8.51 Hz, 1H, Ph), 7.85 (s, 1H, Ph), 7.86 (dd, <i>J</i> = 1.26/8.51 Hz, 1H, Ph), 8.13 (s, 1H, Ph), 8.16 (s, 1H, ind-het), 9.93 (bs, 1H, OH), 10.23 (s, 1H, −CONH−), 13.39 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.1, 116.5, 119.2, 119.7, 120.6, 120.7, 122.1, 124.5, 131.8, 132.7, 133.7, 139.4, 149.4, 165.6. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 286 [M – H]<sup>−</sup>, positive mode 288 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> <i>N</i>-(3,4-Dichlorophenyl)-1<i>H</i>-indole-5-carboxamide (<b>53</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by repeated silica gel chromatography (petroleum ether/ethyl acetate, 1:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>53</b> as a white crystalline solid (52 mg, 17%); mp 234–235 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 6.59 (m, 1H, indol-het), 7.46 (t, <i>J</i> = 3.16 Hz, 1H, indol-het), 7.49 (d, <i>J</i> = 8.51 Hz, 1H, Ph), 7.58 (d, <i>J</i> = 8.82 Hz, 1H, Ph), 7.72 (dd, <i>J</i> = 1.89/8.83 Hz, 1H, Ph), 7.79 (dd, <i>J</i> = 2.53/8.83 Hz, 1H, Ph), 8.20 (d, <i>J</i> = 2.21 Hz, 1H, Ph), 8.26 (d, <i>J</i> = 1.89 Hz, 1H, Ph), 10.34 (s, 1H, −CONH−), 11.39 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 102.5, 111.3, 120.2, 120.8, 121.1, 121.3, 124.6, 125.2, 127.2, 127.2, 130.6, 130.9, 138.0, 140.1, 167.0. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 303 [M – H]<sup>−</sup>, positive mode 305 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> <i>N</i>-(3,4-Dichlorophenyl)imidazo[1,2-<i>a</i>]pyridine-6-carboxamide (<b>55</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by repeated silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>55</b> as a white solid (93 mg, 36%); mp 268–269 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.63 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.67 (d, <i>J</i> = 9.46 Hz, 1H, het), 7.69 (d, <i>J</i> = 0.95 Hz, 1H), 7.72 (d, <i>J</i> = 1.89/9.46 Hz, 1H, het), 7.73 (dd, <i>J</i> = 2.21/8.52 Hz, 1H, Ph), 8.10 (s, 1H, het), 8.13 (d, <i>J</i> = 2.52 Hz, 1H, Ph), 9.25 (dd, <i>J</i> = 0.94/1.89 Hz, 1H, het), 10.58 (s, 1H, −CONH−). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 114.6, 116.4, 119.8, 120.4, 121.6, 123.1, 125.4, 129.3, 130.8, 131.1, 134.9, 139.2, 144.8, 163.9. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 304 [M – H]<sup>−</sup>, positive mode 306 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> <i>N</i>-(3,4-Dichlorophenyl)-[1,2,4]triazolo[4,3-<i>a</i>]pyridine-6-carboxamide (<b>56</b>)</h5><div class="NLM_p last">The compound was prepared following method 2. Purification by repeated silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>56</b> as a yellowish solid (111 mg, 36%); mp 326–327 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 6.63 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.71 (dd, <i>J</i> = 2.20/8.83 Hz, 1H, Ph), 7.82 (dd, <i>J</i> = 1.26/9.45 Hz, 1H, het), 7.89 (d, <i>J</i> = 9.46 Hz, 1H, het), 8.10 (d, <i>J</i> = 2.20 Hz, 1H, Ph), 9.24 (s, 1H, het), 9.42 (s, 1H, het), 10.67 (s, 1H, −CONH−). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 114.8, 120.5, 121.4, 121.7, 125.8, 126.8, 127.6, 130.9, 131.2, 137.8, 139.0, 148.5, 163.2. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 305 [M – H]<sup>−</sup>, positive mode 307 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> General Procedure B for the Preparation of <i>N</i>-Methylated Compounds <b>38a</b>,<b>b</b> and <b>54</b></h4><div class="NLM_p">To a solution of the respective <i>N</i>-(3,4-dichlorophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>15</b>) or <i>N</i>-(3,4-dichlorophenyl)-1<i>H</i>-indole-5-carboxamide (<b>53</b>) (1.0 equiv) and potassium carbonate (1.2 equiv) in DMF (10.0 mL/mmol; extra dry over molecular sieves, 99.8%, Acros) was added methyl iodide (1.3–2.0 equiv). The mixture was stirred at room temperature until completed conversion could be detected (TLC control: CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v), hydrolyzed with water (20 mL/mmol), and acidified with hydrochloric acid (2N, 2.0 mL/mmol). The precipitate formed was filtered, washed three times with water (10 mL), and dried at 70 °C. The crude product was purified by column chromatography on silica gel and recrystallized as indicated below.</div><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> <i>N</i>-(3,4-Dichlorophenyl)-1-methyl-1<i>H</i>-indazole-5-carboxamide (<b>38a</b>)</h5><div class="NLM_p last">Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>38a</b> as a white crystalline solid (37 mg, 47%); mp 193–194 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 4.09 (s, 3H, N1Me), 7.61 (d, <i>J</i> = 8.82 Hz, 1H, Ph), 7.76 (d, <i>J</i> = 8.20 Hz, 1H, Ph), 7.78 (dd, <i>J</i> = 2.21/8.83 Hz, 1H, Ph), 7.98 (dd, <i>J</i> = 1.57/8.82 Hz, 1H, Ph), 8.18 (d, <i>J</i> = 2.52 Hz, 1H, Ph), 8.24 (d, <i>J</i> = 0.63 Hz, 1H, ind-het), 8.46 (dd, <i>J</i> = 0.63/1.57 Hz, 1H, Ph), 10.49 (s, 1H, −CONH−). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 35.7 (N1Me), 109.8, 120.3, 121.5, 121.9, 123.1, 125.0, 125.6, 126.7, 130.7, 131.0, 134.2, 139.7, 140.9, 166.1. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 318 [M – H]<sup>−</sup>, positive mode 320 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> <i>N</i>-(3,4-Dichlorophenyl)-2-methyl-1<i>H</i>-indazole-5-carboxamide (<b>38b</b>)</h5><div class="NLM_p last">Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>38a</b> as a white solid (8 mg, 9%); mp 181–182 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 4.23 (s, 3H, N2Me), 7.60 (d, J = 8.82 Hz, 1H, Ph), 7.68 (dt, <i>J</i> = 0.95/8.82 Hz, 1H), 7.75 (s, 1H, Ph), 7.76 (dd, <i>J</i> = 2.21/8.83 Hz, 1H, Ph), 8.16 (d, <i>J</i> = 0.63 Hz, 1H, Ph), 8.44 (dd, <i>J</i> = 0.94/1.89 Hz, 1H, Ph), 8.58 (s, 1H, ind-het), 10.44 (s, 1H, −CONH−). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 48.8 (N2Me), 116.9, 120.4, 120.9, 121.5, 122.4, 124.6, 125.0, 127.1, 127.2, 130.7, 131.0, 139.8, 149.1, 166.4. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 318 [M – H]<sup>−</sup>, positive mode 320 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> <i>N</i>-(3,4-Dichlorophenyl)-2-methyl-1<i>H</i>-indole-5-carboxamide (<b>54</b>)</h5><div class="NLM_p last">Purification by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) following by recrystallization two times from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub> afforded <b>54</b> as a white solid (17 mg, 68%); mp 179–180 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 3.83 (s, 3H, N1Me), 6.59 (dd, <i>J</i> = 0.95/3.16 Hz, 1H, indol-het), 7.44 (d, <i>J</i> = 3.16 Hz, 1H, indol-het), 7.55 (d, <i>J</i> = 8.83 Hz, 1H, Ph), 7.59 (d, <i>J</i> = 8.82 Hz, 1H, Ph), 7.78 (dd, <i>J</i> = 2.52/3.15 Hz, 1H, Ph), 7.80 (dd, <i>J</i> = 2.52/3.47 Hz, 1H, Ph), 8.20 (d, <i>J</i> = 2.21 Hz, 1H, Ph), 8.26 (d, <i>J</i> = 1.26 Hz, 1H, Ph), 10.35 (s, 1H, −CONH−). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 32.8 (NMe), 101.9, 109.7, 120.2, 121.0, 121.1, 121.4, 124.7, 125.2, 127.5, 130.6, 130.9, 131.5, 138.3, 140.0, 166.9. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 317 [M – H]<sup>−</sup>, positive mode 319 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> General Procedure C for the Preparation Compounds <b>58</b> and <b>59</b></h4><div class="NLM_p">A solution of the corresponding 1<i>H</i>-indazole-5-carboxaldehyde (<b>57</b>, 1.0 equiv), 3,4-dichloroaniline (<b>23a</b>, 1.0 equiv) and acetic acid (0.2 mL) in ethanol (3.0 mL/mmol) was stirred under reflux until a precipitation took place. After cooling to room temperature, water (30 mL) was added and the reaction mixture was sonificated for 5 min. The precipitate formed was filtered and dried at 70 °C and purified by column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 9:1 v/v) and recrystallized from petroleum ether/CH<sub>2</sub>Cl<sub>2</sub>.</div><div id="sec4_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> (<i>E</i>)-<i>N</i>-(3,4-Dichlorophenyl)-1-(1<i>H</i>-indazol-5-yl)methanimine (<b>58</b>)</h5><div class="NLM_p last">White solid (258 mg, 90%); mp 207–208 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.27 (dd, <i>J</i> = 2.52/8.51 Hz, 1H, Ph), 7.55 (d, <i>J</i> = 2.53 Hz, 1H, Ph), 7.63 (s, 1H, Ph), 7.65 (s, 1H, Ph), 8.12 (dd, <i>J</i> = 1.26/8.83 Hz, 1H, Ph), 8.24 (s, 1H, ind-het), 8.29 (s, 1H, Ph), 8.73 (s, 1H, CH═N), 13.35 (s, 1H, NH). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 110.9, 122.1, 122.7, 123.0, 125.1, 125.2, 127.7, 128.9, 131.1, 131.7, 135.2, 141.5, 151.9, 163.2. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 288 [M – H]<sup>−</sup>, positive mode 290 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> (<i>E</i>)-<i>N</i>-(3,4-Dichlorophenyl)-1-(1-methyl-1<i>H</i>-indazol-5-yl)methanimine (<b>59</b>)</h5><div class="NLM_p last">Light-yellowish solid (275 mg, 91%); mp 145–146 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 4.09 (s, 3H, N1Me), 7.28 (dd, <i>J</i> = 2.53/8.52 Hz, 1H, Ph), 7.56 (d, <i>J</i> = 2.53 Hz, 1H, Ph), 7.63 (s, 1H, Ph), 7.65 (s, 1H, Ph), 7.75 (dd, <i>J</i> = 0.63/8.83 Hz, 1H, Ph), 8.05 (dd, <i>J</i> = 1.58/8.83 Hz, 1H, Ph), 8.22 (d, <i>J</i> = 0.94 Hz, 1H, ind-het), 8.28 (s, 1H, Ph), 8.74 (s, 1H, CH═N). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 35.7, 110.5, 122.1, 122.7, 123.6, 125.0, 125.3, 125.2, 127.8, 128.9, 131.1, 131.7, 134.2, 141.1, 151.8, 163.0. LC/ESI-MS (<i>m</i>/<i>z</i>): negative mode 302 [M – H]<sup>−</sup>, positive mode 304 [M + H]<sup>+</sup>.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Biological Experiments</h3><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> MAO-A and MAO-B Inhibition Assays</h4><div class="NLM_p">Stock solutions of the compounds (10 mM) in DMSO were used to prepare the test samples for the MAO assays with a final DMSO concentration of 1.0% as described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The MAO-A and MAO-B enzymatic activity of the compounds was measured using a continuous fluorescence-based assay.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The MAO experiments were performed using the commercial assay kit Amplex Red (compare <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The kit was stored frozen at ≤ −20 °C and protected from light. To ensure an optimal efficiency of the Amplex Red reagent, the rat and human MAO assay was performed at pH 7.4. The quantification of hydrogen peroxide released from the biological sample and the subsequent production of resorufin was monitored using a microplate fluorescence reader (PHERAstar BMG Labtech, Germany) with an excitation at 544 nm and an emission at 590 nm. The MAO experiments were performed in triplicate or quadruplicate at room temperature.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> Rat MAO Inhibition Assays</h5><div class="NLM_p last">To obtain MAO enzyme-containing mitochondrial-enriched fractions of rat, livers from male Sprague–Dawley rats (250–300 g, Harlan Sprague–Dawley, Dublin, VA, US) were obtained. These were livers that were left over from control rats that had been used for other experiments. The livers (10.0 g) were dissected, given into 15.0 mL of an ice-cold 5.0 mM Hepes buffer (pH 7.4), containing 210 mM of mannitol, 70 mM of sucrose, 0.5 mM of ethylene glycoltetraacetic acid (EGTA), and 2.0 mg/mL of bovine serum albumin (BSA), and homogenized using a glass/Teflon potter (10 ups and downs at 1100 rpm). After homogenization, the volume was adjusted to 100 mL with the same buffer. After a low speed centrifugation (10 min at 600<i>g</i>; 4 °C), the supernatant was further centrifuged at 15000 rpm for 5 min at +4 °C. The resulting pellet was resuspended in 2.0 mL of a 50 mM sodium phosphate buffer (pH 7.4) and stored at −80 °C in aliquots of 1.0 mL until further use. Assays were performed in 96-well plates in a final volume of 200 μL at RT. Rat liver mitochondria were pretreated for 15 min at RT with an aqueous solution of clorgyline (30 nM) or selegiline (300 nM) to irreversibly block MAO-A or MAO-B activity, respectively. Test compounds (2.0 μL), dissolved in DMSO (100%), were added to 90.0 μL of mitochondrial preparation (25.0 μg of protein for rat MAO-A and 5.0 μg protein for rat MAO-B) and incubated for 30 min prior to the addition of 90 μL of freshly prepared Amplex Red reagent. The Amplex Red reagent was used as follows: for a 96-well plate, 1.0 mg of Amplex Red, dissolved in 200 μL of DMSO (100%) and 100 μL of reconstituted horseradish peroxidase (HRP 200 U/mL) stock solution (kit vial + 1.0 mL of 50 mM sodium phosphate buffer) were added to 9700 μL of sodium phosphate buffer (250 mM, pH 7.4). The enzymatic reaction was started by the addition of 20 μL/well of an aqueous solution of the substrate <i>p</i>-tyramine (300 μM final concentration). Selegiline and clorgyline (each in a final concentration of 1.0 μM) were used to determine non-MAO-B and non-MAO-A enzyme activity, respectively. Fluorescence measurements were performed for 45 min, and the concentration–response curves of clorgyline and selegiline served as positive controls for the rat MAO-A and rat MAO-B assay, respectively.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Human MAO Inhibition Assays</h4><div class="NLM_p">Recombinant human MAO-A and MAO-B enzymes, expressed in baculovirus-infected insect cells, were purchased from Sigma-Aldrich (M7441, M7316). The assays were carried out in 96-well plates in a final volume of 200 μL at RT. According to the experimental protocol, a solution of test compound (2.0 μL) in DMSO (100%) was added to 90.0 μL of protein solution (for MAO-A, 0.3 μg protein/well, containing 6.6 μL of protein and 9.993 μL of phosphate buffer, 50 mM; for MAO-B, 2.3 μg protein/well containing 51.0 μL of protein and 9.949 μL of buffer) and incubated for 30 min prior to the addition of 90 μL of freshly prepared Amplex Red reagent. The Amplex Red reagent was prepared as described above. The enzymatic reaction was started by the addition of 20 μL/well of an aqueous solution of the substrate <i>p</i>-tyramine (150 μM final concentration). Non-MAO-B and non-MAO-A enzyme activity was determined in the presence of selegiline and clorgyline (each in a final concentration of 1.0 μM) and subtracted from the total activity measured. A sample with DMSO (2.0 μL) was used as a negative control. Fluorescence measurements were performed for 45 min and the concentration–response curves of clorgyline and selegiline served as positive controls for the human MAO-A and human MAO-B assay, respectively.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> Reversibility of MAO-B</h5><div class="NLM_p last">To investigate the reversibility of MAO-B inhibition by compound <b>15</b>, we performed time-dependent inhibition experiments using human MAO-B. Compound <b>15</b> as well as reference compounds selegiline<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and safinamide<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> were examined at their corresponding IC<sub>80</sub> values (determined with 150 μM of the substrate <i>p</i>-tyramine). The human MAO-B enzyme/inhibitor mixtures were not preincubated. The enzyme reaction was started by the addition of a low substrate concentration of 10 μM and the enzymatic activity of the test compounds was measured for 22 min followed by an increase in the substrate concentration to 1.0 mM final concentration of <i>p</i>-tyramine. The enzyme reactivation was monitored by fluorescence measurements over a period of 5 h.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> Kinetic MAO-B Experiments</h5><div class="NLM_p last">To evaluate the mode of MAO-B inhibition, the representative inhibitor <i>N</i>-(3,4-dichlorophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>15</b>) was evaluated in substrate-dependent kinetic experiments, and the corresponding progression curves as well as sets of Lineweaver–Burk plots were generated. The reciprocal MAO-B activity was plotted against the reciprocal substrate concentration. The initial catalytic rates of human MAO-B were measured at six different concentrations of the substrate <i>p</i>-tyramine (0.05, 0.1, 0.25, 0.5, 1.0, and 1.5 mM) in the absence (basal sample) and in the presence of three different concentrations (0.1, 0.5, and 1.0 nM) of the inhibitor <b>15</b>. The enzymatic reactions and measurements were performed using human MAO-B assay conditions as described above for the determination of IC<sub>50</sub> values.</div></div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Data Analysis</h3><div class="NLM_p last">Enzyme inhibition was initially determined with at least two different concentrations (10 and 0.1 μM) of test compound, each performed in triplicate and, if necessary, in quadruplicate. For potent compounds, full concentration–inhibition curves were determined and IC<sub>50</sub> values were calculated by nonlinear regression (curve fit) analysis. Data were expressed as mean IC<sub>50</sub> value ± SEM (standard error of the mean). Generally, SEM values were lower than 10% of the calculated mean. Preparation of the corresponding dose–response curves as well as the nonlinear and linear regression analysis was performed using GraphPad Prism Version 4.0 software (San Diego, CA, USA).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Molecular Modeling Studies</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Data Preparation and Optimization</h4><div id="sec4_6_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> MAO-B Protein</h5><div class="NLM_p last">The crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a>) of the human MAO-B in complex with safinamide (<b>3</b>) was obtained from the PDB web page and prepared using the LeadIT v.2.1.6 software from BioSolveIT GmbH, Germany.<a onclick="showRef(event, 'ref44 ref47'); return false;" href="javascript:void(0);" class="ref ref44 ref47">(44, 47)</a> To decide which chain (A or B) should be considered for the docking experiments, we computed an initial HYDE visual affinity assessment for the two crystallographically recorded ligand positions (SAG_A vs SAG_B). It turned out that, owing to small differences in atomic positions, the ligand crystallized in the pocket formed by chain B exhibited a slightly better agreement between experiment and computation; therefore we chose chain B for all further computations. The protein preparation used defaults throughout, with the exception of a slight increase regarding the radius of the binding site definition, which was set to 7 Å (default: 6.5 Å), motivated by consistency to other experiments (unpublished). Protonation and tautomer selection were carried out automatically by the integrated ProToss functionality in LeadIT. Water selection was determined also automatically by LeadIT; unless otherwise mentioned, this preparation was used for all crystal structure computations, dockings, and scorings.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61, 62)</a></div></div><div id="sec4_6_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> Ligands</h5><div class="NLM_p last">To obtain valid 3D input structures for docking experiments, starting structures of the ligands <b>15</b>, <b>40</b>, and <b>53</b> were drawn in Titan v.1.05 (Wavefunction Inc. 2000), subsequently energy-optimized using the MMFF94 force field, and saved as mol2 files.</div></div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Computational Details</h3><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Docking</h4><div class="NLM_p last">All computations were carried out using the FlexX docking module in LeadIT v.2.1.6 by applying the binding size definitions and water handling described above. A LeadIT Project File (*.fxx) was created and saved on disk. The docking algorithms in LeadIT incorporate both a triangle-based placement algorithm and the so-called Single-Interaction-Scan (FlexSIS), which are activated by default. This way, a 50:50 merge process of poses (triangle vs SIS) is executed. A maximum of 32 poses was stored for postprocessing with HYDE. Computational experiments using a receptor-based pharmacophore, which would force any halogen into the 2V5Z-known halogen binding pocket (HBP), yielded essentially the same poses as the unconstrained docking on high ranks, both as a function of the docking score, as well as in terms of the HYDE computation.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> HYDE Rescoring and HYDE Visual Affinities</h4><div class="NLM_p">HYDE is a recently developed mechanism to rapidly compute estimations of binding affinities (Binding Free Energies). It is based solely on a (weighting-parameter free) description of hydrogen bonds, salt bridges, etc., on the one hand side, and desolvation (dehydration) terms on the other, as given by eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a>:<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/jm-2014-00729a_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>Herein, <i>i</i> is an atom counter running over all contributing protein and ligand atoms. The final, reported affinity estimate corresponds to the sum over all atoms. In contrast to requiring weighting against each other using fitted parameters, these two terms are connected using an atomic logP increment system which enables the user to visualize atom-based contributions to the affinity, and thus to explain unexplained SAR and/or point to room for lead optimization. The individual terms of eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a> take the form:<span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/jm-2014-00729a_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span>and<span class="NLM_disp-formula" id="eq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/jm-2014-00729a_m003.gif" alt="" /></img><span class="labelSpan">(3)</span></span>where plogP is the “partial logP” for a given atom type, <i>f</i><sub>sat</sub>(<i>T</i>) describes the temperature-dependent amount of defects in tetrahedral coordination in bulk water and is constant for a given temperature. The Δinteract term ensures that only differences between the unbound and the bound states in terms of H-bonds are captured, and the Δaccessibility term captures the “buriedness” of a certain group (calculated by a term based on the difference of solvent accessible surface). For further details regarding the methods, refer to the recent publication by Schneider et al.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">HYDE calculations run within a very few seconds per compound on a standard CPU core; their output is an estimated binding affinity, the respective ligand efficiency (LE<sub>HYDE</sub>), and certainly the visualization of an atom-colored molecule in 3D. HYDE-based ligand efficiency values (LE<sub>HYDE</sub>) were calculated in kcal/mol using eq <a class="ref internalNav" href="#eq4" aria-label="4">4</a>:<span class="NLM_disp-formula" id="eq4"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/jm-2014-00729a_m004.gif" alt="" /></img><span class="labelSpan">(4)</span></span>Herein, HA is the number of non-hydrogen atoms of the respective ligand (heavy atoms). The atom colors range from dark-green (contributes favorably to affinity) over white (no contribution) to dark-red (unfavorable contribution to affinity). Because HYDE receptor contributions are projected onto the relevant ligand molecule in the 3D visualization, it may occur that, e.g., a red atom is red because close receptor atoms contribute with a high desolvation penalty. A table in the software enables a quantitative split-up of HYDE atomic energies with respect to their originating atoms (receptor or ligand). Because other important terms such as inter/intramolecular clash and torsional strain are not included in the HYDE kernel mathematics, it is highly advisable to preoptimize respective molecular input so that these terms are negligibly small. This optimization is based on a linear combination of HYDE and classical force field terms, and by default it is automatically carried out upon evoking a HYDE calculation.</div><div class="NLM_p last">For rescoring, previous experience proposed to file 32 FlexX/-SIS placements into HYDE. For this study, however, it turned out indeed that the HYDE best-scored pose for all ligands was always among the top 10 docking solutions (compare in <a class="ref internalNav" href="#sec2" aria-label="Results and Discussion">Results and Discussion</a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Because the former is considered best practice, we filed a maximum of 32 poses into HYDE and selected the best-scored ones thereafter.</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Visual Inspection of Computed Results</h4><div class="NLM_p last">Because the HYDE kernel, as mentioned above, does not contain torsional energy terms, we (additionally to the preoptimizer) double-checked the torsional conspicuous arrangements visually. Results were therefore visualized using the TorsionAnalyzer software allowing a quick assessment of the statistical significance of torsion patterns.<a onclick="showRef(event, 'ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65">(63-65)</a> A multi-SD file of the relevant poses was loaded into TorsionAnalyzer and briefly controlled. It should be stressed that the respective coloring (<i>red</i> = rarely/not observed; <i>orange</i> = observed sometimes; <i>green</i> = observed often) is based on statistics rooting in Cambridge Structural Database (CSD) occurrence and not on any energetics.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80"><a href="/doi/suppl/10.1021/jm500729a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41770" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41770" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and analytic data of carboxylic acids <b>18</b> and <b>19</b>; <sup>1</sup>H and <sup>13</sup>C NMR spectra of compounds <b>10</b> and <b>11</b>, conditions for chromatography; LC/ESI-MS data for all new compounds; stability studies for compounds <b>54</b> and <b>59</b>; analysis of <i>E</i>/<i>Z</i> isomers stability for <b>58</b>; physicochemical profiling of all new compounds including calculated important parameters and plots; pharmacological studies and correlation of inhibition data of rat versus human MAO-B for all tested compounds, and computational analysis of compounds <b>15</b> and <b>30</b> in comparison with safinamide <b>3</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500729a/suppl_file/jm500729a_si_001.pdf">jm500729a_si_001.pdf (1.99 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500729a" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nikolay T. Tzvetkov</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Institute, Pharmaceutical
Chemistry I, PharmaCenter Bonn, University
of Bonn, An der Immenburg
4, D-53121 Bonn, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#523c2628243726393d2412273c3b7f303d3c3c7c3637"><span class="__cf_email__" data-cfemail="f59b818f8390819e9a83b5809b9cd8979a9b9bdb9190">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christa E. Müller</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Institute, Pharmaceutical
Chemistry I, PharmaCenter Bonn, University
of Bonn, An der Immenburg
4, D-53121 Bonn, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#98fbf0eaf1ebecf9b6f5edfdf4f4fdead8edf6f1b5faf7f6f6b6fcfd"><span class="__cf_email__" data-cfemail="eb88839982989f8ac5869e8e87878e99ab9e8582c689848585c58f8e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonja Hinz</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Institute, Pharmaceutical
Chemistry I, PharmaCenter Bonn, University
of Bonn, An der Immenburg
4, D-53121 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Petra Küppers</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Institute, Pharmaceutical
Chemistry I, PharmaCenter Bonn, University
of Bonn, An der Immenburg
4, D-53121 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcus Gastreich</span> - <span class="hlFld-Affiliation affiliation">BioSolveIT GmbH, An der Ziegelei 79, 53757 St. Augustin, Germany</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d177e7097-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Jag Heer and Dr. Miriam Schlenk for helpful discussions and suggestions, Angelika Fischer and Anika Püsche for expert technical assistance in performing MAO inhibition assays, Marion Schneider for performing LC/MS analyses, and Sabine Terhart-Krabbe and Annette Reiner for recording NMR spectra.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i82" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i82"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i83" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i83"> Abbreviations Used</h2><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">AR</td><td class="NLM_def"><p class="first last">adenosine receptor</p></td></tr><tr><td class="NLM_term">BEI</td><td class="NLM_def"><p class="first last">binding efficiency index</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">COMT</td><td class="NLM_def"><p class="first last">catechol-<i>O</i>-methyltransferase</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)-carbodiimide</p></td></tr><tr><td class="NLM_term">EGTA</td><td class="NLM_def"><p class="first last">ethylene glycoltetraacetic acid</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">flavin adenine dinucleotide</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">human</p></td></tr><tr><td class="NLM_term">HBP</td><td class="NLM_def"><p class="first last">hydrogen binding pocket</p></td></tr><tr><td class="NLM_term">HMBC</td><td class="NLM_def"><p class="first last">heteronuclear multiple bond correlation</p></td></tr><tr><td class="NLM_term">HRP</td><td class="NLM_def"><p class="first last">horseradish peroxidase</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">r</td><td class="NLM_def"><p class="first last">rat</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SIS</td><td class="NLM_def"><p class="first last">single-interaction-scan</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40100" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40100" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 65 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Monoamine oxidase B inhibition and neuroprotection</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 6</span><span class="NLM_x">) </span> <span class="NLM_fpage">S62</span><span class="NLM_x">–</span> <span class="NLM_lpage">S68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=S62-S68&issue=Suppl+6&author=N.+Castagnoliauthor=J.+P.+Petzerauthor=S.+Steynauthor=K.+Castagnoliauthor=J.-F.+Chenauthor=M.+A.+Schwarzschildauthor=C.+J.+Van+der+Schyf&title=Monoamine+oxidase+B+inhibition+and+neuroprotection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DSteyn%26aufirst%3DS.%26aulast%3DCastagnoli%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DMonoamine%2520oxidase%2520B%2520inhibition%2520and%2520neuroprotection%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26issue%3DSuppl%25206%26spage%3DS62%26epage%3DS68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shih, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridd, M. J.</span><span> </span><span class="NLM_article-title">Monoamine oxidase: from genes to behavior</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1146%2Fannurev.neuro.22.1.197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=10202537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFemsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=197-217&author=J.+C.+Shihauthor=K.+Chenauthor=M.+J.+Ridd&title=Monoamine+oxidase%3A+from+genes+to+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase: from genes to behavior</span></div><div class="casAuthors">Shih, J. C.; Chen, K.; Ridd, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">197-217</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with ∼130 refs.  Cloning of MAO (monoamine oxidase) A and B has demonstrated unequivocally that these enzymes are made up of different polypeptides, and our understanding of MAO structure, regulation, and function has been significantly advanced by studies using their cDNA.  MAO A and B genes are located on the X-chromosome (Xp11.23) and comprise 15 exons with identical intron-exon organization, which suggests that they are derived from the same ancestral gene.  MAO A and B knock-out mice exhibit distinct differences in neurotransmitter metab. and behavior.  MAO A knock-out mice have elevated brain levels of serotonin, norepinephrine, and dopamine and manifest aggressive behavior similar to human males with a deletion of MAO A.  In contrast, MAO B knock-out mice do not exhibit aggression and only levels of phenylethylamine are increased.  Mice lacking MAO B are resistant to the Parkinsongenic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.  Both MAO A and B knock-out mice show increased reactivity to stress.  These knock-out mice are valuable models for investigating the role of monoamines in psychoses and neurodegenerative and stress-related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9r853xrSk7bVg90H21EOLACvtfcHk0lgVhFZMV47JiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFemsrk%253D&md5=bbe78d2100a36681f2c1c51938ab4b98</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.22.1.197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.22.1.197%26sid%3Dliteratum%253Aachs%26aulast%3DShih%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DRidd%26aufirst%3DM.%2BJ.%26atitle%3DMonoamine%2520oxidase%253A%2520from%2520genes%2520to%2520behavior%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1999%26volume%3D22%26spage%3D197%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton-Vinson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubálek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders</span> <span class="citation_source-journal">Nature Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1038%2Fnsb732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=11753429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=22-26&author=C.+Bindaauthor=P.+Newton-Vinsonauthor=F.+Hub%C3%A1lekauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structure+of+human+monoamine+oxidase+B%2C+a+drug+target+for+the+treatment+of+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders</span></div><div class="casAuthors">Binda, Claudia; Newton-Vinson, Paige; Hubalek, Frantisek; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-26</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is a mitochondrial outer membrane flavoenzyme that is a well-known target for antidepressant and neuroprotective drugs.  Here, the authors detd. the structure of the human liver enzyme to 3 Å resoln.  Human liver MAO B was found to bind to the membrane through a C-terminal transmembrane helix and apolar loops located at various positions in the sequence.  The electron d. showed that pargyline, an analog of the clin. used MAO B inhibitor, deprenyl, binds covalently to the flavin N5 atom.  The active site of MAO B consisted of a 420-Å3 hydrophobic substrate cavity interconnected to an entrance cavity of 290 Å3.  The recognition site for the substrate amino group was an arom. cage formed by Tyr-398 and Tyr-435.  The structure provides a framework for probing the catalytic mechanism, understanding the differences between the MAO A and B isoforms and designing specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8p43h-vsPi7Vg90H21EOLACvtfcHk0lgVhFZMV47JiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D&md5=261d3b1375d833bbfd0a23bdade49be6</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1038%2Fnsb732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb732%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DNewton-Vinson%26aufirst%3DP.%26aulast%3DHub%25C3%25A1lek%26aufirst%3DF.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructure%2520of%2520human%2520monoamine%2520oxidase%2520B%252C%2520a%2520drug%2520target%2520for%2520the%2520treatment%2520of%2520neurological%2520disorders%26jtitle%3DNature%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D22%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hubálek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span> </span><span class="NLM_article-title">Structural comparison of human monoamine oxidases A and B</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">28612</span><span class="NLM_x">–</span> <span class="NLM_lpage">28618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=28612-28618&author=F.+Hub%C3%A1lekauthor=J.+Pohlauthor=D.+E.+Edmondson&title=Structural+comparison+of+human+monoamine+oxidases+A+and+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHub%25C3%25A1lek%26aufirst%3DF.%26aulast%3DPohl%26aufirst%3DJ.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26atitle%3DStructural%2520comparison%2520of%2520human%2520monoamine%2520oxidases%2520A%2520and%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D28612%26epage%3D28618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavie, L.</span><span> </span><span class="NLM_article-title">Selective MAO-A and MAO-B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson’s disease</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1994&pages=2077-2082&author=M.+B.+H.+Youdimauthor=L.+Lavie&title=Selective+MAO-A+and+MAO-B+inhibitors%2C+radical+scavengers+and+nitric+oxide+synthase+inhibitors+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DLavie%26aufirst%3DL.%26atitle%3DSelective%2520MAO-A%2520and%2520MAO-B%2520inhibitors%252C%2520radical%2520scavengers%2520and%2520nitric%2520oxide%2520synthase%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DLife%2520Sci.%26date%3D1994%26volume%3D55%26spage%3D2077%26epage%3D2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hauptmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadenas, E.</span><span> </span><span class="NLM_article-title">The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1006%2Fabbi.1996.0510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=8914926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK28XntVKlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1996&pages=295-304&author=N.+Hauptmannauthor=J.+Grimsbyauthor=J.+C.+Shihauthor=E.+Cadenas&title=The+metabolism+of+tyramine+by+monoamine+oxidase+A%2FB+causes+oxidative+damage+to+mitochondrial+DNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA</span></div><div class="casAuthors">Hauptmann, Nils; Grimsby, Joseph; Shih, Jean C.; Cadenas, Enrique</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-304</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Monoamine oxidases A/B (EC 1.4.3.4, MAO), flavoenzymes located on the outer mitochondrial membrane, catalyze the oxidative deamination of biogenic amines, such as dopamine, serotonin, and norepinephrine.  In this study, the authors examd. whether the H2O2 formed during the two-electron oxidn. of tyramine [4-(2-aminoethyl)phenol] (a substrate for monoamine oxidases A/B) may contribute to the intramitochondrial steady-state concn. of H2O2 ([H2O2]ss) and, thus, be involved in the oxidative impairment of mitochondrial matrix components.  Supplementation of intact, coupled rat brain mitochondria with benzylamine, β-phenylethylamine, or tyramine showed initial rates of H2O2 prodn. ranging from 0.4 to 1.6 nmol H2O/min/mg protein.  ESR anal. of the oxidative deamination of tyramine by intact rat brain mitochondria revealed the formation of hydroxyl (HO•) and carbon-centered radical adducts - the latter probably originating by the HO•-mediated oxidn. of mannitol.  The signals were substantially enhanced upon addn. of FeSO4 and were abolished by catalase.  The intramitochondrial [H2O2]ss calcd. in terms of glutathione peroxidase activity during the metab. of tyramine was 48-fold higher (7.71 × 10-7 M) than that obtained during the oxidn. of succinate via complex II in the presence of antimycin A (1.64 × 10-8 M).  Oxidn. damage to the brain mtDNA was assessed by single strand breakage.  The ratio of nicked DNA for the prepns. treated with tyramine and those without the amine was 1.5, 2.12, and 3.12 at 15, 30, and 60 min, resp.  Preincubation of mitochondria with tranylcypromine (trans-2-phenylcyclopropylamine), an inhibitor to MAO A/B, abolished mtDNA oxidative damage.  Catalase inhibited mtDNA strand breakage by approx. 60%.  Incubation of intact, coupled rat brain mitochondria with chlorodinitrobenzene (CDNB) depleted mitochondrial GSH by 72%.  Tyramine-dependent damage of mtDNA was decreased by 68% in CDNB-treated mitochondria (with 28% remaining GSH).  The [H2O2]ss was slightly increased in CDNB-treated mitochondria: 1.38- and 1.28-fold increase during the oxidn. of succinate in the presence of antimycin A and during the oxidn. of tyramine, resp.  These results suggest that the H2O2 generated during the MAO-catalyzed oxidn. of biogenic amines and possibly certain neurotransmitters at the outer mitochondrial membrane contributes to the intramitochondrial [H2O2]ss and may cause oxidative damage to mtDNA.  This is effected by the intramitochondrial concn. of GSH and might have potential implications for aging and neurodegenerative processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxh4xplKDn47Vg90H21EOLACvtfcHk0lgVhFZMV47JiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntVKlt7w%253D&md5=9f34268c9ffaf56ed4746c7b3415df55</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1996.0510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1996.0510%26sid%3Dliteratum%253Aachs%26aulast%3DHauptmann%26aufirst%3DN.%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26aulast%3DCadenas%26aufirst%3DE.%26atitle%3DThe%2520metabolism%2520of%2520tyramine%2520by%2520monoamine%2520oxidase%2520A%252FB%2520causes%2520oxidative%2520damage%2520to%2520mitochondrial%2520DNA%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1996%26volume%3D335%26spage%3D295%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sayre, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Oxidative stress and neurotoxicity</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700210j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlygsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=172-188&author=L.+M.+Sayreauthor=G.+Perryauthor=M.+A.+Smith&title=Oxidative+stress+and+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress and Neurotoxicity</span></div><div class="casAuthors">Sayre, Lawrence M.; Perry, George; Smith, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-188</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is increasing awareness of the ubiquitous role of oxidative stress in neurodegenerative disease states.  A continuing challenge is to be able to distinguish between oxidative changes that occur early in the disease from those that are secondary manifestations of neuronal degeneration.  This perspective highlights the role of oxidative stress in Alzheimer's, Parkinson's, and Huntington's diseases, amyotrophic lateral sclerosis, and multiple sclerosis, neurodegenerative and neuroinflammatory disorders where there is evidence for a primary contribution of oxidative stress in neuronal death, as opposed to other diseases where oxidative stress more likely plays a secondary or by-stander role.  We begin with a brief review of the biochem. of oxidative stress as it relates to mechanisms that lead to cell death, and why the central nervous system is particularly susceptible to such mechanisms.  Following a review of oxidative stress involvement in individual disease states, some conclusions are provided as to what further research should hope to accomplish in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyOa0kfz_RVLVg90H21EOLACvtfcHk0lhAxzUNrxhiIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlygsr3K&md5=800757a60a32641257fad2fe97fd20bd</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1021%2Ftx700210j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700210j%26sid%3Dliteratum%253Aachs%26aulast%3DSayre%26aufirst%3DL.%2BM.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DOxidative%2520stress%2520and%2520neurotoxicity%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D172%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P. M.</span><span> </span><span class="NLM_article-title">New directions in monoamine oxidase A and B selective inhibitors and substrates</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1991&pages=155-162&author=M.+B.+H.+Youdimauthor=J.+P.+M.+Finberg&title=New+directions+in+monoamine+oxidase+A+and+B+selective+inhibitors+and+substrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DNew%2520directions%2520in%2520monoamine%2520oxidase%2520A%2520and%2520B%2520selective%2520inhibitors%2520and%2520substrates%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1991%26volume%3D41%26spage%3D155%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shih, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span> </span><span class="NLM_article-title">Regulation of MAO-A and MAO-B gene expression</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1995</span><span class="NLM_x">–</span> <span class="NLM_lpage">2005</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.2174%2F0929867043364757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15279563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1995-2005&author=J.+C.+Shihauthor=K.+Chen&title=Regulation+of+MAO-A+and+MAO-B+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of MAO-A and MAO-B gene expression</span></div><div class="casAuthors">Shih, J. C.; Chen, K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1995-2005</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">MAO-A and -B genes are made of 15 exons with identical exon-intron organization.  They are located on X-chromosome organized in opposite direction, tail to tail with 24kb apart.  Both promoters are GC-rich and regulated by transcription factor Sp1.  However, they have distinctly different features.  MAO-B gene, but not MAO-A gene, has TATA box.  MAO B promoter contains two clusters of overlapping Sp1 sites, the CACCC repressor element.  Transcription factors Sp1 and Sp4 can activate MAO-B promoter activity through the proximal cluster of Sp1 sites and its activation can be repressed by the over-expression of Sp3 and a related family member, BTEB2.  Decreased methylation and transcription repressor Sp3 upregulate human MAO-B, but not MAO-A, gene expression during Caco-2 differentiation.  MAO-B, but not MAO-A gene, could be activated by PMA (phorbol 12-myristate 13-acetate) by protein kinase C, MAPkinase signal transduction pathway involves cJun and Egr-1.  The differences in MAO-A and -B gene regulation may explain the different tissue-specific expression and functions of these two important isoenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5ZcVNBHVHTbVg90H21EOLACvtfcHk0lhAxzUNrxhiIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7g%253D&md5=9c1096c9b27e76550d6f3e668c12bf5b</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.2174%2F0929867043364757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364757%26sid%3Dliteratum%253Aachs%26aulast%3DShih%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DK.%26atitle%3DRegulation%2520of%2520MAO-A%2520and%2520MAO-B%2520gene%2520expression%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D1995%26epage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upadhyay, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4210</span><span class="NLM_x">–</span> <span class="NLM_lpage">4230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=4210-4230&author=D.+E.+Edmondsonauthor=C.+Bindaauthor=J.+Wangauthor=A.+K.+Upadhyayauthor=A.+Mattevi&title=Molecular+and+mechanistic+properties+of+the+membrane-bound+mitochondrial+monoamine+oxidases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DUpadhyay%26aufirst%3DA.%2BK.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DMolecular%2520and%2520mechanistic%2520properties%2520of%2520the%2520membrane-bound%2520mitochondrial%2520monoamine%2520oxidases%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D4210%26epage%3D4230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Levitt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pintar, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breakefield, X. O.</span><span> </span><span class="NLM_article-title">Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">6385</span><span class="NLM_x">–</span> <span class="NLM_lpage">6389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1982&pages=6385-6389&author=P.+Levittauthor=J.+E.+Pintarauthor=X.+O.+Breakefield&title=Immunocytochemical+demonstration+of+monoamine+oxidase+B+in+brain+astrocytes+and+serotonergic+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevitt%26aufirst%3DP.%26aulast%3DPintar%26aufirst%3DJ.%2BE.%26aulast%3DBreakefield%26aufirst%3DX.%2BO.%26atitle%3DImmunocytochemical%2520demonstration%2520of%2520monoamine%2520oxidase%2520B%2520in%2520brain%2520astrocytes%2520and%2520serotonergic%2520neurons%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1982%26volume%3D79%26spage%3D6385%26epage%3D6389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">O’Carroll, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobbia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions</span> <span class="citation_source-journal">Naunyn Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1007%2FBF00500765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=6408492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaL3sXitFSmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=1983&pages=198-202&author=A.-M.+O%E2%80%99Carrollauthor=C.+J.+Fowlerauthor=J.+P.+Phillipsauthor=I.+Tobbiaauthor=K.+F.+Tipton&title=The+deamination+of+dopamine+by+human+brain+monoamine+oxidase.+Specificity+for+the+two+enzyme+forms+in+seven+brain+regions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The deamination of dopamine by human brain monoamine oxidase.  Specificity for the two enzyme forms in seven brain regions</span></div><div class="casAuthors">O'Carroll, Anne Marie; Fowler, Christopher J.; Phillips, Jack P.; Tobbia, Iqdam; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">The deamination of dopamine (I)  [51-61-6] was studied in 7 regions of human brain.  Both A and B forms of monamine oxidase (MAO)  [9001-66-5] were active towards I.  The ratio of activities of MAO-A:MAO-B varied considerably from brain region to brain region, from about 1:1 for the cerebral and cerebellar cortex to about 1:2 for the pons and medulla oblongata.  Enzyme titrn. studies and comparisons of the substrate specificities of MAO-A and MAO-B across the brain indicated that I was metabolized by the same MAO active centers as other monoamines.  In the cerebral cortex, the Km values of MAO-A and -B towards I were 210 and 230 μM, resp., indicating that the relative contributions of these 2 forms towards the oxidn. of I will not be affected by changes in its concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd11w8nQN5OrVg90H21EOLACvtfcHk0lj36mNP-gUhgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitFSmtrk%253D&md5=ac03f33b62d3b917845cf5441904dac0</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1007%2FBF00500765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00500765%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Carroll%26aufirst%3DA.-M.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DPhillips%26aufirst%3DJ.%2BP.%26aulast%3DTobbia%26aufirst%3DI.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520deamination%2520of%2520dopamine%2520by%2520human%2520brain%2520monoamine%2520oxidase.%2520Specificity%2520for%2520the%2520two%2520enzyme%2520forms%2520in%2520seven%2520brain%2520regions%26jtitle%3DNaunyn%2520Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1983%26volume%3D322%26spage%3D198%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitahama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fort, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panula, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denney, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jouvet, M.</span><span> </span><span class="NLM_article-title">Histaminergic system in the cat hypothalamus with reference to type B monoamine oxidase</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1002%2Fcne.903300309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=7682224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK3sXkvVKrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=1993&pages=405-420&author=J.+S.+Linauthor=K.+Kitahamaauthor=P.+Fortauthor=P.+Panulaauthor=R.+M.+Denneyauthor=M.+Jouvet&title=Histaminergic+system+in+the+cat+hypothalamus+with+reference+to+type+B+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Histaminergic system in the cat hypothalamus with reference to type B monoamine oxidase</span></div><div class="casAuthors">Lin, J. S.; Kitahama, K.; Fort, P.; Panula, P.; Denney, R. M.; Jouvet, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-20</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    </div><div class="casAbstract">The distribution and morphol. of neurons immunoreactive to histamine and(or) monoamine oxidase B were studied in the cat hypothalamus.  Most histaminic-contg. neurons were also pos. for monoamine oxidase 3, suggesting that histamine metab. could occur in these cells.  However, a few neuron were immunoreactive for only histamine or monoamine oxidase B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGe8YssQz8QrVg90H21EOLACvtfcHk0lj36mNP-gUhgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvVKrur4%253D&md5=a3d7786dd4eb03b2d1cbbf4d043f22a7</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1002%2Fcne.903300309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.903300309%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BS.%26aulast%3DKitahama%26aufirst%3DK.%26aulast%3DFort%26aufirst%3DP.%26aulast%3DPanula%26aufirst%3DP.%26aulast%3DDenney%26aufirst%3DR.%2BM.%26aulast%3DJouvet%26aufirst%3DM.%26atitle%3DHistaminergic%2520system%2520in%2520the%2520cat%2520hypothalamus%2520with%2520reference%2520to%2520type%2520B%2520monoamine%2520oxidase%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D1993%26volume%3D330%26spage%3D405%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Westlund, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denney, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochersperger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abell, C. W.</span><span> </span><span class="NLM_article-title">Distinct monoamine oxidase A and B populations in primate brain</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=1985&pages=181-183&author=K.+N.+Westlundauthor=R.+M.+Denneyauthor=L.+M.+Kocherspergerauthor=R.+M.+Roseauthor=C.+W.+Abell&title=Distinct+monoamine+oxidase+A+and+B+populations+in+primate+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestlund%26aufirst%3DK.%2BN.%26aulast%3DDenney%26aufirst%3DR.%2BM.%26aulast%3DKochersperger%26aufirst%3DL.%2BM.%26aulast%3DRose%26aufirst%3DR.%2BM.%26aulast%3DAbell%26aufirst%3DC.%2BW.%26atitle%3DDistinct%2520monoamine%2520oxidase%2520A%2520and%2520B%2520populations%2520in%2520primate%2520brain%26jtitle%3DScience%26date%3D1985%26volume%3D230%26spage%3D181%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oreland, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcusson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span> </span><span class="NLM_article-title">The effect of age on the activity and molecular properties of human brain monoamine oxidase</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1980&pages=1-20&author=C.+J.+Fowlerauthor=A.+Wibergauthor=L.+Orelandauthor=J.+Marcussonauthor=B.+Winblad&title=The+effect+of+age+on+the+activity+and+molecular+properties+of+human+brain+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DWiberg%26aufirst%3DA.%26aulast%3DOreland%26aufirst%3DL.%26aulast%3DMarcusson%26aufirst%3DJ.%26aulast%3DWinblad%26aufirst%3DB.%26atitle%3DThe%2520effect%2520of%2520age%2520on%2520the%2520activity%2520and%2520molecular%2520properties%2520of%2520human%2520brain%2520monoamine%2520oxidase%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D1980%26volume%3D49%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nicotra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parvez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senatori, O.</span><span> </span><span class="NLM_article-title">Monoamine oxidase expression during development and aging</span> <span class="citation_source-journal">NeuroToxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2FS0161-813X%2803%2900095-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=14697890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSjtLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=155-165&author=A.+Nicotraauthor=F.+Pierucciauthor=H.+Parvezauthor=O.+Senatori&title=Monoamine+oxidase+expression+during+development+and+aging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase expression during development and aging</span></div><div class="casAuthors">Nicotra, Antonietta; Pierucci, Federica; Parvez, Hasan; Senatori, Ornella</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">155-165</span>CODEN:
                <span class="NLM_cas:coden">NRTXDN</span>;
        ISSN:<span class="NLM_cas:issn">0161-813X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A discussion and review on the authors' works.  Monoamine oxidase (MAO) isoenzymes play a major role in regulating the concn. of several bioactive amines, including serotonin and catecholamines.  Both in the nervous system and in peripheral organs, MAOs can potentially modulate all the processes involving these bioactive amines.  In the present article, we review some of the most significant articles published so far on changes in MAOs during development and aging.  The data available on development refer mainly to the mammal brain at fetal and post-fetal stages.  Very little work has been done on studying MAO ontogenesis during early development, i.e., at stages prior to organogenesis, and what has been done refers to non-mammal vertebrates such as fish, amphibians and birds.  MAO A and MAO B changes have been measured as values of enzymic activity, as amt. of protein or, more rarely, as amt. of mRNAs.  A knowledge of MAO developmental changes not only provides a basis for the investigation of factors regulating MAO expression, but can also contribute to a better understanding of the possible trophic and/or morphogenetic role of monoaminergic neurotransmitters in the developing brain.  Transgenic mice lacking MAO A and rodents treated with MAO inhibitors during gestation have been very useful in this second case.  The investigations of changes in MAO A and MAO B during aging in the literature refer mostly to humans, mice and rats.  Interest in studies on aging is stimulated, among other things, by the observation that age-related diseases leading to neurodegenerative phenomena could be accompanied by changes in MAO activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxv_AEJy1Nl7Vg90H21EOLACvtfcHk0lj36mNP-gUhgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSjtLrO&md5=c89dd6fbfdda1ee597c77b27bcd54aba</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2FS0161-813X%2803%2900095-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0161-813X%252803%252900095-0%26sid%3Dliteratum%253Aachs%26aulast%3DNicotra%26aufirst%3DA.%26aulast%3DPierucci%26aufirst%3DF.%26aulast%3DParvez%26aufirst%3DH.%26aulast%3DSenatori%26aufirst%3DO.%26atitle%3DMonoamine%2520oxidase%2520expression%2520during%2520development%2520and%2520aging%26jtitle%3DNeuroToxicology%26date%3D2004%26volume%3D25%26spage%3D155%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nagatsu, T.</span><span> </span><span class="NLM_article-title">Progress in monoamine oxidase (MAO) research and relation to genetic engineering</span> <span class="citation_source-journal">NeuroToxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=11-20&author=T.+Nagatsu&title=Progress+in+monoamine+oxidase+%28MAO%29+research+and+relation+to+genetic+engineering"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagatsu%26aufirst%3DT.%26atitle%3DProgress%2520in%2520monoamine%2520oxidase%2520%2528MAO%2529%2520research%2520and%2520relation%2520to%2520genetic%2520engineering%26jtitle%3DNeuroToxicology%26date%3D2004%26volume%3D25%26spage%3D11%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bortolato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. C.</span><span> </span><span class="NLM_article-title">Monoamine oxidase inactivation: From pathophysiology to therapeutics</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1527</span><span class="NLM_x">–</span> <span class="NLM_lpage">1533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2Fj.addr.2008.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=18652859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWltbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=1527-1533&author=M.+Bortolatoauthor=K.+Chenauthor=J.+C.+Shih&title=Monoamine+oxidase+inactivation%3A+From+pathophysiology+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase inactivation: From pathophysiology to therapeutics</span></div><div class="casAuthors">Bortolato, Marco; Chen, Kevin; Shih, Jean C.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">1527-1533</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidases (MAOs) A and B are mitochondrial bound isoenzymes which catalyze the oxidative deamination of dietary amines and monoamine neurotransmitters, such as serotonin, norepinephrine, dopamine, β-phenylethylamine and other trace amines.  The rapid degrdn. of these mols. ensures the proper functioning of synaptic neurotransmission and is critically important for the regulation of emotional behaviors and other brain functions.  The byproducts of MAO-mediated reactions include several chem. species with neurotoxic potential, such as hydrogen peroxide, ammonia and aldehydes.  As a consequence, it is widely speculated that prolonged excessive activity of these enzymes may be conducive to mitochondrial damages and neurodegenerative disturbances.  In keeping with these premises, the development of MAO inhibitors has led to important breakthroughs in the therapy of several neuropsychiatric disorders, ranging from mood disorders to Parkinson's disease.  Furthermore, the characterization of MAO knockout (KO) mice has revealed that the inactivation of this enzyme produces a no. of functional and behavioral alterations, some of which may be harnessed for therapeutic aims.  In this article, we discuss the intriguing hypothesis that the attenuation of the oxidative stress induced by the inactivation of either MAO isoform may contribute to both antidepressant and antiparkinsonian actions of MAO inhibitors.  This possibility further highlights MAO inactivation as a rich source of novel avenues in the treatment of mental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBs7njlZCb7rVg90H21EOLACvtfcHk0li5zsim_a863Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWltbbK&md5=9085ccfdebab364e9ea78995bcfc16d1</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DBortolato%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26atitle%3DMonoamine%2520oxidase%2520inactivation%253A%2520From%2520pathophysiology%2520to%2520therapeutics%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D1527%26epage%3D1533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachenmayer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laux, G.</span><span> </span><span class="NLM_article-title">Clinical applications of MAO-inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2043</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.2174%2F0929867043364775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15279566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=2033-2043&author=P.+Riedererauthor=L.+Lachenmayerauthor=G.+Laux&title=Clinical+applications+of+MAO-inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical applications of MAO-Inhibitors</span></div><div class="casAuthors">Riederer, P.; Lachenmayer, L.; Laux, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2033-2043</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase inhibitors (MAO-I) have been useful in the treatment of both psychiatric and neurol. disorders over centuries.  Here the authors focus on the development of this drug treatment.  Focus is given on the use of irreversible MAO-I's as well as on reversible ones.  Benefit and side effects are reported for Parkinson's disease, Alzheimer's dementia, depression syndrome and panic disorders.  The preclin. and clin. effects of selegiline with regard to neuroprotection are highlighted and the conclusion is drawn that there is good evidence for a clin. neuroprotective capacity based on the assumption that the 50% recovery of MAO-B is obtained already after a 10 days withdrawal of selegiline.  There is also a focus on selegilines metab. to amphetamine and metamphetamine.  In order to avoid any such effects of metabolic compds. on the cardiovascular system Zydis Selegiline, a melt-tablet avoid of major metab. to amphetamine and metamphetamine is described in detail.  Developments in MAO-I research are discussed in detail as there are moclobemide, lacabemide, rasagiline.  Interactions of MAO-I' with tricyclics and serotonin selective reuptake inhibitors (SSRI's) are described as there is mentioning of interactions of MAO-I's with other compds. in general.  Tables and figures report on clin. studies and on pharmacol. properties of MAO-I's.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9Zf08abfhabVg90H21EOLACvtfcHk0li5zsim_a863Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7c%253D&md5=dabcabed0e363951ad40e258ddffa972</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.2174%2F0929867043364775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364775%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DLachenmayer%26aufirst%3DL.%26aulast%3DLaux%26aufirst%3DG.%26atitle%3DClinical%2520applications%2520of%2520MAO-inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D2033%26epage%3D2043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakhle, Y. S.</span><span> </span><span class="NLM_article-title">Monoamine oxidase: isoforms and inhibitors in Parkinson’d disease and depressive illness</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">S287</span><span class="NLM_x">–</span> <span class="NLM_lpage">S296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=S287-S296&author=M.+B.+H.+Youdimauthor=Y.+S.+Bakhle&title=Monoamine+oxidase%3A+isoforms+and+inhibitors+in+Parkinson%E2%80%99d+disease+and+depressive+illness"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DBakhle%26aufirst%3DY.%2BS.%26atitle%3DMonoamine%2520oxidase%253A%2520isoforms%2520and%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599d%2520disease%2520and%2520depressive%2520illness%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26spage%3DS287%26epage%3DS296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Treatment options in the modern management of Parkinson’s disease</span> <span class="citation_source-journal">Arch. Neurol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1088</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1001%2Farchneur.64.8.1083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=17698697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BD2svotFGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=1083-1088&author=A.+H.+V.+Schapira&title=Treatment+options+in+the+modern+management+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment options in the modern management of Parkinson disease</span></div><div class="casAuthors">Schapira Anthony H V</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1083-8</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCOyv-PhtwZcyail4HZd-ifW6udTcc2ebgvAJBYGtuP7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svotFGrtQ%253D%253D&md5=9ebc6ecfb7791afc421b150548b29fa3</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1001%2Farchneur.64.8.1083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.64.8.1083%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DTreatment%2520options%2520in%2520the%2520modern%2520management%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Neurol.%2520Rev.%26date%3D2007%26volume%3D64%26spage%3D1083%26epage%3D1088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hoskini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenfield, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span> </span><span class="NLM_article-title">Characterization of moclobemide <i>N</i>-oxidation in human microsomes</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=387-397&author=J.+Hoskiniauthor=G.+Shenfieldauthor=M.+Murrayauthor=A.+Gross&title=Characterization+of+moclobemide+N-oxidation+in+human+microsomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoskini%26aufirst%3DJ.%26aulast%3DShenfield%26aufirst%3DG.%26aulast%3DMurray%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520moclobemide%2520N-oxidation%2520in%2520human%2520microsomes%26jtitle%3DXenobiotica%26date%3D2001%26volume%3D31%26spage%3D387%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Finberg, J. P. M.</span><span> </span><span class="NLM_article-title">Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2Fj.pharmthera.2014.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=24607445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=133-152&author=J.+P.+M.+Finberg&title=Update+on+the+pharmacology+of+selective+inhibitors+of+MAO-A+and+MAO-B%3A+Focus+on+modulation+of+CNS+monoamine+neurotransmitter+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release</span></div><div class="casAuthors">Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-152</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Inhibitors of monoamine oxidase (MAO) were initially used in medicine following the discovery of their antidepressant action.  Subsequently their ability to potentiate the effects of an indirectly-acting sympathomimetic amine such as tyramine was discovered, leading to their limitation in clin. use, except for cases of treatment-resistant depression.  More recently, the understanding that: a) potentiation of indirectly-acting sympathomimetic amines is caused by inhibitors of MAO-A but not by inhibitors of MAO-B, and b) that reversible inhibitors of MAO-A cause minimal tyramine potentiation, has led to their re-introduction to clin. use for treatment of depression (reversible MAO-A inhibitors and new dose form MAO-B inhibitor) and treatment of Parkinson's disease (MAO-B inhibitors).  The profound neuroprotective properties of propargyl-based inhibitors of MAO-B in preclin. expts. have drawn attention to the possibility of employing these drugs for their neuroprotective effect in neurodegenerative diseases, and have raised the question of the involvement of the MAO-mediated reaction as a source of reactive free radicals.  Despite the long-standing history of MAO inhibitors in medicine, the way in which they affect neuronal release of monoamine neurotransmitters is still poorly understood.  In recent years, the detailed chem. structure of MAO-B and MAO-A has become available, providing new possibilities for synthesis of mechanism-based inhibitors.  This review describes the latest advances in understanding the way in which MAO inhibitors affect the release of the monoamine neurotransmitters dopamine, noradrenaline and serotonin (5-HT) in the CNS, with an accent on the importance of these effects for the clin. actions of the drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSGMvtQ1Ca5bVg90H21EOLACvtfcHk0liKyNzYT_pYKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D&md5=0f31959bad34842d4aaaba7b8162e5b8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DUpdate%2520on%2520the%2520pharmacology%2520of%2520selective%2520inhibitors%2520of%2520MAO-A%2520and%2520MAO-B%253A%2520Focus%2520on%2520modulation%2520of%2520CNS%2520monoamine%2520neurotransmitter%2520release%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D143%26spage%3D133%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Treatment options in the modern management of Parkinson’s disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1088</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1001%2Farchneur.64.8.1083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=17698697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BD2svotFGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=1083-1088&author=A.+H.+V.+Schapira&title=Treatment+options+in+the+modern+management+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment options in the modern management of Parkinson disease</span></div><div class="casAuthors">Schapira Anthony H V</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1083-8</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCOyv-PhtwZcyail4HZd-ifW6udTcc2ebgvAJBYGtuP7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svotFGrtQ%253D%253D&md5=9ebc6ecfb7791afc421b150548b29fa3</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1001%2Farchneur.64.8.1083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.64.8.1083%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DTreatment%2520options%2520in%2520the%2520modern%2520management%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2007%26volume%3D64%26spage%3D1083%26epage%3D1088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Singer, C.</span><span> </span><span class="NLM_article-title">Managing the patient with newly diagnosed Parkinson’s disease</span> <span class="citation_source-journal">Cleveland Clin. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S3</span><span class="NLM_x">–</span> <span class="NLM_lpage">S7</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=S3-S7&issue=Suppl+2&author=C.+Singer&title=Managing+the+patient+with+newly+diagnosed+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinger%26aufirst%3DC.%26atitle%3DManaging%2520the%2520patient%2520with%2520newly%2520diagnosed%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCleveland%2520Clin.%2520J.%2520Med.%26date%3D2012%26volume%3D79%26issue%3DSuppl%25202%26spage%3DS3%26epage%3DS7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jankovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poewe, W.</span><span> </span><span class="NLM_article-title">Therapies in Parkinson’s disease</span> <span class="citation_source-journal">Curr. Opin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1097%2FWCO.0b013e3283542fc2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=22691758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWjs7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=433-447&author=J.+Jankovicauthor=W.+Poewe&title=Therapies+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Therapies in Parkinson's disease</span></div><div class="casAuthors">Jankovic, Joseph; Poewe, Werner</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">433-447</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review examines currently available therapeutic strategies for Parkinson's disease, emphasizing evidence-based data as well as a patient-centered approach to the treatment of motor and nonmotor symptoms.  Recent findings: Although clin. trials of disease-modifying approaches have been thus far disappointing, steady advances are being made in the symptomatic treatment of Parkinson's disease.  In this review, we focus on recent studies with monoamine oxidase type B inhibitors (selegiline and rasagiline), coenzyme Q10, creatine, and exercise in early Parkinson's disease.  We also discuss the relative merits and disadvantages of delaying the initiation of levodopa therapy, the role of dopamine agonists, particularly ropinirole and pramipexole, and management of motor and behavioral complications, such as fluctuations, dyskinesias and impulse-control disorders.  Novel formulations and delivery approaches for conventional and new drugs are also discussed.  Finally, we review recent studies of surgical treatments of Parkinson's disease, such as deep brain stimulation.  Summary: Numerous clin. trials have provided evidence that health-related quality of life can be substantially improved with early diagnosis and institution of exercise and other phys. measures, appropriate timing of dopaminergic therapy, and strategies to delay and treat levodopa-related motor complications and nonmotor Parkinson's disease-related symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmbLTT8J_WmrVg90H21EOLACvtfcHk0liKyNzYT_pYKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWjs7%252FE&md5=f756cf6cdc4ab07a42653305775aa87a</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1097%2FWCO.0b013e3283542fc2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWCO.0b013e3283542fc2%26sid%3Dliteratum%253Aachs%26aulast%3DJankovic%26aufirst%3DJ.%26aulast%3DPoewe%26aufirst%3DW.%26atitle%3DTherapies%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2012%26volume%3D25%26spage%3D433%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupershmidt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span> </span><span class="NLM_article-title">Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson’s disease</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S132</span><span class="NLM_x">–</span> <span class="NLM_lpage">S136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=S132-S136&issue=Suppl+1&author=M.+B.+H.+Youdimauthor=L.+Kupershmidtauthor=T.+Amitauthor=O.+Weinreb&title=Promises+of+novel+multi-target+neuroprotective+and+neurorestorative+drugs+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DKupershmidt%26aufirst%3DL.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DWeinreb%26aufirst%3DO.%26atitle%3DPromises%2520of%2520novel%2520multi-target%2520neuroprotective%2520and%2520neurorestorative%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2014%26volume%3D20%26issue%3DSuppl%25201%26spage%3DS132%26epage%3DS136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.2174%2F092986711797379302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=21864289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4568-4587&author=L.+Pisaniauthor=M.+Cattoauthor=F.+Leonettiauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=F.+Campagnaauthor=A.+Carotti&title=Targeting+monoamine+oxidases+with+multipotent+ligands%3A+an+emerging+strategy+in+the+search+of+new+drugs+against+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases</span></div><div class="casAuthors">Pisani, L.; Catto, M.; Leonetti, F.; Nicolotti, O.; Stefanachi, A.; Campagna, F.; Carotti, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4568-4587</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The socioeconomic burden of multi-factorial pathologies, such as neurodegenerative diseases (NDs), is enormous worldwide.  Unfortunately, no proven disease-modifying therapy is available yet and in most cases (e.g., Alzheimer's and Parkinson's disease) the approved drugs exert only palliative and symptomatic effects.  Nowadays, an emerging strategy for the discovery of disease-modifying drugs is based on the multi-target directed ligand (MTDL) design, an innovative shift from the traditional approach one-drug-one-target to the more ambitious one-drug-more-targets goal.  Herein, we review the discovery strategy, the mechanism of action and the biopharmacol. evaluation of multipotent ligands exhibiting monoamine oxidase (MAO) inhibition as the core activity with a potential for the treatment of NDs.  In particular, MAO inhibitors exhibiting addnl. acetylcholinesterase (AChE) or nitric oxide synthase (NOS) inhibition, or ion chelation/antioxidant-radical scavenging/anti-inflammatory/A2A receptor antagonist/APP processing modulating activities have been thoroughly examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4N8fMdFNcwrVg90H21EOLACvtfcHk0lhomACNRvwtuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O&md5=2463da84a1da0142e353ff9d3a354fe6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F092986711797379302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797379302%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DTargeting%2520monoamine%2520oxidases%2520with%2520multipotent%2520ligands%253A%2520an%2520emerging%2520strategy%2520in%2520the%2520search%2520of%2520new%2520drugs%2520against%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4568%26epage%3D4587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Patyar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prakash, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhi, B.</span><span> </span><span class="NLM_article-title">Dual inhibition: a novel promising pharmacological approach for different disease conditions</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1111%2Fj.2042-7158.2010.01236.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=21401597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktlantLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=459-471&author=S.+Patyarauthor=A.+Prakashauthor=B.+Medhi&title=Dual+inhibition%3A+a+novel+promising+pharmacological+approach+for+different+disease+conditions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition: a novel promising pharmacological approach for different disease conditions</span></div><div class="casAuthors">Patyar, Sazal; Prakash, Ajay; Medhi, Bikash</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">459-471</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  To overcome the problems assocd. with polypharmacy, which include medication non compliance, adverse drug reactions, drug-drug interactions, and increased pill-burden, various strategies, such as sustained-release drugs and fixed-dose combination regimens (polypills), were developed.  Out of these, a novel and very much promising approach is the use of dual-action drugs.  Amongst the dual-action drugs, there is a class of compds. known as dual inhibitors, which possess the dual inhibitory activity.  The most common examples of dual inhibitors are rivastigmine, ladostigil, asenapine, phenserine, amitriptyline, clomipramine, doxepin, and desipramine.  This review article focuses on the conventional drugs used in different diseases which possess dual inhibition activity as well as those which are still in the preclin./clin. phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoimW_BGkApX7Vg90H21EOLACvtfcHk0lhomACNRvwtuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktlantLs%253D&md5=5cae05a18a9246b765e400230e8ef62f</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2010.01236.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2010.01236.x%26sid%3Dliteratum%253Aachs%26aulast%3DPatyar%26aufirst%3DS.%26aulast%3DPrakash%26aufirst%3DA.%26aulast%3DMedhi%26aufirst%3DB.%26atitle%3DDual%2520inhibition%253A%2520a%2520novel%2520promising%2520pharmacological%2520approach%2520for%2520different%2520disease%2520conditions%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2011%26volume%3D63%26spage%3D459%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and M30 derived from rasagiline</span> <span class="citation_source-journal">Exp. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.5607%2Fen.2013.22.1.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BC3srlt1alsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=1-10&author=M.+B.+H.+Youdim&title=Multi+target+neuroprotective+and+neurorestorative+anti-Parkinson+and+anti-Alzheimer+drugs+ladostigil+and+M30+derived+from+rasagiline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline</span></div><div class="casAuthors">Youdim Moussa B H</div><div class="citationInfo"><span class="NLM_cas:title">Experimental neurobiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>
        ISSN:<span class="NLM_cas:issn">1226-2560</span>.
    </div><div class="casAbstract">Present anti-PD and -AD drugs have limited symptomatic activity and devoid of neuroprotective and neurorestorative property that is needed for disease modifying action.  The complex pathology of PD and AD led us to develop several multi-target neuroprotective and neurorestorative drugs with several CNS targets with the ability for possible disease modifying activity.  Employing the pharmacophore of our anti-parkinson drug rasagiline (Azilect, N-propagrgyl-1-R-aminoindan), we have developed a series of novel multi-functional neuroprotective drugs (A) [TV-3326 (N-propargyl-3R-aminoindan-5yl)-ethyl methylcarbamate)], with both cholinesterase-butyrylesterase and brain selective monoamine-oxidase (MAO) A/B inhibitory activities and (B) the iron chelator-radical scavenging-brain selective monoamine oxidase (MAO) A/B inhibitor and M30 possessing the neuroprotective and neurorescuing propargyl moiety of rasagiline, as potential treatment of AD, DLB and PD with dementia.  Another series of multi-target drugs (M30, HLA-20 series) which are brain permeable iron chelators and potent selective brain MAO inhibitors were also developed.  These series of drugs have the ability of regulating and processing amyloid precursor protein (APP) since APP and alpha-synuclein are metaloproteins (iron-regulated proteins), with an iron responsive element 5"UTR mRNA similar to transferring and ferritin.  Ladostigil inhibits brain acetyl and butyrylcholinesterase in rats after oral doses.  After chronic but not acute treatment, it inhibits MAO-A and -B in the brain.  Ladostigil acts like an anti-depressant in the forced swim test in rats, indicating a potential for anti-depressant activity.  Ladostigil prevents the destruction of nigrostriatal neurons induced by infusion of neurotoxin MPTP in mice.  The propargylamine moiety of ladostigil confers neuroprotective activity against cytotoxicity induced by ischemia and peroxynitrite in cultured neuronal cells.  The multi-target iron chelator M30 has all the properties of ladostigil and similar neuroprotective activity to ladostigil, but is not a ChE inhibitor.  M30 has a neurorestorative activity in post-lesion of nigrostriatal dopamine neurons in MPTP, lacatcystin and 6-hydroxydopamine animal models of PD.  The neurorestorative activity is related to the ability of the drug to activate hypoxia inducing factor (HIF) which induces the production of such neurotrophins as brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF) and erythropoietin as well as glia-derived neurotrophic factor (GDNF).  The unique multiple actions of ladostigil and M30 make the potentially useful drugs for the treatment of dementia with Parkinsonian-like symptoms and depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAEm76m-YqPGhHGZei4OW9fW6udTcc2eaM-QnfIOgwVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srlt1alsA%253D%253D&md5=55dd62729ca05fb17eb58589011677a2</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.5607%2Fen.2013.22.1.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5607%252Fen.2013.22.1.1%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DMulti%2520target%2520neuroprotective%2520and%2520neurorestorative%2520anti-Parkinson%2520and%2520anti-Alzheimer%2520drugs%2520ladostigil%2520and%2520M30%2520derived%2520from%2520rasagiline%26jtitle%3DExp.%2520Neurobiol.%26date%3D2013%26volume%3D22%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel dual inhibitors of AChE and MAO derived from hydroxyl aminoindan and phenethylamine as potential treatment for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020120c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Miskolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+Youdimauthor=M.+Weinstock&title=Novel+dual+inhibitors+of+AChE+and+MAO+derived+from+hydroxyl+aminoindan+and+phenethylamine+as+potential+treatment+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm020120c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020120c%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520dual%2520inhibitors%2520of%2520AChE%2520and%2520MAO%2520derived%2520from%2520hydroxyl%2520aminoindan%2520and%2520phenethylamine%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5260%26epage%3D5279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouplana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and molecular modeling of donepezil and <i>N</i>-[(5-(benzyloxy)-1-methyl-1<i>H</i>-indol-2-yl)methyl]-<i>N</i>-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimeŕs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8251</span><span class="NLM_x">–</span> <span class="NLM_lpage">8270</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200853t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8251-8270&author=I.+Boleaauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=C.+de+los+Riosauthor=M.+Chiouaauthor=R.+Pouplanaauthor=F.+J.+Luqueauthor=M.+Unzetaauthor=J.+Marco-Contellesauthor=A.+Samadi&title=Synthesis%2C+biological+evaluation%2C+and+molecular+modeling+of+donepezil+and+N-%5B%285-%28benzyloxy%29-1-methyl-1H-indol-2-yl%29methyl%5D-N-methylprop-2-yn-1-amine+hybrids+as+new+multipotent+cholinesterase%2Fmonoamine+oxidase+inhibitors+for+the+treatment+of+Alzheime%C5%95s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1021%2Fjm200853t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200853t%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DPouplana%26aufirst%3DR.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520molecular%2520modeling%2520of%2520donepezil%2520and%2520N-%255B%25285-%2528benzyloxy%2529-1-methyl-1H-indol-2-yl%2529methyl%255D-N-methylprop-2-yn-1-amine%2520hybrids%2520as%2520new%2520multipotent%2520cholinesterase%252Fmonoamine%2520oxidase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheime%25C5%2595s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8251%26epage%3D8270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12E"><span><span class="NLM_label">(E) </span><span class="NLM_contrib-group">Bautista-Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolic, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agbabe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indoyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=82-95&author=O.+M.+Bautista-Aguileraauthor=G.+Estebanauthor=I.+Boleaauthor=K.+Nikolicauthor=D.+Agbabeauthor=I.+Moraledaauthor=I.+Iriepaauthor=A.+Smadiauthor=E.+Sorianoauthor=M.+Unzetaauthor=J.+Marco-Contelles&title=Design%2C+synthesis%2C+pharmacological+evaluation%2C+QSAR+analysis%2C+molecular+modeling+and+ADMET+of+novel+donepezil-indoyl+hybrids+as+multipotent+cholinesterase%2Fmonoamine+oxidase+inhibitors+for+the+potential+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12E&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DNikolic%26aufirst%3DK.%26aulast%3DAgbabe%26aufirst%3DD.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DSmadi%26aufirst%3DA.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520pharmacological%2520evaluation%252C%2520QSAR%2520analysis%252C%2520molecular%2520modeling%2520and%2520ADMET%2520of%2520novel%2520donepezil-indoyl%2520hybrids%2520as%2520multipotent%2520cholinesterase%252Fmonoamine%2520oxidase%2520inhibitors%2520for%2520the%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D75%26spage%3D82%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Dual-target-directed drugs that block monoamine oxidase B and adenosine A<sub>2A</sub> receptors for Parkinsońs disease</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=141-151&author=J.+P.+Petzerauthor=N.+Castagnoliauthor=M.+A.+Schwarzschildauthor=J.-F.+Chenauthor=C.+J.+Van+der+Schyf&title=Dual-target-directed+drugs+that+block+monoamine+oxidase+B+and+adenosine+A2A+receptors+for+Parkinso%C5%84s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DDual-target-directed%2520drugs%2520that%2520block%2520monoamine%2520oxidase%2520B%2520and%2520adenosine%2520A2A%2520receptors%2520for%2520Parkinso%25C5%2584s%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoccini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamantini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccioni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minetti, P.</span><span> </span><span class="NLM_article-title">Synthesis of (<i>E</i>)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A<sub>2A</sub> antagonists/MAO-B inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1247</span><span class="NLM_x">–</span> <span class="NLM_lpage">1261</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301686s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1247-1261&author=S.+Rivaraauthor=G.+Piersantiauthor=F.+Bartocciniauthor=G.+Diamantiniauthor=D.+Palaauthor=T.+Riccioniauthor=M.+A.+Stasiauthor=W.+Cabriauthor=F.+Borsiniauthor=M.+Morauthor=G.+Tarziaauthor=P.+Minetti&title=Synthesis+of+%28E%29-8-%283-chlorostyryl%29caffeine+analogues+leading+to+9-deazaxanthine+derivatives+as+dual+A2A+antagonists%2FMAO-B+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm301686s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301686s%26sid%3Dliteratum%253Aachs%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DBartoccini%26aufirst%3DF.%26aulast%3DDiamantini%26aufirst%3DG.%26aulast%3DPala%26aufirst%3DD.%26aulast%3DRiccioni%26aufirst%3DT.%26aulast%3DStasi%26aufirst%3DM.%2BA.%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMinetti%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520%2528E%2529-8-%25283-chlorostyryl%2529caffeine%2520analogues%2520leading%2520to%25209-deazaxanthine%2520derivatives%2520as%2520dual%2520A2A%2520antagonists%252FMAO-B%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1247%26epage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase B by selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1299</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1299-1310&author=J.+P.+Petzerauthor=S.+Steynauthor=K.+P.+Castagnoliauthor=J.-F.+Chenauthor=M.+A.+Schwarzschildauthor=C.+J.+Van+der+Schyfauthor=N.+Castagnoli&title=Inhibition+of+monoamine+oxidase+B+by+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DSteyn%26aufirst%3DS.%26aulast%3DCastagnoli%26aufirst%3DK.%2BP.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DCastagnoli%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520B%2520by%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1299%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vlok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase B by analogues of the adenosine A<sub>2A</sub> receptor antagonists (<i>E</i>)-8-(3-chlorostyryl)caffeine (CSC)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3512</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3512-3521&author=N.+Vlokauthor=S.+F.+Malanauthor=N.+Castagnoliauthor=J.+J.+Berghauthor=J.+P.+Petzer&title=Inhibition+of+monoamine+oxidase+B+by+analogues+of+the+adenosine+A2A+receptor+antagonists+%28E%29-8-%283-chlorostyryl%29caffeine+%28CSC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlok%26aufirst%3DN.%26aulast%3DMalan%26aufirst%3DS.%2BF.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DBergh%26aufirst%3DJ.%2BJ.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520B%2520by%2520analogues%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520antagonists%2520%2528E%2529-8-%25283-chlorostyryl%2529caffeine%2520%2528CSC%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3512%26epage%3D3521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pretorius, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span> </span><span class="NLM_article-title">Dual inhibition of monoamine oxidase B and antagonism of the adenosine A<sub>2A</sub> receptor by (<i>E</i>,<i>E</i>)-8-(4-phenylbutadien-1-yl)caffeine analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8876</span><span class="NLM_x">–</span> <span class="NLM_lpage">8684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8876-8684&author=J.+Pretoriusauthor=S.+F.+Malanauthor=N.+Castagnoliauthor=J.+J.+Berghauthor=J.+P.+Petzer&title=Dual+inhibition+of+monoamine+oxidase+B+and+antagonism+of+the+adenosine+A2A+receptor+by+%28E%2CE%29-8-%284-phenylbutadien-1-yl%29caffeine+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPretorius%26aufirst%3DJ.%26aulast%3DMalan%26aufirst%3DS.%2BF.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DBergh%26aufirst%3DJ.%2BJ.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DDual%2520inhibition%2520of%2520monoamine%2520oxidase%2520B%2520and%2520antagonism%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520by%2520%2528E%252CE%2529-8-%25284-phenylbutadien-1-yl%2529caffeine%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8876%26epage%3D8684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Stößel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlenk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Küppers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span> </span><span class="NLM_article-title">Dual targeting of adenosine A<sub>2A</sub> receptors and monoamine oxidase B by 4<i>H</i>-3,1-benzothiazin-4-ones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4580</span><span class="NLM_x">–</span> <span class="NLM_lpage">4596</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400336x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4580-4596&author=A.+St%C3%B6%C3%9Felauthor=M.+Schlenkauthor=S.+Hinzauthor=P.+K%C3%BCppersauthor=J.+Heerauthor=M.+G%C3%BCtschowauthor=C.+E.+M%C3%BCller&title=Dual+targeting+of+adenosine+A2A+receptors+and+monoamine+oxidase+B+by+4H-3%2C1-benzothiazin-4-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1021%2Fjm400336x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400336x%26sid%3Dliteratum%253Aachs%26aulast%3DSt%25C3%25B6%25C3%259Fel%26aufirst%3DA.%26aulast%3DSchlenk%26aufirst%3DM.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DK%25C3%25BCppers%26aufirst%3DP.%26aulast%3DHeer%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDual%2520targeting%2520of%2520adenosine%2520A2A%2520receptors%2520and%2520monoamine%2520oxidase%2520B%2520by%25204H-3%252C1-benzothiazin-4-ones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4580%26epage%3D4596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Brunschweiger, A.; Koch, P.; Schlenk, M.; Pineda, F.; Küppers, P.; Hinz, S.; Köse, M.; Ullrich, S.; Hockemeyer, J.; Wiese, M.; Müller, C. E.</span><span> </span><span class="NLM_article-title">8-Benzyltetrahydropyrazino[2,1-<i>f</i>]puridiones: water-soluble tricyclic xanthine derivatives as multitarget drugs for neurodegenerative diseases</span>.  <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI <span class="refDoi"> DOI: 10.1002/cmdc.201402082</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1002%2Fcmdc.201402082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+Brunschweiger&author=P.+Koch&author=M.+Schlenk&author=F.+Pineda&author=P.+K%C3%BCppers&author=S.+Hinz&author=M.+K%C3%B6se&author=S.+Ullrich&author=J.+Hockemeyer&author=M.+Wiese&author=C.+E.+M%C3%BCller&title=8-Benzyltetrahydropyrazino%5B2%2C1-f%5Dpuridiones%3A+water-soluble+tricyclic+xanthine+derivatives+as+multitarget+drugs+for+neurodegenerative+diseases&doi=10.1002%2Fcmdc.201402082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402082%26sid%3Dliteratum%253Aachs%26aulast%3DBrunschweiger%26aufirst%3DA.%26atitle%3D8-Benzyltetrahydropyrazino%255B2%252C1-f%255Dpuridiones%253A%2520water-soluble%2520tricyclic%2520xanthine%2520derivatives%2520as%2520multitarget%2520drugs%2520for%2520neurodegenerative%2520diseases%26jtitle%3DChemMedChem%26date%3D2014%26doi%3D10.1002%2Fcmdc.201402082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Knoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magyar, K.</span><span> </span><span class="NLM_article-title">Some puzzling pharmacological effects of monoamine oxidase inhibitors</span> <span class="citation_source-journal">Adv. Biochem. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=5066229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaE3sXhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1972&pages=393-408&author=J.+Knollauthor=K.+Magyar&title=Some+puzzling+pharmacological+effects+of+monoamine+oxidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Puzzling pharmacological effects of monoamine oxidase [MAO] inhibitors</span></div><div class="casAuthors">Knoll, J.; Magyar, K.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biochemical Psychopharmacology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">393-408</span>CODEN:
                <span class="NLM_cas:coden">ABPYBL</span>;
        ISSN:<span class="NLM_cas:issn">0065-2229</span>.
    </div><div class="casAbstract">A discussion and review with 17 refs. of some dissimilar effects various monoamine oxidase inhibitors may have on the metabolism of biogenic amines.  Studies with the optical isomers of Deprenil [2079-54-1] indicate that multiple forms of the enzyme monoamine oxidase may exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCM6fPp82whLVg90H21EOLACvtfcHk0litVdT9DpMW9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhsA%253D%253D&md5=8a0fe1c36cedef71af1bde3b408913f9</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnoll%26aufirst%3DJ.%26aulast%3DMagyar%26aufirst%3DK.%26atitle%3DSome%2520puzzling%2520pharmacological%2520effects%2520of%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DAdv.%2520Biochem.%2520Psychopharmacol.%26date%3D1972%26volume%3D5%26spage%3D393%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Birkmayer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrozi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Implications of combined treatment with Madopar and l-deprenyl in Parkinson’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1977&pages=439-443&author=W.+Birkmayerauthor=P.+Riedererauthor=L.+Ambroziauthor=M.+B.+H.+Youdim&title=Implications+of+combined+treatment+with+Madopar+and+l-deprenyl+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirkmayer%26aufirst%3DW.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DAmbrozi%26aufirst%3DL.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DImplications%2520of%2520combined%2520treatment%2520with%2520Madopar%2520and%2520l-deprenyl%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D1977%26volume%3D2%26spage%3D439%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Reynolds, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jellinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seemann, D.</span><span> </span><span class="NLM_article-title">Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (<span class="smallcaps smallerCapital">l</span>)-deprenyl administration</span> <span class="citation_source-journal">J. Neural. Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=271-277&author=G.+P.+Reynoldsauthor=P.+Riedererauthor=M.+Sandlerauthor=K.+Jellingerauthor=D.+Seemann&title=Amphetamine+and+2-phenylethylamine+in+post-mortem+Parkinsonian+brain+after+%28l%29-deprenyl+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DG.%2BP.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DSandler%26aufirst%3DM.%26aulast%3DJellinger%26aufirst%3DK.%26aulast%3DSeemann%26aufirst%3DD.%26atitle%3DAmphetamine%2520and%25202-phenylethylamine%2520in%2520post-mortem%2520Parkinsonian%2520brain%2520after%2520%2528l%2529-deprenyl%2520administration%26jtitle%3DJ.%2520Neural.%2520Transm.%26date%3D1978%26volume%3D43%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachenmayer, L.</span><span> </span><span class="NLM_article-title">Selegiline’s neuroprotective capacity revisited</span> <span class="citation_source-journal">J. Neural. Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2003&pages=1273-1278&author=P.+Riedererauthor=L.+Lachenmayer&title=Selegiline%E2%80%99s+neuroprotective+capacity+revisited"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DLachenmayer%26aufirst%3DL.%26atitle%3DSelegiline%25E2%2580%2599s%2520neuroprotective%2520capacity%2520revisited%26jtitle%3DJ.%2520Neural.%2520Transm.%26date%3D2003%26volume%3D110%26spage%3D1273%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Pålhagen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinonen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hägglund, J.</span><span> </span><span class="NLM_article-title">Selegiline slows the progression of the symptoms of Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1200-1206&author=S.+P%C3%A5lhagenauthor=E.+Heinonenauthor=J.+H%C3%A4gglund&title=Selegiline+slows+the+progression+of+the+symptoms+of+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A5lhagen%26aufirst%3DS.%26aulast%3DHeinonen%26aufirst%3DE.%26aulast%3DH%25C3%25A4gglund%26aufirst%3DJ.%26atitle%3DSelegiline%2520slows%2520the%2520progression%2520of%2520the%2520symptoms%2520of%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D66%26spage%3D1200%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lakhan, S. E.</span><span> </span><span class="NLM_article-title">From a Parkinson’s disease expert: rasagiline and the future of therapy</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">3</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1186%2F1750-1326-2-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=17224059" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1-3&author=S.+E.+Lakhan&title=From+a+Parkinson%E2%80%99s+disease+expert%3A+rasagiline+and+the+future+of+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-2-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-2-1%26sid%3Dliteratum%253Aachs%26aulast%3DLakhan%26aufirst%3DS.%2BE.%26atitle%3DFrom%2520a%2520Parkinson%25E2%2580%2599s%2520disease%2520expert%253A%2520rasagiline%2520and%2520the%2520future%2520of%2520therapy%26jtitle%3DMol.%2520Neurodegener.%26date%3D2007%26volume%3D2%26spage%3D1%26epage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Teo, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S.-L.</span><span> </span><span class="NLM_article-title">Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease</span> <span class="citation_source-journal">Transl. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=2-10&author=K.+C.+Teoauthor=S.-L.+Ho&title=Monoamine+oxidase-B+%28MAO-B%29+inhibitors%3A+implications+for+disease-modification+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTeo%26aufirst%3DK.%2BC.%26aulast%3DHo%26aufirst%3DS.-L.%26atitle%3DMonoamine%2520oxidase-B%2520%2528MAO-B%2529%2520inhibitors%253A%2520implications%2520for%2520disease-modification%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DTransl.%2520Neurodegener.%26date%3D2013%26spage%3D2%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crivelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismaili, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fariello, R. G.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2Fj.phrs.2003.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15082032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVCgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=77-85&author=A.+Marzoauthor=L.+D.+Boauthor=N.+C.+Montiauthor=F.+Crivelliauthor=S.+Ismailiauthor=C.+Cacciaauthor=C.+Cattaneoauthor=R.+G.+Fariello&title=Pharmacokinetics+and+pharmacodynamics+of+safinamide%2C+a+neuroprotectant+with+antiparkinsonian+and+anticonvulsant+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity</span></div><div class="casAuthors">Marzo, Antonio; Dal Bo, Lorenzo; Monti, Nunzia Ceppi; Crivelli, Fabrizio; Ismaili, Shevqet; Caccia, Carla; Cattaneo, Carlo; Fariello, Ruggero G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-85</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Objective: This paper describes the pharmacokinetics and the pharmacodynamics, in terms of monoamino oxidase type B (MAO-B) inhibition, in male healthy volunteers of orally administered safinamide, a new neuroprotectant that in exptl. models has demonstrated strong anticonvulsant and antiparkinson activities.  Methods: Four clin. trials covering the dose range of 25-10,000 μg/kg were carried out to describe pharmacokinetics, pharmacodynamics and tolerability of safinamide, administered in single or repeated dose regimen to steady state, including a food interaction trial.  All the above trials were carried out after the Ethics Committee's approval and signature of the consent form by the volunteers.  In single dose trials blood sampling covered a 24 h-period in pharmacodynamic trials, 48 h-period in pharmacokinetic trials.  In the case of repeated dose regimen to steady state a pre-dose sample was drawn on the first six study days, whereas the curve was explored on the 7th study day, prolonging blood sampling over a 48 h-period after the last dosing.  Safinamide level was detd. in plasma by a very sensitive and specific LC-MS-MS method, with a low limit of quantification of 0.5 ng/mL of plasma.  Pharmacokinetic anal. was carried out with non-compartmental method and, in one case, also with the two-compartmental method.  Monoamine oxidase activity of both types A and B (MAO-A and MAO-B) was detd. in plasma at different times (MAO-B) and correlated to safinamide levels, or in urine (MAO-A).  Results: Pharmacokinetics of safinamide proved to be linearly and proportionally related to the administered doses.  The absorption of safinamide was rapid with peak plasma concns. ranging from 2 to 4 h.  Food prolonged the rate and did not affect the extent of absorption of safinamide.  In repeat dose regimen once daily, the steady state was reached on the 5th study day with a marginal accumulation factor of 1.5-1.7.  The drug was cleared with a t1/2 of about 22 h.  Safinamide reversibly inhibited MAO-B enzyme.  Full inhibition was obsd. with single doses≥600 μg/kg, and a relevant, dose dependent, progressive inhibition was encountered with doses starting from 25 μg/kg.  Even at the highest single dose of 10 mg/kg no evidence of MAO-A inhibition was obsd.  Conclusion: Enteral absorption of the drug is linear and proportional to the doses administered.  The drug is cleared from the body with a t1/2 of ≃22 h, without producing any clin. relevant accumulation at steady state.  The MAO-B inhibitory activity, without affecting MAO-A, is useful to prevent a dopamine bioinactivation in patients suffering from Parkinson's disease.  Safinamide tolerability in the four clin. trials proved to be good.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7hAsD1-PSs7Vg90H21EOLACvtfcHk0liZ11SiQWzkwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVCgs7w%253D&md5=a9e13d65d797cf7db330346f2ddd08a2</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2003.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2003.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DMarzo%26aufirst%3DA.%26aulast%3DBo%26aufirst%3DL.%2BD.%26aulast%3DMonti%26aufirst%3DN.%2BC.%26aulast%3DCrivelli%26aufirst%3DF.%26aulast%3DIsmaili%26aufirst%3DS.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCattaneo%26aufirst%3DC.%26aulast%3DFariello%26aufirst%3DR.%2BG.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520safinamide%252C%2520a%2520neuroprotectant%2520with%2520antiparkinsonian%2520and%2520anticonvulsant%2520activity%26jtitle%3DPharmacol.%2520Res.%26date%3D2004%26volume%3D50%26spage%3D77%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fariello, R. G.</span><span> </span><span class="NLM_article-title">Safinamide</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=110-116&author=R.+G.+Fariello&title=Safinamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFariello%26aufirst%3DR.%2BG.%26atitle%3DSafinamide%26jtitle%3DNeurotherapeutics%26date%3D2007%26volume%3D4%26spage%3D110%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Onofrj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A.</span><span> </span><span class="NLM_article-title">An expert opinion on safinamide in Parkinson’s disease</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1115</span><span class="NLM_x">–</span> <span class="NLM_lpage">1125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1115-1125&author=M.+Onofrjauthor=L.+Bonanniauthor=A.+Thomas&title=An+expert+opinion+on+safinamide+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnofrj%26aufirst%3DM.%26aulast%3DBonanni%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DA.%26atitle%3DAn%2520expert%2520opinion%2520on%2520safinamide%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1115%26epage%3D1125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Safinamide in the treatment of Prakinsońs disease</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">–</span> <span class="NLM_lpage">2268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1517%2F14656566.2010.511612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=20707760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVansbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=2261-2268&author=A.+H.+V.+Schapira&title=Safinamide+in+the+treatment+of+Prakinso%C5%84s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Safinamide in the treatment of Parkinson's disease</span></div><div class="casAuthors">Schapira, Anthony H. V.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2261-2268</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Current therapy for Parkinson's disease (PD) is primarily directed at reversing the motor symptoms that are the consequence of dopamine deficiency and includes levodopa, dopamine agonists and monoamine oxidase (MAO) B inhibitors.  New drugs offering both dopaminergic and non-dopaminergic actions could offer a significant advantage.  Areas covered in this review: This review surveys the current treatment strategies for PD.  Defining unmet needs and how a new compd. - safinamide, which has both dopaminergic and non-dopaminergic actions - might address these.  What the reader will gain: The reader will gain an understanding of safinamide and its mechanisms of action, including reversible MAOB inhibition and reduced dopamine reuptake with antiglutamatergic effects, and how it may potentially provide improvement of PD motor symptoms with an antidyskinetic effect through its effect on glutamate release.  The clin. trial profile of safinamide is reviewed.  Early results are promising in terms of improved motor function and reduced OFF' time.  Addnl. Phase III trials are now in progress for this adjunctive indication.  Finally, the reader will understand the potential role for safinamide in the selection and sequencing of drugs for PD.  Take home message: safinamide combines both dopaminergic and non-dopaminergic actions that may add a new dimension to PD treatment options as an adjunct to current drugs.  Its efficacy is under active evaluation in Phase III clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIFyv3AWzo67Vg90H21EOLACvtfcHk0liZ11SiQWzkwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVansbbJ&md5=c916e62cd01d0b9a0fc3df71915f4ac4</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1517%2F14656566.2010.511612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2010.511612%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DSafinamide%2520in%2520the%2520treatment%2520of%2520Prakinso%25C5%2584s%2520disease%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2010%26volume%3D11%26spage%3D2261%26epage%3D2268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Seithel-Keuth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freisleben, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lissy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krösser, A.</span><span> </span><span class="NLM_article-title">Absolute bioavailability and effect of food on the disposition of safinamide immediate release tablets in healthy adult subjects</span> <span class="citation_source-journal">Clin. Pharmacol. Drug Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1002%2Fcpdd.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ynsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=79-89&author=A.+Seithel-Keuthauthor=A.+Johneauthor=A.+Freislebenauthor=K.+Kupasauthor=M.+Lissyauthor=A.+Kr%C3%B6sser&title=Absolute+bioavailability+and+effect+of+food+on+the+disposition+of+safinamide+immediate+release+tablets+in+healthy+adult+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17eR"><div class="casContent"><span class="casTitleNuber">17e</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute bioavailability and effect of food on the disposition of safinamide immediate release tablets in healthy adult subjects</span></div><div class="casAuthors">Seithel-Keuth, Annick; Johne, Andreas; Freisleben, Achim; Kupas, Katrin; Lissy, Michael; Kroesser, Sonja</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-89</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The objectives of this study were to establish the basic i.v. (IV) single-dose PK of safinamide and its major human metabolites, the abs. bioavailability (BA) and food effect on safinamide tablets.  Fourteen healthy adult male and female subjects received 50 mg safinamide single-dose treatments according to a randomized, 3-period, 2-sequence crossover design: immediate release (IR) tablets, administered after an overnight fast and after a standardized high-fat, high-calorie breakfast, and IV soln., administered over 30 min.  Treatments were sepd. by wash-out intervals of at least 17 days.  Serial blood samples were collected for 240 h postdosing to evaluate safinamide parent drug and metabolite concns. for the detn. of PK parameters.  The abs. BA of safinamide 50 mg IR tablets was high, with geoMean AUC0-∞ ratios of about 95% (90% CI: 90-99%) indicating that safinamide is virtually completely absorbed after oral administration.  Safinamide IR tablets did not display a food effect on exposure parameters; both 90% CIs for the ratios fed/fasted of AUC0-∞ and Cmax were entirely within the bioequivalence acceptance margins of 80-125%.  Only tmax was delayed by about 30% in the fed state.  Oral and IV safinamide 50 mg single-dose administrations were generally well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq4aIoZJolc7Vg90H21EOLACvtfcHk0lg6PJVTGoOxCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ynsbjL&md5=eacd460390260703463f1fdb78952973</span></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.2%26sid%3Dliteratum%253Aachs%26aulast%3DSeithel-Keuth%26aufirst%3DA.%26aulast%3DJohne%26aufirst%3DA.%26aulast%3DFreisleben%26aufirst%3DA.%26aulast%3DKupas%26aufirst%3DK.%26aulast%3DLissy%26aufirst%3DM.%26aulast%3DKr%25C3%25B6sser%26aufirst%3DA.%26atitle%3DAbsolute%2520bioavailability%2520and%2520effect%2520of%2520food%2520on%2520the%2520disposition%2520of%2520safinamide%2520immediate%2520release%2520tablets%2520in%2520healthy%2520adult%2520subjects%26jtitle%3DClin.%2520Pharmacol.%2520Drug%2520Dev.%26date%3D2013%26volume%3D2%26spage%3D79%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P. M.</span><span> </span><span class="NLM_article-title">Rasagiline [<i>N</i>-propargyl-1<i>R</i>(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1038%2Fsj.bjp.0703826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=11159700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=500-506&author=M.+B.+H.+Youdimauthor=A.+Grossauthor=J.+P.+M.+Finberg&title=Rasagiline+%5BN-propargyl-1R%28%2B%29-aminoindan%5D%2C+a+selective+and+potent+inhibitor+of+mitochondrial+monoamine+oxidase+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span></div><div class="casAuthors">Youdim, Moussa B. H.; Gross, Aviva; Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">500-506</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rasagiline [N-propargyl-1R(+)-aminoindan], was examd. for its monoamine oxidase (MAO) A and B inhibitor activities in rats together with its S(-)-enantiomer (TVP 1022) and the racemic compd. (AGN-1135) and compared to selegiline (1-deprenyl).  The tissues that were studied for MAO inhibition were the brain, liver and small intestine.  While rasagiline and AGN1135 are highly potent selective irreversible inhibitors of MAO in vitro and in vivo, the S(-) enantiomer is relatively inactive in the tissues examd.  The in vitro IC50 values for inhibition of rat brain MAO activity by rasagiline are 4.43±0.92 nM (type B), and 412±123 nM (type A).  The ED50 values for ex vivo inhibition of MAO in the brain and liver by a single dose of rasagiline are 0.1±0.01, 0.042±0.0045 mg kg-1 resp. for MAO-B, and 6.48±0.81, 2.38±0.35 mg kg-1 resp. for MAO-A.  Selective MAO-B inhibition in the liver and brain was maintained on chronic (21 days) oral dosage with ED50 values of 0.014±0.002 and 0.013±0.001 mg kg-1 resp.  The degree of selectivity of rasagiline for inhibition of MAO-B as opposed to MAO-A was similar to that of selegiline.  Rasagiline was three to 15 times more potent than selegiline for inhibition of MAO-B in rat brain and liver in vivo on acute and chronic administration, but had similar potency in vitro.  These data together with lack of tyramine sympathomimetic potentiation by rasagiline, at selective MAO-B inhibitory dosage, indicate that this inhibitor like selegiline may be a useful agent in the treatment of Parkinson's disease in either symptomatic or L-DOPA adjunct therapy, but lack of amphetamine-like metabolites could present a therapeutic advantage for rasagiline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq020sdG8LiPbVg90H21EOLACvtfcHk0lg6PJVTGoOxCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D&md5=692cfb1e7f679e073f6cbdb2c8650ba9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703826%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DRasagiline%2520%255BN-propargyl-1R%2528%252B%2529-aminoindan%255D%252C%2520a%2520selective%2520and%2520potent%2520inhibitor%2520of%2520mitochondrial%2520monoamine%2520oxidase%2520B%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D132%26spage%3D500%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Clarke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartig, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corn, T. H.</span><span> </span><span class="NLM_article-title">A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1241</span><span class="NLM_x">–</span> <span class="NLM_lpage">1255</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2003&pages=1241-1255&author=A.+Clarkeauthor=F.+Brewerauthor=E.+S.+Johnsonauthor=N.+Mallardauthor=F.+Hartigauthor=S.+Taylorauthor=T.+H.+Corn&title=A+new+formulation+of+selegiline%3A+improved+bioavailability+and+selectivity+for+MAO-B+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DA.%26aulast%3DBrewer%26aufirst%3DF.%26aulast%3DJohnson%26aufirst%3DE.%2BS.%26aulast%3DMallard%26aufirst%3DN.%26aulast%3DHartig%26aufirst%3DF.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DCorn%26aufirst%3DT.%2BH.%26atitle%3DA%2520new%2520formulation%2520of%2520selegiline%253A%2520improved%2520bioavailability%2520and%2520selectivity%2520for%2520MAO-B%2520inhibition%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2003%26volume%3D110%26spage%3D1241%26epage%3D1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Clarke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corn, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boce, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrington, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacMahon, D. G.</span><span> </span><span class="NLM_article-title">A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1257</span><span class="NLM_x">–</span> <span class="NLM_lpage">1271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2003&pages=1257-1271&author=A.+Clarkeauthor=E.+S.+Johnsonauthor=N.+Mallardauthor=T.+H.+Cornauthor=A.+Johnstonauthor=M.+Boceauthor=S.+Warringtonauthor=D.+G.+MacMahon&title=A+new+low-dose+formulation+of+selegiline%3A+clinical+efficacy%2C+patient+preference+and+selectivity+for+MAO-B+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DE.%2BS.%26aulast%3DMallard%26aufirst%3DN.%26aulast%3DCorn%26aufirst%3DT.%2BH.%26aulast%3DJohnston%26aufirst%3DA.%26aulast%3DBoce%26aufirst%3DM.%26aulast%3DWarrington%26aufirst%3DS.%26aulast%3DMacMahon%26aufirst%3DD.%2BG.%26atitle%3DA%2520new%2520low-dose%2520formulation%2520of%2520selegiline%253A%2520clinical%2520efficacy%252C%2520patient%2520preference%2520and%2520selectivity%2520for%2520MAO-B%2520inhibition%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2003%26volume%3D110%26spage%3D1257%26epage%3D1271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lees, A.</span><span> </span><span class="NLM_article-title">Alternatives to levodopa in the initial treatment of early Parkinson’s disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">740</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.2165%2F00002512-200522090-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=16156677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2005&pages=731-740&author=A.+Lees&title=Alternatives+to+levodopa+in+the+initial+treatment+of+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Alternatives to levodopa in the initial treatment of early parkinson's disease</span></div><div class="casAuthors">Lees, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">731-740</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is primarily a disease of elderly patients.  This article reviews current knowledge and recent developments relating to drugs that can be used as alternatives to levodopa as initial treatment of PD.  Synthetic orally acting dopamine agonists have found increasing favor as an option for early PD in relatively young patients.  This strategy is based on evidence that this approach may delay the onset of motor fluctuations, at least during the first 5 years of treatment.  S.c. apomorphine infusions may attenuate motor fluctuations in late-stage disease, and transdermal rotigotine, a dopamine agonist in development, has also been shown to be efficacious.  The greater proclivity for dopamine agonists to cause psychotoxicity has, however, limited their routine use in the elderly.  Selective monoamine oxidase type B (MAO-B) inhibitors, used as monotherapy, delay the need for the introduction of levodopa by about 9 mo.  These agents appear to be less efficacious than dopamine agonists but are better tolerated.  Concern has been expressed about the potential of the MAO-B inhibitor selegiline (deprenyl) to induce cardiovascular adverse effects (orthostatic hypotension), either directly or through its amphetamine catabolites.  Rasagiline is a new MAO-B inhibitor that is not broken down to amphetamine derivs. and is indicated as both monotherapy in early PD and as adjunctive therapy in PD patients with motor fluctuations.  Two older classes of agents have undergone a resurgence of interest in recent years.  Amantadine, which enhances dopaminergic transmission and has antiglutamate activity, is occasionally used as monotherapy but has recently been widely used as an antidyskinetic agent in late-stage PD.  Anticholinergic drugs, such as benztropine (benzatropine) and orphenadrine also provide control of symptoms when used as monotherapy, but their psychotoxic, cognitive and autonomic adverse events make them inappropriate for the treatment of the elderly.  Effective therapy in PD should prevent disease progression and abolish motor and cognitive handicap.  Currently, none of the existing drugs meets all these needs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZoKtxp2djj7Vg90H21EOLACvtfcHk0lg6PJVTGoOxCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtbrN&md5=df3ab7c50632db266f027b420323c413</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2165%2F00002512-200522090-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-200522090-00002%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DA.%26atitle%3DAlternatives%2520to%2520levodopa%2520in%2520the%2520initial%2520treatment%2520of%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D2005%26volume%3D22%26spage%3D731%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Parkinson Study Group.</span><span> </span><span class="NLM_article-title">A controlled, randomized, delayed-start study of rasagiline in early Parkinson’s disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1001%2Farchneur.61.4.561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15096406" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2004&pages=561-566&author=Parkinson+Study+Group.&title=A+controlled%2C+randomized%2C+delayed-start+study+of+rasagiline+in+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1001%2Farchneur.61.4.561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.61.4.561%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DA%2520controlled%252C%2520randomized%252C%2520delayed-start%2520study%2520of%2520rasagiline%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2004%26volume%3D61%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hubálek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span> </span><span class="NLM_article-title">Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1760</span><span class="NLM_x">–</span> <span class="NLM_lpage">1766</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0310885" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1760-1766&author=F.+Hub%C3%A1lekauthor=C.+Bindaauthor=M.+Liauthor=Y.+Herzigauthor=J.+Sterlingauthor=M.+B.+H.+Youdimauthor=A.+Matteviauthor=D.+E.+Edmondson&title=Inactivation+of+purified+human+recombinant+monoamine+oxidases+A+and+B+by+rasagiline+and+its+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm0310885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0310885%26sid%3Dliteratum%253Aachs%26aulast%3DHub%25C3%25A1lek%26aufirst%3DF.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26atitle%3DInactivation%2520of%2520purified%2520human%2520recombinant%2520monoamine%2520oxidases%2520A%2520and%2520B%2520by%2520rasagiline%2520and%2520its%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1760%26epage%3D1766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Prins, L. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, S. F.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase by indole and benzofuran derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4458</span><span class="NLM_x">–</span> <span class="NLM_lpage">4466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4458-4466&author=L.+H.+A.+Prinsauthor=J.+P.+Petzerauthor=S.+F.+Malan&title=Inhibition+of+monoamine+oxidase+by+indole+and+benzofuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrins%26aufirst%3DL.%2BH.%2BA.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DMalan%26aufirst%3DS.%2BF.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520by%2520indole%2520and%2520benzofuran%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4458%26epage%3D4466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hampel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möller, H.-J.</span><span> </span><span class="NLM_article-title">A review of the reversible MAO-A inhibitor moclobemide in geriatric patients</span> <span class="citation_source-journal">Hum. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1002%2F%28SICI%291099-1077%28199801%2913%3A1%3C43%3A%3AAID-HUP953%3E3.0.CO%3B2-Z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=43-51&author=H.+Hampelauthor=C.+Bergerauthor=K.+Buchauthor=H.-J.+M%C3%B6ller&title=A+review+of+the+reversible+MAO-A+inhibitor+moclobemide+in+geriatric+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1077%28199801%2913%3A1%3C43%3A%3AAID-HUP953%3E3.0.CO%3B2-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1077%2528199801%252913%253A1%253C43%253A%253AAID-HUP953%253E3.0.CO%253B2-Z%26sid%3Dliteratum%253Aachs%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DC.%26aulast%3DBuch%26aufirst%3DK.%26aulast%3DM%25C3%25B6ller%26aufirst%3DH.-J.%26atitle%3DA%2520review%2520of%2520the%2520reversible%2520MAO-A%2520inhibitor%2520moclobemide%2520in%2520geriatric%2520patients%26jtitle%3DHum.%2520Psychopharmacol.%26date%3D1998%26volume%3D12%26spage%3D43%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Malek, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosset, D. G.</span><span> </span><span class="NLM_article-title">Investigational agents in the treatment of Parkinson’s disease: focus on safinamide</span> <span class="citation_source-journal">J. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKltbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=85-90&author=N.+M.+Malekauthor=D.+G.+Grosset&title=Investigational+agents+in+the+treatment+of+Parkinson%E2%80%99s+disease%3A+focus+on+safinamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Investigational agents in the treatment of Parkinson's disease: focus on safinamide</span></div><div class="casAuthors">Malek, Naveed M.; Grosset, Donald G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-90</span>CODEN:
                <span class="NLM_cas:coden">JEPOCA</span>;
        ISSN:<span class="NLM_cas:issn">1179-1454</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">The authors review management issues in Parkinson's disease (PD) and provide an overview of the current pharmacol. management strategies, with a specific focus on safinamide.  Current therapeutic management of PD largely involves strategies to optimize the replacement of deficient dopamine, using levodopa, dopamine agonists and inhibitors of dopamine-metabolizing enzymes.  Currently under investigation for use in the treatment of PD, safinamide has multiple modes of action including monoamine oxidase B inhibition.  It is well absorbed orally, has a long plasma half-life and does not have liver enzyme-inducing or liver enzyme-inhibiting activity.  Peak plasma concn. occurs 2-4 h after single oral doses.  Safinamide as monotherapy and as an adjunct to dopamine agonists improves Unified Parkinson's disease Rating Scale motor scores.  One randomized, placebo-controlled trial involving 168 patients given a median safinamide dose of 70 mg/day (range 40-90 mg/day) significantly increased the proportion of responders-defined as patients improving their Unified Parkinson's disease Rating Scale motor scores by 30% or more from baseline - after 3 mo (37.5% for safinamide vs. 21.4% for placebo; P < 0.05).  Safinamide increased "on" time with no or minor dyskinesia compared with the placebo in another trial, but dyskinesia severity was not reduced.  Safinamide was well tolerated, with an adverse effect profile similar to that of the placebo.  Further Phase III trial data for safinamide efficacy is awaited and will be of interest in a comparison with other developments in PD therapeutics: modified formulations of available compds., new drug classes such as adenosine receptor antagonists and gene-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRrqERbxUmTLVg90H21EOLACvtfcHk0ljsY2CYMbJgcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKltbzP&md5=cdab0d82b395e1e15fa011e21aed473f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DN.%2BM.%26aulast%3DGrosset%26aufirst%3DD.%2BG.%26atitle%3DInvestigational%2520agents%2520in%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520focus%2520on%2520safinamide%26jtitle%3DJ.%2520Exp.%2520Pharmacol.%26date%3D2012%26volume%3D4%26spage%3D85%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Schapira, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgohain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onofrj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Study 017 Investigators</span><span> </span><span class="NLM_article-title">Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson’s disease</span> <span class="citation_source-journal">Eur. J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1111%2Fj.1468-1331.2012.03840.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=22967035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BC38bmtV2qsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=271-280&author=A.+H.+Schapiraauthor=F.+Stocchiauthor=R.+Borgohainauthor=M.+Onofrjauthor=M.+Bhattauthor=P.+Lorenzanaauthor=V.+Luciniauthor=R.+Giulianiauthor=R.+Anandauthor=Study+017+Investigators&title=Long-term+efficacy+and+safety+of+safinamide+as+add-on+therapy+in+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease</span></div><div class="casAuthors">Schapira A H V; Stocchi F; Borgohain R; Onofrj M; Bhatt M; Lorenzana P; Lucini V; Giuliani R; Anand R</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology : the official journal of the European Federation of Neurological Societies</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Safinamide is an α-aminoamide with both dopaminergic and non-dopaminergic mechanisms of action in Phase III clinical development as a once-daily add-on to dopamine agonist (DA) therapy for early Parkinson's disease (PD).  METHODS:  Study 017 was a 12-month, randomized, double-blind, placebo-controlled pre-planned extension study to the previously reported Study 015.  Patients received safinamide 100 or 200 mg/day or placebo added to a single DA in early PD.  The primary efficacy endpoint was the time from baseline (Study 015 randomization) to 'intervention', defined as increase in DA dose; addition of another DA, levodopa or other PD treatment; or discontinuation due to lack of efficacy.  Safinamide groups were pooled for the primary efficacy endpoint analysis; post hoc analyses were performed on each separate dose group.  RESULTS:  Of the 269 patients randomized in Study 015, 227 (84%) enrolled in Study 017 and 187/227 (82%) patients completed the extension study.  Median time to intervention was 559 and 466 days in the pooled safinamide and placebo groups, respectively (log-rank test; P = 0.3342).  In post hoc analyses, patients receiving safinamide 100 mg/day experienced a significantly lower rate of intervention compared with placebo (25% vs. 51%, respectively) and a delay in median time to intervention of 9 days (P < 0.05; 240- to 540-day analysis).  CONCLUSIONS:  The pooled data from the safinamide groups failed to reach statistical significance for the primary endpoint of median time from baseline to additional drug intervention.  Post hoc analyses indicate that safinamide 100 mg/day may be effective as add-on treatment to DA in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTW8Q7CptAmznthwrmtH4OBfW6udTcc2eaG9ANlF5Kndbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bmtV2qsw%253D%253D&md5=ae238c6d3d0f0952fc6993bd03615335</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-1331.2012.03840.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-1331.2012.03840.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26aulast%3DStocchi%26aufirst%3DF.%26aulast%3DBorgohain%26aufirst%3DR.%26aulast%3DOnofrj%26aufirst%3DM.%26aulast%3DBhatt%26aufirst%3DM.%26aulast%3DLorenzana%26aufirst%3DP.%26aulast%3DLucini%26aufirst%3DV.%26aulast%3DGiuliani%26aufirst%3DR.%26aulast%3DAnand%26aufirst%3DR.%26aulast%3D%26atitle%3DLong-term%2520efficacy%2520and%2520safety%2520of%2520safinamide%2520as%2520add-on%2520therapy%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2013%26volume%3D20%26spage%3D271%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maestroni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faravelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curatolo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fariello, R. G.</span><span> </span><span class="NLM_article-title">Safinamide: from molecular targets to a new anti-parkinson drug</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">7_suppl_2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S18</span><span class="NLM_x">–</span> <span class="NLM_lpage">S23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=S18-S23&issue=7_suppl_2&author=C.+Cacciaauthor=R.+Majauthor=M.+Calabresiauthor=S.+Maestroniauthor=L.+Faravelliauthor=L.+Curatoloauthor=P.+Salvatiauthor=R.+G.+Fariello&title=Safinamide%3A+from+molecular+targets+to+a+new+anti-parkinson+drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DMaj%26aufirst%3DR.%26aulast%3DCalabresi%26aufirst%3DM.%26aulast%3DMaestroni%26aufirst%3DS.%26aulast%3DFaravelli%26aufirst%3DL.%26aulast%3DCuratolo%26aufirst%3DL.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DFariello%26aufirst%3DR.%2BG.%26atitle%3DSafinamide%253A%2520from%2520molecular%2520targets%2520to%2520a%2520new%2520anti-parkinson%2520drug%26jtitle%3DNeurology%26date%3D2006%26volume%3D67%26issue%3D7_suppl_2%26spage%3DS18%26epage%3DS23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Monoamine oxidase B inhibitors for the treatment of Parkinson’s disease: a review of symptomatic and potential disease-modifying effects</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1061-1071&author=A.+H.+V.+Schapira&title=Monoamine+oxidase+B+inhibitors+for+the+treatment+of+Parkinson%E2%80%99s+disease%3A+a+review+of+symptomatic+and+potential+disease-modifying+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DMonoamine%2520oxidase%2520B%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520review%2520of%2520symptomatic%2520and%2520potential%2520disease-modifying%2520effects%26jtitle%3DCNS%2520Drugs%26date%3D2011%26volume%3D25%26spage%3D1061%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capaldi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Solid-phase synthesis and insights into structure–activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4909</span><span class="NLM_x">–</span> <span class="NLM_lpage">4916</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070725e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4909-4916&author=F.+Leonettiauthor=C.+Capaldiauthor=L.+Pisaniauthor=O.+Nicolottiauthor=G.+Muncipintoauthor=A.+Stefanachiauthor=S.+Cellamareauthor=C.+Cacciaauthor=A.+Carotti&title=Solid-phase+synthesis+and+insights+into+structure%E2%80%93activity+relationships+of+safinamide+analogues+as+potent+and+selective+inhibitors+of+type+B+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm070725e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070725e%26sid%3Dliteratum%253Aachs%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCapaldi%26aufirst%3DC.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DSolid-phase%2520synthesis%2520and%2520insights%2520into%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520safinamide%2520analogues%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520type%2520B%2520monoamine%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4909%26epage%3D4916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Mertens, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">Alkynyl-coumarinyl ethers as MAO-B inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1928</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1916-1928&author=M.+D.+Mertensauthor=S.+Hinzauthor=C.+E.+M%C3%BCllerauthor=M.+G%C3%BCtschow&title=Alkynyl-coumarinyl+ethers+as+MAO-B+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMertens%26aufirst%3DM.%2BD.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DAlkynyl-coumarinyl%2520ethers%2520as%2520MAO-B%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1916%26epage%3D1928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Pérez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernándes-Álvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Relevance of benzyloxy group in 2-indoyl methylamines in the selective MAO-B inhibition</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1038%2Fsj.bjp.0702600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=10433493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK1MXktlOmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1999&pages=869-876&author=V.+P%C3%A9rezauthor=J.+L.+Marcoauthor=E.+Fern%C3%A1ndes-%C3%81lvarezauthor=M.+Unzeta&title=Relevance+of+benzyloxy+group+in+2-indoyl+methylamines+in+the+selective+MAO-B+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition</span></div><div class="casAuthors">Perez, Virgili; Marco, Jose Luis; Fernandez-Alvarez, Eldiberto; Unzeta, Mercedes</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">869-876</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Previous studies with indolyl derivs. as monoamine oxidase (MAO) inhibitors have shown the relevance of the indole structure for recognition by the active site of this enzyme.  We now report a new series of mols. with structural features which det. the selectivity of MAO inhibition.  A benzyloxy group attached at position 5 of the indole ring is crit. for this selective behavior.  Amongst all of these benzyloxy-indolyl methylamines, N-(2-propynyl)-2-(5-benzyloxyindol)methylamine FA-73 was the most potent MAO-B "suicide" inhibitor studied.  The Ki values for MAO-A and MAO-B were 800±60 and 0.75±0.15 nM, resp.  These data represent a selectivity value of 1066 for MAO-B, being 48 times more selective than L-deprenyl (Ki values of 376±0.032 and 16.8±0.1 nM for MAO A and MAO-B, resp.).  The IC50 values for dopamine uptake in striatal synaptosomal fractions from rats were 150±8 μM for FA-73 and 68±10 μM for L-deprenyl whereas in human caudate tissue the IC50 values were 0.36±0.015 μM for FA-73 and 0.10±0.007 μM for L-deprenyl.  Moreover, mouse brain MAO-B activity was 90% ex vivo inhibited by both compds. 1 h after 4 mg kg-1 administration, MAO-A activity was not affected.  These novel mols. should provide a better understanding of the active site of monoamine oxidase and could be the starting point for the design of further selective, non-amphetamine-like MAO-B inhibitors with therapeutic potential for the treatment of neurol. disorders, such as parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoynmDOjiKQgbVg90H21EOLACvtfcHk0ljlO_QQEfbzog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktlOmsrw%253D&md5=756c3b6564fe28ee128fdcf06b730f6c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702600%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DV.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3DFern%25C3%25A1ndes-%25C3%2581lvarez%26aufirst%3DE.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DRelevance%2520of%2520benzyloxy%2520group%2520in%25202-indoyl%2520methylamines%2520in%2520the%2520selective%2520MAO-B%2520inhibition%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D127%26spage%3D869%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Herraiz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arán, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillén, H.</span><span> </span><span class="NLM_article-title">Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO)</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1080%2F10715760903159170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=19669997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2009&pages=975-984&author=T.+Herraizauthor=V.+J.+Ar%C3%A1nauthor=H.+Guill%C3%A9n&title=Nitroindazole+compounds+inhibit+the+oxidative+activation+of+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+%28MPTP%29+neurotoxin+to+neurotoxic+pyridinium+cations+by+human+monoamine+oxidase+%28MAO%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO)</span></div><div class="casAuthors">Herraiz, Tomas; Aran, Vicente J.; Guillen, Hugo</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">975-984</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Monoamine oxidase (MAO) B is a mitochondrial enzyme selectively involved in the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to toxic pyridinium cations producing Parkinsonism in animal models.  Various synthesized 5-nitroindazoles, 6-nitroindazole and the neuroprotectant 7-nitroindazole were examd. as inhibitors of MAO and as antioxidants and radical scavengers.  The oxidn. of MPTP by human MAO-B and mitochondria was assessed by HPLC.  Simple nitroindazoles inhibited MPTP oxidn. to 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) and 1-methyl-4-phenylpyridinium (MPP+) in a competitive and reversible manner.  5-Nitroindazole (IC50 = 0.99 μM, Ki = 0.102 μM) and 6-nitroindazole (IC50 = 2.5 μM) were better inhibitors of human MAO-B than 7-nitroindazole (IC50 = 27.8 μM).  6-Nitroindazole also inhibited MAO-A.  Nitroindazole isomers were good hydroxyl radical (OH·) scavengers, with 5-nitro-, 6-nitro- and 7-nitroindazole showing similar activity (k ∼ 1010 M-1 s-1).  Neuroprotective actions of nitroindazoles (7-nitroindazole) could be linked to their MAO-inhibitory and antiradical properties besides inhibition on nitric oxide synthase (NOS).  5-Nitro- and 6-nitroindazole, previously reported as weak NOS inhibitors, were better inhibitors of human MAO-B and more active against MPTP neurotoxin oxidn. (lower MPDP+ and MPP+ levels) than 7-nitroindazole and acted as good radical scavengers and could be potential neuroprotective agents in addn. to MAO-B inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6dQrH_I7F_rVg90H21EOLACvtfcHk0ljloNs2s4A1fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhurnI&md5=89706a0fb15d525003b9814318ec9f38</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F10715760903159170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760903159170%26sid%3Dliteratum%253Aachs%26aulast%3DHerraiz%26aufirst%3DT.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DGuill%25C3%25A9n%26aufirst%3DH.%26atitle%3DNitroindazole%2520compounds%2520inhibit%2520the%2520oxidative%2520activation%2520of%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520%2528MPTP%2529%2520neurotoxin%2520to%2520neurotoxic%2520pyridinium%2520cations%2520by%2520human%2520monoamine%2520oxidase%2520%2528MAO%2529%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2009%26volume%3D43%26spage%3D975%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miscioscia, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passeleu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2<i>H</i>-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6685</span><span class="NLM_x">–</span> <span class="NLM_lpage">6706</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9010127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6685-6706&author=L.+Pisaniauthor=G.+Muncipintoauthor=T.+F.+Misciosciaauthor=O.+Nicolottiauthor=F.+Leonettiauthor=M.+Cattoauthor=C.+Cacciaauthor=P.+Salvatiauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=C.+Passeleuauthor=A.+Carotti&title=Discovery+of+a+novel+class+of+potent+coumarin+monoamine+oxidase+B+inhibitors%3A+development+and+biopharmacological+profiling+of+7-%5B%283-chlorobenzyl%29oxy%5D-4-%5B%28methylamino%29methyl%5D-2H-chromen-2-one+methanesulfonate+%28NW-1772%29+as+a+highly+potent%2C+selective%2C+reversible%2C+and+orally+active+monoamine+oxidase+B+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm9010127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9010127%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DMiscioscia%26aufirst%3DT.%2BF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DPasseleu%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520potent%2520coumarin%2520monoamine%2520oxidase%2520B%2520inhibitors%253A%2520development%2520and%2520biopharmacological%2520profiling%2520of%25207-%255B%25283-chlorobenzyl%2529oxy%255D-4-%255B%2528methylamino%2529methyl%255D-2H-chromen-2-one%2520methanesulfonate%2520%2528NW-1772%2529%2520as%2520a%2520highly%2520potent%252C%2520selective%252C%2520reversible%252C%2520and%2520orally%2520active%2520monoamine%2520oxidase%2520B%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6685%26epage%3D6706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Van der Walt, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milczek, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase by (<i>E</i>)-styrylisatin analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2509</span><span class="NLM_x">–</span> <span class="NLM_lpage">2513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2509-2513&author=E.+M.+Van+der+Waltauthor=E.+M.+Milczekauthor=S.+F.+Malanauthor=D.+E.+Edmondsonauthor=N.+Castagnoliauthor=J.+J.+Berghauthor=J.+P.+Petzer&title=Inhibition+of+monoamine+oxidase+by+%28E%29-styrylisatin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BWalt%26aufirst%3DE.%2BM.%26aulast%3DMilczek%26aufirst%3DE.%2BM.%26aulast%3DMalan%26aufirst%3DS.%2BF.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DBergh%26aufirst%3DJ.%2BJ.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520by%2520%2528E%2529-styrylisatin%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2509%26epage%3D2513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manley-King, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=261-274&author=C.+I.+Manley-Kingauthor=J.+J.+Berghauthor=J.+P.+Petzer&title=Inhibition+of+monoamine+oxidase+by+selected+C5-+and+C6-substituted+isatin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley-King%26aufirst%3DC.%2BI.%26aulast%3DBergh%26aufirst%3DJ.%2BJ.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520by%2520selected%2520C5-%2520and%2520C6-substituted%2520isatin%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D261%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Prat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesionde rats</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2000&pages=409-417&author=G.+Pratauthor=V.+P%C3%A9rezauthor=A.+Rubiauthor=M.+Casasauthor=M.+Unzeta&title=The+novel+type+B+MAO+inhibitor+PF9601N+enhances+the+duration+of+L-DOPA-induced+contralateral+turning+in+6-hydroxydopamine+lesionde+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrat%26aufirst%3DG.%26aulast%3DP%25C3%25A9rez%26aufirst%3DV.%26aulast%3DRubi%26aufirst%3DA.%26aulast%3DCasas%26aufirst%3DM.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DThe%2520novel%2520type%2520B%2520MAO%2520inhibitor%2520PF9601N%2520enhances%2520the%2520duration%2520of%2520L-DOPA-induced%2520contralateral%2520turning%2520in%25206-hydroxydopamine%2520lesionde%2520rats%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2000%26volume%3D107%26spage%3D409%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bellik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessina, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valoti, M.</span><span> </span><span class="NLM_article-title">Antioxidant properties of PF9601N, a novel MAO-B inhibitor: assessment of its ability to interact with reactive nitrogen species</span> <span class="citation_source-journal">Acta Biochim. Polym.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=20532254" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2010&pages=235-239&author=L.+Bellikauthor=S.+Dragoniauthor=F.+Pessinaauthor=E.+Sanzauthor=M.+Unzetaauthor=M.+Valoti&title=Antioxidant+properties+of+PF9601N%2C+a+novel+MAO-B+inhibitor%3A+assessment+of+its+ability+to+interact+with+reactive+nitrogen+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellik%26aufirst%3DL.%26aulast%3DDragoni%26aufirst%3DS.%26aulast%3DPessina%26aufirst%3DF.%26aulast%3DSanz%26aufirst%3DE.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DValoti%26aufirst%3DM.%26atitle%3DAntioxidant%2520properties%2520of%2520PF9601N%252C%2520a%2520novel%2520MAO-B%2520inhibitor%253A%2520assessment%2520of%2520its%2520ability%2520to%2520interact%2520with%2520reactive%2520nitrogen%2520species%26jtitle%3DActa%2520Biochim.%2520Polym.%26date%3D2010%26volume%3D57%26spage%3D235%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Unzeta, M.; Sanz, E.</span>; <span> </span><span class="NLM_article-title">Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson’s disease</span>. In  <span class="citation_source-book">International Review of Neurobiology</span>, <span class="NLM_edition">1st</span> ed.; <span class="NLM_contrib-group">Youdim, M. B. H.; Riederer, P.</span>, Eds.; <span class="NLM_series">Monoamine Oxidases and Their Inhibitors</span>; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">100</span>, pp  <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=218-229&author=M.+Unzeta&author=E.+Sanzauthor=M.+B.+H.+Youdim&author=P.+Riederer&title=International+Review+of+Neurobiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DNovel%2520MAO-B%2520inhibitors%253A%2520potential%2520therapeutic%2520use%2520of%2520the%2520selective%2520MAO-B%2520inhibitor%2520PF9601N%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26btitle%3DInternational%2520Review%2520of%2520Neurobiology%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26pub%3DElsevier%26date%3D2011%26volume%3D100%26spage%3D218%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Müller, C. E.; Hockemeyer, J.; Tzvetkov, N. T.; Burbiel, J.</span><span> </span><span class="NLM_article-title">8-Ethynyl-xanthine derivatives as selective A<sub>2A</sub> receptor antagonists</span>. PCT Int. Appl. WO 2008077557,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=C.+E.+M%C3%BCller&author=J.+Hockemeyer&author=N.+T.+Tzvetkov&author=J.+Burbiel&title=8-Ethynyl-xanthine+derivatives+as+selective+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D8-Ethynyl-xanthine%2520derivatives%2520as%2520selective%2520A2A%2520receptor%2520antagonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldeco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span> </span><span class="NLM_article-title">Molecular insights into human monoamine oxidase B inhibition by the glitazone anti-diabetes drugs</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=39-42&author=C.+Bindaauthor=M.+Aldecoauthor=W.+J.+Geldenhuysauthor=M.+Tortoriciauthor=A.+Matteviauthor=D.+E.+Edmondson&title=Molecular+insights+into+human+monoamine+oxidase+B+inhibition+by+the+glitazone+anti-diabetes+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DAldeco%26aufirst%3DM.%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DTortorici%26aufirst%3DM.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26atitle%3DMolecular%2520insights%2520into%2520human%2520monoamine%2520oxidase%2520B%2520inhibition%2520by%2520the%2520glitazone%2520anti-diabetes%2520drugs%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D3%26spage%3D39%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Raffa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daidone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schillaci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plescia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torta, L.</span><span> </span><span class="NLM_article-title">Synthesis and antifungal activity of new <i>N</i>-isoxazolyl-2-iodomenzamides</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2FS0014-827X%2898%2900108-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=10321034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK1MXivFKhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=90-94&author=D.+Raffaauthor=G.+Daidoneauthor=B.+Maggioauthor=D.+Schillaciauthor=S.+Plesciaauthor=L.+Torta&title=Synthesis+and+antifungal+activity+of+new+N-isoxazolyl-2-iodomenzamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antifungal activity of new N-isoxazolyl-2-iodobenzamides</span></div><div class="casAuthors">Raffa, Demetrio; Daidone, Giuseppe; Maggio, Benedetta; Schillaci, Domenico; Plescia, Fabiana; Torta, Livio</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">90-94</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">N-Isoxazolyl-2-iodobenzamides with a benodanil-like structure were synthesized by refluxing in acetic acid the corresponding benzotriazinones with potassium iodide for 1 h with the aim to ascertain if they were active as fungicides against Phytophthora citricola Saw., Botrytis cinerea Pers., Rhizoctonia sp. and Alternaria sp.  Among the tested iodo derivs., I and II possess interesting activities against the aforesaid fungal strains, in several cases similar to that of benodanil taken as ref. drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY6VJpxp0etbVg90H21EOLACvtfcHk0lhT3De7WlW2sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFKhtrs%253D&md5=bfc060401133404bbdefe4809c9226e4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2898%2900108-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252898%252900108-6%26sid%3Dliteratum%253Aachs%26aulast%3DRaffa%26aufirst%3DD.%26aulast%3DDaidone%26aufirst%3DG.%26aulast%3DMaggio%26aufirst%3DB.%26aulast%3DSchillaci%26aufirst%3DD.%26aulast%3DPlescia%26aufirst%3DS.%26aulast%3DTorta%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520antifungal%2520activity%2520of%2520new%2520N-isoxazolyl-2-iodomenzamides%26jtitle%3DFarmaco%26date%3D1999%26volume%3D54%26spage%3D90%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Tzvetkov, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Euler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span> </span><span class="NLM_article-title">Regioselective synthesis of 7,8-dihydroimidazo[5,1-<i>c</i>][1,2,4]triazine-3,6-(2<i>H</i>,4<i>H</i>)-dione derivatives: a new drug-like heterocyclic scaffold</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1593</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.3762%2Fbjoc.8.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=23209490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVCmt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=1584-1593&author=N.+T.+Tzvetkovauthor=H.+Eulerauthor=C.+E.+M%C3%BCller&title=Regioselective+synthesis+of+7%2C8-dihydroimidazo%5B5%2C1-c%5D%5B1%2C2%2C4%5Dtriazine-3%2C6-%282H%2C4H%29-dione+derivatives%3A+a+new+drug-like+heterocyclic+scaffold"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of 7,8-dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione derivatives: a new drug-like heterocyclic scaffold</span></div><div class="casAuthors">Tzvetkov, Nikolay T.; Euler, Harald; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1584-1593, No. 181</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">Dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione derivs. were prepd. by successive N3- and N1-alkylation of hydantoins, followed by regioselective thionation and subsequent cyclization under mild conditions.  In a final alkylation step a further substituent may be introduced.  The synthetic strategy allows broad structural variation of this new drug-like heterobicyclic scaffold.  In addn. to extensive NMR and MS analyses, the structure of one deriv. was confirmed by X-ray crystallog. (for compd. I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtG42ok5JA67Vg90H21EOLACvtfcHk0lhT3De7WlW2sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVCmt7nI&md5=618d3632663893d76c256655646cfb9a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.8.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.8.181%26sid%3Dliteratum%253Aachs%26aulast%3DTzvetkov%26aufirst%3DN.%2BT.%26aulast%3DEuler%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DRegioselective%2520synthesis%2520of%25207%252C8-dihydroimidazo%255B5%252C1-c%255D%255B1%252C2%252C4%255Dtriazine-3%252C6-%25282H%252C4H%2529-dione%2520derivatives%253A%2520a%2520new%2520drug-like%2520heterocyclic%2520scaffold%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2012%26volume%3D8%26spage%3D1584%26epage%3D1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonsignori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidempergher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinciroli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">AcArthur, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fariello, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span> </span><span class="NLM_article-title">Synthesis and anticonvulsant activity of a new class of 2-[(arylalkyl)amino]alkanamide derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970599m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK1cXms1Oitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=579-590&author=P.+Pevarelloauthor=A.+Bonsignoriauthor=P.+Dostertauthor=F.+Heidempergherauthor=V.+Pinciroliauthor=M.+Colomboauthor=R.+A.+AcArthurauthor=P.+Salvatiauthor=C.+Postauthor=R.+G.+Farielloauthor=M.+Varasi&title=Synthesis+and+anticonvulsant+activity+of+a+new+class+of+2-%5B%28arylalkyl%29amino%5Dalkanamide+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Anticonvulsant Activity of a New Class of 2-[(Arylalkyl)amino]alkanamide Derivatives</span></div><div class="casAuthors">Pevarello, Paolo; Bonsignori, Alberto; Dostert, Philippe; Heidempergher, Franco; Pinciroli, Vittorio; Colombo, Maristella; McArthur, Robert A.; Salvati, Patricia; Post, Claes; Fariello, Ruggero G.; Varasi, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">579-590</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from milacemide, a weak anticonvulsant, trying to elucidate its mechanism of action a structurally novel class of potent and preclinically safe anticonvulsants was discovered.  The structure-activity relationship study within this series of compds was reported.  Different parts of the structural lead 2-[[4-(3-chlorobenzoxy)benzyl]amino]acetamide were varied, and many potent anticonvulsants were found.  (S)-2-[[4-(3-fluorobenzoxy)benzyl]amino]propanamide methanesulfonate, (PNU-151774E), emerged as the promising candidate for further development for its potent anticonvulsant activity and outstanding therapeutic indexes in different animal tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy8FzAw312mrVg90H21EOLACvtfcHk0lhT3De7WlW2sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1Oitw%253D%253D&md5=2297e82ce9a4feb069a761bd0a1d87f5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm970599m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970599m%26sid%3Dliteratum%253Aachs%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBonsignori%26aufirst%3DA.%26aulast%3DDostert%26aufirst%3DP.%26aulast%3DHeidempergher%26aufirst%3DF.%26aulast%3DPinciroli%26aufirst%3DV.%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DAcArthur%26aufirst%3DR.%2BA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DPost%26aufirst%3DC.%26aulast%3DFariello%26aufirst%3DR.%2BG.%26aulast%3DVarasi%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520anticonvulsant%2520activity%2520of%2520a%2520new%2520class%2520of%25202-%255B%2528arylalkyl%2529amino%255Dalkanamide%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D579%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Raffa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascioferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daidone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plescia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schillaci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusimano, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colomba, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolomeo, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studies</span> <span class="citation_source-journal">Arch. Pharm. Chem. Lett. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1002%2Fardp.200800159" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2009&pages=265-273&author=D.+Raffaauthor=B.+Maggioauthor=S.+Cascioferroauthor=M.+V.+Raimondiauthor=G.+Daidoneauthor=S.+Plesciaauthor=D.+Schillaciauthor=M.+G.+Cusimanoauthor=L.+Titoneauthor=C.+Colombaauthor=M.+Tolomeo&title=N-%28Indazolyl%29benzamido+derivatives+as+CDK1+inhibitors%3A+design%2C+synthesis%2C+biological+activity%2C+and+molecular+docking+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fardp.200800159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200800159%26sid%3Dliteratum%253Aachs%26aulast%3DRaffa%26aufirst%3DD.%26aulast%3DMaggio%26aufirst%3DB.%26aulast%3DCascioferro%26aufirst%3DS.%26aulast%3DRaimondi%26aufirst%3DM.%2BV.%26aulast%3DDaidone%26aufirst%3DG.%26aulast%3DPlescia%26aufirst%3DS.%26aulast%3DSchillaci%26aufirst%3DD.%26aulast%3DCusimano%26aufirst%3DM.%2BG.%26aulast%3DTitone%26aufirst%3DL.%26aulast%3DColomba%26aufirst%3DC.%26aulast%3DTolomeo%26aufirst%3DM.%26atitle%3DN-%2528Indazolyl%2529benzamido%2520derivatives%2520as%2520CDK1%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520biological%2520activity%252C%2520and%2520molecular%2520docking%2520studies%26jtitle%3DArch.%2520Pharm.%2520Chem.%2520Lett.%2520Sci.%26date%3D2009%26volume%3D342%26spage%3D265%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barbanti, E.; Caccia, C.; Salvati, P.; Velardi, F.; Ruffilli, T.; Bogogna, L.</span><span> </span><span class="NLM_article-title">Process for the production of 2-[4-(3- and 2-fluorobenzyloxy)benzylamino]propanamides</span>. U.S. Patent 8076515,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=E.+Barbanti&author=C.+Caccia&author=P.+Salvati&author=F.+Velardi&author=T.+Ruffilli&author=L.+Bogogna&title=Process+for+the+production+of+2-%5B4-%283-+and+2-fluorobenzyloxy%29benzylamino%5Dpropanamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbanti%26aufirst%3DE.%26atitle%3DProcess%2520for%2520the%2520production%2520of%25202-%255B4-%25283-%2520and%25202-fluorobenzyloxy%2529benzylamino%255Dpropanamides%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span> </span><span class="NLM_article-title">A validated chiral liquid chromatographic method for the enantiomeric separation of safinamide mesylate, a new anti-Parkinson drug</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2Fj.jpba.2010.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=21277726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFyqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=220-234&author=K.+Zhangauthor=N.+Xueauthor=X.+Shiauthor=W.+Liuauthor=J.+Mengauthor=Y.+Du&title=A+validated+chiral+liquid+chromatographic+method+for+the+enantiomeric+separation+of+safinamide+mesylate%2C+a+new+anti-Parkinson+drug"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">A validated chiral liquid chromatographic method for the enantiomeric separation of safinamide mesilate, a new anti-Parkinson drug</span></div><div class="casAuthors">Zhang, Kai; Xue, Na; Shi, Xiaowei; Liu, Weina; Meng, Jing; Du, Yumin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">220-224</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A enantioselective reversed-phase high performance liq. chromatog. method was developed for the enantiomeric resoln. of safinamide mesylate, 2(S)-[4-(3-fluorobenzyloxy)benzylamino] propionamide methanesulfonate, a neuroprotectant with antiparkinsonian and anticonvulsant activity for the treatment of Parkinson disease.  The enantiomers of safinamide mesylate were baseline resolved on a Chiralcel OD-RH (150 mm × 4.6 mm, 5 μm) column using a mobile phase system contg. 300 mM sodium di-hydrogen phosphate buffer (pH 3.0):MeOH:acetonitrile (65:25:10, vol./vol./v).  The resoln. between the enantiomers was not < 3.0.  The pH value of buffer soln. in the mobile phase has played a key role in enhancing chromatog. efficiency and resoln. between the enantiomers.  The developed method was validated and proved to be robust.  The limit of detection and limit of quantification of (R)-enantiomer were found to be 15 and 50 ng/mL, resp., for 20 μL injection vol.  The percentage recovery of (R)-enantiomer was ranged from 94.2 to 103.7 in bulk drug samples of safinamide mesylate.  The sample soln. and mobile phase were found to be stable at least for 48 h.  The final optimized method was successfully applied to sep. (R)-enantiomer from safinamide mesylate and was proven to be reproducible and accurate for the quant. detn. of (R)-enantiomer in bulk drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyI6UJzgmavbVg90H21EOLACvtfcHk0ljYNaSMriZhhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFyqt7Y%253D&md5=07567e019448b5fea124dce25543b17a</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2010.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2010.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DXue%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DY.%26atitle%3DA%2520validated%2520chiral%2520liquid%2520chromatographic%2520method%2520for%2520the%2520enantiomeric%2520separation%2520of%2520safinamide%2520mesylate%252C%2520a%2520new%2520anti-Parkinson%2520drug%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2011%26volume%3D55%26spage%3D220%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hockemeyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbiel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span> </span><span class="NLM_article-title">Multigram-scale syntheses, stability, and photoreactions of A<sub>2A</sub> adenosine receptor antagonists with 8-styrylxanthine structure: Potential drugs for Parkinson’s disease</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3308</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0358574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=3308-3318&author=J.+Hockemeyerauthor=J.+C.+Burbielauthor=C.+E.+M%C3%BCller&title=Multigram-scale+syntheses%2C+stability%2C+and+photoreactions+of+A2A+adenosine+receptor+antagonists+with+8-styrylxanthine+structure%3A+Potential+drugs+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1021%2Fjo0358574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0358574%26sid%3Dliteratum%253Aachs%26aulast%3DHockemeyer%26aufirst%3DJ.%26aulast%3DBurbiel%26aufirst%3DJ.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMultigram-scale%2520syntheses%252C%2520stability%252C%2520and%2520photoreactions%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%2520with%25208-styrylxanthine%2520structure%253A%2520Potential%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D3308%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geis, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hipp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schobert, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frobenius, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandoval-Ramirez, J.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A<sub>2A</sub>-selective adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4396</span><span class="NLM_x">–</span> <span class="NLM_lpage">4405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970515%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4396-4405&author=C.+E.+M%C3%BCllerauthor=U.+Geisauthor=J.+Hippauthor=U.+Schobertauthor=W.+Frobeniusauthor=M.+Pawlowskiauthor=F.+Suzukiauthor=J.+Sandoval-Ramirez&title=Synthesis+and+structure%E2%80%93activity+relationships+of+3%2C7-dimethyl-1-propargylxanthine+derivatives%2C+A2A-selective+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1021%2Fjm970515%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970515%252B%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DGeis%26aufirst%3DU.%26aulast%3DHipp%26aufirst%3DJ.%26aulast%3DSchobert%26aufirst%3DU.%26aulast%3DFrobenius%26aufirst%3DW.%26aulast%3DPawlowski%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DSandoval-Ramirez%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%25203%252C7-dimethyl-1-propargylxanthine%2520derivatives%252C%2520A2A-selective%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4396%26epage%3D4405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Yáñez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraiz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orallo, F.</span><span> </span><span class="NLM_article-title">Inhibitory effects of <i>cis</i>- and <i>trans</i>-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2006&pages=688-695&author=M.+Y%C3%A1%C3%B1ezauthor=N.+Fraizauthor=E.+Canoauthor=F.+Orallo&title=Inhibitory+effects+of+cis-+and+trans-resveratrol+on+noradrenaline+and+5-hydroxytryptamine+uptake+and+on+monoamine+oxidase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DFraiz%26aufirst%3DN.%26aulast%3DCano%26aufirst%3DE.%26aulast%3DOrallo%26aufirst%3DF.%26atitle%3DInhibitory%2520effects%2520of%2520cis-%2520and%2520trans-resveratrol%2520on%2520noradrenaline%2520and%25205-hydroxytryptamine%2520uptake%2520and%2520on%2520monoamine%2520oxidase%2520activity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D344%26spage%3D688%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Holt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palcie, M. M.</span><span> </span><span class="NLM_article-title">A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1997&pages=384-392&author=A.+Holtauthor=D.+F.+Sharmanauthor=G.+B.+Bakerauthor=M.+M.+Palcie&title=A+continuous+spectrophotometric+assay+for+monoamine+oxidase+and+related+enzymes+in+tissue+homogenates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DA.%26aulast%3DSharman%26aufirst%3DD.%2BF.%26aulast%3DBaker%26aufirst%3DG.%2BB.%26aulast%3DPalcie%26aufirst%3DM.%2BM.%26atitle%3DA%2520continuous%2520spectrophotometric%2520assay%2520for%2520monoamine%2520oxidase%2520and%2520related%2520enzymes%2520in%2520tissue%2520homogenates%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D244%26spage%3D384%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structures of monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5848</span><span class="NLM_x">–</span> <span class="NLM_lpage">5852</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+of+monoamine+oxidase+B+complexes+with+selective+noncovalent+inhibitors%3A+safinamide+and+coumarin+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520of%2520monoamine%2520oxidase%2520B%2520complexes%2520with%2520selective%2520noncovalent%2520inhibitors%253A%2520safinamide%2520and%2520coumarin%2520analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5848%26epage%3D5852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubálek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Crystal structures of monoamine oxidase B in complex with four inhibitors of the <i>N</i>-propargylaminoindan class</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1774</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031087c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1767-1774&author=C.+Bindaauthor=F.+Hub%C3%A1lekauthor=L.+Minauthor=Y.+Herzigauthor=J.+Sterlingauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Crystal+structures+of+monoamine+oxidase+B+in+complex+with+four+inhibitors+of+the+N-propargylaminoindan+class"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N-Propargylaminoindan Class</span></div><div class="casAuthors">Binda, Claudia; Hubalek, Frantisek; Li, Min; Herzig, Yaacov; Sterling, Jeffrey; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1767-1774</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is an outer mitochondrial membrane enzyme that catalyzes the oxidn. of arylalkylamine neurotransmitters.  The crystal structures of MAO B in complex with four of the N-propargylaminoindan class of MAO covalent inhibitors (rasagiline, N-propargyl-1(S)-aminoindan, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan) have been detd. at a resoln. of better than 2.1 Å.  Rasagiline, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan adopt essentially the same conformation with the extended propargyl chain covalently bound to the flavin and the indan ring located in the rear of the substrate cavity.  N-Propargyl-1(S)-aminoindan binds with the indan ring in a flipped conformation with respect to the other inhibitors, which causes a slight movement of the Tyr326 side chain.  Four ordered water mols. are an integral part of the active site and establish H-bond interactions to the inhibitor atoms.  These structural studies may guide future drug design to improve selectivity and efficacy by introducing appropriate substituents on the rasagiline mol. scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkiXn0OI5eubVg90H21EOLACvtfcHk0ljX704p41KgQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D&md5=7b3df3c611e3f0dd59342a59096402dd</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm031087c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031087c%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DHub%25C3%25A1lek%26aufirst%3DF.%26aulast%3DMin%26aufirst%3DL.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DCrystal%2520structures%2520of%2520monoamine%2520oxidase%2520B%2520in%2520complex%2520with%2520four%2520inhibitors%2520of%2520the%2520N-propargylaminoindan%2520class%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1767%26epage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Novaroli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reist, M.</span><span> </span><span class="NLM_article-title">Impact of species-dependent differences on screening, design, and development of MAO B inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6264</span><span class="NLM_x">–</span> <span class="NLM_lpage">6272</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060441e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6264-6272&author=L.+Novaroliauthor=A.+Dainaauthor=E.+Favreauthor=J.+Bravoauthor=A.+Carottiauthor=F.+Leonettiauthor=M.+Cattoauthor=P.+A.+Carruptauthor=M.+Reist&title=Impact+of+species-dependent+differences+on+screening%2C+design%2C+and+development+of+MAO+B+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm060441e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060441e%26sid%3Dliteratum%253Aachs%26aulast%3DNovaroli%26aufirst%3DL.%26aulast%3DDaina%26aufirst%3DA.%26aulast%3DFavre%26aufirst%3DE.%26aulast%3DBravo%26aufirst%3DJ.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DReist%26aufirst%3DM.%26atitle%3DImpact%2520of%2520species-dependent%2520differences%2520on%2520screening%252C%2520design%252C%2520and%2520development%2520of%2520MAO%2520B%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6264%26epage%3D6272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span>FlexS/FlexV, <span class="NLM_edition">v.2.1.2</span>; <span class="NLM_publisher-name">BioSolveIT GmbH</span>, <span class="NLM_publisher-loc">Sankt Augustin, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.biosolveit.de" class="extLink">http://www.biosolveit.de</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FlexS%2FFlexV%2C+v.2.1.2%3B+BioSolveIT+GmbH%2C+Sankt+Augustin%2C+Germany%2C+2013%3B+http%3A%2F%2Fwww.biosolveit.de."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DFlexS%252FFlexV%26pub%3DBioSolveIT%2520GmbH%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Schneider, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">A consistent description of HYdrogen bond and DEhydratation energies in protein–ligand complexes: methods behind the HYDE scoring function</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=15-29&author=N.+Schneiderauthor=G.+Langeauthor=S.+Hindleauthor=R.+Kleinauthor=M.+Rarey&title=A+consistent+description+of+HYdrogen+bond+and+DEhydratation+energies+in+protein%E2%80%93ligand+complexes%3A+methods+behind+the+HYDE+scoring+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DN.%26aulast%3DLange%26aufirst%3DG.%26aulast%3DHindle%26aufirst%3DS.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DA%2520consistent%2520description%2520of%2520HYdrogen%2520bond%2520and%2520DEhydratation%2520energies%2520in%2520protein%25E2%2580%2593ligand%2520complexes%253A%2520methods%2520behind%2520the%2520HYDE%2520scoring%2520function%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D15%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Schneider, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briem, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claußen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gastreich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemmen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Substantial improvements in large-scale redocking and screening using the novel HYDE scoring function</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">701</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=701-723&author=N.+Schneiderauthor=S.+Hindleauthor=G.+Langeauthor=R.+Kleinauthor=J.+Albrechtauthor=H.+Briemauthor=K.+Beyerauthor=H.+Clau%C3%9Fenauthor=M.+Gastreichauthor=C.+Lemmenauthor=M.+Rarey&title=Substantial+improvements+in+large-scale+redocking+and+screening+using+the+novel+HYDE+scoring+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DN.%26aulast%3DHindle%26aufirst%3DS.%26aulast%3DLange%26aufirst%3DG.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DAlbrecht%26aufirst%3DJ.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DBeyer%26aufirst%3DK.%26aulast%3DClau%25C3%259Fen%26aufirst%3DH.%26aulast%3DGastreich%26aufirst%3DM.%26aulast%3DLemmen%26aufirst%3DC.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DSubstantial%2520improvements%2520in%2520large-scale%2520redocking%2520and%2520screening%2520using%2520the%2520novel%2520HYDE%2520scoring%2520function%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2012%26volume%3D26%26spage%3D701%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">The docking pose graphics were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+docking+pose+graphics+were+performed+with+the+UCSF+Chimera+package.+Chimera+is+developed+by+the+Resource+for+Biocomputing%2C+Visualization%2C+and+Informatics+at+the+University+of+California%2C+San+Francisco+%28supported+by+NIGMS+P41-GM103311%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit50b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pettersen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrin, T. E.</span><span> </span><span class="NLM_article-title">UCSF Chimera—a visualization system for exploratory research and analysis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera%E2%80%94a+visualization+system+for+exploratory+research+and+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera%25E2%2580%2594a%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groom&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eb-xfUK1palybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices for effective drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1517%2F17460441.2.4.469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=23484756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=469-488&author=C.+Abad-Zapatero&title=Ligand+efficiency+indices+for+effective+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices for effective drug discovery</span></div><div class="casAuthors">Abad-Zapatero, Cele</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-488</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Successful drug discovery requires the optimization of a large no. of variables ranging from strictly physicochem. parameters such as mol. wt. to more complex parameters related to toxicity and bioavailability.  Presently, structure-based methodologies influence many aspects of the drug discovery process from lead discovery to the final preclin. characterization.  However, crit. biol. issues along the path to the market have diminished the impact and power of this methodol.  The physicochem. properties of the novel chem. entities designed and guided by structural methods have become the subject of intense scrutiny from lead discovery to drug candidate.  The idea of ligand efficiency (binding energy/non-hydrogen atoms) has recently emerged as a useful guide to optimize fragment and lead selection in the discovery process.  More generalized concepts of ligand efficiency, related to efficiency per dalton and per unit of polar surface area, have also been introduced and will be discussed in the broader context.  Preliminary results and trends obtained using ligand efficiencies as guides are reviewed and their future application to guide drug discovery will be discussed, as well as their integration into the structure-based drug design methods to make them more effective and numerically robust.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmKduo41JcS7Vg90H21EOLACvtfcHk0lga-MKWBi1u3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D&md5=a1682fbc4545d8eab3a44417c0e88869</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.4.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.4.469%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520effective%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D469%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Schultes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Graaf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaksma, E. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krämer, O.</span><span> </span><span class="NLM_article-title">Ligand efficiency as a guide in fragment hit selection and optimization</span> <span class="citation_source-journal">Drug Discovery Today Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e157</span><span class="NLM_x">–</span> <span class="NLM_lpage">e162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=e157-e162&author=S.+Schultesauthor=C.+de+Graafauthor=E.+E.+J.+Haaksmaauthor=I.+J.+P.+de+Eschauthor=R.+Leursauthor=O.+Kr%C3%A4mer&title=Ligand+efficiency+as+a+guide+in+fragment+hit+selection+and+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchultes%26aufirst%3DS.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DHaaksma%26aufirst%3DE.%2BE.%2BJ.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DO.%26atitle%3DLigand%2520efficiency%2520as%2520a%2520guide%2520in%2520fragment%2520hit%2520selection%2520and%2520optimization%26jtitle%3DDrug%2520Discovery%2520Today%2520Technol.%26date%3D2010%26volume%3D7%26spage%3De157%26epage%3De162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lgThpezoiO1ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enhance alignment of drug-like properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enhance+alignment+of+drug-like+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgThpezoiO1ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enhance%2520alignment%2520of%2520drug-like%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">814</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=807-814&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+1.+Prediction+of+intestinal+absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25201.%2520Prediction%2520of%2520intestinal%2520absorption%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D807%26epage%3D814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Sally, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinter, A.</span><span> </span><span class="NLM_article-title">Molecular field technology and its applications in drug discovery</span> <span class="citation_source-journal">Innovative Pharm. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=14-18&author=R.+Sallyauthor=A.+Vinter&title=Molecular+field+technology+and+its+applications+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSally%26aufirst%3DR.%26aulast%3DVinter%26aufirst%3DA.%26atitle%3DMolecular%2520field%2520technology%2520and%2520its%2520applications%2520in%2520drug%2520discovery%26jtitle%3DInnovative%2520Pharm.%2520Technol.%26date%3D2007%26spage%3D14%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, J.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices as guideposts for drug discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2FS1359-6446%2805%2903386-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15809192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=464-469&author=C.+Abad-Zapateroauthor=J.+Metz&title=Ligand+efficiency+indices+as+guideposts+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices as guideposts for drug discovery</span></div><div class="casAuthors">Abad-Zapatero Cele; Metz James T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">464-9</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHqVfZXUq224qdXsLcGTEUfW6udTcc2eZrrAqQxL2emLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D&md5=1720f263a306122c86a57463e5a39287</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903386-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903386-6%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DMetz%26aufirst%3DJ.%26atitle%3DLigand%2520efficiency%2520indices%2520as%2520guideposts%2520for%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D464%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Lippert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Fast automated placement of polar hydrogen atoms in protein–ligand complexes</span> <span class="citation_source-journal">J. Cheminform.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1186%2F1758-2946-1-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BC3c7psV2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=13-24&author=T.+Lippertauthor=M.+Rarey&title=Fast+automated+placement+of+polar+hydrogen+atoms+in+protein%E2%80%93ligand+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Fast automated placement of polar hydrogen atoms in protein-ligand complexes</span></div><div class="casAuthors">Lippert Tobias; Rarey Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cheminformatics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Hydrogen bonds play a major role in the stabilization of protein-ligand complexes.  The ability of a functional group to form them depends on the position of its hydrogen atoms.  An accurate knowledge of the positions of hydrogen atoms in proteins is therefore important to correctly identify hydrogen bonds and their properties.  The high mobility of hydrogen atoms introduces several degrees of freedom: Tautomeric states, where a hydrogen atom alters its binding partner, torsional changes where the position of the hydrogen atom is rotated around the last heavy-atom bond in a residue, and protonation states, where the number of hydrogen atoms at a functional group may change.  Also, side-chain flips in glutamine and asparagine and histidine residues, which are common crystallographic ambiguities must be identified before structure-based calculations can be conducted.  RESULTS:  We have implemented a method to determine the most probable hydrogen atom positions in a given protein-ligand complex.  Optimality of hydrogen bond geometries is determined by an empirical scoring function which is used in molecular docking.  This allows to evaluate protein-ligand interactions with an established model.  Also, our method allows to resolve common crystallographic ambiguities such as as flipped amide groups and histidine residues.  To ensure high speed, we make use of a dynamic programming approach.  CONCLUSION:  Our results were checked against selected high-resolution structures from an external dataset, for which the positions of the hydrogen atoms have been validated manually.  The quality of our results is comparable to that of other programs, with the advantage of being fast enough to be applied on-the-fly for interactive usage or during score evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQW_MJ6K-6QK8-crCu0nI_sfW6udTcc2eZrrAqQxL2emLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7psV2huw%253D%253D&md5=b9159a5244c6c814c163703421376ea0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-1-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-1-13%26sid%3Dliteratum%253Aachs%26aulast%3DLippert%26aufirst%3DT.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DFast%2520automated%2520placement%2520of%2520polar%2520hydrogen%2520atoms%2520in%2520protein%25E2%2580%2593ligand%2520complexes%26jtitle%3DJ.%2520Cheminform.%26date%3D2009%26volume%3D1%26spage%3D13%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Bietz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbaczek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Hydrogen placement in protein–ligand complexes under consideration of tautomerism</span> <span class="citation_source-journal">J. Cheminform.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">P13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=P13&issue=Suppl+1&author=S.+Bietzauthor=S.+Urbaczekauthor=M.+Rarey&title=Hydrogen+placement+in+protein%E2%80%93ligand+complexes+under+consideration+of+tautomerism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBietz%26aufirst%3DS.%26aulast%3DUrbaczek%26aufirst%3DS.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DHydrogen%2520placement%2520in%2520protein%25E2%2580%2593ligand%2520complexes%2520under%2520consideration%2520of%2520tautomerism%26jtitle%3DJ.%2520Cheminform.%26date%3D2011%26volume%3D3%26issue%3DSuppl%25201%26spage%3DP13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Schärfer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz-Gasch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinzerling, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inhester, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">CONFECT: Conformations from an expert collection of torsion patterns</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1690</span><span class="NLM_x">–</span> <span class="NLM_lpage">1700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1690-1700&author=C.+Sch%C3%A4rferauthor=T.+Schulz-Gaschauthor=J.+Hertauthor=L.+Heinzerlingauthor=B.+Schulzauthor=T.+Inhesterauthor=M.+Stahlauthor=M.+Rarey&title=CONFECT%3A+Conformations+from+an+expert+collection+of+torsion+patterns"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25A4rfer%26aufirst%3DC.%26aulast%3DSchulz-Gasch%26aufirst%3DT.%26aulast%3DHert%26aufirst%3DJ.%26aulast%3DHeinzerling%26aufirst%3DL.%26aulast%3DSchulz%26aufirst%3DB.%26aulast%3DInhester%26aufirst%3DT.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DCONFECT%253A%2520Conformations%2520from%2520an%2520expert%2520collection%2520of%2520torsion%2520patterns%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1690%26epage%3D1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Schärfer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz-Gasch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Torsion angle preferences in drug-like chemical space: A comprehensive guide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2016</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3016816" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2016-2028&author=C.+Sch%C3%A4rferauthor=T.+Schulz-Gaschauthor=H.+C.+Ehrlichauthor=W.+Gubaauthor=M.+Rareyauthor=M.+Stahl&title=Torsion+angle+preferences+in+drug-like+chemical+space%3A+A+comprehensive+guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm3016816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3016816%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25A4rfer%26aufirst%3DC.%26aulast%3DSchulz-Gasch%26aufirst%3DT.%26aulast%3DEhrlich%26aufirst%3DH.%2BC.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DRarey%26aufirst%3DM.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DTorsion%2520angle%2520preferences%2520in%2520drug-like%2520chemical%2520space%253A%2520A%2520comprehensive%2520guide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2016%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span>TorsionAnalyzer was developed in collaboration between  F. Hoffmann-LaRoche, Switzerland, and the Center for Bioinformatics (ZBH) of the University of Hamburg: <a href="http://www.biosolveit.de/TorsionAnalyzer/" class="extLink">http://www.biosolveit.de/TorsionAnalyzer/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TorsionAnalyzer+was+developed+in+collaboration+between+F.+Hoffmann-LaRoche%2C+Switzerland%2C+and+the+Center+for+Bioinformatics+%28ZBH%29+of+the+University+of+Hamburg%3A+http%3A%2F%2Fwww.biosolveit.de%2FTorsionAnalyzer%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a'],'ref2':['cit2a','cit2b','cit2c'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b','cit8c','cit8d'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c','cit10d'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c','cit12d','cit12E'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b','cit14c','cit14d','cit14e'],'ref15':['cit15a','cit15b','cit15c','cit15d','cit15e'],'ref16':['cit16a','cit16b'],'ref17':['cit17a','cit17b','cit17c','cit17d','cit17e'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33a','cit33b','cit33c'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40a','cit40b'],'ref41':['cit41a','cit41b'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50a','cit50b'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 51 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Elisa Sassetti, Mads H. Clausen, <span class="NLM_string-name hlFld-ContribAuthor">Luca Laraia</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of Reactive Oxygen Species Production. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5252-5275. <a href="https://doi.org/10.1021/acs.jmedchem.0c01914" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01914%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252BReactive%252BOxygen%252BSpecies%252BProduction%26aulast%3DSassetti%26aufirst%3DElisa%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D04112020%26date%3D15042021%26volume%3D64%26issue%3D9%26spage%3D5252%26epage%3D5275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anand Kumar Pandey, Shiv Chand, Rahul Singh, Saurabh Kumar, <span class="NLM_string-name hlFld-ContribAuthor">Krishna Nand Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Iodine-Catalyzed Synthesis of 3-Arylthioindoles Employing a 1-Aryltriazene/CS2 Combination as a New Sulfenylation Source. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (13)
                                     , 7627-7635. <a href="https://doi.org/10.1021/acsomega.0c00472" title="DOI URL">https://doi.org/10.1021/acsomega.0c00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c00472%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DIodine-Catalyzed%252BSynthesis%252Bof%252B3-Arylthioindoles%252BEmploying%252Ba%252B1-Aryltriazene%25252FCS2%252BCombination%252Bas%252Ba%252BNew%252BSulfenylation%252BSource%26aulast%3DPandey%26aufirst%3DAnand%2BKumar%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03022020%26date%3D13032020%26date%3D24032020%26volume%3D5%26issue%3D13%26spage%3D7627%26epage%3D7635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob M.  Ganley</span> and <span class="hlFld-ContribAuthor ">Charles S.  Yeung</span>  . </span><span class="cited-content_cbyCitation_article-title">Unprotected Indazoles Are Resilient to Ring-Opening Isomerization: A Case Study on Catalytic C–S Couplings in the Presence of Strong Base. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (24)
                                     , 13557-13562. <a href="https://doi.org/10.1021/acs.joc.7b02712" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02712%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DUnprotected%252BIndazoles%252BAre%252BResilient%252Bto%252BRing-Opening%252BIsomerization%25253A%252BA%252BCase%252BStudy%252Bon%252BCatalytic%252BC%2525E2%252580%252593S%252BCouplings%252Bin%252Bthe%252BPresence%252Bof%252BStrong%252BBase%26aulast%3DGanley%26aufirst%3DJacob%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D25102017%26date%3D05122017%26date%3D15122017%26date%3D27112017%26volume%3D82%26issue%3D24%26spage%3D13557%26epage%3D13562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min-Ho  Nam</span>, <span class="hlFld-ContribAuthor ">Moosung  Park</span>, <span class="hlFld-ContribAuthor ">Hyeri  Park</span>, <span class="hlFld-ContribAuthor ">Youngjae  Kim</span>, <span class="hlFld-ContribAuthor ">Seulki  Yoon</span>, <span class="hlFld-ContribAuthor ">Vikram Shahaji  Sawant</span>, <span class="hlFld-ContribAuthor ">Ji Won  Choi</span>, <span class="hlFld-ContribAuthor ">Jong-Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Ki Duk  Park</span>, <span class="hlFld-ContribAuthor ">Sun-Joon  Min</span>, <span class="hlFld-ContribAuthor ">C. Justin  Lee</span>, and <span class="hlFld-ContribAuthor ">Hyunah  Choo</span>  . </span><span class="cited-content_cbyCitation_article-title">Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (7)
                                     , 1519-1529. <a href="https://doi.org/10.1021/acschemneuro.7b00050" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00050%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIndole-Substituted%252BBenzothiazoles%252Band%252BBenzoxazoles%252Bas%252BSelective%252Band%252BReversible%252BMAO-B%252BInhibitors%252Bfor%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DNam%26aufirst%3DMin-Ho%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D01022017%26date%3D23032017%26date%3D30032017%26date%3D19072017%26date%3D23032017%26volume%3D8%26issue%3D7%26spage%3D1519%26epage%3D1529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaofeng  Wu</span>, <span class="hlFld-ContribAuthor ">Lihong  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Shi</span>, <span class="hlFld-ContribAuthor ">Qiuyu  Gong</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Li</span>, and <span class="hlFld-ContribAuthor ">Huimin  Ma</span>  . </span><span class="cited-content_cbyCitation_article-title">Sensitive and Selective Ratiometric Fluorescence Probes for Detection of Intracellular Endogenous Monoamine Oxidase A. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2016,</strong> <em>88 </em>
                                    (2)
                                     , 1440-1446. <a href="https://doi.org/10.1021/acs.analchem.5b04303" title="DOI URL">https://doi.org/10.1021/acs.analchem.5b04303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.5b04303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.5b04303%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DSensitive%252Band%252BSelective%252BRatiometric%252BFluorescence%252BProbes%252Bfor%252BDetection%252Bof%252BIntracellular%252BEndogenous%252BMonoamine%252BOxidase%252BA%26aulast%3DWu%26aufirst%3DXiaofeng%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13112015%26date%3D10122015%26date%3D22122015%26date%3D19012016%26date%3D10122015%26volume%3D88%26issue%3D2%26spage%3D1440%26epage%3D1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maheshwara Reddy  Nadiveedhi</span>, <span class="hlFld-ContribAuthor ">Mahammad Sadik  Shaik</span>, <span class="hlFld-ContribAuthor ">Suresh Kumar  Krishnammagari</span>, <span class="hlFld-ContribAuthor ">Suresh Reddy  Cirandur</span>. </span><span class="cited-content_cbyCitation_article-title">Metal‐free multicomponent synthesis and
              in vitro
              antioxidant activity of indolylpyrazolopyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2021,</strong> <em>58 </em>
                                    (7)
                                     , 1472-1483. <a href="https://doi.org/10.1002/jhet.4273" title="DOI URL">https://doi.org/10.1002/jhet.4273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4273%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DMetal%2525E2%252580%252590free%252Bmulticomponent%252Bsynthesis%252Band%252Bin%252Bvitro%252Bantioxidant%252Bactivity%252Bof%252Bindolylpyrazolopyrimidines%26aulast%3DNadiveedhi%26aufirst%3DMaheshwara%2BReddy%26date%3D2021%26date%3D2021%26volume%3D58%26issue%3D7%26spage%3D1472%26epage%3D1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Rui-Feng  Zeng</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Yue  Ding</span>, <span class="hlFld-ContribAuthor ">Yi-Ting  Yang</span>, <span class="hlFld-ContribAuthor ">Jun  Yang</span>, <span class="hlFld-ContribAuthor ">Tong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>109 </em>, 104685. <a href="https://doi.org/10.1016/j.bioorg.2021.104685" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104685</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104685%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252B3%25252C4-dihydrocoumarins%252Bas%252Bpotent%252Band%252Bselective%252Bmonoamine%252Boxidase-B%252Binhibitors%252Bwith%252Bthe%252Bneuroprotection%252Bagainst%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DLiu%26aufirst%3DLi%26date%3D2021%26volume%3D109%26spage%3D104685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaquan  Cao</span>, <span class="hlFld-ContribAuthor ">Chunying  Luo</span>, <span class="hlFld-ContribAuthor ">Pu  Yang</span>, <span class="hlFld-ContribAuthor ">Pan  Li</span>, <span class="hlFld-ContribAuthor ">Chunli  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Indazole scaffold: a generalist for marketed and clinical drugs. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (3)
                                     , 501-518. <a href="https://doi.org/10.1007/s00044-020-02665-7" title="DOI URL">https://doi.org/10.1007/s00044-020-02665-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02665-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02665-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DIndazole%252Bscaffold%25253A%252Ba%252Bgeneralist%252Bfor%252Bmarketed%252Band%252Bclinical%252Bdrugs%26aulast%3DCao%26aufirst%3DYaquan%26date%3D2021%26date%3D2020%26volume%3D30%26issue%3D3%26spage%3D501%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahdieh Sadat  Sajadi</span>, <span class="hlFld-ContribAuthor ">Ali  Darehkordi</span>, <span class="hlFld-ContribAuthor ">Seyed Mohammad Sadegh  Hosseini</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N-aryl-3H-indazol-3-imine and N-aryl-1H-indazol-3-amine via Na2WO4/H2O2 mediated by intramolecular N–N coupling. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>84 </em>, 132023. <a href="https://doi.org/10.1016/j.tet.2021.132023" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132023%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252BN-aryl-3H-indazol-3-imine%252Band%252BN-aryl-1H-indazol-3-amine%252Bvia%252BNa2WO4%25252FH2O2%252Bmediated%252Bby%252Bintramolecular%252BN%2525E2%252580%252593N%252Bcoupling%26aulast%3DSajadi%26aufirst%3DMahdieh%2BSadat%26date%3D2021%26volume%3D84%26spage%3D132023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Wang</span>, <span class="hlFld-ContribAuthor ">Nianhang  Chen</span>, <span class="hlFld-ContribAuthor ">Alex Gutterres  Taranto</span>, <span class="hlFld-ContribAuthor ">Yuting  Jin</span>, <span class="hlFld-ContribAuthor ">Congcong  Wen</span>, <span class="hlFld-ContribAuthor ">De-Xin  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Accelerating the identification of subtype selective inhibitors via Three-Dimensional Biologically Relevant Spectrum (BRS-3D): The monoamine oxidase subtypes as a case study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>106 </em>, 104503. <a href="https://doi.org/10.1016/j.bioorg.2020.104503" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104503%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAccelerating%252Bthe%252Bidentification%252Bof%252Bsubtype%252Bselective%252Binhibitors%252Bvia%252BThree-Dimensional%252BBiologically%252BRelevant%252BSpectrum%252B%252528BRS-3D%252529%25253A%252BThe%252Bmonoamine%252Boxidase%252Bsubtypes%252Bas%252Ba%252Bcase%252Bstudy%26aulast%3DWang%26aufirst%3DDong%26date%3D2021%26volume%3D106%26spage%3D104503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Wen  Yang</span>, <span class="hlFld-ContribAuthor ">Li-Wen  Lu</span>, <span class="hlFld-ContribAuthor ">Xue-Qing  Zhang</span>, <span class="hlFld-ContribAuthor ">Shang-Song  Bao</span>, <span class="hlFld-ContribAuthor ">Fei  Cao</span>, <span class="hlFld-ContribAuthor ">Zhi-Yong  Guo</span>, <span class="hlFld-ContribAuthor ">Zhang-Shuang  Deng</span>, <span class="hlFld-ContribAuthor ">Peter  Proksch</span>. </span><span class="cited-content_cbyCitation_article-title">Xylariaopyrones E–I, five new α-pyrone derivatives from the endophytic fungus
              Xylariales
              sp. (HM-1). </span><span class="cited-content_cbyCitation_journal-name">Natural Product Research</span><span> <strong>2020,</strong> <em> </em>, 1-9. <a href="https://doi.org/10.1080/14786419.2020.1826480" title="DOI URL">https://doi.org/10.1080/14786419.2020.1826480</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14786419.2020.1826480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14786419.2020.1826480%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Research%26atitle%3DXylariaopyrones%252BE%2525E2%252580%252593I%25252C%252Bfive%252Bnew%252B%2525CE%2525B1-pyrone%252Bderivatives%252Bfrom%252Bthe%252Bendophytic%252Bfungus%252BXylariales%252Bsp.%252B%252528HM-1%252529%26aulast%3DYang%26aufirst%3DWen-Wen%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ganga Reddy  Gaddam</span>, <span class="hlFld-ContribAuthor ">Pramod Kumar  Dubey</span>, <span class="hlFld-ContribAuthor ">Venkata Ramana Reddy  Chittireddy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Indolyl Pyrazole Scaffolds as Potential Anti-cancer Agents and their Molecular Modelling Studies. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2020,</strong> <em>17 </em>
                                    (7)
                                     , 828-839. <a href="https://doi.org/10.2174/1570180816666191024103534" title="DOI URL">https://doi.org/10.2174/1570180816666191024103534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180816666191024103534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180816666191024103534%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DSynthesis%252Bof%252BIndolyl%252BPyrazole%252BScaffolds%252Bas%252BPotential%252BAnti-cancer%252BAgents%252Band%252Btheir%252BMolecular%252BModelling%252BStudies%26aulast%3DGaddam%26aufirst%3DGanga%2BReddy%26date%3D2020%26volume%3D17%26issue%3D7%26spage%3D828%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Liu</span>, <span class="hlFld-ContribAuthor ">Zhi-Wen  Chu</span>, <span class="hlFld-ContribAuthor ">Dong-Guo  Xia</span>, <span class="hlFld-ContribAuthor ">Hai-Qun  Cao</span>, <span class="hlFld-ContribAuthor ">Xian-Hai  Lv</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103807. <a href="https://doi.org/10.1016/j.bioorg.2020.103807" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103807%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bmulti-substituted%252Bbenzo-indole%252Bpyrazole%252Bschiff%252Bbase%252Bderivatives%252Bwith%252Bantibacterial%252Bactivity%252Btargeting%252BDNA%252Bgyrase%26aulast%3DLiu%26aufirst%3DHao%26date%3D2020%26volume%3D99%26spage%3D103807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorota  Łażewska</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Olejarz-Maciej</span>, <span class="hlFld-ContribAuthor ">David  Reiner</span>, <span class="hlFld-ContribAuthor ">Maria  Kaleta</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Zygmunt</span>, <span class="hlFld-ContribAuthor ">Agata  Doroz-Płonka</span>, <span class="hlFld-ContribAuthor ">Tadeusz  Karcz</span>, <span class="hlFld-ContribAuthor ">Annika  Frank</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kieć-Kononowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (10)
                                     , 3411. <a href="https://doi.org/10.3390/ijms21103411" title="DOI URL">https://doi.org/10.3390/ijms21103411</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21103411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21103411%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDual%252BTarget%252BLigands%252Bwith%252B4-tert-Butylphenoxy%252BScaffold%252Bas%252BHistamine%252BH3%252BReceptor%252BAntagonists%252Band%252BMonoamine%252BOxidase%252BB%252BInhibitors%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DDorota%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D10%26spage%3D3411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue-Jie  Tan</span>, <span class="hlFld-ContribAuthor ">Di  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ming  Hei</span>, <span class="hlFld-ContribAuthor ">Feng-Cun  Yang</span>, <span class="hlFld-ContribAuthor ">Ya-Ling  Zhu</span>, <span class="hlFld-ContribAuthor ">Dian-Xiang  Xing</span>, <span class="hlFld-ContribAuthor ">Jian-Ping  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, crystal structures, antiproliferative activities and reverse docking studies of eight novel Schiff bases derived from benzil. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section C Structural Chemistry</span><span> <strong>2020,</strong> <em>76 </em>
                                    (1)
                                     , 44-63. <a href="https://doi.org/10.1107/S2053229619015687" title="DOI URL">https://doi.org/10.1107/S2053229619015687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2053229619015687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2053229619015687%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520C%2520Structural%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcrystal%252Bstructures%25252C%252Bantiproliferative%252Bactivities%252Band%252Breverse%252Bdocking%252Bstudies%252Bof%252Beight%252Bnovel%252BSchiff%252Bbases%252Bderived%252Bfrom%252Bbenzil%26aulast%3DTan%26aufirst%3DXue-Jie%26date%3D2020%26date%3D2020%26volume%3D76%26issue%3D1%26spage%3D44%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Elkamhawy</span>, <span class="hlFld-ContribAuthor ">Sora  Paik</span>, <span class="hlFld-ContribAuthor ">Hyeon Jeong  Kim</span>, <span class="hlFld-ContribAuthor ">Jong-Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Ashwini M.  Londhe</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Ki Duk  Park</span>, <span class="hlFld-ContribAuthor ">Eun Joo  Roh</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of
              N
              -(1-(3-fluorobenzoyl)-1
              H
              -indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1568-1580. <a href="https://doi.org/10.1080/14756366.2020.1800666" title="DOI URL">https://doi.org/10.1080/14756366.2020.1800666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1800666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1800666%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN%252B-%2525281-%2525283-fluorobenzoyl%252529-1%252BH%252B-indol-5-yl%252529pyrazine-2-carboxamide%25253A%252Ba%252Bnovel%25252C%252Bselective%25252C%252Band%252Bcompetitive%252Bindole-based%252Blead%252Binhibitor%252Bfor%252Bhuman%252Bmonoamine%252Boxidase%252BB%26aulast%3DElkamhawy%26aufirst%3DAhmed%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1568%26epage%3D1580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pradeep  Paudel</span>, <span class="hlFld-ContribAuthor ">Se Eun  Park</span>, <span class="hlFld-ContribAuthor ">Su Hui  Seong</span>, <span class="hlFld-ContribAuthor ">Hyun Ah  Jung</span>, <span class="hlFld-ContribAuthor ">Jae Sue  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Diels–Alder Type Adducts from Morus alba Root Bark Targeting Human Monoamine Oxidase and Dopaminergic Receptors for the Management of Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (24)
                                     , 6232. <a href="https://doi.org/10.3390/ijms20246232" title="DOI URL">https://doi.org/10.3390/ijms20246232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20246232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20246232%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNovel%252BDiels%2525E2%252580%252593Alder%252BType%252BAdducts%252Bfrom%252BMorus%252Balba%252BRoot%252BBark%252BTargeting%252BHuman%252BMonoamine%252BOxidase%252Band%252BDopaminergic%252BReceptors%252Bfor%252Bthe%252BManagement%252Bof%252BNeurodegenerative%252BDiseases%26aulast%3DPaudel%26aufirst%3DPradeep%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D24%26spage%3D6232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuxuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Fanghui  Ma</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>, <span class="hlFld-ContribAuthor ">Yanguang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of spiro[imidazolidine-4,3′-indolin]-2′-imines
              via
              copper(
              i
              )-catalyzed formal [2 + 2 + 1] cycloaddition of 3-diazoindolin-2-imines and triazines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (39)
                                     , 8849-8852. <a href="https://doi.org/10.1039/C9OB01767D" title="DOI URL">https://doi.org/10.1039/C9OB01767D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01767D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01767D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPreparation%252Bof%252Bspiro%25255Bimidazolidine-4%25252C3%2525E2%252580%2525B2-indolin%25255D-2%2525E2%252580%2525B2-imines%252Bvia%252Bcopper%252528%252Bi%252B%252529-catalyzed%252Bformal%252B%25255B2%252B%25252B%252B2%252B%25252B%252B1%25255D%252Bcycloaddition%252Bof%252B3-diazoindolin-2-imines%252Band%252Btriazines%26aulast%3DZhou%26aufirst%3DYuxuan%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D39%26spage%3D8849%26epage%3D8852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolay T.  Tzvetkov</span>, <span class="hlFld-ContribAuthor ">Hans-Georg  Stammler</span>, <span class="hlFld-ContribAuthor ">Maya G.  Georgieva</span>, <span class="hlFld-ContribAuthor ">Daniela  Russo</span>, <span class="hlFld-ContribAuthor ">Immacolata  Faraone</span>, <span class="hlFld-ContribAuthor ">Aneliya A.  Balacheva</span>, <span class="hlFld-ContribAuthor ">Silvia  Hristova</span>, <span class="hlFld-ContribAuthor ">Atanas G.  Atanasov</span>, <span class="hlFld-ContribAuthor ">Luigi  Milella</span>, <span class="hlFld-ContribAuthor ">Liudmil  Antonov</span>, <span class="hlFld-ContribAuthor ">Marcus  Gastreich</span>. </span><span class="cited-content_cbyCitation_article-title">Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>179 </em>, 404-422. <a href="https://doi.org/10.1016/j.ejmech.2019.06.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCarboxamides%252Bvs.%252Bmethanimines%25253A%252BCrystal%252Bstructures%25252C%252Bbinding%252Binteractions%25252C%252Bphotophysical%252Bstudies%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B%252528indazole-5-yl%252529methanimines%252Bas%252Bmonoamine%252Boxidase%252BB%252Band%252Bacetylcholinesterase%252Binhibitors%26aulast%3DTzvetkov%26aufirst%3DNikolay%2BT.%26date%3D2019%26volume%3D179%26spage%3D404%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wan-Yin  Fang</span>, <span class="hlFld-ContribAuthor ">L.  Ravindar</span>, <span class="hlFld-ContribAuthor ">K.P.  Rakesh</span>, <span class="hlFld-ContribAuthor ">H.M.  Manukumar</span>, <span class="hlFld-ContribAuthor ">C.S.  Shantharam</span>, <span class="hlFld-ContribAuthor ">Njud S.  Alharbi</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>173 </em>, 117-153. <a href="https://doi.org/10.1016/j.ejmech.2019.03.063" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.063%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Bapproaches%252Band%252Bpharmaceutical%252Bapplications%252Bof%252Bchloro-containing%252Bmolecules%252Bfor%252Bdrug%252Bdiscovery%25253A%252BA%252Bcritical%252Breview%26aulast%3DFang%26aufirst%3DWan-Yin%26date%3D2019%26volume%3D173%26spage%3D117%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Takao</span>, <span class="hlFld-ContribAuthor ">Shiori  U</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Kamauchi</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Sugita</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of 2-(indolylmethylidene)-2,3-dihydro-1-benzofuran-3-one and 2-(indolyl)-4H-chromen-4-one derivatives as novel monoamine oxidases inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>87 </em>, 594-600. <a href="https://doi.org/10.1016/j.bioorg.2019.03.042" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.03.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.03.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252B2-%252528indolylmethylidene%252529-2%25252C3-dihydro-1-benzofuran-3-one%252Band%252B2-%252528indolyl%252529-4H-chromen-4-one%252Bderivatives%252Bas%252Bnovel%252Bmonoamine%252Boxidases%252Binhibitors%26aulast%3DTakao%26aufirst%3DKoichi%26date%3D2019%26volume%3D87%26spage%3D594%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zohreh  Bakherad</span>, <span class="hlFld-ContribAuthor ">Maliheh  Safavi</span>, <span class="hlFld-ContribAuthor ">Afshin  Fassihi</span>, <span class="hlFld-ContribAuthor ">Hojjat  Sadeghi-Aliabadi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Bakherad</span>, <span class="hlFld-ContribAuthor ">Hossein  Rastegar</span>, <span class="hlFld-ContribAuthor ">Jahan B.  Ghasemi</span>, <span class="hlFld-ContribAuthor ">Saghi  Sepehri</span>, <span class="hlFld-ContribAuthor ">Lotfollah  Saghaie</span>, <span class="hlFld-ContribAuthor ">Mohammad  Mahdavi</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-cancer, anti-oxidant and molecular docking studies of thiosemicarbazone indole-based derivatives. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2019,</strong> <em>45 </em>
                                    (5)
                                     , 2827-2854. <a href="https://doi.org/10.1007/s11164-019-03765-9" title="DOI URL">https://doi.org/10.1007/s11164-019-03765-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-019-03765-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-019-03765-9%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DAnti-cancer%25252C%252Banti-oxidant%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252Bthiosemicarbazone%252Bindole-based%252Bderivatives%26aulast%3DBakherad%26aufirst%3DZohreh%26date%3D2019%26date%3D2019%26volume%3D45%26issue%3D5%26spage%3D2827%26epage%3D2854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zohreh  Bakherad</span>, <span class="hlFld-ContribAuthor ">Maliheh  Safavi</span>, <span class="hlFld-ContribAuthor ">Afshin  Fassihi</span>, <span class="hlFld-ContribAuthor ">Hojjat  Sadeghi‐Aliabadi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Bakherad</span>, <span class="hlFld-ContribAuthor ">Hossein  Rastegar</span>, <span class="hlFld-ContribAuthor ">Mina  Saeedi</span>, <span class="hlFld-ContribAuthor ">Jahan B  Ghasemi</span>, <span class="hlFld-ContribAuthor ">Lotfollah  Saghaie</span>, <span class="hlFld-ContribAuthor ">Mohammad  Mahdavi</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Novel Cytotoxic Indole‐Thiosemicarbazone Derivatives: Biological Evaluation and Docking Study. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em>16 </em>
                                    (4)
                                     <a href="https://doi.org/10.1002/cbdv.201800470" title="DOI URL">https://doi.org/10.1002/cbdv.201800470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201800470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201800470%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNovel%252BCytotoxic%252BIndole%2525E2%252580%252590Thiosemicarbazone%252BDerivatives%25253A%252BBiological%252BEvaluation%252Band%252BDocking%252BStudy%26aulast%3DBakherad%26aufirst%3DZohreh%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhengmin  Yang</span>, <span class="hlFld-ContribAuthor ">Wenxiu  Li</span>, <span class="hlFld-ContribAuthor ">Hua  Chen</span>, <span class="hlFld-ContribAuthor ">Qingyuan  Mo</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Shulin  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng  Hou</span>, <span class="hlFld-ContribAuthor ">Jiangke  Qin</span>, <span class="hlFld-ContribAuthor ">Guifa  Su</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor structure-guided design and synthesis of near-infrared fluorescent probes for monoamine oxidase A (MAO-A) and its application in living cells and
              in vivo. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (17)
                                     , 2477-2480. <a href="https://doi.org/10.1039/C8CC10084E" title="DOI URL">https://doi.org/10.1039/C8CC10084E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC10084E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC10084E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DInhibitor%252Bstructure-guided%252Bdesign%252Band%252Bsynthesis%252Bof%252Bnear-infrared%252Bfluorescent%252Bprobes%252Bfor%252Bmonoamine%252Boxidase%252BA%252B%252528MAO-A%252529%252Band%252Bits%252Bapplication%252Bin%252Bliving%252Bcells%252Band%252Bin%252Bvivo%26aulast%3DYang%26aufirst%3DZhengmin%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D17%26spage%3D2477%26epage%3D2480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolay T.  Tzvetkov</span>, <span class="hlFld-ContribAuthor ">Hans-Georg  Stammler</span>, <span class="hlFld-ContribAuthor ">Silvia  Hristova</span>, <span class="hlFld-ContribAuthor ">Atanas G.  Atanasov</span>, <span class="hlFld-ContribAuthor ">Liudmil  Antonov</span>. </span><span class="cited-content_cbyCitation_article-title">(Pyrrolo-pyridin-5-yl)benzamides: BBB permeable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 793-809. <a href="https://doi.org/10.1016/j.ejmech.2018.11.009" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.009%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%252528Pyrrolo-pyridin-5-yl%252529benzamides%25253A%252BBBB%252Bpermeable%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Bwith%252Bneuroprotective%252Beffect%252Bon%252Bcortical%252Bneurons%26aulast%3DTzvetkov%26aufirst%3DNikolay%2BT.%26date%3D2019%26volume%3D162%26spage%3D793%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorota  Łażewska</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Olejarz-Maciej</span>, <span class="hlFld-ContribAuthor ">Maria  Kaleta</span>, <span class="hlFld-ContribAuthor ">Marek  Bajda</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Tadeusz  Karcz</span>, <span class="hlFld-ContribAuthor ">Agata  Doroz-Płonka</span>, <span class="hlFld-ContribAuthor ">Urszula  Cichoń</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuder</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kieć-Kononowicz</span>. </span><span class="cited-content_cbyCitation_article-title">4-tert-Pentylphenoxyalkyl derivatives – Histamine H3 receptor ligands and monoamine oxidase B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (23-24)
                                     , 3596-3600. <a href="https://doi.org/10.1016/j.bmcl.2018.10.048" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.10.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.10.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.10.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4-tert-Pentylphenoxyalkyl%252Bderivatives%252B%2525E2%252580%252593%252BHistamine%252BH3%252Breceptor%252Bligands%252Band%252Bmonoamine%252Boxidase%252BB%252Binhibitors%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DDorota%26date%3D2018%26volume%3D28%26issue%3D23-24%26spage%3D3596%26epage%3D3600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jith C.  Janardhanan</span>, <span class="hlFld-ContribAuthor ">Rakesh K.  Mishra</span>, <span class="hlFld-ContribAuthor ">Gourab  Das</span>, <span class="hlFld-ContribAuthor ">Suresh  Sini</span>, <span class="hlFld-ContribAuthor ">Purushothaman  Jayamurthy</span>, <span class="hlFld-ContribAuthor ">Cherumuttathu H.  Suresh</span>, <span class="hlFld-ContribAuthor ">Vakayil K.  Praveen</span>, <span class="hlFld-ContribAuthor ">Narayanapillai  Manoj</span>, <span class="hlFld-ContribAuthor ">Beneesh P.  Babu</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalizable 1
              H
              -Indazoles by Palladium Catalyzed Aza-Nenitzescu Reaction: Pharmacophores to Donor-Acceptor Type Multi-Luminescent Fluorophores. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>7 </em>
                                    (10)
                                     , 2094-2104. <a href="https://doi.org/10.1002/ajoc.201800413" title="DOI URL">https://doi.org/10.1002/ajoc.201800413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201800413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201800413%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFunctionalizable%252B1%252BH%252B-Indazoles%252Bby%252BPalladium%252BCatalyzed%252BAza-Nenitzescu%252BReaction%25253A%252BPharmacophores%252Bto%252BDonor-Acceptor%252BType%252BMulti-Luminescent%252BFluorophores%26aulast%3DJanardhanan%26aufirst%3DJith%2BC.%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D10%26spage%3D2094%26epage%3D2104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shakeel  Ahmad</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>, <span class="hlFld-ContribAuthor ">Saquib  Jalil</span>, <span class="hlFld-ContribAuthor ">Muhammad  Shafiq</span>, <span class="hlFld-ContribAuthor ">Matloob  Ahmad</span>, <span class="hlFld-ContribAuthor ">Sadia  Sultan</span>, <span class="hlFld-ContribAuthor ">Mazhar  Iqbal</span>, <span class="hlFld-ContribAuthor ">Sana  Aslam</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, monoamine oxidase inhibition, molecular docking and dynamic simulations of novel 2,1-benzothiazine-2,2-dioxide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>80 </em>, 498-510. <a href="https://doi.org/10.1016/j.bioorg.2018.04.012" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.04.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.04.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Bmonoamine%252Boxidase%252Binhibition%25252C%252Bmolecular%252Bdocking%252Band%252Bdynamic%252Bsimulations%252Bof%252Bnovel%252B2%25252C1-benzothiazine-2%25252C2-dioxide%252Bderivatives%26aulast%3DAhmad%26aufirst%3DShakeel%26date%3D2018%26volume%3D80%26spage%3D498%26epage%3D510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ireen  Denya</span>, <span class="hlFld-ContribAuthor ">Sarel F.  Malan</span>, <span class="hlFld-ContribAuthor ">Jacques  Joubert</span>. </span><span class="cited-content_cbyCitation_article-title">Indazole derivatives and their therapeutic applications: a patent review (2013-2017). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (6)
                                     , 441-453. <a href="https://doi.org/10.1080/13543776.2018.1472240" title="DOI URL">https://doi.org/10.1080/13543776.2018.1472240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1472240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1472240%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DIndazole%252Bderivatives%252Band%252Btheir%252Btherapeutic%252Bapplications%25253A%252Ba%252Bpatent%252Breview%252B%2525282013-2017%252529%26aulast%3DDenya%26aufirst%3DIreen%26date%3D2018%26date%3D2018%26volume%3D28%26issue%3D6%26spage%3D441%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gurjaspreet  Singh</span>, <span class="hlFld-ContribAuthor ">Pooja  Kalra</span>, <span class="hlFld-ContribAuthor ">Aanchal  Arora</span>, <span class="hlFld-ContribAuthor ">Akshpreet  Singh</span>, <span class="hlFld-ContribAuthor ">Geetika  Sharma</span>, <span class="hlFld-ContribAuthor ">Sanchita</span>, <span class="hlFld-ContribAuthor ">Indresh Kumar  Maurya</span>, <span class="hlFld-ContribAuthor ">Sanjay  Dutta</span>, <span class="hlFld-ContribAuthor ">Parthapratim  Munshi</span>, <span class="hlFld-ContribAuthor ">Vikas  Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Acetylenic Indole-Encapsulated Schiff Bases: Synthesis, In Silico Studies as Potent Antimicrobial Agents, Cytotoxic Evaluation and Synergistic Effects. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (8)
                                     , 2366-2375. <a href="https://doi.org/10.1002/slct.201703018" title="DOI URL">https://doi.org/10.1002/slct.201703018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201703018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201703018%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAcetylenic%252BIndole-Encapsulated%252BSchiff%252BBases%25253A%252BSynthesis%25252C%252BIn%252BSilico%252BStudies%252Bas%252BPotent%252BAntimicrobial%252BAgents%25252C%252BCytotoxic%252BEvaluation%252Band%252BSynergistic%252BEffects%26aulast%3DSingh%26aufirst%3DGurjaspreet%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D8%26spage%3D2366%26epage%3D2375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Jian-wei  Hou</span>, <span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Xin-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Yue  Ding</span>, <span class="hlFld-ContribAuthor ">Tong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of resveratrol-indazole hybrids as novel monoamine oxidases inhibitors with amyloid- β aggregation inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>76 </em>, 130-139. <a href="https://doi.org/10.1016/j.bioorg.2017.11.009" title="DOI URL">https://doi.org/10.1016/j.bioorg.2017.11.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2017.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2017.11.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bresveratrol-indazole%252Bhybrids%252Bas%252Bnovel%252Bmonoamine%252Boxidases%252Binhibitors%252Bwith%252Bamyloid-%252B%2525CE%2525B2%252Baggregation%252Binhibition%26aulast%3DLan%26aufirst%3DJin-Shuai%26date%3D2018%26volume%3D76%26spage%3D130%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fanghui  Ma</span>, <span class="hlFld-ContribAuthor ">Jing  Qian</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>, <span class="hlFld-ContribAuthor ">Yanguang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient synthesis of 2-amino-3-(arylthio)indoles
              via
              the Rh-catalyzed reaction of 3-diazoindol-2-imines with thioesters. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (3)
                                     , 439-443. <a href="https://doi.org/10.1039/C7OB02597A" title="DOI URL">https://doi.org/10.1039/C7OB02597A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB02597A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB02597A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DConvenient%252Bsynthesis%252Bof%252B2-amino-3-%252528arylthio%252529indoles%252Bvia%252Bthe%252BRh-catalyzed%252Breaction%252Bof%252B3-diazoindol-2-imines%252Bwith%252Bthioesters%26aulast%3DMa%26aufirst%3DFanghui%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D3%26spage%3D439%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">André  Shamsabadi</span>, <span class="hlFld-ContribAuthor ">Vijay  Chudasama</span>. </span><span class="cited-content_cbyCitation_article-title">A facile route to 1
              H
              - and 2
              H
              -indazoles from readily accessible acyl hydrazides by exploiting a novel aryne-based molecular rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (79)
                                     , 11180-11183. <a href="https://doi.org/10.1039/C8CC06556J" title="DOI URL">https://doi.org/10.1039/C8CC06556J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC06556J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC06556J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bfacile%252Broute%252Bto%252B1%252BH%252B-%252Band%252B2%252BH%252B-indazoles%252Bfrom%252Breadily%252Baccessible%252Bacyl%252Bhydrazides%252Bby%252Bexploiting%252Ba%252Bnovel%252Baryne-based%252Bmolecular%252Brearrangement%26aulast%3DShamsabadi%26aufirst%3DAndr%25C3%25A9%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D79%26spage%3D11180%26epage%3D11183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolay T.  Tzvetkov</span>, <span class="hlFld-ContribAuthor ">Hans-Georg  Stammler</span>, <span class="hlFld-ContribAuthor ">Liudmil  Antonov</span>. </span><span class="cited-content_cbyCitation_article-title">Tautomerism of N-(3,4-dichlorophenyl)-1H-indazole-5-carboxamide – A new selective, highly potent and reversible MAO-B inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2017,</strong> <em>1149 </em>, 273-281. <a href="https://doi.org/10.1016/j.molstruc.2017.07.108" title="DOI URL">https://doi.org/10.1016/j.molstruc.2017.07.108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2017.07.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2017.07.108%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DTautomerism%252Bof%252BN-%2525283%25252C4-dichlorophenyl%252529-1H-indazole-5-carboxamide%252B%2525E2%252580%252593%252BA%252Bnew%252Bselective%25252C%252Bhighly%252Bpotent%252Band%252Breversible%252BMAO-B%252Binhibitor%26aulast%3DTzvetkov%26aufirst%3DNikolay%2BT.%26date%3D2017%26volume%3D1149%26spage%3D273%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María Carmen  Costas-Lago</span>, <span class="hlFld-ContribAuthor ">Pedro  Besada</span>, <span class="hlFld-ContribAuthor ">Fernanda  Rodríguez-Enríquez</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>, <span class="hlFld-ContribAuthor ">Santiago  Vilar</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>, <span class="hlFld-ContribAuthor ">Carmen  Terán</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 1-11. <a href="https://doi.org/10.1016/j.ejmech.2017.07.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure-activity%252Brelationship%252Bstudy%252Bof%252Bnovel%252B3-heteroarylcoumarins%252Bbased%252Bon%252Bpyridazine%252Bscaffold%252Bas%252Bselective%252BMAO-B%252Binhibitors%26aulast%3DCostas-Lago%26aufirst%3DMar%25C3%25ADa%2BCarmen%26date%3D2017%26volume%3D139%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Yue  Ding</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Ping  Kang</span>, <span class="hlFld-ContribAuthor ">Jian-Wei  Hou</span>, <span class="hlFld-ContribAuthor ">Xin-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Tong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel coumarin- N -benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 48-59. <a href="https://doi.org/10.1016/j.ejmech.2017.07.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bcoumarin-%252BN%252B-benzyl%252Bpyridinium%252Bhybrids%252Bas%252Bmulti-target%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLan%26aufirst%3DJin-Shuai%26date%3D2017%26volume%3D139%26spage%3D48%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jungeun  Lee</span>, <span class="hlFld-ContribAuthor ">Yeongcheol  Lee</span>, <span class="hlFld-ContribAuthor ">So Jung  Park</span>, <span class="hlFld-ContribAuthor ">Joohee  Lee</span>, <span class="hlFld-ContribAuthor ">Yeong Shik  Kim</span>, <span class="hlFld-ContribAuthor ">Young-Ger  Suh</span>, <span class="hlFld-ContribAuthor ">Jeeyeon  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of highly selective and potent monoamine oxidase B inhibitors: Contribution of additional phenyl rings introduced into 2-aryl-1,3,4-oxadiazin-5(6 H )-one. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>130 </em>, 365-378. <a href="https://doi.org/10.1016/j.ejmech.2017.02.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.02.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.02.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bhighly%252Bselective%252Band%252Bpotent%252Bmonoamine%252Boxidase%252BB%252Binhibitors%25253A%252BContribution%252Bof%252Badditional%252Bphenyl%252Brings%252Bintroduced%252Binto%2525C2%2525A02-aryl-1%25252C3%25252C4-oxadiazin-5%2525286%252BH%252B%252529-one%26aulast%3DLee%26aufirst%3DJungeun%26date%3D2017%26volume%3D130%26spage%3D365%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naeem  Abbas</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>, <span class="hlFld-ContribAuthor ">Syeda Mahwish  Bakht</span>, <span class="hlFld-ContribAuthor ">Aliya  Ibrar</span>, <span class="hlFld-ContribAuthor ">Imtiaz  Khan</span>, <span class="hlFld-ContribAuthor ">Sadaf  Batool</span>, <span class="hlFld-ContribAuthor ">Aamer  Saeed</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Symmetrical aryl linked bis-iminothiazolidinones as new chemical entities for the inhibition of monoamine oxidases: Synthesis, in vitro biological evaluation and molecular modelling analysis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2017,</strong> <em>70 </em>, 17-26. <a href="https://doi.org/10.1016/j.bioorg.2016.11.004" title="DOI URL">https://doi.org/10.1016/j.bioorg.2016.11.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2016.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2016.11.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSymmetrical%252Baryl%252Blinked%252Bbis-iminothiazolidinones%252Bas%252Bnew%252Bchemical%252Bentities%252Bfor%252Bthe%252Binhibition%252Bof%252Bmonoamine%252Boxidases%25253A%252BSynthesis%25252C%252Bin%252Bvitro%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodelling%252Banalysis%26aulast%3DAbbas%26aufirst%3DNaeem%26date%3D2017%26volume%3D70%26spage%3D17%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolay T.  Tzvetkov</span>, <span class="hlFld-ContribAuthor ">Hans-Georg  Stammler</span>, <span class="hlFld-ContribAuthor ">Beate  Neumann</span>, <span class="hlFld-ContribAuthor ">Silvia  Hristova</span>, <span class="hlFld-ContribAuthor ">Liudmil  Antonov</span>, <span class="hlFld-ContribAuthor ">Marcus  Gastreich</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structures, binding interactions, and ADME evaluation of brain penetrant  N -substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>127 </em>, 470-492. <a href="https://doi.org/10.1016/j.ejmech.2017.01.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCrystal%252Bstructures%25252C%252Bbinding%252Binteractions%25252C%252Band%252BADME%252Bevaluation%252Bof%252Bbrain%252Bpenetrant%252BN%252B-substituted%252Bindazole-5-carboxamides%252Bas%252Bsubnanomolar%25252C%252Bselective%252Bmonoamine%252Boxidase%252BB%252Band%252Bdual%252BMAO-A%25252FB%252Binhibitors%26aulast%3DTzvetkov%26aufirst%3DNikolay%2BT.%26date%3D2017%26volume%3D127%26spage%3D470%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Tong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Yong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian-wei  Hou</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Yue  Ding</span>, <span class="hlFld-ContribAuthor ">Zhen-zhen  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of small molecules bearing a benzyloxy substituent as novel and potent monoamine oxidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 471-478. <a href="https://doi.org/10.1039/C6MD00586A" title="DOI URL">https://doi.org/10.1039/C6MD00586A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00586A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00586A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bsmall%252Bmolecules%252Bbearing%252Ba%252Bbenzyloxy%252Bsubstituent%252Bas%252Bnovel%252Band%252Bpotent%252Bmonoamine%252Boxidase%252Binhibitors%26aulast%3DLan%26aufirst%3DJin-Shuai%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D2%26spage%3D471%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolay T.  Tzvetkov</span>, <span class="hlFld-ContribAuthor ">Liudmil  Antonov</span>. </span><span class="cited-content_cbyCitation_article-title">Subnanomolar indazole-5-carboxamide inhibitors of monoamine oxidase B (MAO-B) continued: indications of iron binding, experimental evidence for optimised solubility and brain penetration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 960-967. <a href="https://doi.org/10.1080/14756366.2017.1344980" title="DOI URL">https://doi.org/10.1080/14756366.2017.1344980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2017.1344980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2017.1344980%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSubnanomolar%252Bindazole-5-carboxamide%252Binhibitors%252Bof%252Bmonoamine%252Boxidase%252BB%252B%252528MAO-B%252529%252Bcontinued%25253A%252Bindications%252Bof%252Biron%252Bbinding%25252C%252Bexperimental%252Bevidence%252Bfor%252Boptimised%252Bsolubility%252Band%252Bbrain%252Bpenetration%26aulast%3DTzvetkov%26aufirst%3DNikolay%2BT.%26date%3D2017%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D960%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pooja R.  Kamath</span>, <span class="hlFld-ContribAuthor ">Dhanya  Sunil</span>, <span class="hlFld-ContribAuthor ">A. Abdul  Ajees</span>, <span class="hlFld-ContribAuthor ">K.S.R.  Pai</span>, <span class="hlFld-ContribAuthor ">Shubankar  Biswas</span>. </span><span class="cited-content_cbyCitation_article-title">N′-((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)benzohydrazide as a probable Bcl-2/Bcl-xL inhibitor with apoptotic and anti-metastatic potential. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>120 </em>, 134-147. <a href="https://doi.org/10.1016/j.ejmech.2016.05.010" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.05.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.05.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN%2525E2%252580%2525B2-%252528%2525282-%2525286-bromo-2-oxo-2H-chromen-3-yl%252529-1H-indol-3-yl%252529methylene%252529benzohydrazide%252Bas%252Ba%252Bprobable%252BBcl-2%25252FBcl-xL%252Binhibitor%252Bwith%252Bapoptotic%252Band%252Banti-metastatic%252Bpotential%26aulast%3DKamath%26aufirst%3DPooja%2BR.%26date%3D2016%26volume%3D120%26spage%3D134%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rani  Sasidharan</span>, <span class="hlFld-ContribAuthor ">Sreedharannair Leelabaiamma  Manju</span>, <span class="hlFld-ContribAuthor ">Gülberk  Uçar</span>, <span class="hlFld-ContribAuthor ">Ipek  Baysal</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Indole-Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO-B Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2016,</strong> <em>349 </em>
                                    (8)
                                     , 627-637. <a href="https://doi.org/10.1002/ardp.201600088" title="DOI URL">https://doi.org/10.1002/ardp.201600088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201600088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201600088%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DIdentification%252Bof%252BIndole-Based%252BChalcones%25253A%252BDiscovery%252Bof%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BReversible%252BClass%252Bof%252BMAO-B%252BInhibitors%26aulast%3DSasidharan%26aufirst%3DRani%26date%3D2016%26date%3D2016%26volume%3D349%26issue%3D8%26spage%3D627%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Min  Wang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel donepezil–coumarin hybrids as multi-target agents for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (7)
                                     , 1528-1539. <a href="https://doi.org/10.1016/j.bmc.2016.02.023" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.02.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.02.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bdonepezil%2525E2%252580%252593coumarin%252Bhybrids%252Bas%252Bmulti-target%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DXie%26aufirst%3DSai-Sai%26date%3D2016%26volume%3D24%26issue%3D7%26spage%3D1528%26epage%3D1539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Yang</span>, <span class="hlFld-ContribAuthor ">Wanmei  Li</span>, <span class="hlFld-ContribAuthor ">Chengcai  Xia</span>, <span class="hlFld-ContribAuthor ">Beibei  Ying</span>, <span class="hlFld-ContribAuthor ">Chao  Shen</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Controlled Selectivity in C−S Bond Formation: Highly Efficient Synthesis of C2- and C3-Sulfonylindoles. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2016,</strong> <em>8 </em>
                                    (2)
                                     , 304-307. <a href="https://doi.org/10.1002/cctc.201500917" title="DOI URL">https://doi.org/10.1002/cctc.201500917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.201500917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.201500917%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DCatalyst-Controlled%252BSelectivity%252Bin%252BC%2525E2%252588%252592S%252BBond%252BFormation%25253A%252BHighly%252BEfficient%252BSynthesis%252Bof%252BC2-%252Band%252BC3-Sulfonylindoles%26aulast%3DYang%26aufirst%3DYong%26date%3D2016%26date%3D2015%26volume%3D8%26issue%3D2%26spage%3D304%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhupinder  Kumar</span>, <span class="hlFld-ContribAuthor ">Sheetal  Sheetal</span>, <span class="hlFld-ContribAuthor ">Anil K.  Mantha</span>, <span class="hlFld-ContribAuthor ">Vinod  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments on the structure–activity relationship studies of MAO inhibitors and their role in different neurological disorders. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (48)
                                     , 42660-42683. <a href="https://doi.org/10.1039/C6RA00302H" title="DOI URL">https://doi.org/10.1039/C6RA00302H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA00302H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA00302H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DRecent%252Bdevelopments%252Bon%252Bthe%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudies%252Bof%252BMAO%252Binhibitors%252Band%252Btheir%252Brole%252Bin%252Bdifferent%252Bneurological%252Bdisorders%26aulast%3DKumar%26aufirst%3DBhupinder%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D48%26spage%3D42660%26epage%3D42683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Min  Wang</span>, <span class="hlFld-ContribAuthor ">Xue-Mei  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Acetophenone derivatives: novel and potent small molecule inhibitors of monoamine oxidase B. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (12)
                                     , 2146-2157. <a href="https://doi.org/10.1039/C5MD00357A" title="DOI URL">https://doi.org/10.1039/C5MD00357A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00357A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00357A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DAcetophenone%252Bderivatives%25253A%252Bnovel%252Band%252Bpotent%252Bsmall%252Bmolecule%252Binhibitors%252Bof%252Bmonoamine%252Boxidase%252BB%26aulast%3DWang%26aufirst%3DZhi-Min%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D12%26spage%3D2146%26epage%3D2157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesc X.  Ruiz</span>, <span class="hlFld-ContribAuthor ">Alexandra  Cousido-Siah</span>, <span class="hlFld-ContribAuthor ">Sergio  Porté</span>, <span class="hlFld-ContribAuthor ">Marta  Domínguez</span>, <span class="hlFld-ContribAuthor ">Isidro  Crespo</span>, <span class="hlFld-ContribAuthor ">Chris  Rechlin</span>, <span class="hlFld-ContribAuthor ">André  Mitschler</span>, <span class="hlFld-ContribAuthor ">Ángel R.  de Lera</span>, <span class="hlFld-ContribAuthor ">María Jesús  Martín</span>, <span class="hlFld-ContribAuthor ">Jesús Ángel  de la Fuente</span>, <span class="hlFld-ContribAuthor ">Gerhard  Klebe</span>, <span class="hlFld-ContribAuthor ">Xavier  Parés</span>, <span class="hlFld-ContribAuthor ">Jaume  Farrés</span>, <span class="hlFld-ContribAuthor ">Alberto  Podjarny</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (12)
                                     , 1989-2003. <a href="https://doi.org/10.1002/cmdc.201500393" title="DOI URL">https://doi.org/10.1002/cmdc.201500393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500393%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructural%252BDeterminants%252Bof%252Bthe%252BSelectivity%252Bof%252B3-Benzyluracil-1-acetic%252BAcids%252Btoward%252BHuman%252BEnzymes%252BAldose%252BReductase%252Band%252BAKR1B10%26aulast%3DRuiz%26aufirst%3DFrancesc%2BX.%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D12%26spage%3D1989%26epage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pooja R.  Kamath</span>, <span class="hlFld-ContribAuthor ">Dhanya  Sunil</span>, <span class="hlFld-ContribAuthor ">A. Abdul  Ajees</span>, <span class="hlFld-ContribAuthor ">K.S.R.  Pai</span>, <span class="hlFld-ContribAuthor ">Shubhankar  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Some new indole–coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2015,</strong> <em>63 </em>, 101-109. <a href="https://doi.org/10.1016/j.bioorg.2015.10.001" title="DOI URL">https://doi.org/10.1016/j.bioorg.2015.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2015.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSome%252Bnew%252Bindole%2525E2%252580%252593coumarin%252Bhybrids%25253B%252BSynthesis%25252C%252Banticancer%252Band%252BBcl-2%252Bdocking%252Bstudies%26aulast%3DKamath%26aufirst%3DPooja%2BR.%26date%3D2015%26volume%3D63%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji Won  Choi</span>, <span class="hlFld-ContribAuthor ">Bo Ko  Jang</span>, <span class="hlFld-ContribAuthor ">Nam-chul  Cho</span>, <span class="hlFld-ContribAuthor ">Jong-Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Seul Ki  Yeon</span>, <span class="hlFld-ContribAuthor ">Eun Ji  Ju</span>, <span class="hlFld-ContribAuthor ">Yong Sup  Lee</span>, <span class="hlFld-ContribAuthor ">Gyoonhee  Han</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Dong Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Ki Duk  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (19)
                                     , 6486-6496. <a href="https://doi.org/10.1016/j.bmc.2015.08.012" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.08.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.08.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Ba%252Bseries%252Bof%252Bunsaturated%252Bketone%252Bderivatives%252Bas%252Bselective%252Band%252Breversible%252Bmonoamine%252Boxidase%252Binhibitors%26aulast%3DChoi%26aufirst%3DJi%2BWon%26date%3D2015%26volume%3D23%26issue%3D19%26spage%3D6486%26epage%3D6496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Ming  Huang</span>, <span class="hlFld-ContribAuthor ">Ya-Jian  Hu</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Chromanones: selective and reversible monoamine oxidase B inhibitors with nanomolar potency. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (7)
                                     , 1293-1302. <a href="https://doi.org/10.1039/C5MD00124B" title="DOI URL">https://doi.org/10.1039/C5MD00124B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00124B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00124B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DChromanones%25253A%252Bselective%252Band%252Breversible%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Bwith%252Bnanomolar%252Bpotency%26aulast%3DLan%26aufirst%3DJin-Shuai%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D7%26spage%3D1293%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of irreversible (Irr) and reversible (Rev) MAO-B inhibitors in clinical use.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures and potencies of previously described MAO-B inhibitors.<a onclick="showRef(event, 'ref11 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref11 ref29 ref30 ref31 ref32">(11, 29-32)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Rational design strategy to obtain MAO-B inhibitor <b>10</b> and further structural optimization to obtain class I MAO-B inhibitor <b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indazol-5-yl-amides <b>10</b>–<b>14</b> and <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) for <b>10</b>–<b>14</b>,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> carboxylic acid <b>18</b>, <b>19</b>, or <b>21a</b>–<b>c</b> (1.0 equiv), 5-amino-1<i>H</i>-indazole (<b>17</b>, 1.0 equiv), TBTU/DIPEA (1.2 equiv), acetonitrile, RT, 3–72 h, yield 23–73%; (ii) for <b>16</b>, 2-(3,4-dichlorophenyl)acetic acid (<b>20</b>, 1.0 equiv), 5-amino-1<i>H</i>-indazole (<b>17</b>, 1.0 equiv), EDC–HCl (1.1 equiv), methanol, RT, 3–4 h, yield 56% (<b>16</b>).</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Indazole-5-carboxamides <b>15</b>, <b>26</b>–<b>37</b>, and <b>38a</b>–<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) for <b>15</b>, <b>32</b> and <b>34</b>, 1<i>H</i>-indazole-5-carboxylic acid (<b>22</b>, 1.0 equiv), differently substituted anilines <b>23a</b>,<b>h</b>,<b>j</b> (1.0 equiv), TBTU/DIPEA (1.2 equiv), acetonitrile, RT, 3–72 h, yield 11–30%; (ii) for <b>15</b>, <b>26</b>–<b>31</b>, <b>33</b>, and <b>35</b>–<b>37</b>, 1<i>H</i>-indazole-5-carboxylic acid (<b>22</b>, 1.0 equiv), differently substituted anilines <b>23a</b>–<b>g</b>,<b>i</b>,<b>k</b>, <b>24</b> and <b>25</b> (1.0 equiv), EDC–HCl (1.1 equiv), methanol, RT, 3–4 h, yield 18–67%; (iii) <i>N</i>-(3,4-dichlorophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>15</b>, 1.0 equiv), MeI (1.3–2.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.3 equiv), DMF, RT, 16–20 h, yield 47% (<b>38a</b>) and 9% (<b>38b</b>).</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Indazole-6-carboxamides <b>40</b>–<b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1<i>H</i>-indazole-6-carboxylic acid (<b>39</b>, 1.0 equiv), differently substituted anilines <b>23a</b>,<b>c</b>–<b>k</b> (1.0 equiv), EDC-HCl (1.1 equiv), methanol, RT, 3–4 h, yield 22–71%.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Indole-5-carboxamides <b>53</b> and <b>54</b> and <i>N</i>-(3,4-Dichlorophenyl)carboxamide Derivatives <b>55</b> and <b>56</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) carboxylic acids <b>50</b>–<b>52</b> (1.0 equiv), 3,4-dichloroaniline (<b>23a</b>, 1.0 equiv), EDC–HCl (1.1 equiv), methanol, RT, 3–4 h, yield 17–36%; (ii) <i>N</i>-(3,4-dichlorophenyl)-1<i>H</i>-indole-5-carboxamide (<b>53</b>, 1.0 equiv), MeI (1.3–2.0 equiv), K<sub>2</sub>CO<sub>3</sub> (1.3 equiv), DMF, RT, 16–20 h, yield 68%.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0015.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 3,4-Dichlorophenyl-substituted (1<i>H</i>-indazol-5-yl)methanimines <b>58</b> and <b>59</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1<i>H</i>-indazole- or 1-methyl-1<i>H</i>-indazole-5-carboxaldehyde (<b>57a</b>,<b>b</b>, 1.0 equiv), 3,4-dichloroaniline (<b>23a</b>, 1.0 equiv), acetic acid (0.2 equiv), ethanol, reflux, 1–24 h, yields 89% (<b>58</b>) and 90% (<b>59</b>).</p></p></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reactivation of MAO-B: recombinant human MAO-B enzyme was treated under assay conditions with inhibitor <b>15</b> at a concentration that presents its IC<sub>80</sub> value (1.0 nM) in the presence of the substrate <i>p</i>-tyramine. The irreversible MAO-B inhibitor selegiline (<b>1</b>) and the reversible inhibitor safinamide (<b>3</b>) were applied at concentrations of 30 and 50 nM, respectively. After a preincubation period of 22 min, the substrate concentration was increased from 10 μM to 1.0 mM, and the fluorescence was measured over a period of 5 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mode of MAO-B inhibition: saturation curves (top) and Lineweaver–Burk plot (bottom) of the inhibition of recombinant human MAO-B enzyme by different concentrations of <b>15</b> (0, 0.1, 0.5, and 1.0 nM) in the presence of <i>p</i>-tyramine (0.05, 0.1, 0.25, 0.5, 1.0, and 1.5 mM) as a substrate. In the Lineweaver–Burk plot, the reciprocal MAO-B inhibitory activity was plotted against the reciprocal substrate concentration (double reciprocal plot, <i>n</i> = 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Predicted binding modes of <b>15</b> (A) and <b>40</b> (B) in the human MAO-B (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a>) active site. The ligands and the cocrystallized safinamide <b>3</b> are colored in orange, light blue, and broken white, respectively. For clarity, only the relevant residue side chains are shown in gray. Clipping planes have been used for better visibility. All structures are represented as stick models. The postulated H-bond interactions between the carbonyl group and the water molecule HOH1247 are displayed as pink lines.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compounds <b>15</b> (A) and <b>40</b> (B) placed within the PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z">2V5Z</a> cavity in a HYDE Visual Affinity Assessment (ligands rendered in stick model with atom coloring by HYDE: green = favorable, red = unfavorable for affinity; the relevant ligand atoms C3, N1, and N2 are labeled in white, atoms of LEU171 and TYR398 behind the binding site surface). The surface has been colored by the respective amino acid elements; clipping planes have been used to enhance visibility and therefore not all atoms are visible for all residues and FAD.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Distribution of clogP versus pIC<sub>50</sub> values (human MAO-B) for reference compounds and newly developed inhibitors. The reference drugs and selected novel classes of MAO-B inhibitors are indicated in red (<b>1</b>, <b>2</b>, and <b>3</b>), green (indazole-5-carboxamides, class I), violet (indole-5-carboxamides, class II), and orange (indazol-5-yl)methanimines, class III) circles, respectively (also see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The blue dashed lines represent the preferred range for clogP values. The red dashed line indicates the average clogP value of 3.09 of all synthesized compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/medium/jm-2014-00729a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0010.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure optimization process of lead structure <b>15</b> toward derivative <b>30</b> with improved properties by replacement of the 3-Cl (step a), or the 3,4-di-Cl atoms (step b) with one (<b>29</b>) or two fluorine atoms (<b>30</b>). The binding efficiency index (BEI) is defined as BEI = pIC<sub>50</sub>/<i>M</i><sub>R</sub> (in 1/kDa).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-15/jm500729a/production/images/large/jm-2014-00729a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500729a&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 65 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Monoamine oxidase B inhibition and neuroprotection</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 6</span><span class="NLM_x">) </span> <span class="NLM_fpage">S62</span><span class="NLM_x">–</span> <span class="NLM_lpage">S68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=S62-S68&issue=Suppl+6&author=N.+Castagnoliauthor=J.+P.+Petzerauthor=S.+Steynauthor=K.+Castagnoliauthor=J.-F.+Chenauthor=M.+A.+Schwarzschildauthor=C.+J.+Van+der+Schyf&title=Monoamine+oxidase+B+inhibition+and+neuroprotection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DSteyn%26aufirst%3DS.%26aulast%3DCastagnoli%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DMonoamine%2520oxidase%2520B%2520inhibition%2520and%2520neuroprotection%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26issue%3DSuppl%25206%26spage%3DS62%26epage%3DS68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shih, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridd, M. J.</span><span> </span><span class="NLM_article-title">Monoamine oxidase: from genes to behavior</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1146%2Fannurev.neuro.22.1.197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=10202537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFemsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=197-217&author=J.+C.+Shihauthor=K.+Chenauthor=M.+J.+Ridd&title=Monoamine+oxidase%3A+from+genes+to+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase: from genes to behavior</span></div><div class="casAuthors">Shih, J. C.; Chen, K.; Ridd, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">197-217</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with ∼130 refs.  Cloning of MAO (monoamine oxidase) A and B has demonstrated unequivocally that these enzymes are made up of different polypeptides, and our understanding of MAO structure, regulation, and function has been significantly advanced by studies using their cDNA.  MAO A and B genes are located on the X-chromosome (Xp11.23) and comprise 15 exons with identical intron-exon organization, which suggests that they are derived from the same ancestral gene.  MAO A and B knock-out mice exhibit distinct differences in neurotransmitter metab. and behavior.  MAO A knock-out mice have elevated brain levels of serotonin, norepinephrine, and dopamine and manifest aggressive behavior similar to human males with a deletion of MAO A.  In contrast, MAO B knock-out mice do not exhibit aggression and only levels of phenylethylamine are increased.  Mice lacking MAO B are resistant to the Parkinsongenic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.  Both MAO A and B knock-out mice show increased reactivity to stress.  These knock-out mice are valuable models for investigating the role of monoamines in psychoses and neurodegenerative and stress-related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9r853xrSk7bVg90H21EOLACvtfcHk0lhZzY8Q-uw06A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFemsrk%253D&md5=bbe78d2100a36681f2c1c51938ab4b98</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.22.1.197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.22.1.197%26sid%3Dliteratum%253Aachs%26aulast%3DShih%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DRidd%26aufirst%3DM.%2BJ.%26atitle%3DMonoamine%2520oxidase%253A%2520from%2520genes%2520to%2520behavior%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1999%26volume%3D22%26spage%3D197%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton-Vinson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubálek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders</span> <span class="citation_source-journal">Nature Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1038%2Fnsb732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=11753429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=22-26&author=C.+Bindaauthor=P.+Newton-Vinsonauthor=F.+Hub%C3%A1lekauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structure+of+human+monoamine+oxidase+B%2C+a+drug+target+for+the+treatment+of+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders</span></div><div class="casAuthors">Binda, Claudia; Newton-Vinson, Paige; Hubalek, Frantisek; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-26</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is a mitochondrial outer membrane flavoenzyme that is a well-known target for antidepressant and neuroprotective drugs.  Here, the authors detd. the structure of the human liver enzyme to 3 Å resoln.  Human liver MAO B was found to bind to the membrane through a C-terminal transmembrane helix and apolar loops located at various positions in the sequence.  The electron d. showed that pargyline, an analog of the clin. used MAO B inhibitor, deprenyl, binds covalently to the flavin N5 atom.  The active site of MAO B consisted of a 420-Å3 hydrophobic substrate cavity interconnected to an entrance cavity of 290 Å3.  The recognition site for the substrate amino group was an arom. cage formed by Tyr-398 and Tyr-435.  The structure provides a framework for probing the catalytic mechanism, understanding the differences between the MAO A and B isoforms and designing specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8p43h-vsPi7Vg90H21EOLACvtfcHk0lhZzY8Q-uw06A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D&md5=261d3b1375d833bbfd0a23bdade49be6</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1038%2Fnsb732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb732%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DNewton-Vinson%26aufirst%3DP.%26aulast%3DHub%25C3%25A1lek%26aufirst%3DF.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructure%2520of%2520human%2520monoamine%2520oxidase%2520B%252C%2520a%2520drug%2520target%2520for%2520the%2520treatment%2520of%2520neurological%2520disorders%26jtitle%3DNature%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D22%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hubálek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span> </span><span class="NLM_article-title">Structural comparison of human monoamine oxidases A and B</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">28612</span><span class="NLM_x">–</span> <span class="NLM_lpage">28618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=28612-28618&author=F.+Hub%C3%A1lekauthor=J.+Pohlauthor=D.+E.+Edmondson&title=Structural+comparison+of+human+monoamine+oxidases+A+and+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHub%25C3%25A1lek%26aufirst%3DF.%26aulast%3DPohl%26aufirst%3DJ.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26atitle%3DStructural%2520comparison%2520of%2520human%2520monoamine%2520oxidases%2520A%2520and%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D28612%26epage%3D28618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavie, L.</span><span> </span><span class="NLM_article-title">Selective MAO-A and MAO-B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson’s disease</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1994&pages=2077-2082&author=M.+B.+H.+Youdimauthor=L.+Lavie&title=Selective+MAO-A+and+MAO-B+inhibitors%2C+radical+scavengers+and+nitric+oxide+synthase+inhibitors+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DLavie%26aufirst%3DL.%26atitle%3DSelective%2520MAO-A%2520and%2520MAO-B%2520inhibitors%252C%2520radical%2520scavengers%2520and%2520nitric%2520oxide%2520synthase%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DLife%2520Sci.%26date%3D1994%26volume%3D55%26spage%3D2077%26epage%3D2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hauptmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadenas, E.</span><span> </span><span class="NLM_article-title">The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1006%2Fabbi.1996.0510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=8914926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK28XntVKlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1996&pages=295-304&author=N.+Hauptmannauthor=J.+Grimsbyauthor=J.+C.+Shihauthor=E.+Cadenas&title=The+metabolism+of+tyramine+by+monoamine+oxidase+A%2FB+causes+oxidative+damage+to+mitochondrial+DNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA</span></div><div class="casAuthors">Hauptmann, Nils; Grimsby, Joseph; Shih, Jean C.; Cadenas, Enrique</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">295-304</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Monoamine oxidases A/B (EC 1.4.3.4, MAO), flavoenzymes located on the outer mitochondrial membrane, catalyze the oxidative deamination of biogenic amines, such as dopamine, serotonin, and norepinephrine.  In this study, the authors examd. whether the H2O2 formed during the two-electron oxidn. of tyramine [4-(2-aminoethyl)phenol] (a substrate for monoamine oxidases A/B) may contribute to the intramitochondrial steady-state concn. of H2O2 ([H2O2]ss) and, thus, be involved in the oxidative impairment of mitochondrial matrix components.  Supplementation of intact, coupled rat brain mitochondria with benzylamine, β-phenylethylamine, or tyramine showed initial rates of H2O2 prodn. ranging from 0.4 to 1.6 nmol H2O/min/mg protein.  ESR anal. of the oxidative deamination of tyramine by intact rat brain mitochondria revealed the formation of hydroxyl (HO•) and carbon-centered radical adducts - the latter probably originating by the HO•-mediated oxidn. of mannitol.  The signals were substantially enhanced upon addn. of FeSO4 and were abolished by catalase.  The intramitochondrial [H2O2]ss calcd. in terms of glutathione peroxidase activity during the metab. of tyramine was 48-fold higher (7.71 × 10-7 M) than that obtained during the oxidn. of succinate via complex II in the presence of antimycin A (1.64 × 10-8 M).  Oxidn. damage to the brain mtDNA was assessed by single strand breakage.  The ratio of nicked DNA for the prepns. treated with tyramine and those without the amine was 1.5, 2.12, and 3.12 at 15, 30, and 60 min, resp.  Preincubation of mitochondria with tranylcypromine (trans-2-phenylcyclopropylamine), an inhibitor to MAO A/B, abolished mtDNA oxidative damage.  Catalase inhibited mtDNA strand breakage by approx. 60%.  Incubation of intact, coupled rat brain mitochondria with chlorodinitrobenzene (CDNB) depleted mitochondrial GSH by 72%.  Tyramine-dependent damage of mtDNA was decreased by 68% in CDNB-treated mitochondria (with 28% remaining GSH).  The [H2O2]ss was slightly increased in CDNB-treated mitochondria: 1.38- and 1.28-fold increase during the oxidn. of succinate in the presence of antimycin A and during the oxidn. of tyramine, resp.  These results suggest that the H2O2 generated during the MAO-catalyzed oxidn. of biogenic amines and possibly certain neurotransmitters at the outer mitochondrial membrane contributes to the intramitochondrial [H2O2]ss and may cause oxidative damage to mtDNA.  This is effected by the intramitochondrial concn. of GSH and might have potential implications for aging and neurodegenerative processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxh4xplKDn47Vg90H21EOLACvtfcHk0lj2f4ru2dLn2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntVKlt7w%253D&md5=9f34268c9ffaf56ed4746c7b3415df55</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1996.0510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1996.0510%26sid%3Dliteratum%253Aachs%26aulast%3DHauptmann%26aufirst%3DN.%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26aulast%3DCadenas%26aufirst%3DE.%26atitle%3DThe%2520metabolism%2520of%2520tyramine%2520by%2520monoamine%2520oxidase%2520A%252FB%2520causes%2520oxidative%2520damage%2520to%2520mitochondrial%2520DNA%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1996%26volume%3D335%26spage%3D295%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sayre, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span> </span><span class="NLM_article-title">Oxidative stress and neurotoxicity</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700210j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlygsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=172-188&author=L.+M.+Sayreauthor=G.+Perryauthor=M.+A.+Smith&title=Oxidative+stress+and+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress and Neurotoxicity</span></div><div class="casAuthors">Sayre, Lawrence M.; Perry, George; Smith, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-188</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is increasing awareness of the ubiquitous role of oxidative stress in neurodegenerative disease states.  A continuing challenge is to be able to distinguish between oxidative changes that occur early in the disease from those that are secondary manifestations of neuronal degeneration.  This perspective highlights the role of oxidative stress in Alzheimer's, Parkinson's, and Huntington's diseases, amyotrophic lateral sclerosis, and multiple sclerosis, neurodegenerative and neuroinflammatory disorders where there is evidence for a primary contribution of oxidative stress in neuronal death, as opposed to other diseases where oxidative stress more likely plays a secondary or by-stander role.  We begin with a brief review of the biochem. of oxidative stress as it relates to mechanisms that lead to cell death, and why the central nervous system is particularly susceptible to such mechanisms.  Following a review of oxidative stress involvement in individual disease states, some conclusions are provided as to what further research should hope to accomplish in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyOa0kfz_RVLVg90H21EOLACvtfcHk0lgCBANpjEBu1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlygsr3K&md5=800757a60a32641257fad2fe97fd20bd</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1021%2Ftx700210j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700210j%26sid%3Dliteratum%253Aachs%26aulast%3DSayre%26aufirst%3DL.%2BM.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DOxidative%2520stress%2520and%2520neurotoxicity%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D172%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P. M.</span><span> </span><span class="NLM_article-title">New directions in monoamine oxidase A and B selective inhibitors and substrates</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1991&pages=155-162&author=M.+B.+H.+Youdimauthor=J.+P.+M.+Finberg&title=New+directions+in+monoamine+oxidase+A+and+B+selective+inhibitors+and+substrates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DNew%2520directions%2520in%2520monoamine%2520oxidase%2520A%2520and%2520B%2520selective%2520inhibitors%2520and%2520substrates%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1991%26volume%3D41%26spage%3D155%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shih, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span> </span><span class="NLM_article-title">Regulation of MAO-A and MAO-B gene expression</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1995</span><span class="NLM_x">–</span> <span class="NLM_lpage">2005</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.2174%2F0929867043364757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15279563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1995-2005&author=J.+C.+Shihauthor=K.+Chen&title=Regulation+of+MAO-A+and+MAO-B+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of MAO-A and MAO-B gene expression</span></div><div class="casAuthors">Shih, J. C.; Chen, K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1995-2005</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">MAO-A and -B genes are made of 15 exons with identical exon-intron organization.  They are located on X-chromosome organized in opposite direction, tail to tail with 24kb apart.  Both promoters are GC-rich and regulated by transcription factor Sp1.  However, they have distinctly different features.  MAO-B gene, but not MAO-A gene, has TATA box.  MAO B promoter contains two clusters of overlapping Sp1 sites, the CACCC repressor element.  Transcription factors Sp1 and Sp4 can activate MAO-B promoter activity through the proximal cluster of Sp1 sites and its activation can be repressed by the over-expression of Sp3 and a related family member, BTEB2.  Decreased methylation and transcription repressor Sp3 upregulate human MAO-B, but not MAO-A, gene expression during Caco-2 differentiation.  MAO-B, but not MAO-A gene, could be activated by PMA (phorbol 12-myristate 13-acetate) by protein kinase C, MAPkinase signal transduction pathway involves cJun and Egr-1.  The differences in MAO-A and -B gene regulation may explain the different tissue-specific expression and functions of these two important isoenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5ZcVNBHVHTbVg90H21EOLACvtfcHk0lgCBANpjEBu1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7g%253D&md5=9c1096c9b27e76550d6f3e668c12bf5b</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.2174%2F0929867043364757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364757%26sid%3Dliteratum%253Aachs%26aulast%3DShih%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DK.%26atitle%3DRegulation%2520of%2520MAO-A%2520and%2520MAO-B%2520gene%2520expression%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D1995%26epage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upadhyay, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4210</span><span class="NLM_x">–</span> <span class="NLM_lpage">4230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=4210-4230&author=D.+E.+Edmondsonauthor=C.+Bindaauthor=J.+Wangauthor=A.+K.+Upadhyayauthor=A.+Mattevi&title=Molecular+and+mechanistic+properties+of+the+membrane-bound+mitochondrial+monoamine+oxidases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DUpadhyay%26aufirst%3DA.%2BK.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DMolecular%2520and%2520mechanistic%2520properties%2520of%2520the%2520membrane-bound%2520mitochondrial%2520monoamine%2520oxidases%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D4210%26epage%3D4230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Levitt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pintar, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breakefield, X. O.</span><span> </span><span class="NLM_article-title">Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">6385</span><span class="NLM_x">–</span> <span class="NLM_lpage">6389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1982&pages=6385-6389&author=P.+Levittauthor=J.+E.+Pintarauthor=X.+O.+Breakefield&title=Immunocytochemical+demonstration+of+monoamine+oxidase+B+in+brain+astrocytes+and+serotonergic+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevitt%26aufirst%3DP.%26aulast%3DPintar%26aufirst%3DJ.%2BE.%26aulast%3DBreakefield%26aufirst%3DX.%2BO.%26atitle%3DImmunocytochemical%2520demonstration%2520of%2520monoamine%2520oxidase%2520B%2520in%2520brain%2520astrocytes%2520and%2520serotonergic%2520neurons%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1982%26volume%3D79%26spage%3D6385%26epage%3D6389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">O’Carroll, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobbia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions</span> <span class="citation_source-journal">Naunyn Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1007%2FBF00500765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=6408492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaL3sXitFSmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=1983&pages=198-202&author=A.-M.+O%E2%80%99Carrollauthor=C.+J.+Fowlerauthor=J.+P.+Phillipsauthor=I.+Tobbiaauthor=K.+F.+Tipton&title=The+deamination+of+dopamine+by+human+brain+monoamine+oxidase.+Specificity+for+the+two+enzyme+forms+in+seven+brain+regions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The deamination of dopamine by human brain monoamine oxidase.  Specificity for the two enzyme forms in seven brain regions</span></div><div class="casAuthors">O'Carroll, Anne Marie; Fowler, Christopher J.; Phillips, Jack P.; Tobbia, Iqdam; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">198-202</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">The deamination of dopamine (I)  [51-61-6] was studied in 7 regions of human brain.  Both A and B forms of monamine oxidase (MAO)  [9001-66-5] were active towards I.  The ratio of activities of MAO-A:MAO-B varied considerably from brain region to brain region, from about 1:1 for the cerebral and cerebellar cortex to about 1:2 for the pons and medulla oblongata.  Enzyme titrn. studies and comparisons of the substrate specificities of MAO-A and MAO-B across the brain indicated that I was metabolized by the same MAO active centers as other monoamines.  In the cerebral cortex, the Km values of MAO-A and -B towards I were 210 and 230 μM, resp., indicating that the relative contributions of these 2 forms towards the oxidn. of I will not be affected by changes in its concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd11w8nQN5OrVg90H21EOLACvtfcHk0ljoO9CPDEmChg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitFSmtrk%253D&md5=ac03f33b62d3b917845cf5441904dac0</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1007%2FBF00500765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00500765%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Carroll%26aufirst%3DA.-M.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DPhillips%26aufirst%3DJ.%2BP.%26aulast%3DTobbia%26aufirst%3DI.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520deamination%2520of%2520dopamine%2520by%2520human%2520brain%2520monoamine%2520oxidase.%2520Specificity%2520for%2520the%2520two%2520enzyme%2520forms%2520in%2520seven%2520brain%2520regions%26jtitle%3DNaunyn%2520Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1983%26volume%3D322%26spage%3D198%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitahama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fort, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panula, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denney, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jouvet, M.</span><span> </span><span class="NLM_article-title">Histaminergic system in the cat hypothalamus with reference to type B monoamine oxidase</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1002%2Fcne.903300309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=7682224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK3sXkvVKrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=1993&pages=405-420&author=J.+S.+Linauthor=K.+Kitahamaauthor=P.+Fortauthor=P.+Panulaauthor=R.+M.+Denneyauthor=M.+Jouvet&title=Histaminergic+system+in+the+cat+hypothalamus+with+reference+to+type+B+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Histaminergic system in the cat hypothalamus with reference to type B monoamine oxidase</span></div><div class="casAuthors">Lin, J. S.; Kitahama, K.; Fort, P.; Panula, P.; Denney, R. M.; Jouvet, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-20</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    </div><div class="casAbstract">The distribution and morphol. of neurons immunoreactive to histamine and(or) monoamine oxidase B were studied in the cat hypothalamus.  Most histaminic-contg. neurons were also pos. for monoamine oxidase 3, suggesting that histamine metab. could occur in these cells.  However, a few neuron were immunoreactive for only histamine or monoamine oxidase B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGe8YssQz8QrVg90H21EOLACvtfcHk0ljoO9CPDEmChg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvVKrur4%253D&md5=a3d7786dd4eb03b2d1cbbf4d043f22a7</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1002%2Fcne.903300309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.903300309%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BS.%26aulast%3DKitahama%26aufirst%3DK.%26aulast%3DFort%26aufirst%3DP.%26aulast%3DPanula%26aufirst%3DP.%26aulast%3DDenney%26aufirst%3DR.%2BM.%26aulast%3DJouvet%26aufirst%3DM.%26atitle%3DHistaminergic%2520system%2520in%2520the%2520cat%2520hypothalamus%2520with%2520reference%2520to%2520type%2520B%2520monoamine%2520oxidase%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D1993%26volume%3D330%26spage%3D405%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Westlund, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denney, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochersperger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abell, C. W.</span><span> </span><span class="NLM_article-title">Distinct monoamine oxidase A and B populations in primate brain</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=1985&pages=181-183&author=K.+N.+Westlundauthor=R.+M.+Denneyauthor=L.+M.+Kocherspergerauthor=R.+M.+Roseauthor=C.+W.+Abell&title=Distinct+monoamine+oxidase+A+and+B+populations+in+primate+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestlund%26aufirst%3DK.%2BN.%26aulast%3DDenney%26aufirst%3DR.%2BM.%26aulast%3DKochersperger%26aufirst%3DL.%2BM.%26aulast%3DRose%26aufirst%3DR.%2BM.%26aulast%3DAbell%26aufirst%3DC.%2BW.%26atitle%3DDistinct%2520monoamine%2520oxidase%2520A%2520and%2520B%2520populations%2520in%2520primate%2520brain%26jtitle%3DScience%26date%3D1985%26volume%3D230%26spage%3D181%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oreland, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcusson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span> </span><span class="NLM_article-title">The effect of age on the activity and molecular properties of human brain monoamine oxidase</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1980&pages=1-20&author=C.+J.+Fowlerauthor=A.+Wibergauthor=L.+Orelandauthor=J.+Marcussonauthor=B.+Winblad&title=The+effect+of+age+on+the+activity+and+molecular+properties+of+human+brain+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DWiberg%26aufirst%3DA.%26aulast%3DOreland%26aufirst%3DL.%26aulast%3DMarcusson%26aufirst%3DJ.%26aulast%3DWinblad%26aufirst%3DB.%26atitle%3DThe%2520effect%2520of%2520age%2520on%2520the%2520activity%2520and%2520molecular%2520properties%2520of%2520human%2520brain%2520monoamine%2520oxidase%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D1980%26volume%3D49%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nicotra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parvez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senatori, O.</span><span> </span><span class="NLM_article-title">Monoamine oxidase expression during development and aging</span> <span class="citation_source-journal">NeuroToxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2FS0161-813X%2803%2900095-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=14697890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSjtLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=155-165&author=A.+Nicotraauthor=F.+Pierucciauthor=H.+Parvezauthor=O.+Senatori&title=Monoamine+oxidase+expression+during+development+and+aging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase expression during development and aging</span></div><div class="casAuthors">Nicotra, Antonietta; Pierucci, Federica; Parvez, Hasan; Senatori, Ornella</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">155-165</span>CODEN:
                <span class="NLM_cas:coden">NRTXDN</span>;
        ISSN:<span class="NLM_cas:issn">0161-813X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A discussion and review on the authors' works.  Monoamine oxidase (MAO) isoenzymes play a major role in regulating the concn. of several bioactive amines, including serotonin and catecholamines.  Both in the nervous system and in peripheral organs, MAOs can potentially modulate all the processes involving these bioactive amines.  In the present article, we review some of the most significant articles published so far on changes in MAOs during development and aging.  The data available on development refer mainly to the mammal brain at fetal and post-fetal stages.  Very little work has been done on studying MAO ontogenesis during early development, i.e., at stages prior to organogenesis, and what has been done refers to non-mammal vertebrates such as fish, amphibians and birds.  MAO A and MAO B changes have been measured as values of enzymic activity, as amt. of protein or, more rarely, as amt. of mRNAs.  A knowledge of MAO developmental changes not only provides a basis for the investigation of factors regulating MAO expression, but can also contribute to a better understanding of the possible trophic and/or morphogenetic role of monoaminergic neurotransmitters in the developing brain.  Transgenic mice lacking MAO A and rodents treated with MAO inhibitors during gestation have been very useful in this second case.  The investigations of changes in MAO A and MAO B during aging in the literature refer mostly to humans, mice and rats.  Interest in studies on aging is stimulated, among other things, by the observation that age-related diseases leading to neurodegenerative phenomena could be accompanied by changes in MAO activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxv_AEJy1Nl7Vg90H21EOLACvtfcHk0lijsWP3gAxv9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSjtLrO&md5=c89dd6fbfdda1ee597c77b27bcd54aba</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2FS0161-813X%2803%2900095-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0161-813X%252803%252900095-0%26sid%3Dliteratum%253Aachs%26aulast%3DNicotra%26aufirst%3DA.%26aulast%3DPierucci%26aufirst%3DF.%26aulast%3DParvez%26aufirst%3DH.%26aulast%3DSenatori%26aufirst%3DO.%26atitle%3DMonoamine%2520oxidase%2520expression%2520during%2520development%2520and%2520aging%26jtitle%3DNeuroToxicology%26date%3D2004%26volume%3D25%26spage%3D155%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nagatsu, T.</span><span> </span><span class="NLM_article-title">Progress in monoamine oxidase (MAO) research and relation to genetic engineering</span> <span class="citation_source-journal">NeuroToxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=11-20&author=T.+Nagatsu&title=Progress+in+monoamine+oxidase+%28MAO%29+research+and+relation+to+genetic+engineering"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagatsu%26aufirst%3DT.%26atitle%3DProgress%2520in%2520monoamine%2520oxidase%2520%2528MAO%2529%2520research%2520and%2520relation%2520to%2520genetic%2520engineering%26jtitle%3DNeuroToxicology%26date%3D2004%26volume%3D25%26spage%3D11%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bortolato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. C.</span><span> </span><span class="NLM_article-title">Monoamine oxidase inactivation: From pathophysiology to therapeutics</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1527</span><span class="NLM_x">–</span> <span class="NLM_lpage">1533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2Fj.addr.2008.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=18652859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWltbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=1527-1533&author=M.+Bortolatoauthor=K.+Chenauthor=J.+C.+Shih&title=Monoamine+oxidase+inactivation%3A+From+pathophysiology+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase inactivation: From pathophysiology to therapeutics</span></div><div class="casAuthors">Bortolato, Marco; Chen, Kevin; Shih, Jean C.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">1527-1533</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidases (MAOs) A and B are mitochondrial bound isoenzymes which catalyze the oxidative deamination of dietary amines and monoamine neurotransmitters, such as serotonin, norepinephrine, dopamine, β-phenylethylamine and other trace amines.  The rapid degrdn. of these mols. ensures the proper functioning of synaptic neurotransmission and is critically important for the regulation of emotional behaviors and other brain functions.  The byproducts of MAO-mediated reactions include several chem. species with neurotoxic potential, such as hydrogen peroxide, ammonia and aldehydes.  As a consequence, it is widely speculated that prolonged excessive activity of these enzymes may be conducive to mitochondrial damages and neurodegenerative disturbances.  In keeping with these premises, the development of MAO inhibitors has led to important breakthroughs in the therapy of several neuropsychiatric disorders, ranging from mood disorders to Parkinson's disease.  Furthermore, the characterization of MAO knockout (KO) mice has revealed that the inactivation of this enzyme produces a no. of functional and behavioral alterations, some of which may be harnessed for therapeutic aims.  In this article, we discuss the intriguing hypothesis that the attenuation of the oxidative stress induced by the inactivation of either MAO isoform may contribute to both antidepressant and antiparkinsonian actions of MAO inhibitors.  This possibility further highlights MAO inactivation as a rich source of novel avenues in the treatment of mental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBs7njlZCb7rVg90H21EOLACvtfcHk0lijsWP3gAxv9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWltbbK&md5=9085ccfdebab364e9ea78995bcfc16d1</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2008.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2008.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DBortolato%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26atitle%3DMonoamine%2520oxidase%2520inactivation%253A%2520From%2520pathophysiology%2520to%2520therapeutics%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D1527%26epage%3D1533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachenmayer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laux, G.</span><span> </span><span class="NLM_article-title">Clinical applications of MAO-inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2043</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.2174%2F0929867043364775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15279566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=2033-2043&author=P.+Riedererauthor=L.+Lachenmayerauthor=G.+Laux&title=Clinical+applications+of+MAO-inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical applications of MAO-Inhibitors</span></div><div class="casAuthors">Riederer, P.; Lachenmayer, L.; Laux, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2033-2043</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase inhibitors (MAO-I) have been useful in the treatment of both psychiatric and neurol. disorders over centuries.  Here the authors focus on the development of this drug treatment.  Focus is given on the use of irreversible MAO-I's as well as on reversible ones.  Benefit and side effects are reported for Parkinson's disease, Alzheimer's dementia, depression syndrome and panic disorders.  The preclin. and clin. effects of selegiline with regard to neuroprotection are highlighted and the conclusion is drawn that there is good evidence for a clin. neuroprotective capacity based on the assumption that the 50% recovery of MAO-B is obtained already after a 10 days withdrawal of selegiline.  There is also a focus on selegilines metab. to amphetamine and metamphetamine.  In order to avoid any such effects of metabolic compds. on the cardiovascular system Zydis Selegiline, a melt-tablet avoid of major metab. to amphetamine and metamphetamine is described in detail.  Developments in MAO-I research are discussed in detail as there are moclobemide, lacabemide, rasagiline.  Interactions of MAO-I' with tricyclics and serotonin selective reuptake inhibitors (SSRI's) are described as there is mentioning of interactions of MAO-I's with other compds. in general.  Tables and figures report on clin. studies and on pharmacol. properties of MAO-I's.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9Zf08abfhabVg90H21EOLACvtfcHk0ljztpgjuAd7Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7c%253D&md5=dabcabed0e363951ad40e258ddffa972</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.2174%2F0929867043364775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364775%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DLachenmayer%26aufirst%3DL.%26aulast%3DLaux%26aufirst%3DG.%26atitle%3DClinical%2520applications%2520of%2520MAO-inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D2033%26epage%3D2043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakhle, Y. S.</span><span> </span><span class="NLM_article-title">Monoamine oxidase: isoforms and inhibitors in Parkinson’d disease and depressive illness</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">S287</span><span class="NLM_x">–</span> <span class="NLM_lpage">S296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=S287-S296&author=M.+B.+H.+Youdimauthor=Y.+S.+Bakhle&title=Monoamine+oxidase%3A+isoforms+and+inhibitors+in+Parkinson%E2%80%99d+disease+and+depressive+illness"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DBakhle%26aufirst%3DY.%2BS.%26atitle%3DMonoamine%2520oxidase%253A%2520isoforms%2520and%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599d%2520disease%2520and%2520depressive%2520illness%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26spage%3DS287%26epage%3DS296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Treatment options in the modern management of Parkinson’s disease</span> <span class="citation_source-journal">Arch. Neurol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1088</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1001%2Farchneur.64.8.1083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=17698697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BD2svotFGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=1083-1088&author=A.+H.+V.+Schapira&title=Treatment+options+in+the+modern+management+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment options in the modern management of Parkinson disease</span></div><div class="casAuthors">Schapira Anthony H V</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1083-8</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCOyv-PhtwZcyail4HZd-ifW6udTcc2ebfY21H0qCbArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svotFGrtQ%253D%253D&md5=9ebc6ecfb7791afc421b150548b29fa3</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1001%2Farchneur.64.8.1083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.64.8.1083%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DTreatment%2520options%2520in%2520the%2520modern%2520management%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Neurol.%2520Rev.%26date%3D2007%26volume%3D64%26spage%3D1083%26epage%3D1088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hoskini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenfield, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span> </span><span class="NLM_article-title">Characterization of moclobemide <i>N</i>-oxidation in human microsomes</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=387-397&author=J.+Hoskiniauthor=G.+Shenfieldauthor=M.+Murrayauthor=A.+Gross&title=Characterization+of+moclobemide+N-oxidation+in+human+microsomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoskini%26aufirst%3DJ.%26aulast%3DShenfield%26aufirst%3DG.%26aulast%3DMurray%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520moclobemide%2520N-oxidation%2520in%2520human%2520microsomes%26jtitle%3DXenobiotica%26date%3D2001%26volume%3D31%26spage%3D387%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Finberg, J. P. M.</span><span> </span><span class="NLM_article-title">Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2Fj.pharmthera.2014.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=24607445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=133-152&author=J.+P.+M.+Finberg&title=Update+on+the+pharmacology+of+selective+inhibitors+of+MAO-A+and+MAO-B%3A+Focus+on+modulation+of+CNS+monoamine+neurotransmitter+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release</span></div><div class="casAuthors">Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-152</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Inhibitors of monoamine oxidase (MAO) were initially used in medicine following the discovery of their antidepressant action.  Subsequently their ability to potentiate the effects of an indirectly-acting sympathomimetic amine such as tyramine was discovered, leading to their limitation in clin. use, except for cases of treatment-resistant depression.  More recently, the understanding that: a) potentiation of indirectly-acting sympathomimetic amines is caused by inhibitors of MAO-A but not by inhibitors of MAO-B, and b) that reversible inhibitors of MAO-A cause minimal tyramine potentiation, has led to their re-introduction to clin. use for treatment of depression (reversible MAO-A inhibitors and new dose form MAO-B inhibitor) and treatment of Parkinson's disease (MAO-B inhibitors).  The profound neuroprotective properties of propargyl-based inhibitors of MAO-B in preclin. expts. have drawn attention to the possibility of employing these drugs for their neuroprotective effect in neurodegenerative diseases, and have raised the question of the involvement of the MAO-mediated reaction as a source of reactive free radicals.  Despite the long-standing history of MAO inhibitors in medicine, the way in which they affect neuronal release of monoamine neurotransmitters is still poorly understood.  In recent years, the detailed chem. structure of MAO-B and MAO-A has become available, providing new possibilities for synthesis of mechanism-based inhibitors.  This review describes the latest advances in understanding the way in which MAO inhibitors affect the release of the monoamine neurotransmitters dopamine, noradrenaline and serotonin (5-HT) in the CNS, with an accent on the importance of these effects for the clin. actions of the drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSGMvtQ1Ca5bVg90H21EOLACvtfcHk0ljJePIAmJKA1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGht7o%253D&md5=0f31959bad34842d4aaaba7b8162e5b8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DUpdate%2520on%2520the%2520pharmacology%2520of%2520selective%2520inhibitors%2520of%2520MAO-A%2520and%2520MAO-B%253A%2520Focus%2520on%2520modulation%2520of%2520CNS%2520monoamine%2520neurotransmitter%2520release%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D143%26spage%3D133%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Treatment options in the modern management of Parkinson’s disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1088</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1001%2Farchneur.64.8.1083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=17698697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BD2svotFGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=1083-1088&author=A.+H.+V.+Schapira&title=Treatment+options+in+the+modern+management+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment options in the modern management of Parkinson disease</span></div><div class="casAuthors">Schapira Anthony H V</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1083-8</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCOyv-PhtwZcyail4HZd-ifW6udTcc2eYMelFf-6srL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svotFGrtQ%253D%253D&md5=9ebc6ecfb7791afc421b150548b29fa3</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1001%2Farchneur.64.8.1083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.64.8.1083%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DTreatment%2520options%2520in%2520the%2520modern%2520management%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2007%26volume%3D64%26spage%3D1083%26epage%3D1088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Singer, C.</span><span> </span><span class="NLM_article-title">Managing the patient with newly diagnosed Parkinson’s disease</span> <span class="citation_source-journal">Cleveland Clin. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S3</span><span class="NLM_x">–</span> <span class="NLM_lpage">S7</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=S3-S7&issue=Suppl+2&author=C.+Singer&title=Managing+the+patient+with+newly+diagnosed+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinger%26aufirst%3DC.%26atitle%3DManaging%2520the%2520patient%2520with%2520newly%2520diagnosed%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCleveland%2520Clin.%2520J.%2520Med.%26date%3D2012%26volume%3D79%26issue%3DSuppl%25202%26spage%3DS3%26epage%3DS7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jankovic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poewe, W.</span><span> </span><span class="NLM_article-title">Therapies in Parkinson’s disease</span> <span class="citation_source-journal">Curr. Opin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1097%2FWCO.0b013e3283542fc2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=22691758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWjs7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=433-447&author=J.+Jankovicauthor=W.+Poewe&title=Therapies+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Therapies in Parkinson's disease</span></div><div class="casAuthors">Jankovic, Joseph; Poewe, Werner</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">433-447</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review examines currently available therapeutic strategies for Parkinson's disease, emphasizing evidence-based data as well as a patient-centered approach to the treatment of motor and nonmotor symptoms.  Recent findings: Although clin. trials of disease-modifying approaches have been thus far disappointing, steady advances are being made in the symptomatic treatment of Parkinson's disease.  In this review, we focus on recent studies with monoamine oxidase type B inhibitors (selegiline and rasagiline), coenzyme Q10, creatine, and exercise in early Parkinson's disease.  We also discuss the relative merits and disadvantages of delaying the initiation of levodopa therapy, the role of dopamine agonists, particularly ropinirole and pramipexole, and management of motor and behavioral complications, such as fluctuations, dyskinesias and impulse-control disorders.  Novel formulations and delivery approaches for conventional and new drugs are also discussed.  Finally, we review recent studies of surgical treatments of Parkinson's disease, such as deep brain stimulation.  Summary: Numerous clin. trials have provided evidence that health-related quality of life can be substantially improved with early diagnosis and institution of exercise and other phys. measures, appropriate timing of dopaminergic therapy, and strategies to delay and treat levodopa-related motor complications and nonmotor Parkinson's disease-related symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmbLTT8J_WmrVg90H21EOLACvtfcHk0liq_5xpP3ltHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWjs7%252FE&md5=f756cf6cdc4ab07a42653305775aa87a</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1097%2FWCO.0b013e3283542fc2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWCO.0b013e3283542fc2%26sid%3Dliteratum%253Aachs%26aulast%3DJankovic%26aufirst%3DJ.%26aulast%3DPoewe%26aufirst%3DW.%26atitle%3DTherapies%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2012%26volume%3D25%26spage%3D433%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupershmidt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span> </span><span class="NLM_article-title">Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson’s disease</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S132</span><span class="NLM_x">–</span> <span class="NLM_lpage">S136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=S132-S136&issue=Suppl+1&author=M.+B.+H.+Youdimauthor=L.+Kupershmidtauthor=T.+Amitauthor=O.+Weinreb&title=Promises+of+novel+multi-target+neuroprotective+and+neurorestorative+drugs+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DKupershmidt%26aufirst%3DL.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DWeinreb%26aufirst%3DO.%26atitle%3DPromises%2520of%2520novel%2520multi-target%2520neuroprotective%2520and%2520neurorestorative%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2014%26volume%3D20%26issue%3DSuppl%25201%26spage%3DS132%26epage%3DS136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.2174%2F092986711797379302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=21864289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4568-4587&author=L.+Pisaniauthor=M.+Cattoauthor=F.+Leonettiauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=F.+Campagnaauthor=A.+Carotti&title=Targeting+monoamine+oxidases+with+multipotent+ligands%3A+an+emerging+strategy+in+the+search+of+new+drugs+against+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases</span></div><div class="casAuthors">Pisani, L.; Catto, M.; Leonetti, F.; Nicolotti, O.; Stefanachi, A.; Campagna, F.; Carotti, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4568-4587</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The socioeconomic burden of multi-factorial pathologies, such as neurodegenerative diseases (NDs), is enormous worldwide.  Unfortunately, no proven disease-modifying therapy is available yet and in most cases (e.g., Alzheimer's and Parkinson's disease) the approved drugs exert only palliative and symptomatic effects.  Nowadays, an emerging strategy for the discovery of disease-modifying drugs is based on the multi-target directed ligand (MTDL) design, an innovative shift from the traditional approach one-drug-one-target to the more ambitious one-drug-more-targets goal.  Herein, we review the discovery strategy, the mechanism of action and the biopharmacol. evaluation of multipotent ligands exhibiting monoamine oxidase (MAO) inhibition as the core activity with a potential for the treatment of NDs.  In particular, MAO inhibitors exhibiting addnl. acetylcholinesterase (AChE) or nitric oxide synthase (NOS) inhibition, or ion chelation/antioxidant-radical scavenging/anti-inflammatory/A2A receptor antagonist/APP processing modulating activities have been thoroughly examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4N8fMdFNcwrVg90H21EOLACvtfcHk0liq_5xpP3ltHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O&md5=2463da84a1da0142e353ff9d3a354fe6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F092986711797379302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797379302%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DTargeting%2520monoamine%2520oxidases%2520with%2520multipotent%2520ligands%253A%2520an%2520emerging%2520strategy%2520in%2520the%2520search%2520of%2520new%2520drugs%2520against%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4568%26epage%3D4587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Patyar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prakash, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhi, B.</span><span> </span><span class="NLM_article-title">Dual inhibition: a novel promising pharmacological approach for different disease conditions</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1111%2Fj.2042-7158.2010.01236.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=21401597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktlantLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=459-471&author=S.+Patyarauthor=A.+Prakashauthor=B.+Medhi&title=Dual+inhibition%3A+a+novel+promising+pharmacological+approach+for+different+disease+conditions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition: a novel promising pharmacological approach for different disease conditions</span></div><div class="casAuthors">Patyar, Sazal; Prakash, Ajay; Medhi, Bikash</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">459-471</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  To overcome the problems assocd. with polypharmacy, which include medication non compliance, adverse drug reactions, drug-drug interactions, and increased pill-burden, various strategies, such as sustained-release drugs and fixed-dose combination regimens (polypills), were developed.  Out of these, a novel and very much promising approach is the use of dual-action drugs.  Amongst the dual-action drugs, there is a class of compds. known as dual inhibitors, which possess the dual inhibitory activity.  The most common examples of dual inhibitors are rivastigmine, ladostigil, asenapine, phenserine, amitriptyline, clomipramine, doxepin, and desipramine.  This review article focuses on the conventional drugs used in different diseases which possess dual inhibition activity as well as those which are still in the preclin./clin. phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoimW_BGkApX7Vg90H21EOLACvtfcHk0liq_5xpP3ltHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktlantLs%253D&md5=5cae05a18a9246b765e400230e8ef62f</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2010.01236.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2010.01236.x%26sid%3Dliteratum%253Aachs%26aulast%3DPatyar%26aufirst%3DS.%26aulast%3DPrakash%26aufirst%3DA.%26aulast%3DMedhi%26aufirst%3DB.%26atitle%3DDual%2520inhibition%253A%2520a%2520novel%2520promising%2520pharmacological%2520approach%2520for%2520different%2520disease%2520conditions%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2011%26volume%3D63%26spage%3D459%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and M30 derived from rasagiline</span> <span class="citation_source-journal">Exp. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.5607%2Fen.2013.22.1.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BC3srlt1alsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=1-10&author=M.+B.+H.+Youdim&title=Multi+target+neuroprotective+and+neurorestorative+anti-Parkinson+and+anti-Alzheimer+drugs+ladostigil+and+M30+derived+from+rasagiline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline</span></div><div class="casAuthors">Youdim Moussa B H</div><div class="citationInfo"><span class="NLM_cas:title">Experimental neurobiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>
        ISSN:<span class="NLM_cas:issn">1226-2560</span>.
    </div><div class="casAbstract">Present anti-PD and -AD drugs have limited symptomatic activity and devoid of neuroprotective and neurorestorative property that is needed for disease modifying action.  The complex pathology of PD and AD led us to develop several multi-target neuroprotective and neurorestorative drugs with several CNS targets with the ability for possible disease modifying activity.  Employing the pharmacophore of our anti-parkinson drug rasagiline (Azilect, N-propagrgyl-1-R-aminoindan), we have developed a series of novel multi-functional neuroprotective drugs (A) [TV-3326 (N-propargyl-3R-aminoindan-5yl)-ethyl methylcarbamate)], with both cholinesterase-butyrylesterase and brain selective monoamine-oxidase (MAO) A/B inhibitory activities and (B) the iron chelator-radical scavenging-brain selective monoamine oxidase (MAO) A/B inhibitor and M30 possessing the neuroprotective and neurorescuing propargyl moiety of rasagiline, as potential treatment of AD, DLB and PD with dementia.  Another series of multi-target drugs (M30, HLA-20 series) which are brain permeable iron chelators and potent selective brain MAO inhibitors were also developed.  These series of drugs have the ability of regulating and processing amyloid precursor protein (APP) since APP and alpha-synuclein are metaloproteins (iron-regulated proteins), with an iron responsive element 5"UTR mRNA similar to transferring and ferritin.  Ladostigil inhibits brain acetyl and butyrylcholinesterase in rats after oral doses.  After chronic but not acute treatment, it inhibits MAO-A and -B in the brain.  Ladostigil acts like an anti-depressant in the forced swim test in rats, indicating a potential for anti-depressant activity.  Ladostigil prevents the destruction of nigrostriatal neurons induced by infusion of neurotoxin MPTP in mice.  The propargylamine moiety of ladostigil confers neuroprotective activity against cytotoxicity induced by ischemia and peroxynitrite in cultured neuronal cells.  The multi-target iron chelator M30 has all the properties of ladostigil and similar neuroprotective activity to ladostigil, but is not a ChE inhibitor.  M30 has a neurorestorative activity in post-lesion of nigrostriatal dopamine neurons in MPTP, lacatcystin and 6-hydroxydopamine animal models of PD.  The neurorestorative activity is related to the ability of the drug to activate hypoxia inducing factor (HIF) which induces the production of such neurotrophins as brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF) and erythropoietin as well as glia-derived neurotrophic factor (GDNF).  The unique multiple actions of ladostigil and M30 make the potentially useful drugs for the treatment of dementia with Parkinsonian-like symptoms and depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAEm76m-YqPGhHGZei4OW9fW6udTcc2eah3pFhBL5SxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srlt1alsA%253D%253D&md5=55dd62729ca05fb17eb58589011677a2</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.5607%2Fen.2013.22.1.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5607%252Fen.2013.22.1.1%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DMulti%2520target%2520neuroprotective%2520and%2520neurorestorative%2520anti-Parkinson%2520and%2520anti-Alzheimer%2520drugs%2520ladostigil%2520and%2520M30%2520derived%2520from%2520rasagiline%26jtitle%3DExp.%2520Neurobiol.%26date%3D2013%26volume%3D22%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel dual inhibitors of AChE and MAO derived from hydroxyl aminoindan and phenethylamine as potential treatment for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020120c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Miskolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+Youdimauthor=M.+Weinstock&title=Novel+dual+inhibitors+of+AChE+and+MAO+derived+from+hydroxyl+aminoindan+and+phenethylamine+as+potential+treatment+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm020120c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020120c%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520dual%2520inhibitors%2520of%2520AChE%2520and%2520MAO%2520derived%2520from%2520hydroxyl%2520aminoindan%2520and%2520phenethylamine%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5260%26epage%3D5279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouplana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and molecular modeling of donepezil and <i>N</i>-[(5-(benzyloxy)-1-methyl-1<i>H</i>-indol-2-yl)methyl]-<i>N</i>-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimeŕs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8251</span><span class="NLM_x">–</span> <span class="NLM_lpage">8270</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200853t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8251-8270&author=I.+Boleaauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=C.+de+los+Riosauthor=M.+Chiouaauthor=R.+Pouplanaauthor=F.+J.+Luqueauthor=M.+Unzetaauthor=J.+Marco-Contellesauthor=A.+Samadi&title=Synthesis%2C+biological+evaluation%2C+and+molecular+modeling+of+donepezil+and+N-%5B%285-%28benzyloxy%29-1-methyl-1H-indol-2-yl%29methyl%5D-N-methylprop-2-yn-1-amine+hybrids+as+new+multipotent+cholinesterase%2Fmonoamine+oxidase+inhibitors+for+the+treatment+of+Alzheime%C5%95s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1021%2Fjm200853t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200853t%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DPouplana%26aufirst%3DR.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520molecular%2520modeling%2520of%2520donepezil%2520and%2520N-%255B%25285-%2528benzyloxy%2529-1-methyl-1H-indol-2-yl%2529methyl%255D-N-methylprop-2-yn-1-amine%2520hybrids%2520as%2520new%2520multipotent%2520cholinesterase%252Fmonoamine%2520oxidase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheime%25C5%2595s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8251%26epage%3D8270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12E"><span><span class="NLM_label">(E) </span><span class="NLM_contrib-group">Bautista-Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolic, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agbabe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indoyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=82-95&author=O.+M.+Bautista-Aguileraauthor=G.+Estebanauthor=I.+Boleaauthor=K.+Nikolicauthor=D.+Agbabeauthor=I.+Moraledaauthor=I.+Iriepaauthor=A.+Smadiauthor=E.+Sorianoauthor=M.+Unzetaauthor=J.+Marco-Contelles&title=Design%2C+synthesis%2C+pharmacological+evaluation%2C+QSAR+analysis%2C+molecular+modeling+and+ADMET+of+novel+donepezil-indoyl+hybrids+as+multipotent+cholinesterase%2Fmonoamine+oxidase+inhibitors+for+the+potential+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12E&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DNikolic%26aufirst%3DK.%26aulast%3DAgbabe%26aufirst%3DD.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DSmadi%26aufirst%3DA.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520pharmacological%2520evaluation%252C%2520QSAR%2520analysis%252C%2520molecular%2520modeling%2520and%2520ADMET%2520of%2520novel%2520donepezil-indoyl%2520hybrids%2520as%2520multipotent%2520cholinesterase%252Fmonoamine%2520oxidase%2520inhibitors%2520for%2520the%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D75%26spage%3D82%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Dual-target-directed drugs that block monoamine oxidase B and adenosine A<sub>2A</sub> receptors for Parkinsońs disease</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=141-151&author=J.+P.+Petzerauthor=N.+Castagnoliauthor=M.+A.+Schwarzschildauthor=J.-F.+Chenauthor=C.+J.+Van+der+Schyf&title=Dual-target-directed+drugs+that+block+monoamine+oxidase+B+and+adenosine+A2A+receptors+for+Parkinso%C5%84s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DDual-target-directed%2520drugs%2520that%2520block%2520monoamine%2520oxidase%2520B%2520and%2520adenosine%2520A2A%2520receptors%2520for%2520Parkinso%25C5%2584s%2520disease%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoccini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamantini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccioni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minetti, P.</span><span> </span><span class="NLM_article-title">Synthesis of (<i>E</i>)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A<sub>2A</sub> antagonists/MAO-B inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1247</span><span class="NLM_x">–</span> <span class="NLM_lpage">1261</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301686s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1247-1261&author=S.+Rivaraauthor=G.+Piersantiauthor=F.+Bartocciniauthor=G.+Diamantiniauthor=D.+Palaauthor=T.+Riccioniauthor=M.+A.+Stasiauthor=W.+Cabriauthor=F.+Borsiniauthor=M.+Morauthor=G.+Tarziaauthor=P.+Minetti&title=Synthesis+of+%28E%29-8-%283-chlorostyryl%29caffeine+analogues+leading+to+9-deazaxanthine+derivatives+as+dual+A2A+antagonists%2FMAO-B+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm301686s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301686s%26sid%3Dliteratum%253Aachs%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DBartoccini%26aufirst%3DF.%26aulast%3DDiamantini%26aufirst%3DG.%26aulast%3DPala%26aufirst%3DD.%26aulast%3DRiccioni%26aufirst%3DT.%26aulast%3DStasi%26aufirst%3DM.%2BA.%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DBorsini%26aufirst%3DF.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMinetti%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520%2528E%2529-8-%25283-chlorostyryl%2529caffeine%2520analogues%2520leading%2520to%25209-deazaxanthine%2520derivatives%2520as%2520dual%2520A2A%2520antagonists%252FMAO-B%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1247%26epage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase B by selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1299</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1299-1310&author=J.+P.+Petzerauthor=S.+Steynauthor=K.+P.+Castagnoliauthor=J.-F.+Chenauthor=M.+A.+Schwarzschildauthor=C.+J.+Van+der+Schyfauthor=N.+Castagnoli&title=Inhibition+of+monoamine+oxidase+B+by+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DSteyn%26aufirst%3DS.%26aulast%3DCastagnoli%26aufirst%3DK.%2BP.%26aulast%3DChen%26aufirst%3DJ.-F.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DCastagnoli%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520B%2520by%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1299%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vlok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase B by analogues of the adenosine A<sub>2A</sub> receptor antagonists (<i>E</i>)-8-(3-chlorostyryl)caffeine (CSC)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3512</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3512-3521&author=N.+Vlokauthor=S.+F.+Malanauthor=N.+Castagnoliauthor=J.+J.+Berghauthor=J.+P.+Petzer&title=Inhibition+of+monoamine+oxidase+B+by+analogues+of+the+adenosine+A2A+receptor+antagonists+%28E%29-8-%283-chlorostyryl%29caffeine+%28CSC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlok%26aufirst%3DN.%26aulast%3DMalan%26aufirst%3DS.%2BF.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DBergh%26aufirst%3DJ.%2BJ.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520B%2520by%2520analogues%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520antagonists%2520%2528E%2529-8-%25283-chlorostyryl%2529caffeine%2520%2528CSC%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3512%26epage%3D3521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pretorius, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span> </span><span class="NLM_article-title">Dual inhibition of monoamine oxidase B and antagonism of the adenosine A<sub>2A</sub> receptor by (<i>E</i>,<i>E</i>)-8-(4-phenylbutadien-1-yl)caffeine analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">8876</span><span class="NLM_x">–</span> <span class="NLM_lpage">8684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8876-8684&author=J.+Pretoriusauthor=S.+F.+Malanauthor=N.+Castagnoliauthor=J.+J.+Berghauthor=J.+P.+Petzer&title=Dual+inhibition+of+monoamine+oxidase+B+and+antagonism+of+the+adenosine+A2A+receptor+by+%28E%2CE%29-8-%284-phenylbutadien-1-yl%29caffeine+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPretorius%26aufirst%3DJ.%26aulast%3DMalan%26aufirst%3DS.%2BF.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DBergh%26aufirst%3DJ.%2BJ.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DDual%2520inhibition%2520of%2520monoamine%2520oxidase%2520B%2520and%2520antagonism%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520by%2520%2528E%252CE%2529-8-%25284-phenylbutadien-1-yl%2529caffeine%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8876%26epage%3D8684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Stößel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlenk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Küppers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span> </span><span class="NLM_article-title">Dual targeting of adenosine A<sub>2A</sub> receptors and monoamine oxidase B by 4<i>H</i>-3,1-benzothiazin-4-ones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4580</span><span class="NLM_x">–</span> <span class="NLM_lpage">4596</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400336x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4580-4596&author=A.+St%C3%B6%C3%9Felauthor=M.+Schlenkauthor=S.+Hinzauthor=P.+K%C3%BCppersauthor=J.+Heerauthor=M.+G%C3%BCtschowauthor=C.+E.+M%C3%BCller&title=Dual+targeting+of+adenosine+A2A+receptors+and+monoamine+oxidase+B+by+4H-3%2C1-benzothiazin-4-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1021%2Fjm400336x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400336x%26sid%3Dliteratum%253Aachs%26aulast%3DSt%25C3%25B6%25C3%259Fel%26aufirst%3DA.%26aulast%3DSchlenk%26aufirst%3DM.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DK%25C3%25BCppers%26aufirst%3DP.%26aulast%3DHeer%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDual%2520targeting%2520of%2520adenosine%2520A2A%2520receptors%2520and%2520monoamine%2520oxidase%2520B%2520by%25204H-3%252C1-benzothiazin-4-ones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4580%26epage%3D4596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Brunschweiger, A.; Koch, P.; Schlenk, M.; Pineda, F.; Küppers, P.; Hinz, S.; Köse, M.; Ullrich, S.; Hockemeyer, J.; Wiese, M.; Müller, C. E.</span><span> </span><span class="NLM_article-title">8-Benzyltetrahydropyrazino[2,1-<i>f</i>]puridiones: water-soluble tricyclic xanthine derivatives as multitarget drugs for neurodegenerative diseases</span>.  <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span>DOI <span class="refDoi"> DOI: 10.1002/cmdc.201402082</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1002%2Fcmdc.201402082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+Brunschweiger&author=P.+Koch&author=M.+Schlenk&author=F.+Pineda&author=P.+K%C3%BCppers&author=S.+Hinz&author=M.+K%C3%B6se&author=S.+Ullrich&author=J.+Hockemeyer&author=M.+Wiese&author=C.+E.+M%C3%BCller&title=8-Benzyltetrahydropyrazino%5B2%2C1-f%5Dpuridiones%3A+water-soluble+tricyclic+xanthine+derivatives+as+multitarget+drugs+for+neurodegenerative+diseases&doi=10.1002%2Fcmdc.201402082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402082%26sid%3Dliteratum%253Aachs%26aulast%3DBrunschweiger%26aufirst%3DA.%26atitle%3D8-Benzyltetrahydropyrazino%255B2%252C1-f%255Dpuridiones%253A%2520water-soluble%2520tricyclic%2520xanthine%2520derivatives%2520as%2520multitarget%2520drugs%2520for%2520neurodegenerative%2520diseases%26jtitle%3DChemMedChem%26date%3D2014%26doi%3D10.1002%2Fcmdc.201402082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Knoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magyar, K.</span><span> </span><span class="NLM_article-title">Some puzzling pharmacological effects of monoamine oxidase inhibitors</span> <span class="citation_source-journal">Adv. Biochem. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=5066229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaE3sXhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1972&pages=393-408&author=J.+Knollauthor=K.+Magyar&title=Some+puzzling+pharmacological+effects+of+monoamine+oxidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Puzzling pharmacological effects of monoamine oxidase [MAO] inhibitors</span></div><div class="casAuthors">Knoll, J.; Magyar, K.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biochemical Psychopharmacology</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">393-408</span>CODEN:
                <span class="NLM_cas:coden">ABPYBL</span>;
        ISSN:<span class="NLM_cas:issn">0065-2229</span>.
    </div><div class="casAbstract">A discussion and review with 17 refs. of some dissimilar effects various monoamine oxidase inhibitors may have on the metabolism of biogenic amines.  Studies with the optical isomers of Deprenil [2079-54-1] indicate that multiple forms of the enzyme monoamine oxidase may exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCM6fPp82whLVg90H21EOLACvtfcHk0li9ui4M1HnirA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhsA%253D%253D&md5=8a0fe1c36cedef71af1bde3b408913f9</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnoll%26aufirst%3DJ.%26aulast%3DMagyar%26aufirst%3DK.%26atitle%3DSome%2520puzzling%2520pharmacological%2520effects%2520of%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DAdv.%2520Biochem.%2520Psychopharmacol.%26date%3D1972%26volume%3D5%26spage%3D393%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Birkmayer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrozi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Implications of combined treatment with Madopar and l-deprenyl in Parkinson’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1977&pages=439-443&author=W.+Birkmayerauthor=P.+Riedererauthor=L.+Ambroziauthor=M.+B.+H.+Youdim&title=Implications+of+combined+treatment+with+Madopar+and+l-deprenyl+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirkmayer%26aufirst%3DW.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DAmbrozi%26aufirst%3DL.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DImplications%2520of%2520combined%2520treatment%2520with%2520Madopar%2520and%2520l-deprenyl%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D1977%26volume%3D2%26spage%3D439%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Reynolds, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jellinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seemann, D.</span><span> </span><span class="NLM_article-title">Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (<span class="smallcaps smallerCapital">l</span>)-deprenyl administration</span> <span class="citation_source-journal">J. Neural. Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=271-277&author=G.+P.+Reynoldsauthor=P.+Riedererauthor=M.+Sandlerauthor=K.+Jellingerauthor=D.+Seemann&title=Amphetamine+and+2-phenylethylamine+in+post-mortem+Parkinsonian+brain+after+%28l%29-deprenyl+administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DG.%2BP.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DSandler%26aufirst%3DM.%26aulast%3DJellinger%26aufirst%3DK.%26aulast%3DSeemann%26aufirst%3DD.%26atitle%3DAmphetamine%2520and%25202-phenylethylamine%2520in%2520post-mortem%2520Parkinsonian%2520brain%2520after%2520%2528l%2529-deprenyl%2520administration%26jtitle%3DJ.%2520Neural.%2520Transm.%26date%3D1978%26volume%3D43%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachenmayer, L.</span><span> </span><span class="NLM_article-title">Selegiline’s neuroprotective capacity revisited</span> <span class="citation_source-journal">J. Neural. Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2003&pages=1273-1278&author=P.+Riedererauthor=L.+Lachenmayer&title=Selegiline%E2%80%99s+neuroprotective+capacity+revisited"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DLachenmayer%26aufirst%3DL.%26atitle%3DSelegiline%25E2%2580%2599s%2520neuroprotective%2520capacity%2520revisited%26jtitle%3DJ.%2520Neural.%2520Transm.%26date%3D2003%26volume%3D110%26spage%3D1273%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Pålhagen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinonen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hägglund, J.</span><span> </span><span class="NLM_article-title">Selegiline slows the progression of the symptoms of Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1200-1206&author=S.+P%C3%A5lhagenauthor=E.+Heinonenauthor=J.+H%C3%A4gglund&title=Selegiline+slows+the+progression+of+the+symptoms+of+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A5lhagen%26aufirst%3DS.%26aulast%3DHeinonen%26aufirst%3DE.%26aulast%3DH%25C3%25A4gglund%26aufirst%3DJ.%26atitle%3DSelegiline%2520slows%2520the%2520progression%2520of%2520the%2520symptoms%2520of%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D66%26spage%3D1200%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lakhan, S. E.</span><span> </span><span class="NLM_article-title">From a Parkinson’s disease expert: rasagiline and the future of therapy</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">3</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1186%2F1750-1326-2-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=17224059" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1-3&author=S.+E.+Lakhan&title=From+a+Parkinson%E2%80%99s+disease+expert%3A+rasagiline+and+the+future+of+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-2-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-2-1%26sid%3Dliteratum%253Aachs%26aulast%3DLakhan%26aufirst%3DS.%2BE.%26atitle%3DFrom%2520a%2520Parkinson%25E2%2580%2599s%2520disease%2520expert%253A%2520rasagiline%2520and%2520the%2520future%2520of%2520therapy%26jtitle%3DMol.%2520Neurodegener.%26date%3D2007%26volume%3D2%26spage%3D1%26epage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Teo, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S.-L.</span><span> </span><span class="NLM_article-title">Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease</span> <span class="citation_source-journal">Transl. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=2-10&author=K.+C.+Teoauthor=S.-L.+Ho&title=Monoamine+oxidase-B+%28MAO-B%29+inhibitors%3A+implications+for+disease-modification+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTeo%26aufirst%3DK.%2BC.%26aulast%3DHo%26aufirst%3DS.-L.%26atitle%3DMonoamine%2520oxidase-B%2520%2528MAO-B%2529%2520inhibitors%253A%2520implications%2520for%2520disease-modification%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DTransl.%2520Neurodegener.%26date%3D2013%26spage%3D2%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crivelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismaili, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fariello, R. G.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2Fj.phrs.2003.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15082032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVCgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=77-85&author=A.+Marzoauthor=L.+D.+Boauthor=N.+C.+Montiauthor=F.+Crivelliauthor=S.+Ismailiauthor=C.+Cacciaauthor=C.+Cattaneoauthor=R.+G.+Fariello&title=Pharmacokinetics+and+pharmacodynamics+of+safinamide%2C+a+neuroprotectant+with+antiparkinsonian+and+anticonvulsant+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity</span></div><div class="casAuthors">Marzo, Antonio; Dal Bo, Lorenzo; Monti, Nunzia Ceppi; Crivelli, Fabrizio; Ismaili, Shevqet; Caccia, Carla; Cattaneo, Carlo; Fariello, Ruggero G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-85</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Objective: This paper describes the pharmacokinetics and the pharmacodynamics, in terms of monoamino oxidase type B (MAO-B) inhibition, in male healthy volunteers of orally administered safinamide, a new neuroprotectant that in exptl. models has demonstrated strong anticonvulsant and antiparkinson activities.  Methods: Four clin. trials covering the dose range of 25-10,000 μg/kg were carried out to describe pharmacokinetics, pharmacodynamics and tolerability of safinamide, administered in single or repeated dose regimen to steady state, including a food interaction trial.  All the above trials were carried out after the Ethics Committee's approval and signature of the consent form by the volunteers.  In single dose trials blood sampling covered a 24 h-period in pharmacodynamic trials, 48 h-period in pharmacokinetic trials.  In the case of repeated dose regimen to steady state a pre-dose sample was drawn on the first six study days, whereas the curve was explored on the 7th study day, prolonging blood sampling over a 48 h-period after the last dosing.  Safinamide level was detd. in plasma by a very sensitive and specific LC-MS-MS method, with a low limit of quantification of 0.5 ng/mL of plasma.  Pharmacokinetic anal. was carried out with non-compartmental method and, in one case, also with the two-compartmental method.  Monoamine oxidase activity of both types A and B (MAO-A and MAO-B) was detd. in plasma at different times (MAO-B) and correlated to safinamide levels, or in urine (MAO-A).  Results: Pharmacokinetics of safinamide proved to be linearly and proportionally related to the administered doses.  The absorption of safinamide was rapid with peak plasma concns. ranging from 2 to 4 h.  Food prolonged the rate and did not affect the extent of absorption of safinamide.  In repeat dose regimen once daily, the steady state was reached on the 5th study day with a marginal accumulation factor of 1.5-1.7.  The drug was cleared with a t1/2 of about 22 h.  Safinamide reversibly inhibited MAO-B enzyme.  Full inhibition was obsd. with single doses≥600 μg/kg, and a relevant, dose dependent, progressive inhibition was encountered with doses starting from 25 μg/kg.  Even at the highest single dose of 10 mg/kg no evidence of MAO-A inhibition was obsd.  Conclusion: Enteral absorption of the drug is linear and proportional to the doses administered.  The drug is cleared from the body with a t1/2 of ≃22 h, without producing any clin. relevant accumulation at steady state.  The MAO-B inhibitory activity, without affecting MAO-A, is useful to prevent a dopamine bioinactivation in patients suffering from Parkinson's disease.  Safinamide tolerability in the four clin. trials proved to be good.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7hAsD1-PSs7Vg90H21EOLACvtfcHk0lhRkE1cfih1Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVCgs7w%253D&md5=a9e13d65d797cf7db330346f2ddd08a2</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2003.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2003.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DMarzo%26aufirst%3DA.%26aulast%3DBo%26aufirst%3DL.%2BD.%26aulast%3DMonti%26aufirst%3DN.%2BC.%26aulast%3DCrivelli%26aufirst%3DF.%26aulast%3DIsmaili%26aufirst%3DS.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCattaneo%26aufirst%3DC.%26aulast%3DFariello%26aufirst%3DR.%2BG.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520safinamide%252C%2520a%2520neuroprotectant%2520with%2520antiparkinsonian%2520and%2520anticonvulsant%2520activity%26jtitle%3DPharmacol.%2520Res.%26date%3D2004%26volume%3D50%26spage%3D77%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fariello, R. G.</span><span> </span><span class="NLM_article-title">Safinamide</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=110-116&author=R.+G.+Fariello&title=Safinamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFariello%26aufirst%3DR.%2BG.%26atitle%3DSafinamide%26jtitle%3DNeurotherapeutics%26date%3D2007%26volume%3D4%26spage%3D110%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Onofrj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A.</span><span> </span><span class="NLM_article-title">An expert opinion on safinamide in Parkinson’s disease</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1115</span><span class="NLM_x">–</span> <span class="NLM_lpage">1125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1115-1125&author=M.+Onofrjauthor=L.+Bonanniauthor=A.+Thomas&title=An+expert+opinion+on+safinamide+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnofrj%26aufirst%3DM.%26aulast%3DBonanni%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DA.%26atitle%3DAn%2520expert%2520opinion%2520on%2520safinamide%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1115%26epage%3D1125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Safinamide in the treatment of Prakinsońs disease</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2261</span><span class="NLM_x">–</span> <span class="NLM_lpage">2268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1517%2F14656566.2010.511612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=20707760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVansbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=2261-2268&author=A.+H.+V.+Schapira&title=Safinamide+in+the+treatment+of+Prakinso%C5%84s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Safinamide in the treatment of Parkinson's disease</span></div><div class="casAuthors">Schapira, Anthony H. V.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2261-2268</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Current therapy for Parkinson's disease (PD) is primarily directed at reversing the motor symptoms that are the consequence of dopamine deficiency and includes levodopa, dopamine agonists and monoamine oxidase (MAO) B inhibitors.  New drugs offering both dopaminergic and non-dopaminergic actions could offer a significant advantage.  Areas covered in this review: This review surveys the current treatment strategies for PD.  Defining unmet needs and how a new compd. - safinamide, which has both dopaminergic and non-dopaminergic actions - might address these.  What the reader will gain: The reader will gain an understanding of safinamide and its mechanisms of action, including reversible MAOB inhibition and reduced dopamine reuptake with antiglutamatergic effects, and how it may potentially provide improvement of PD motor symptoms with an antidyskinetic effect through its effect on glutamate release.  The clin. trial profile of safinamide is reviewed.  Early results are promising in terms of improved motor function and reduced OFF' time.  Addnl. Phase III trials are now in progress for this adjunctive indication.  Finally, the reader will understand the potential role for safinamide in the selection and sequencing of drugs for PD.  Take home message: safinamide combines both dopaminergic and non-dopaminergic actions that may add a new dimension to PD treatment options as an adjunct to current drugs.  Its efficacy is under active evaluation in Phase III clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIFyv3AWzo67Vg90H21EOLACvtfcHk0lg6egK7Xj55Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVansbbJ&md5=c916e62cd01d0b9a0fc3df71915f4ac4</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1517%2F14656566.2010.511612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2010.511612%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DSafinamide%2520in%2520the%2520treatment%2520of%2520Prakinso%25C5%2584s%2520disease%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2010%26volume%3D11%26spage%3D2261%26epage%3D2268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Seithel-Keuth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freisleben, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lissy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krösser, A.</span><span> </span><span class="NLM_article-title">Absolute bioavailability and effect of food on the disposition of safinamide immediate release tablets in healthy adult subjects</span> <span class="citation_source-journal">Clin. Pharmacol. Drug Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1002%2Fcpdd.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ynsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=79-89&author=A.+Seithel-Keuthauthor=A.+Johneauthor=A.+Freislebenauthor=K.+Kupasauthor=M.+Lissyauthor=A.+Kr%C3%B6sser&title=Absolute+bioavailability+and+effect+of+food+on+the+disposition+of+safinamide+immediate+release+tablets+in+healthy+adult+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17eR"><div class="casContent"><span class="casTitleNuber">17e</span><div class="casTitle"><span class="NLM_cas:atitle">Absolute bioavailability and effect of food on the disposition of safinamide immediate release tablets in healthy adult subjects</span></div><div class="casAuthors">Seithel-Keuth, Annick; Johne, Andreas; Freisleben, Achim; Kupas, Katrin; Lissy, Michael; Kroesser, Sonja</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-89</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The objectives of this study were to establish the basic i.v. (IV) single-dose PK of safinamide and its major human metabolites, the abs. bioavailability (BA) and food effect on safinamide tablets.  Fourteen healthy adult male and female subjects received 50 mg safinamide single-dose treatments according to a randomized, 3-period, 2-sequence crossover design: immediate release (IR) tablets, administered after an overnight fast and after a standardized high-fat, high-calorie breakfast, and IV soln., administered over 30 min.  Treatments were sepd. by wash-out intervals of at least 17 days.  Serial blood samples were collected for 240 h postdosing to evaluate safinamide parent drug and metabolite concns. for the detn. of PK parameters.  The abs. BA of safinamide 50 mg IR tablets was high, with geoMean AUC0-∞ ratios of about 95% (90% CI: 90-99%) indicating that safinamide is virtually completely absorbed after oral administration.  Safinamide IR tablets did not display a food effect on exposure parameters; both 90% CIs for the ratios fed/fasted of AUC0-∞ and Cmax were entirely within the bioequivalence acceptance margins of 80-125%.  Only tmax was delayed by about 30% in the fed state.  Oral and IV safinamide 50 mg single-dose administrations were generally well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq4aIoZJolc7Vg90H21EOLACvtfcHk0lg6egK7Xj55Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ynsbjL&md5=eacd460390260703463f1fdb78952973</span></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.2%26sid%3Dliteratum%253Aachs%26aulast%3DSeithel-Keuth%26aufirst%3DA.%26aulast%3DJohne%26aufirst%3DA.%26aulast%3DFreisleben%26aufirst%3DA.%26aulast%3DKupas%26aufirst%3DK.%26aulast%3DLissy%26aufirst%3DM.%26aulast%3DKr%25C3%25B6sser%26aufirst%3DA.%26atitle%3DAbsolute%2520bioavailability%2520and%2520effect%2520of%2520food%2520on%2520the%2520disposition%2520of%2520safinamide%2520immediate%2520release%2520tablets%2520in%2520healthy%2520adult%2520subjects%26jtitle%3DClin.%2520Pharmacol.%2520Drug%2520Dev.%26date%3D2013%26volume%3D2%26spage%3D79%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P. M.</span><span> </span><span class="NLM_article-title">Rasagiline [<i>N</i>-propargyl-1<i>R</i>(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1038%2Fsj.bjp.0703826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=11159700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=500-506&author=M.+B.+H.+Youdimauthor=A.+Grossauthor=J.+P.+M.+Finberg&title=Rasagiline+%5BN-propargyl-1R%28%2B%29-aminoindan%5D%2C+a+selective+and+potent+inhibitor+of+mitochondrial+monoamine+oxidase+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span></div><div class="casAuthors">Youdim, Moussa B. H.; Gross, Aviva; Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">500-506</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rasagiline [N-propargyl-1R(+)-aminoindan], was examd. for its monoamine oxidase (MAO) A and B inhibitor activities in rats together with its S(-)-enantiomer (TVP 1022) and the racemic compd. (AGN-1135) and compared to selegiline (1-deprenyl).  The tissues that were studied for MAO inhibition were the brain, liver and small intestine.  While rasagiline and AGN1135 are highly potent selective irreversible inhibitors of MAO in vitro and in vivo, the S(-) enantiomer is relatively inactive in the tissues examd.  The in vitro IC50 values for inhibition of rat brain MAO activity by rasagiline are 4.43±0.92 nM (type B), and 412±123 nM (type A).  The ED50 values for ex vivo inhibition of MAO in the brain and liver by a single dose of rasagiline are 0.1±0.01, 0.042±0.0045 mg kg-1 resp. for MAO-B, and 6.48±0.81, 2.38±0.35 mg kg-1 resp. for MAO-A.  Selective MAO-B inhibition in the liver and brain was maintained on chronic (21 days) oral dosage with ED50 values of 0.014±0.002 and 0.013±0.001 mg kg-1 resp.  The degree of selectivity of rasagiline for inhibition of MAO-B as opposed to MAO-A was similar to that of selegiline.  Rasagiline was three to 15 times more potent than selegiline for inhibition of MAO-B in rat brain and liver in vivo on acute and chronic administration, but had similar potency in vitro.  These data together with lack of tyramine sympathomimetic potentiation by rasagiline, at selective MAO-B inhibitory dosage, indicate that this inhibitor like selegiline may be a useful agent in the treatment of Parkinson's disease in either symptomatic or L-DOPA adjunct therapy, but lack of amphetamine-like metabolites could present a therapeutic advantage for rasagiline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq020sdG8LiPbVg90H21EOLACvtfcHk0lg6egK7Xj55Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D&md5=692cfb1e7f679e073f6cbdb2c8650ba9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703826%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%2BM.%26atitle%3DRasagiline%2520%255BN-propargyl-1R%2528%252B%2529-aminoindan%255D%252C%2520a%2520selective%2520and%2520potent%2520inhibitor%2520of%2520mitochondrial%2520monoamine%2520oxidase%2520B%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D132%26spage%3D500%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Clarke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartig, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corn, T. H.</span><span> </span><span class="NLM_article-title">A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1241</span><span class="NLM_x">–</span> <span class="NLM_lpage">1255</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2003&pages=1241-1255&author=A.+Clarkeauthor=F.+Brewerauthor=E.+S.+Johnsonauthor=N.+Mallardauthor=F.+Hartigauthor=S.+Taylorauthor=T.+H.+Corn&title=A+new+formulation+of+selegiline%3A+improved+bioavailability+and+selectivity+for+MAO-B+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DA.%26aulast%3DBrewer%26aufirst%3DF.%26aulast%3DJohnson%26aufirst%3DE.%2BS.%26aulast%3DMallard%26aufirst%3DN.%26aulast%3DHartig%26aufirst%3DF.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DCorn%26aufirst%3DT.%2BH.%26atitle%3DA%2520new%2520formulation%2520of%2520selegiline%253A%2520improved%2520bioavailability%2520and%2520selectivity%2520for%2520MAO-B%2520inhibition%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2003%26volume%3D110%26spage%3D1241%26epage%3D1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Clarke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corn, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boce, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrington, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacMahon, D. G.</span><span> </span><span class="NLM_article-title">A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">1257</span><span class="NLM_x">–</span> <span class="NLM_lpage">1271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2003&pages=1257-1271&author=A.+Clarkeauthor=E.+S.+Johnsonauthor=N.+Mallardauthor=T.+H.+Cornauthor=A.+Johnstonauthor=M.+Boceauthor=S.+Warringtonauthor=D.+G.+MacMahon&title=A+new+low-dose+formulation+of+selegiline%3A+clinical+efficacy%2C+patient+preference+and+selectivity+for+MAO-B+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DE.%2BS.%26aulast%3DMallard%26aufirst%3DN.%26aulast%3DCorn%26aufirst%3DT.%2BH.%26aulast%3DJohnston%26aufirst%3DA.%26aulast%3DBoce%26aufirst%3DM.%26aulast%3DWarrington%26aufirst%3DS.%26aulast%3DMacMahon%26aufirst%3DD.%2BG.%26atitle%3DA%2520new%2520low-dose%2520formulation%2520of%2520selegiline%253A%2520clinical%2520efficacy%252C%2520patient%2520preference%2520and%2520selectivity%2520for%2520MAO-B%2520inhibition%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2003%26volume%3D110%26spage%3D1257%26epage%3D1271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lees, A.</span><span> </span><span class="NLM_article-title">Alternatives to levodopa in the initial treatment of early Parkinson’s disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">740</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.2165%2F00002512-200522090-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=16156677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2005&pages=731-740&author=A.+Lees&title=Alternatives+to+levodopa+in+the+initial+treatment+of+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Alternatives to levodopa in the initial treatment of early parkinson's disease</span></div><div class="casAuthors">Lees, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">731-740</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is primarily a disease of elderly patients.  This article reviews current knowledge and recent developments relating to drugs that can be used as alternatives to levodopa as initial treatment of PD.  Synthetic orally acting dopamine agonists have found increasing favor as an option for early PD in relatively young patients.  This strategy is based on evidence that this approach may delay the onset of motor fluctuations, at least during the first 5 years of treatment.  S.c. apomorphine infusions may attenuate motor fluctuations in late-stage disease, and transdermal rotigotine, a dopamine agonist in development, has also been shown to be efficacious.  The greater proclivity for dopamine agonists to cause psychotoxicity has, however, limited their routine use in the elderly.  Selective monoamine oxidase type B (MAO-B) inhibitors, used as monotherapy, delay the need for the introduction of levodopa by about 9 mo.  These agents appear to be less efficacious than dopamine agonists but are better tolerated.  Concern has been expressed about the potential of the MAO-B inhibitor selegiline (deprenyl) to induce cardiovascular adverse effects (orthostatic hypotension), either directly or through its amphetamine catabolites.  Rasagiline is a new MAO-B inhibitor that is not broken down to amphetamine derivs. and is indicated as both monotherapy in early PD and as adjunctive therapy in PD patients with motor fluctuations.  Two older classes of agents have undergone a resurgence of interest in recent years.  Amantadine, which enhances dopaminergic transmission and has antiglutamate activity, is occasionally used as monotherapy but has recently been widely used as an antidyskinetic agent in late-stage PD.  Anticholinergic drugs, such as benztropine (benzatropine) and orphenadrine also provide control of symptoms when used as monotherapy, but their psychotoxic, cognitive and autonomic adverse events make them inappropriate for the treatment of the elderly.  Effective therapy in PD should prevent disease progression and abolish motor and cognitive handicap.  Currently, none of the existing drugs meets all these needs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZoKtxp2djj7Vg90H21EOLACvtfcHk0liCg4f7ko1PCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtbrN&md5=df3ab7c50632db266f027b420323c413</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2165%2F00002512-200522090-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-200522090-00002%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DA.%26atitle%3DAlternatives%2520to%2520levodopa%2520in%2520the%2520initial%2520treatment%2520of%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D2005%26volume%3D22%26spage%3D731%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Parkinson Study Group.</span><span> </span><span class="NLM_article-title">A controlled, randomized, delayed-start study of rasagiline in early Parkinson’s disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1001%2Farchneur.61.4.561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15096406" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2004&pages=561-566&author=Parkinson+Study+Group.&title=A+controlled%2C+randomized%2C+delayed-start+study+of+rasagiline+in+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1001%2Farchneur.61.4.561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.61.4.561%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DA%2520controlled%252C%2520randomized%252C%2520delayed-start%2520study%2520of%2520rasagiline%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2004%26volume%3D61%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hubálek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span> </span><span class="NLM_article-title">Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1760</span><span class="NLM_x">–</span> <span class="NLM_lpage">1766</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0310885" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1760-1766&author=F.+Hub%C3%A1lekauthor=C.+Bindaauthor=M.+Liauthor=Y.+Herzigauthor=J.+Sterlingauthor=M.+B.+H.+Youdimauthor=A.+Matteviauthor=D.+E.+Edmondson&title=Inactivation+of+purified+human+recombinant+monoamine+oxidases+A+and+B+by+rasagiline+and+its+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm0310885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0310885%26sid%3Dliteratum%253Aachs%26aulast%3DHub%25C3%25A1lek%26aufirst%3DF.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26atitle%3DInactivation%2520of%2520purified%2520human%2520recombinant%2520monoamine%2520oxidases%2520A%2520and%2520B%2520by%2520rasagiline%2520and%2520its%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1760%26epage%3D1766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Prins, L. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, S. F.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase by indole and benzofuran derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4458</span><span class="NLM_x">–</span> <span class="NLM_lpage">4466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4458-4466&author=L.+H.+A.+Prinsauthor=J.+P.+Petzerauthor=S.+F.+Malan&title=Inhibition+of+monoamine+oxidase+by+indole+and+benzofuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrins%26aufirst%3DL.%2BH.%2BA.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DMalan%26aufirst%3DS.%2BF.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520by%2520indole%2520and%2520benzofuran%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4458%26epage%3D4466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hampel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möller, H.-J.</span><span> </span><span class="NLM_article-title">A review of the reversible MAO-A inhibitor moclobemide in geriatric patients</span> <span class="citation_source-journal">Hum. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1002%2F%28SICI%291099-1077%28199801%2913%3A1%3C43%3A%3AAID-HUP953%3E3.0.CO%3B2-Z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=43-51&author=H.+Hampelauthor=C.+Bergerauthor=K.+Buchauthor=H.-J.+M%C3%B6ller&title=A+review+of+the+reversible+MAO-A+inhibitor+moclobemide+in+geriatric+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1077%28199801%2913%3A1%3C43%3A%3AAID-HUP953%3E3.0.CO%3B2-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1077%2528199801%252913%253A1%253C43%253A%253AAID-HUP953%253E3.0.CO%253B2-Z%26sid%3Dliteratum%253Aachs%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DC.%26aulast%3DBuch%26aufirst%3DK.%26aulast%3DM%25C3%25B6ller%26aufirst%3DH.-J.%26atitle%3DA%2520review%2520of%2520the%2520reversible%2520MAO-A%2520inhibitor%2520moclobemide%2520in%2520geriatric%2520patients%26jtitle%3DHum.%2520Psychopharmacol.%26date%3D1998%26volume%3D12%26spage%3D43%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Malek, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosset, D. G.</span><span> </span><span class="NLM_article-title">Investigational agents in the treatment of Parkinson’s disease: focus on safinamide</span> <span class="citation_source-journal">J. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKltbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=85-90&author=N.+M.+Malekauthor=D.+G.+Grosset&title=Investigational+agents+in+the+treatment+of+Parkinson%E2%80%99s+disease%3A+focus+on+safinamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Investigational agents in the treatment of Parkinson's disease: focus on safinamide</span></div><div class="casAuthors">Malek, Naveed M.; Grosset, Donald G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-90</span>CODEN:
                <span class="NLM_cas:coden">JEPOCA</span>;
        ISSN:<span class="NLM_cas:issn">1179-1454</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">The authors review management issues in Parkinson's disease (PD) and provide an overview of the current pharmacol. management strategies, with a specific focus on safinamide.  Current therapeutic management of PD largely involves strategies to optimize the replacement of deficient dopamine, using levodopa, dopamine agonists and inhibitors of dopamine-metabolizing enzymes.  Currently under investigation for use in the treatment of PD, safinamide has multiple modes of action including monoamine oxidase B inhibition.  It is well absorbed orally, has a long plasma half-life and does not have liver enzyme-inducing or liver enzyme-inhibiting activity.  Peak plasma concn. occurs 2-4 h after single oral doses.  Safinamide as monotherapy and as an adjunct to dopamine agonists improves Unified Parkinson's disease Rating Scale motor scores.  One randomized, placebo-controlled trial involving 168 patients given a median safinamide dose of 70 mg/day (range 40-90 mg/day) significantly increased the proportion of responders-defined as patients improving their Unified Parkinson's disease Rating Scale motor scores by 30% or more from baseline - after 3 mo (37.5% for safinamide vs. 21.4% for placebo; P < 0.05).  Safinamide increased "on" time with no or minor dyskinesia compared with the placebo in another trial, but dyskinesia severity was not reduced.  Safinamide was well tolerated, with an adverse effect profile similar to that of the placebo.  Further Phase III trial data for safinamide efficacy is awaited and will be of interest in a comparison with other developments in PD therapeutics: modified formulations of available compds., new drug classes such as adenosine receptor antagonists and gene-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRrqERbxUmTLVg90H21EOLACvtfcHk0ljWrnEvUIUsvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKltbzP&md5=cdab0d82b395e1e15fa011e21aed473f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalek%26aufirst%3DN.%2BM.%26aulast%3DGrosset%26aufirst%3DD.%2BG.%26atitle%3DInvestigational%2520agents%2520in%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520focus%2520on%2520safinamide%26jtitle%3DJ.%2520Exp.%2520Pharmacol.%26date%3D2012%26volume%3D4%26spage%3D85%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Schapira, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stocchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgohain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onofrj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Study 017 Investigators</span><span> </span><span class="NLM_article-title">Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson’s disease</span> <span class="citation_source-journal">Eur. J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1111%2Fj.1468-1331.2012.03840.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=22967035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BC38bmtV2qsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=271-280&author=A.+H.+Schapiraauthor=F.+Stocchiauthor=R.+Borgohainauthor=M.+Onofrjauthor=M.+Bhattauthor=P.+Lorenzanaauthor=V.+Luciniauthor=R.+Giulianiauthor=R.+Anandauthor=Study+017+Investigators&title=Long-term+efficacy+and+safety+of+safinamide+as+add-on+therapy+in+early+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease</span></div><div class="casAuthors">Schapira A H V; Stocchi F; Borgohain R; Onofrj M; Bhatt M; Lorenzana P; Lucini V; Giuliani R; Anand R</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology : the official journal of the European Federation of Neurological Societies</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Safinamide is an α-aminoamide with both dopaminergic and non-dopaminergic mechanisms of action in Phase III clinical development as a once-daily add-on to dopamine agonist (DA) therapy for early Parkinson's disease (PD).  METHODS:  Study 017 was a 12-month, randomized, double-blind, placebo-controlled pre-planned extension study to the previously reported Study 015.  Patients received safinamide 100 or 200 mg/day or placebo added to a single DA in early PD.  The primary efficacy endpoint was the time from baseline (Study 015 randomization) to 'intervention', defined as increase in DA dose; addition of another DA, levodopa or other PD treatment; or discontinuation due to lack of efficacy.  Safinamide groups were pooled for the primary efficacy endpoint analysis; post hoc analyses were performed on each separate dose group.  RESULTS:  Of the 269 patients randomized in Study 015, 227 (84%) enrolled in Study 017 and 187/227 (82%) patients completed the extension study.  Median time to intervention was 559 and 466 days in the pooled safinamide and placebo groups, respectively (log-rank test; P = 0.3342).  In post hoc analyses, patients receiving safinamide 100 mg/day experienced a significantly lower rate of intervention compared with placebo (25% vs. 51%, respectively) and a delay in median time to intervention of 9 days (P < 0.05; 240- to 540-day analysis).  CONCLUSIONS:  The pooled data from the safinamide groups failed to reach statistical significance for the primary endpoint of median time from baseline to additional drug intervention.  Post hoc analyses indicate that safinamide 100 mg/day may be effective as add-on treatment to DA in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTW8Q7CptAmznthwrmtH4OBfW6udTcc2ebB-a_sPgl6Irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bmtV2qsw%253D%253D&md5=ae238c6d3d0f0952fc6993bd03615335</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-1331.2012.03840.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-1331.2012.03840.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26aulast%3DStocchi%26aufirst%3DF.%26aulast%3DBorgohain%26aufirst%3DR.%26aulast%3DOnofrj%26aufirst%3DM.%26aulast%3DBhatt%26aufirst%3DM.%26aulast%3DLorenzana%26aufirst%3DP.%26aulast%3DLucini%26aufirst%3DV.%26aulast%3DGiuliani%26aufirst%3DR.%26aulast%3DAnand%26aufirst%3DR.%26aulast%3D%26atitle%3DLong-term%2520efficacy%2520and%2520safety%2520of%2520safinamide%2520as%2520add-on%2520therapy%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2013%26volume%3D20%26spage%3D271%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maestroni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faravelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curatolo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fariello, R. G.</span><span> </span><span class="NLM_article-title">Safinamide: from molecular targets to a new anti-parkinson drug</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">7_suppl_2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S18</span><span class="NLM_x">–</span> <span class="NLM_lpage">S23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=S18-S23&issue=7_suppl_2&author=C.+Cacciaauthor=R.+Majauthor=M.+Calabresiauthor=S.+Maestroniauthor=L.+Faravelliauthor=L.+Curatoloauthor=P.+Salvatiauthor=R.+G.+Fariello&title=Safinamide%3A+from+molecular+targets+to+a+new+anti-parkinson+drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DMaj%26aufirst%3DR.%26aulast%3DCalabresi%26aufirst%3DM.%26aulast%3DMaestroni%26aufirst%3DS.%26aulast%3DFaravelli%26aufirst%3DL.%26aulast%3DCuratolo%26aufirst%3DL.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DFariello%26aufirst%3DR.%2BG.%26atitle%3DSafinamide%253A%2520from%2520molecular%2520targets%2520to%2520a%2520new%2520anti-parkinson%2520drug%26jtitle%3DNeurology%26date%3D2006%26volume%3D67%26issue%3D7_suppl_2%26spage%3DS18%26epage%3DS23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Monoamine oxidase B inhibitors for the treatment of Parkinson’s disease: a review of symptomatic and potential disease-modifying effects</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1061-1071&author=A.+H.+V.+Schapira&title=Monoamine+oxidase+B+inhibitors+for+the+treatment+of+Parkinson%E2%80%99s+disease%3A+a+review+of+symptomatic+and+potential+disease-modifying+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DMonoamine%2520oxidase%2520B%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520review%2520of%2520symptomatic%2520and%2520potential%2520disease-modifying%2520effects%26jtitle%3DCNS%2520Drugs%26date%3D2011%26volume%3D25%26spage%3D1061%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capaldi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Solid-phase synthesis and insights into structure–activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4909</span><span class="NLM_x">–</span> <span class="NLM_lpage">4916</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070725e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4909-4916&author=F.+Leonettiauthor=C.+Capaldiauthor=L.+Pisaniauthor=O.+Nicolottiauthor=G.+Muncipintoauthor=A.+Stefanachiauthor=S.+Cellamareauthor=C.+Cacciaauthor=A.+Carotti&title=Solid-phase+synthesis+and+insights+into+structure%E2%80%93activity+relationships+of+safinamide+analogues+as+potent+and+selective+inhibitors+of+type+B+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm070725e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070725e%26sid%3Dliteratum%253Aachs%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCapaldi%26aufirst%3DC.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DSolid-phase%2520synthesis%2520and%2520insights%2520into%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520safinamide%2520analogues%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520type%2520B%2520monoamine%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4909%26epage%3D4916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Mertens, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">Alkynyl-coumarinyl ethers as MAO-B inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1928</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1916-1928&author=M.+D.+Mertensauthor=S.+Hinzauthor=C.+E.+M%C3%BCllerauthor=M.+G%C3%BCtschow&title=Alkynyl-coumarinyl+ethers+as+MAO-B+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMertens%26aufirst%3DM.%2BD.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DAlkynyl-coumarinyl%2520ethers%2520as%2520MAO-B%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1916%26epage%3D1928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Pérez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernándes-Álvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Relevance of benzyloxy group in 2-indoyl methylamines in the selective MAO-B inhibition</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1038%2Fsj.bjp.0702600" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=10433493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK1MXktlOmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1999&pages=869-876&author=V.+P%C3%A9rezauthor=J.+L.+Marcoauthor=E.+Fern%C3%A1ndes-%C3%81lvarezauthor=M.+Unzeta&title=Relevance+of+benzyloxy+group+in+2-indoyl+methylamines+in+the+selective+MAO-B+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition</span></div><div class="casAuthors">Perez, Virgili; Marco, Jose Luis; Fernandez-Alvarez, Eldiberto; Unzeta, Mercedes</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">869-876</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Previous studies with indolyl derivs. as monoamine oxidase (MAO) inhibitors have shown the relevance of the indole structure for recognition by the active site of this enzyme.  We now report a new series of mols. with structural features which det. the selectivity of MAO inhibition.  A benzyloxy group attached at position 5 of the indole ring is crit. for this selective behavior.  Amongst all of these benzyloxy-indolyl methylamines, N-(2-propynyl)-2-(5-benzyloxyindol)methylamine FA-73 was the most potent MAO-B "suicide" inhibitor studied.  The Ki values for MAO-A and MAO-B were 800±60 and 0.75±0.15 nM, resp.  These data represent a selectivity value of 1066 for MAO-B, being 48 times more selective than L-deprenyl (Ki values of 376±0.032 and 16.8±0.1 nM for MAO A and MAO-B, resp.).  The IC50 values for dopamine uptake in striatal synaptosomal fractions from rats were 150±8 μM for FA-73 and 68±10 μM for L-deprenyl whereas in human caudate tissue the IC50 values were 0.36±0.015 μM for FA-73 and 0.10±0.007 μM for L-deprenyl.  Moreover, mouse brain MAO-B activity was 90% ex vivo inhibited by both compds. 1 h after 4 mg kg-1 administration, MAO-A activity was not affected.  These novel mols. should provide a better understanding of the active site of monoamine oxidase and could be the starting point for the design of further selective, non-amphetamine-like MAO-B inhibitors with therapeutic potential for the treatment of neurol. disorders, such as parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoynmDOjiKQgbVg90H21EOLACvtfcHk0ljL373b504CSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktlOmsrw%253D&md5=756c3b6564fe28ee128fdcf06b730f6c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702600%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez%26aufirst%3DV.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3DFern%25C3%25A1ndes-%25C3%2581lvarez%26aufirst%3DE.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DRelevance%2520of%2520benzyloxy%2520group%2520in%25202-indoyl%2520methylamines%2520in%2520the%2520selective%2520MAO-B%2520inhibition%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D127%26spage%3D869%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Herraiz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arán, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillén, H.</span><span> </span><span class="NLM_article-title">Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO)</span> <span class="citation_source-journal">Free Radical Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1080%2F10715760903159170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=19669997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2009&pages=975-984&author=T.+Herraizauthor=V.+J.+Ar%C3%A1nauthor=H.+Guill%C3%A9n&title=Nitroindazole+compounds+inhibit+the+oxidative+activation+of+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine+%28MPTP%29+neurotoxin+to+neurotoxic+pyridinium+cations+by+human+monoamine+oxidase+%28MAO%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO)</span></div><div class="casAuthors">Herraiz, Tomas; Aran, Vicente J.; Guillen, Hugo</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">975-984</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Monoamine oxidase (MAO) B is a mitochondrial enzyme selectively involved in the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to toxic pyridinium cations producing Parkinsonism in animal models.  Various synthesized 5-nitroindazoles, 6-nitroindazole and the neuroprotectant 7-nitroindazole were examd. as inhibitors of MAO and as antioxidants and radical scavengers.  The oxidn. of MPTP by human MAO-B and mitochondria was assessed by HPLC.  Simple nitroindazoles inhibited MPTP oxidn. to 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) and 1-methyl-4-phenylpyridinium (MPP+) in a competitive and reversible manner.  5-Nitroindazole (IC50 = 0.99 μM, Ki = 0.102 μM) and 6-nitroindazole (IC50 = 2.5 μM) were better inhibitors of human MAO-B than 7-nitroindazole (IC50 = 27.8 μM).  6-Nitroindazole also inhibited MAO-A.  Nitroindazole isomers were good hydroxyl radical (OH·) scavengers, with 5-nitro-, 6-nitro- and 7-nitroindazole showing similar activity (k ∼ 1010 M-1 s-1).  Neuroprotective actions of nitroindazoles (7-nitroindazole) could be linked to their MAO-inhibitory and antiradical properties besides inhibition on nitric oxide synthase (NOS).  5-Nitro- and 6-nitroindazole, previously reported as weak NOS inhibitors, were better inhibitors of human MAO-B and more active against MPTP neurotoxin oxidn. (lower MPDP+ and MPP+ levels) than 7-nitroindazole and acted as good radical scavengers and could be potential neuroprotective agents in addn. to MAO-B inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6dQrH_I7F_rVg90H21EOLACvtfcHk0lgWqzgXOc_-Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhurnI&md5=89706a0fb15d525003b9814318ec9f38</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F10715760903159170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760903159170%26sid%3Dliteratum%253Aachs%26aulast%3DHerraiz%26aufirst%3DT.%26aulast%3DAr%25C3%25A1n%26aufirst%3DV.%2BJ.%26aulast%3DGuill%25C3%25A9n%26aufirst%3DH.%26atitle%3DNitroindazole%2520compounds%2520inhibit%2520the%2520oxidative%2520activation%2520of%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine%2520%2528MPTP%2529%2520neurotoxin%2520to%2520neurotoxic%2520pyridinium%2520cations%2520by%2520human%2520monoamine%2520oxidase%2520%2528MAO%2529%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2009%26volume%3D43%26spage%3D975%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miscioscia, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passeleu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2<i>H</i>-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6685</span><span class="NLM_x">–</span> <span class="NLM_lpage">6706</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9010127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6685-6706&author=L.+Pisaniauthor=G.+Muncipintoauthor=T.+F.+Misciosciaauthor=O.+Nicolottiauthor=F.+Leonettiauthor=M.+Cattoauthor=C.+Cacciaauthor=P.+Salvatiauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=C.+Passeleuauthor=A.+Carotti&title=Discovery+of+a+novel+class+of+potent+coumarin+monoamine+oxidase+B+inhibitors%3A+development+and+biopharmacological+profiling+of+7-%5B%283-chlorobenzyl%29oxy%5D-4-%5B%28methylamino%29methyl%5D-2H-chromen-2-one+methanesulfonate+%28NW-1772%29+as+a+highly+potent%2C+selective%2C+reversible%2C+and+orally+active+monoamine+oxidase+B+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm9010127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9010127%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DMiscioscia%26aufirst%3DT.%2BF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DPasseleu%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520potent%2520coumarin%2520monoamine%2520oxidase%2520B%2520inhibitors%253A%2520development%2520and%2520biopharmacological%2520profiling%2520of%25207-%255B%25283-chlorobenzyl%2529oxy%255D-4-%255B%2528methylamino%2529methyl%255D-2H-chromen-2-one%2520methanesulfonate%2520%2528NW-1772%2529%2520as%2520a%2520highly%2520potent%252C%2520selective%252C%2520reversible%252C%2520and%2520orally%2520active%2520monoamine%2520oxidase%2520B%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6685%26epage%3D6706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Van der Walt, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milczek, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase by (<i>E</i>)-styrylisatin analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2509</span><span class="NLM_x">–</span> <span class="NLM_lpage">2513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2509-2513&author=E.+M.+Van+der+Waltauthor=E.+M.+Milczekauthor=S.+F.+Malanauthor=D.+E.+Edmondsonauthor=N.+Castagnoliauthor=J.+J.+Berghauthor=J.+P.+Petzer&title=Inhibition+of+monoamine+oxidase+by+%28E%29-styrylisatin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BWalt%26aufirst%3DE.%2BM.%26aulast%3DMilczek%26aufirst%3DE.%2BM.%26aulast%3DMalan%26aufirst%3DS.%2BF.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DBergh%26aufirst%3DJ.%2BJ.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520by%2520%2528E%2529-styrylisatin%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2509%26epage%3D2513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manley-King, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=261-274&author=C.+I.+Manley-Kingauthor=J.+J.+Berghauthor=J.+P.+Petzer&title=Inhibition+of+monoamine+oxidase+by+selected+C5-+and+C6-substituted+isatin+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley-King%26aufirst%3DC.%2BI.%26aulast%3DBergh%26aufirst%3DJ.%2BJ.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520by%2520selected%2520C5-%2520and%2520C6-substituted%2520isatin%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D261%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Prat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesionde rats</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2000&pages=409-417&author=G.+Pratauthor=V.+P%C3%A9rezauthor=A.+Rubiauthor=M.+Casasauthor=M.+Unzeta&title=The+novel+type+B+MAO+inhibitor+PF9601N+enhances+the+duration+of+L-DOPA-induced+contralateral+turning+in+6-hydroxydopamine+lesionde+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrat%26aufirst%3DG.%26aulast%3DP%25C3%25A9rez%26aufirst%3DV.%26aulast%3DRubi%26aufirst%3DA.%26aulast%3DCasas%26aufirst%3DM.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DThe%2520novel%2520type%2520B%2520MAO%2520inhibitor%2520PF9601N%2520enhances%2520the%2520duration%2520of%2520L-DOPA-induced%2520contralateral%2520turning%2520in%25206-hydroxydopamine%2520lesionde%2520rats%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2000%26volume%3D107%26spage%3D409%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bellik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessina, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valoti, M.</span><span> </span><span class="NLM_article-title">Antioxidant properties of PF9601N, a novel MAO-B inhibitor: assessment of its ability to interact with reactive nitrogen species</span> <span class="citation_source-journal">Acta Biochim. Polym.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=20532254" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2010&pages=235-239&author=L.+Bellikauthor=S.+Dragoniauthor=F.+Pessinaauthor=E.+Sanzauthor=M.+Unzetaauthor=M.+Valoti&title=Antioxidant+properties+of+PF9601N%2C+a+novel+MAO-B+inhibitor%3A+assessment+of+its+ability+to+interact+with+reactive+nitrogen+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellik%26aufirst%3DL.%26aulast%3DDragoni%26aufirst%3DS.%26aulast%3DPessina%26aufirst%3DF.%26aulast%3DSanz%26aufirst%3DE.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DValoti%26aufirst%3DM.%26atitle%3DAntioxidant%2520properties%2520of%2520PF9601N%252C%2520a%2520novel%2520MAO-B%2520inhibitor%253A%2520assessment%2520of%2520its%2520ability%2520to%2520interact%2520with%2520reactive%2520nitrogen%2520species%26jtitle%3DActa%2520Biochim.%2520Polym.%26date%3D2010%26volume%3D57%26spage%3D235%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Unzeta, M.; Sanz, E.</span>; <span> </span><span class="NLM_article-title">Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson’s disease</span>. In  <span class="citation_source-book">International Review of Neurobiology</span>, <span class="NLM_edition">1st</span> ed.; <span class="NLM_contrib-group">Youdim, M. B. H.; Riederer, P.</span>, Eds.; <span class="NLM_series">Monoamine Oxidases and Their Inhibitors</span>; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">100</span>, pp  <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=218-229&author=M.+Unzeta&author=E.+Sanzauthor=M.+B.+H.+Youdim&author=P.+Riederer&title=International+Review+of+Neurobiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DNovel%2520MAO-B%2520inhibitors%253A%2520potential%2520therapeutic%2520use%2520of%2520the%2520selective%2520MAO-B%2520inhibitor%2520PF9601N%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26btitle%3DInternational%2520Review%2520of%2520Neurobiology%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26pub%3DElsevier%26date%3D2011%26volume%3D100%26spage%3D218%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Müller, C. E.; Hockemeyer, J.; Tzvetkov, N. T.; Burbiel, J.</span><span> </span><span class="NLM_article-title">8-Ethynyl-xanthine derivatives as selective A<sub>2A</sub> receptor antagonists</span>. PCT Int. Appl. WO 2008077557,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=C.+E.+M%C3%BCller&author=J.+Hockemeyer&author=N.+T.+Tzvetkov&author=J.+Burbiel&title=8-Ethynyl-xanthine+derivatives+as+selective+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3D8-Ethynyl-xanthine%2520derivatives%2520as%2520selective%2520A2A%2520receptor%2520antagonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldeco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span> </span><span class="NLM_article-title">Molecular insights into human monoamine oxidase B inhibition by the glitazone anti-diabetes drugs</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=39-42&author=C.+Bindaauthor=M.+Aldecoauthor=W.+J.+Geldenhuysauthor=M.+Tortoriciauthor=A.+Matteviauthor=D.+E.+Edmondson&title=Molecular+insights+into+human+monoamine+oxidase+B+inhibition+by+the+glitazone+anti-diabetes+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DAldeco%26aufirst%3DM.%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DTortorici%26aufirst%3DM.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26atitle%3DMolecular%2520insights%2520into%2520human%2520monoamine%2520oxidase%2520B%2520inhibition%2520by%2520the%2520glitazone%2520anti-diabetes%2520drugs%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D3%26spage%3D39%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Raffa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daidone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schillaci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plescia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torta, L.</span><span> </span><span class="NLM_article-title">Synthesis and antifungal activity of new <i>N</i>-isoxazolyl-2-iodomenzamides</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2FS0014-827X%2898%2900108-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=10321034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK1MXivFKhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=90-94&author=D.+Raffaauthor=G.+Daidoneauthor=B.+Maggioauthor=D.+Schillaciauthor=S.+Plesciaauthor=L.+Torta&title=Synthesis+and+antifungal+activity+of+new+N-isoxazolyl-2-iodomenzamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antifungal activity of new N-isoxazolyl-2-iodobenzamides</span></div><div class="casAuthors">Raffa, Demetrio; Daidone, Giuseppe; Maggio, Benedetta; Schillaci, Domenico; Plescia, Fabiana; Torta, Livio</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">90-94</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">N-Isoxazolyl-2-iodobenzamides with a benodanil-like structure were synthesized by refluxing in acetic acid the corresponding benzotriazinones with potassium iodide for 1 h with the aim to ascertain if they were active as fungicides against Phytophthora citricola Saw., Botrytis cinerea Pers., Rhizoctonia sp. and Alternaria sp.  Among the tested iodo derivs., I and II possess interesting activities against the aforesaid fungal strains, in several cases similar to that of benodanil taken as ref. drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY6VJpxp0etbVg90H21EOLACvtfcHk0lj-HVlbZbm3pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFKhtrs%253D&md5=bfc060401133404bbdefe4809c9226e4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2898%2900108-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252898%252900108-6%26sid%3Dliteratum%253Aachs%26aulast%3DRaffa%26aufirst%3DD.%26aulast%3DDaidone%26aufirst%3DG.%26aulast%3DMaggio%26aufirst%3DB.%26aulast%3DSchillaci%26aufirst%3DD.%26aulast%3DPlescia%26aufirst%3DS.%26aulast%3DTorta%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520antifungal%2520activity%2520of%2520new%2520N-isoxazolyl-2-iodomenzamides%26jtitle%3DFarmaco%26date%3D1999%26volume%3D54%26spage%3D90%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Tzvetkov, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Euler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span> </span><span class="NLM_article-title">Regioselective synthesis of 7,8-dihydroimidazo[5,1-<i>c</i>][1,2,4]triazine-3,6-(2<i>H</i>,4<i>H</i>)-dione derivatives: a new drug-like heterocyclic scaffold</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1593</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.3762%2Fbjoc.8.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=23209490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVCmt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=1584-1593&author=N.+T.+Tzvetkovauthor=H.+Eulerauthor=C.+E.+M%C3%BCller&title=Regioselective+synthesis+of+7%2C8-dihydroimidazo%5B5%2C1-c%5D%5B1%2C2%2C4%5Dtriazine-3%2C6-%282H%2C4H%29-dione+derivatives%3A+a+new+drug-like+heterocyclic+scaffold"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective synthesis of 7,8-dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione derivatives: a new drug-like heterocyclic scaffold</span></div><div class="casAuthors">Tzvetkov, Nikolay T.; Euler, Harald; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1584-1593, No. 181</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">Dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione derivs. were prepd. by successive N3- and N1-alkylation of hydantoins, followed by regioselective thionation and subsequent cyclization under mild conditions.  In a final alkylation step a further substituent may be introduced.  The synthetic strategy allows broad structural variation of this new drug-like heterobicyclic scaffold.  In addn. to extensive NMR and MS analyses, the structure of one deriv. was confirmed by X-ray crystallog. (for compd. I).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtG42ok5JA67Vg90H21EOLACvtfcHk0lj-HVlbZbm3pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVCmt7nI&md5=618d3632663893d76c256655646cfb9a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.8.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.8.181%26sid%3Dliteratum%253Aachs%26aulast%3DTzvetkov%26aufirst%3DN.%2BT.%26aulast%3DEuler%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DRegioselective%2520synthesis%2520of%25207%252C8-dihydroimidazo%255B5%252C1-c%255D%255B1%252C2%252C4%255Dtriazine-3%252C6-%25282H%252C4H%2529-dione%2520derivatives%253A%2520a%2520new%2520drug-like%2520heterocyclic%2520scaffold%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2012%26volume%3D8%26spage%3D1584%26epage%3D1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonsignori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidempergher, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinciroli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">AcArthur, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fariello, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span> </span><span class="NLM_article-title">Synthesis and anticonvulsant activity of a new class of 2-[(arylalkyl)amino]alkanamide derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970599m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK1cXms1Oitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=579-590&author=P.+Pevarelloauthor=A.+Bonsignoriauthor=P.+Dostertauthor=F.+Heidempergherauthor=V.+Pinciroliauthor=M.+Colomboauthor=R.+A.+AcArthurauthor=P.+Salvatiauthor=C.+Postauthor=R.+G.+Farielloauthor=M.+Varasi&title=Synthesis+and+anticonvulsant+activity+of+a+new+class+of+2-%5B%28arylalkyl%29amino%5Dalkanamide+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Anticonvulsant Activity of a New Class of 2-[(Arylalkyl)amino]alkanamide Derivatives</span></div><div class="casAuthors">Pevarello, Paolo; Bonsignori, Alberto; Dostert, Philippe; Heidempergher, Franco; Pinciroli, Vittorio; Colombo, Maristella; McArthur, Robert A.; Salvati, Patricia; Post, Claes; Fariello, Ruggero G.; Varasi, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">579-590</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from milacemide, a weak anticonvulsant, trying to elucidate its mechanism of action a structurally novel class of potent and preclinically safe anticonvulsants was discovered.  The structure-activity relationship study within this series of compds was reported.  Different parts of the structural lead 2-[[4-(3-chlorobenzoxy)benzyl]amino]acetamide were varied, and many potent anticonvulsants were found.  (S)-2-[[4-(3-fluorobenzoxy)benzyl]amino]propanamide methanesulfonate, (PNU-151774E), emerged as the promising candidate for further development for its potent anticonvulsant activity and outstanding therapeutic indexes in different animal tests.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy8FzAw312mrVg90H21EOLACvtfcHk0lgsVARpf-YJzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1Oitw%253D%253D&md5=2297e82ce9a4feb069a761bd0a1d87f5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm970599m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970599m%26sid%3Dliteratum%253Aachs%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBonsignori%26aufirst%3DA.%26aulast%3DDostert%26aufirst%3DP.%26aulast%3DHeidempergher%26aufirst%3DF.%26aulast%3DPinciroli%26aufirst%3DV.%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DAcArthur%26aufirst%3DR.%2BA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DPost%26aufirst%3DC.%26aulast%3DFariello%26aufirst%3DR.%2BG.%26aulast%3DVarasi%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520anticonvulsant%2520activity%2520of%2520a%2520new%2520class%2520of%25202-%255B%2528arylalkyl%2529amino%255Dalkanamide%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D579%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Raffa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascioferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondi, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daidone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plescia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schillaci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusimano, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colomba, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolomeo, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studies</span> <span class="citation_source-journal">Arch. Pharm. Chem. Lett. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1002%2Fardp.200800159" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2009&pages=265-273&author=D.+Raffaauthor=B.+Maggioauthor=S.+Cascioferroauthor=M.+V.+Raimondiauthor=G.+Daidoneauthor=S.+Plesciaauthor=D.+Schillaciauthor=M.+G.+Cusimanoauthor=L.+Titoneauthor=C.+Colombaauthor=M.+Tolomeo&title=N-%28Indazolyl%29benzamido+derivatives+as+CDK1+inhibitors%3A+design%2C+synthesis%2C+biological+activity%2C+and+molecular+docking+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fardp.200800159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.200800159%26sid%3Dliteratum%253Aachs%26aulast%3DRaffa%26aufirst%3DD.%26aulast%3DMaggio%26aufirst%3DB.%26aulast%3DCascioferro%26aufirst%3DS.%26aulast%3DRaimondi%26aufirst%3DM.%2BV.%26aulast%3DDaidone%26aufirst%3DG.%26aulast%3DPlescia%26aufirst%3DS.%26aulast%3DSchillaci%26aufirst%3DD.%26aulast%3DCusimano%26aufirst%3DM.%2BG.%26aulast%3DTitone%26aufirst%3DL.%26aulast%3DColomba%26aufirst%3DC.%26aulast%3DTolomeo%26aufirst%3DM.%26atitle%3DN-%2528Indazolyl%2529benzamido%2520derivatives%2520as%2520CDK1%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520biological%2520activity%252C%2520and%2520molecular%2520docking%2520studies%26jtitle%3DArch.%2520Pharm.%2520Chem.%2520Lett.%2520Sci.%26date%3D2009%26volume%3D342%26spage%3D265%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barbanti, E.; Caccia, C.; Salvati, P.; Velardi, F.; Ruffilli, T.; Bogogna, L.</span><span> </span><span class="NLM_article-title">Process for the production of 2-[4-(3- and 2-fluorobenzyloxy)benzylamino]propanamides</span>. U.S. Patent 8076515,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=E.+Barbanti&author=C.+Caccia&author=P.+Salvati&author=F.+Velardi&author=T.+Ruffilli&author=L.+Bogogna&title=Process+for+the+production+of+2-%5B4-%283-+and+2-fluorobenzyloxy%29benzylamino%5Dpropanamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbanti%26aufirst%3DE.%26atitle%3DProcess%2520for%2520the%2520production%2520of%25202-%255B4-%25283-%2520and%25202-fluorobenzyloxy%2529benzylamino%255Dpropanamides%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span> </span><span class="NLM_article-title">A validated chiral liquid chromatographic method for the enantiomeric separation of safinamide mesylate, a new anti-Parkinson drug</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2Fj.jpba.2010.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=21277726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFyqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=220-234&author=K.+Zhangauthor=N.+Xueauthor=X.+Shiauthor=W.+Liuauthor=J.+Mengauthor=Y.+Du&title=A+validated+chiral+liquid+chromatographic+method+for+the+enantiomeric+separation+of+safinamide+mesylate%2C+a+new+anti-Parkinson+drug"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">A validated chiral liquid chromatographic method for the enantiomeric separation of safinamide mesilate, a new anti-Parkinson drug</span></div><div class="casAuthors">Zhang, Kai; Xue, Na; Shi, Xiaowei; Liu, Weina; Meng, Jing; Du, Yumin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">220-224</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A enantioselective reversed-phase high performance liq. chromatog. method was developed for the enantiomeric resoln. of safinamide mesylate, 2(S)-[4-(3-fluorobenzyloxy)benzylamino] propionamide methanesulfonate, a neuroprotectant with antiparkinsonian and anticonvulsant activity for the treatment of Parkinson disease.  The enantiomers of safinamide mesylate were baseline resolved on a Chiralcel OD-RH (150 mm × 4.6 mm, 5 μm) column using a mobile phase system contg. 300 mM sodium di-hydrogen phosphate buffer (pH 3.0):MeOH:acetonitrile (65:25:10, vol./vol./v).  The resoln. between the enantiomers was not < 3.0.  The pH value of buffer soln. in the mobile phase has played a key role in enhancing chromatog. efficiency and resoln. between the enantiomers.  The developed method was validated and proved to be robust.  The limit of detection and limit of quantification of (R)-enantiomer were found to be 15 and 50 ng/mL, resp., for 20 μL injection vol.  The percentage recovery of (R)-enantiomer was ranged from 94.2 to 103.7 in bulk drug samples of safinamide mesylate.  The sample soln. and mobile phase were found to be stable at least for 48 h.  The final optimized method was successfully applied to sep. (R)-enantiomer from safinamide mesylate and was proven to be reproducible and accurate for the quant. detn. of (R)-enantiomer in bulk drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyI6UJzgmavbVg90H21EOLACvtfcHk0lgsVARpf-YJzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFyqt7Y%253D&md5=07567e019448b5fea124dce25543b17a</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2010.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2010.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DXue%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DY.%26atitle%3DA%2520validated%2520chiral%2520liquid%2520chromatographic%2520method%2520for%2520the%2520enantiomeric%2520separation%2520of%2520safinamide%2520mesylate%252C%2520a%2520new%2520anti-Parkinson%2520drug%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2011%26volume%3D55%26spage%3D220%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hockemeyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbiel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C. E.</span><span> </span><span class="NLM_article-title">Multigram-scale syntheses, stability, and photoreactions of A<sub>2A</sub> adenosine receptor antagonists with 8-styrylxanthine structure: Potential drugs for Parkinson’s disease</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3308</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0358574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=3308-3318&author=J.+Hockemeyerauthor=J.+C.+Burbielauthor=C.+E.+M%C3%BCller&title=Multigram-scale+syntheses%2C+stability%2C+and+photoreactions+of+A2A+adenosine+receptor+antagonists+with+8-styrylxanthine+structure%3A+Potential+drugs+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1021%2Fjo0358574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0358574%26sid%3Dliteratum%253Aachs%26aulast%3DHockemeyer%26aufirst%3DJ.%26aulast%3DBurbiel%26aufirst%3DJ.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMultigram-scale%2520syntheses%252C%2520stability%252C%2520and%2520photoreactions%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%2520with%25208-styrylxanthine%2520structure%253A%2520Potential%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D3308%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Müller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geis, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hipp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schobert, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frobenius, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandoval-Ramirez, J.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A<sub>2A</sub>-selective adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4396</span><span class="NLM_x">–</span> <span class="NLM_lpage">4405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970515%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4396-4405&author=C.+E.+M%C3%BCllerauthor=U.+Geisauthor=J.+Hippauthor=U.+Schobertauthor=W.+Frobeniusauthor=M.+Pawlowskiauthor=F.+Suzukiauthor=J.+Sandoval-Ramirez&title=Synthesis+and+structure%E2%80%93activity+relationships+of+3%2C7-dimethyl-1-propargylxanthine+derivatives%2C+A2A-selective+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1021%2Fjm970515%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970515%252B%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DGeis%26aufirst%3DU.%26aulast%3DHipp%26aufirst%3DJ.%26aulast%3DSchobert%26aufirst%3DU.%26aulast%3DFrobenius%26aufirst%3DW.%26aulast%3DPawlowski%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DF.%26aulast%3DSandoval-Ramirez%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%25203%252C7-dimethyl-1-propargylxanthine%2520derivatives%252C%2520A2A-selective%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4396%26epage%3D4405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Yáñez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraiz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orallo, F.</span><span> </span><span class="NLM_article-title">Inhibitory effects of <i>cis</i>- and <i>trans</i>-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2006&pages=688-695&author=M.+Y%C3%A1%C3%B1ezauthor=N.+Fraizauthor=E.+Canoauthor=F.+Orallo&title=Inhibitory+effects+of+cis-+and+trans-resveratrol+on+noradrenaline+and+5-hydroxytryptamine+uptake+and+on+monoamine+oxidase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DY%25C3%25A1%25C3%25B1ez%26aufirst%3DM.%26aulast%3DFraiz%26aufirst%3DN.%26aulast%3DCano%26aufirst%3DE.%26aulast%3DOrallo%26aufirst%3DF.%26atitle%3DInhibitory%2520effects%2520of%2520cis-%2520and%2520trans-resveratrol%2520on%2520noradrenaline%2520and%25205-hydroxytryptamine%2520uptake%2520and%2520on%2520monoamine%2520oxidase%2520activity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D344%26spage%3D688%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Holt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palcie, M. M.</span><span> </span><span class="NLM_article-title">A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1997&pages=384-392&author=A.+Holtauthor=D.+F.+Sharmanauthor=G.+B.+Bakerauthor=M.+M.+Palcie&title=A+continuous+spectrophotometric+assay+for+monoamine+oxidase+and+related+enzymes+in+tissue+homogenates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DA.%26aulast%3DSharman%26aufirst%3DD.%2BF.%26aulast%3DBaker%26aufirst%3DG.%2BB.%26aulast%3DPalcie%26aufirst%3DM.%2BM.%26atitle%3DA%2520continuous%2520spectrophotometric%2520assay%2520for%2520monoamine%2520oxidase%2520and%2520related%2520enzymes%2520in%2520tissue%2520homogenates%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D244%26spage%3D384%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structures of monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5848</span><span class="NLM_x">–</span> <span class="NLM_lpage">5852</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+of+monoamine+oxidase+B+complexes+with+selective+noncovalent+inhibitors%3A+safinamide+and+coumarin+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520of%2520monoamine%2520oxidase%2520B%2520complexes%2520with%2520selective%2520noncovalent%2520inhibitors%253A%2520safinamide%2520and%2520coumarin%2520analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5848%26epage%3D5852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubálek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Crystal structures of monoamine oxidase B in complex with four inhibitors of the <i>N</i>-propargylaminoindan class</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1774</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031087c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1767-1774&author=C.+Bindaauthor=F.+Hub%C3%A1lekauthor=L.+Minauthor=Y.+Herzigauthor=J.+Sterlingauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Crystal+structures+of+monoamine+oxidase+B+in+complex+with+four+inhibitors+of+the+N-propargylaminoindan+class"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N-Propargylaminoindan Class</span></div><div class="casAuthors">Binda, Claudia; Hubalek, Frantisek; Li, Min; Herzig, Yaacov; Sterling, Jeffrey; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1767-1774</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is an outer mitochondrial membrane enzyme that catalyzes the oxidn. of arylalkylamine neurotransmitters.  The crystal structures of MAO B in complex with four of the N-propargylaminoindan class of MAO covalent inhibitors (rasagiline, N-propargyl-1(S)-aminoindan, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan) have been detd. at a resoln. of better than 2.1 Å.  Rasagiline, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan adopt essentially the same conformation with the extended propargyl chain covalently bound to the flavin and the indan ring located in the rear of the substrate cavity.  N-Propargyl-1(S)-aminoindan binds with the indan ring in a flipped conformation with respect to the other inhibitors, which causes a slight movement of the Tyr326 side chain.  Four ordered water mols. are an integral part of the active site and establish H-bond interactions to the inhibitor atoms.  These structural studies may guide future drug design to improve selectivity and efficacy by introducing appropriate substituents on the rasagiline mol. scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkiXn0OI5eubVg90H21EOLACvtfcHk0lgJNmXO5yf30w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D&md5=7b3df3c611e3f0dd59342a59096402dd</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm031087c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031087c%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DHub%25C3%25A1lek%26aufirst%3DF.%26aulast%3DMin%26aufirst%3DL.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DCrystal%2520structures%2520of%2520monoamine%2520oxidase%2520B%2520in%2520complex%2520with%2520four%2520inhibitors%2520of%2520the%2520N-propargylaminoindan%2520class%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1767%26epage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Novaroli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reist, M.</span><span> </span><span class="NLM_article-title">Impact of species-dependent differences on screening, design, and development of MAO B inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6264</span><span class="NLM_x">–</span> <span class="NLM_lpage">6272</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060441e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6264-6272&author=L.+Novaroliauthor=A.+Dainaauthor=E.+Favreauthor=J.+Bravoauthor=A.+Carottiauthor=F.+Leonettiauthor=M.+Cattoauthor=P.+A.+Carruptauthor=M.+Reist&title=Impact+of+species-dependent+differences+on+screening%2C+design%2C+and+development+of+MAO+B+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm060441e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060441e%26sid%3Dliteratum%253Aachs%26aulast%3DNovaroli%26aufirst%3DL.%26aulast%3DDaina%26aufirst%3DA.%26aulast%3DFavre%26aufirst%3DE.%26aulast%3DBravo%26aufirst%3DJ.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DReist%26aufirst%3DM.%26atitle%3DImpact%2520of%2520species-dependent%2520differences%2520on%2520screening%252C%2520design%252C%2520and%2520development%2520of%2520MAO%2520B%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6264%26epage%3D6272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span>FlexS/FlexV, <span class="NLM_edition">v.2.1.2</span>; <span class="NLM_publisher-name">BioSolveIT GmbH</span>, <span class="NLM_publisher-loc">Sankt Augustin, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.biosolveit.de" class="extLink">http://www.biosolveit.de</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FlexS%2FFlexV%2C+v.2.1.2%3B+BioSolveIT+GmbH%2C+Sankt+Augustin%2C+Germany%2C+2013%3B+http%3A%2F%2Fwww.biosolveit.de."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DFlexS%252FFlexV%26pub%3DBioSolveIT%2520GmbH%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Schneider, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">A consistent description of HYdrogen bond and DEhydratation energies in protein–ligand complexes: methods behind the HYDE scoring function</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=15-29&author=N.+Schneiderauthor=G.+Langeauthor=S.+Hindleauthor=R.+Kleinauthor=M.+Rarey&title=A+consistent+description+of+HYdrogen+bond+and+DEhydratation+energies+in+protein%E2%80%93ligand+complexes%3A+methods+behind+the+HYDE+scoring+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DN.%26aulast%3DLange%26aufirst%3DG.%26aulast%3DHindle%26aufirst%3DS.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DA%2520consistent%2520description%2520of%2520HYdrogen%2520bond%2520and%2520DEhydratation%2520energies%2520in%2520protein%25E2%2580%2593ligand%2520complexes%253A%2520methods%2520behind%2520the%2520HYDE%2520scoring%2520function%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D15%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Schneider, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hindle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briem, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claußen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gastreich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemmen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Substantial improvements in large-scale redocking and screening using the novel HYDE scoring function</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">701</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=701-723&author=N.+Schneiderauthor=S.+Hindleauthor=G.+Langeauthor=R.+Kleinauthor=J.+Albrechtauthor=H.+Briemauthor=K.+Beyerauthor=H.+Clau%C3%9Fenauthor=M.+Gastreichauthor=C.+Lemmenauthor=M.+Rarey&title=Substantial+improvements+in+large-scale+redocking+and+screening+using+the+novel+HYDE+scoring+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DN.%26aulast%3DHindle%26aufirst%3DS.%26aulast%3DLange%26aufirst%3DG.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DAlbrecht%26aufirst%3DJ.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DBeyer%26aufirst%3DK.%26aulast%3DClau%25C3%259Fen%26aufirst%3DH.%26aulast%3DGastreich%26aufirst%3DM.%26aulast%3DLemmen%26aufirst%3DC.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DSubstantial%2520improvements%2520in%2520large-scale%2520redocking%2520and%2520screening%2520using%2520the%2520novel%2520HYDE%2520scoring%2520function%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2012%26volume%3D26%26spage%3D701%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">The docking pose graphics were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+docking+pose+graphics+were+performed+with+the+UCSF+Chimera+package.+Chimera+is+developed+by+the+Resource+for+Biocomputing%2C+Visualization%2C+and+Informatics+at+the+University+of+California%2C+San+Francisco+%28supported+by+NIGMS+P41-GM103311%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit50b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pettersen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrin, T. E.</span><span> </span><span class="NLM_article-title">UCSF Chimera—a visualization system for exploratory research and analysis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera%E2%80%94a+visualization+system+for+exploratory+research+and+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera%25E2%2580%2594a%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groom&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eaUlVLPKC7hWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices for effective drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1517%2F17460441.2.4.469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=23484756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=469-488&author=C.+Abad-Zapatero&title=Ligand+efficiency+indices+for+effective+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices for effective drug discovery</span></div><div class="casAuthors">Abad-Zapatero, Cele</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-488</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Successful drug discovery requires the optimization of a large no. of variables ranging from strictly physicochem. parameters such as mol. wt. to more complex parameters related to toxicity and bioavailability.  Presently, structure-based methodologies influence many aspects of the drug discovery process from lead discovery to the final preclin. characterization.  However, crit. biol. issues along the path to the market have diminished the impact and power of this methodol.  The physicochem. properties of the novel chem. entities designed and guided by structural methods have become the subject of intense scrutiny from lead discovery to drug candidate.  The idea of ligand efficiency (binding energy/non-hydrogen atoms) has recently emerged as a useful guide to optimize fragment and lead selection in the discovery process.  More generalized concepts of ligand efficiency, related to efficiency per dalton and per unit of polar surface area, have also been introduced and will be discussed in the broader context.  Preliminary results and trends obtained using ligand efficiencies as guides are reviewed and their future application to guide drug discovery will be discussed, as well as their integration into the structure-based drug design methods to make them more effective and numerically robust.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmKduo41JcS7Vg90H21EOLACvtfcHk0liCnrPwc29AUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D&md5=a1682fbc4545d8eab3a44417c0e88869</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.4.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.4.469%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520effective%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D469%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Schultes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Graaf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaksma, E. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krämer, O.</span><span> </span><span class="NLM_article-title">Ligand efficiency as a guide in fragment hit selection and optimization</span> <span class="citation_source-journal">Drug Discovery Today Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e157</span><span class="NLM_x">–</span> <span class="NLM_lpage">e162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=e157-e162&author=S.+Schultesauthor=C.+de+Graafauthor=E.+E.+J.+Haaksmaauthor=I.+J.+P.+de+Eschauthor=R.+Leursauthor=O.+Kr%C3%A4mer&title=Ligand+efficiency+as+a+guide+in+fragment+hit+selection+and+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchultes%26aufirst%3DS.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DHaaksma%26aufirst%3DE.%2BE.%2BJ.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DO.%26atitle%3DLigand%2520efficiency%2520as%2520a%2520guide%2520in%2520fragment%2520hit%2520selection%2520and%2520optimization%26jtitle%3DDrug%2520Discovery%2520Today%2520Technol.%26date%3D2010%26volume%3D7%26spage%3De157%26epage%3De162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lhcuBERUiSvRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enhance alignment of drug-like properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enhance+alignment+of+drug-like+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lhcuBERUiSvRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enhance%2520alignment%2520of%2520drug-like%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">814</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=807-814&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+1.+Prediction+of+intestinal+absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25201.%2520Prediction%2520of%2520intestinal%2520absorption%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D807%26epage%3D814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Sally, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinter, A.</span><span> </span><span class="NLM_article-title">Molecular field technology and its applications in drug discovery</span> <span class="citation_source-journal">Innovative Pharm. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=14-18&author=R.+Sallyauthor=A.+Vinter&title=Molecular+field+technology+and+its+applications+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSally%26aufirst%3DR.%26aulast%3DVinter%26aufirst%3DA.%26atitle%3DMolecular%2520field%2520technology%2520and%2520its%2520applications%2520in%2520drug%2520discovery%26jtitle%3DInnovative%2520Pharm.%2520Technol.%26date%3D2007%26spage%3D14%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, J.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices as guideposts for drug discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1016%2FS1359-6446%2805%2903386-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm500729a&amp;key=15809192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=464-469&author=C.+Abad-Zapateroauthor=J.+Metz&title=Ligand+efficiency+indices+as+guideposts+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices as guideposts for drug discovery</span></div><div class="casAuthors">Abad-Zapatero Cele; Metz James T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">464-9</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHqVfZXUq224qdXsLcGTEUfW6udTcc2eZMx9r93f-LFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D&md5=1720f263a306122c86a57463e5a39287</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903386-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903386-6%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DMetz%26aufirst%3DJ.%26atitle%3DLigand%2520efficiency%2520indices%2520as%2520guideposts%2520for%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D464%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Lippert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Fast automated placement of polar hydrogen atoms in protein–ligand complexes</span> <span class="citation_source-journal">J. Cheminform.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm500729a&amp;key=10.1186%2F1758-2946-1-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm500729a&amp;key=1%3ACAS%3A280%3ADC%252BC3c7psV2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=13-24&author=T.+Lippertauthor=M.+Rarey&title=Fast+automated+placement+of+polar+hydrogen+atoms+in+protein%E2%80%93ligand+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Fast automated placement of polar hydrogen atoms in protein-ligand complexes</span></div><div class="casAuthors">Lippert Tobias; Rarey Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cheminformatics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Hydrogen bonds play a major role in the stabilization of protein-ligand complexes.  The ability of a functional group to form them depends on the position of its hydrogen atoms.  An accurate knowledge of the positions of hydrogen atoms in proteins is therefore important to correctly identify hydrogen bonds and their properties.  The high mobility of hydrogen atoms introduces several degrees of freedom: Tautomeric states, where a hydrogen atom alters its binding partner, torsional changes where the position of the hydrogen atom is rotated around the last heavy-atom bond in a residue, and protonation states, where the number of hydrogen atoms at a functional group may change.  Also, side-chain flips in glutamine and asparagine and histidine residues, which are common crystallographic ambiguities must be identified before structure-based calculations can be conducted.  RESULTS:  We have implemented a method to determine the most probable hydrogen atom positions in a given protein-ligand complex.  Optimality of hydrogen bond geometries is determined by an empirical scoring function which is used in molecular docking.  This allows to evaluate protein-ligand interactions with an established model.  Also, our method allows to resolve common crystallographic ambiguities such as as flipped amide groups and histidine residues.  To ensure high speed, we make use of a dynamic programming approach.  CONCLUSION:  Our results were checked against selected high-resolution structures from an external dataset, for which the positions of the hydrogen atoms have been validated manually.  The quality of our results is comparable to that of other programs, with the advantage of being fast enough to be applied on-the-fly for interactive usage or during score evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQW_MJ6K-6QK8-crCu0nI_sfW6udTcc2eZMx9r93f-LFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7psV2huw%253D%253D&md5=b9159a5244c6c814c163703421376ea0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1186%2F1758-2946-1-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-2946-1-13%26sid%3Dliteratum%253Aachs%26aulast%3DLippert%26aufirst%3DT.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DFast%2520automated%2520placement%2520of%2520polar%2520hydrogen%2520atoms%2520in%2520protein%25E2%2580%2593ligand%2520complexes%26jtitle%3DJ.%2520Cheminform.%26date%3D2009%26volume%3D1%26spage%3D13%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Bietz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbaczek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">Hydrogen placement in protein–ligand complexes under consideration of tautomerism</span> <span class="citation_source-journal">J. Cheminform.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">P13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=P13&issue=Suppl+1&author=S.+Bietzauthor=S.+Urbaczekauthor=M.+Rarey&title=Hydrogen+placement+in+protein%E2%80%93ligand+complexes+under+consideration+of+tautomerism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBietz%26aufirst%3DS.%26aulast%3DUrbaczek%26aufirst%3DS.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DHydrogen%2520placement%2520in%2520protein%25E2%2580%2593ligand%2520complexes%2520under%2520consideration%2520of%2520tautomerism%26jtitle%3DJ.%2520Cheminform.%26date%3D2011%26volume%3D3%26issue%3DSuppl%25201%26spage%3DP13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Schärfer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz-Gasch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinzerling, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inhester, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">CONFECT: Conformations from an expert collection of torsion patterns</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1690</span><span class="NLM_x">–</span> <span class="NLM_lpage">1700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1690-1700&author=C.+Sch%C3%A4rferauthor=T.+Schulz-Gaschauthor=J.+Hertauthor=L.+Heinzerlingauthor=B.+Schulzauthor=T.+Inhesterauthor=M.+Stahlauthor=M.+Rarey&title=CONFECT%3A+Conformations+from+an+expert+collection+of+torsion+patterns"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25A4rfer%26aufirst%3DC.%26aulast%3DSchulz-Gasch%26aufirst%3DT.%26aulast%3DHert%26aufirst%3DJ.%26aulast%3DHeinzerling%26aufirst%3DL.%26aulast%3DSchulz%26aufirst%3DB.%26aulast%3DInhester%26aufirst%3DT.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DCONFECT%253A%2520Conformations%2520from%2520an%2520expert%2520collection%2520of%2520torsion%2520patterns%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1690%26epage%3D1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Schärfer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz-Gasch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Torsion angle preferences in drug-like chemical space: A comprehensive guide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2016</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3016816" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2016-2028&author=C.+Sch%C3%A4rferauthor=T.+Schulz-Gaschauthor=H.+C.+Ehrlichauthor=W.+Gubaauthor=M.+Rareyauthor=M.+Stahl&title=Torsion+angle+preferences+in+drug-like+chemical+space%3A+A+comprehensive+guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm3016816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3016816%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25A4rfer%26aufirst%3DC.%26aulast%3DSchulz-Gasch%26aufirst%3DT.%26aulast%3DEhrlich%26aufirst%3DH.%2BC.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DRarey%26aufirst%3DM.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DTorsion%2520angle%2520preferences%2520in%2520drug-like%2520chemical%2520space%253A%2520A%2520comprehensive%2520guide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2016%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span>TorsionAnalyzer was developed in collaboration between  F. Hoffmann-LaRoche, Switzerland, and the Center for Bioinformatics (ZBH) of the University of Hamburg: <a href="http://www.biosolveit.de/TorsionAnalyzer/" class="extLink">http://www.biosolveit.de/TorsionAnalyzer/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=TorsionAnalyzer+was+developed+in+collaboration+between+F.+Hoffmann-LaRoche%2C+Switzerland%2C+and+the+Center+for+Bioinformatics+%28ZBH%29+of+the+University+of+Hamburg%3A+http%3A%2F%2Fwww.biosolveit.de%2FTorsionAnalyzer%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V5Z','PDB','2V5Z'); return false;">PDB: 2V5Z</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i80"><a href="/doi/suppl/10.1021/jm500729a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_08786"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and analytic data of carboxylic acids <b>18</b> and <b>19</b>; <sup>1</sup>H and <sup>13</sup>C NMR spectra of compounds <b>10</b> and <b>11</b>, conditions for chromatography; LC/ESI-MS data for all new compounds; stability studies for compounds <b>54</b> and <b>59</b>; analysis of <i>E</i>/<i>Z</i> isomers stability for <b>58</b>; physicochemical profiling of all new compounds including calculated important parameters and plots; pharmacological studies and correlation of inhibition data of rat versus human MAO-B for all tested compounds, and computational analysis of compounds <b>15</b> and <b>30</b> in comparison with safinamide <b>3</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500729a/suppl_file/jm500729a_si_001.pdf">jm500729a_si_001.pdf (1.99 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500729a&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-15%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm500729a" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500729a" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679956617c2f2458","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
